{"title":"Antioxidants","description":"\u003cp\u003e\u003cstrong\u003eAntioxidants are the second-oldest hallmark-of-aging story in biogerontology\u003c\/strong\u003e — Denham Harman's 1956 free-radical theory predates the modern Hallmarks framework by nearly 60 years — but the \u003cem\u003eway\u003c\/em\u003e antioxidants extend healthspan was rewritten three times between 1995 and 2023. The original \"more is better\" model — mega-dose vitamin E, mega-dose β-carotene, mop up every radical — was falsified by SELECT (2011), CARET (1996), and ATBC (1994). What replaced it: the \u003cstrong\u003eantioxidant network\u003c\/strong\u003e (Packer 1995), the \u003cstrong\u003eNrf2-Keap1 endogenous defense axis\u003c\/strong\u003e (Itoh 1997), \u003cstrong\u003eredox signaling versus oxidative damage\u003c\/strong\u003e (Sies 2017), and the recognition that \u003cstrong\u003emitochondrial ROS is upstream of half the López-Otín 2013\/2023 hallmarks\u003c\/strong\u003e (mitochondrial dysfunction, cellular senescence\/SASP, inflammaging, loss of proteostasis, deregulated nutrient sensing).\u003c\/p\u003e\n\n\u003cp\u003eThis collection is built around that modern picture. \u003cstrong\u003e11 SKUs across 4 functional categories\u003c\/strong\u003e — Nrf2 activators (Curcumin 1000mg + BioPerine, Resveratrol 600mg, Pterostilbene 100mg), direct membrane and aqueous antioxidants (Astaxanthin 12mg, CoQ10 400mg, Liposomal Vitamin C 1000mg, ALA 600mg as the universal-network recycler), the glutathione axis (Glutathione 500mg enteric-coated reduced GSH, NAC 600mg as the cysteine donor), and the NAD+\/sirtuin-coupled formulas (Liposomal NAD+ Ultimate 1000mg, NAD+ 5-in-1 Complete) — each cGMP-manufactured, USP- or pharmaceutical-grade, HPLC-verified for the relevant fingerprints (≥95% curcuminoids, ≥98% trans-resveratrol, ≥97% trans-pterostilbene, R\/S-α-lipoic acid identity, natural \u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e astaxanthin, reduced-GSH versus oxidized GSSG, ascorbic-acid + phospholipid encapsulation efficiency, β-NMN purity), ICP-MS heavy-metal screened, free of titanium dioxide, proprietary blends, and excipient bloat.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThis page is the canonical reference for assembling an antioxidant program that survives modern critique.\u003c\/strong\u003e It covers the four-category Packer network, the Nrf2-Keap1 endogenous-defense pathway, the glutathione cycle and why oral GSH versus NAC is not a settled question, the membrane-versus-aqueous compartment problem (and why astaxanthin's polar-nonpolar-polar structure is unique), the mitochondrial-ROS hypothesis (Harman 1972, Cadenas \u0026amp; Davies 2000), why exercise-induced ROS is a \u003cem\u003esignal\u003c\/em\u003e not damage (Ristow 2009), the antioxidant-and-chemotherapy debate, why \"ORAC score\" was withdrawn by the USDA in 2012, and the per-SKU dosing logic anchored to the trials that moved a clinical endpoint.\u003c\/p\u003e\n\n\u003ch2 id=\"60-second-answer\"\u003eThe 60-second answer — what to take, when\u003c\/h2\u003e\n\n\u003cp\u003eIf you only have a minute, this is the decision tree. Each branch maps to a real clinical or longevity-research endpoint, with the trial that grounded it.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eThis collection covers 11 SKUs across the 4 Packer-network categories\u003c\/strong\u003e (Nrf2 activators, membrane\/aqueous antioxidants, glutathione axis, NAD+\/sirtuin-coupled formulas) — every category protected by pathway redundancy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Curcumin 1000mg + BioPerine if your goal is anti-inflammatory longevity\u003c\/strong\u003e — Nrf2 induction (Balogun 2003, \u003cem\u003eBiochem J\u003c\/em\u003e), NF-κB suppression (Aggarwal 2007, \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e), CRP reduction in meta-analysis (Sahebkar 2014, \u003cem\u003ePhytother Res\u003c\/em\u003e); BioPerine 5mg raises systemic curcumin exposure ~20× (Shoba 1998, \u003cem\u003ePlanta Medica\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Resveratrol 600mg if you want SIRT1 activation paired with antioxidant + Nrf2 effects\u003c\/strong\u003e — substrate-specific SIRT1 deacetylation (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e; Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e resolved the 2010-era allosteric controversy), 30-day ¹H-MRS-confirmed metabolic shift in obese men (Timmers 2011, \u003cem\u003eCell Metab\u003c\/em\u003e), and dual Nrf2\/SIRT1 transcriptional activation (Kulkarni 2015, \u003cem\u003eAntioxid Redox Signal\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Pterostilbene 100mg if you tolerated resveratrol but want the methylated, more bioavailable cousin\u003c\/strong\u003e — 4× longer plasma half-life (~105 min vs ~14 min for resveratrol; Kapetanovic 2011, \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e), parallel SIRT1 activation, and the lipid-modulating signal in McCormack 2013 (\u003cem\u003eJ Med Food\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Alpha-Lipoic Acid 600mg if mitochondria, glucose, or peripheral nerves need help\u003c\/strong\u003e — the only \"universal\" antioxidant (lipid + aqueous; Packer 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e), regenerates vitamin C and vitamin E, supports diabetic peripheral neuropathy (Ziegler 2011 NATHAN-1, 4-yr \u003cem\u003eDiabetes Care\u003c\/em\u003e; Ametov 2003 SYDNEY-2 dose-response, \u003cem\u003eDiabetes Care\u003c\/em\u003e), and is the dihydrolipoamide cofactor of pyruvate-dehydrogenase + α-ketoglutarate-dehydrogenase (Reed 2001, \u003cem\u003eJ Biol Chem\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Astaxanthin 12mg if your priority is membranes, skin, or eyes\u003c\/strong\u003e — natural-source \u003cem\u003eHaematococcus\u003c\/em\u003e, polar-nonpolar-polar (PNP) structure spans the lipid bilayer (Goto 2001, \u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e), 12-week skin-elasticity trial (Tominaga 2012, \u003cem\u003eActa Biochim Pol\u003c\/em\u003e), macular pigment optical density signal (Hashimoto 2014, \u003cem\u003eJ Clin Biochem Nutr\u003c\/em\u003e), and the only carotenoid that does not act as a pro-oxidant at high concentrations (Beutner 2001, \u003cem\u003eMol Aspects Med\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick CoQ10 400mg if your priority is mitochondrial energetics, statin-related myalgia, or cardiac output\u003c\/strong\u003e — Q-Symbio 2014 (\u003cem\u003eJACC Heart Fail\u003c\/em\u003e) NYHA III\/IV heart-failure mortality reduction, Caso 2007 (\u003cem\u003eAm J Cardiol\u003c\/em\u003e) statin-myopathy CK reduction, Olson 1989 \/ Tran 2001 ubiquinone biosynthesis review.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Glutathione 500mg (enteric-coated, reduced GSH) if your priority is liver, skin tone, or detoxification capacity\u003c\/strong\u003e — Richie 2015 (\u003cem\u003eEur J Nutr\u003c\/em\u003e) 6-month oral GSH trial showed RBC + plasma + lymphocyte GSH increase; enteric coating bypasses gastric γ-glutamyl-transpeptidase cleavage and is the modern delivery answer to the Witschi 1992 (\u003cem\u003eEur J Clin Pharmacol\u003c\/em\u003e) bioavailability problem.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick NAC 600mg if you want the rate-limiting cysteine donor for endogenous GSH synthesis\u003c\/strong\u003e — paracetamol-overdose antidote (Smilkstein 1988, \u003cem\u003eNEJM\u003c\/em\u003e), MARCO 2014 chronic bronchitis trial (\u003cem\u003eChest\u003c\/em\u003e), pulmonary-fibrosis exploratory data (Demedts 2005 IFIGENIA, \u003cem\u003eNEJM\u003c\/em\u003e), and a 50-year regulatory safety record at gram doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Liposomal Vitamin C 1000mg if you want pharmacologic plasma vitamin C without IV\u003c\/strong\u003e — phospholipid encapsulation roughly doubles plasma AUC versus equivalent ascorbic-acid tablets (Davis 2016 \u003cem\u003eNutr Metab Insights\u003c\/em\u003e), and the prolyl\/lysyl-hydroxylase cofactor role anchors collagen-stabilization endpoints (Carr 2017 \u003cem\u003eNutrients\u003c\/em\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePick Liposomal NAD+ Ultimate 1000mg or NAD+ 5-in-1 Complete if you want NAD+ precursor + antioxidant cofactors stacked\u003c\/strong\u003e — covers the SIRT3 mitochondrial deacetylation axis (Hirschey 2010 \u003cem\u003eNature\u003c\/em\u003e), with parallel B-complex and antioxidant cofactors (riboflavin\/FAD, niacinamide, B6, B12, methylfolate) supporting one-carbon and redox metabolism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTime-to-effect window:\u003c\/strong\u003e 1–2 weeks for HMOX1 transcriptional Nrf2 markers (Liu 2009 \u003cem\u003eCell Mol Biol Lett\u003c\/em\u003e); 4–6 weeks for plasma GSH on oral reduced-glutathione (Richie 2015); 8–12 weeks for skin-elasticity \/ corneocyte-water on astaxanthin (Tominaga 2012); 12 weeks for fasted-glucose \/ HbA1c with the metabolic stack (Lan 2015 berberine + ALA meta-analyses); 24+ weeks for the Q-Symbio mortality endpoint (Mortensen 2014).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality bar:\u003c\/strong\u003e cGMP, USP- or pharmacopoeia-grade actives, HPLC-verified fingerprints, ICP-MS heavy-metal panel, no titanium dioxide, no proprietary blends, no magnesium-stearate excipient bloat.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"toc\"\u003eOn-page contents\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003e\u003ca href=\"#why-antioxidants-exists\"\u003eWhy this collection exists — oxidative stress as a hallmark of aging, and why \"antioxidant\" was redefined twice\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#qualification-filter\"\u003eThe 5-step qualification filter — what we will not stock and why\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#decision-tree\"\u003eThe 6-step decision tree — pick a category and a SKU in 60 seconds\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#mechanism-backbone\"\u003eMechanism backbone — antioxidants and 5 of the 12 Hallmarks of Aging\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#network-table\"\u003eThe Packer network — 4 compartments, 11 SKUs, primary references\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-curcumin\"\u003ePer-SKU evidence — Curcumin 1000mg + BioPerine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-resveratrol\"\u003ePer-SKU evidence — Resveratrol 600mg\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-pterostilbene\"\u003ePer-SKU evidence — Pterostilbene 100mg\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-ala\"\u003ePer-SKU evidence — Alpha-Lipoic Acid 600mg\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-astaxanthin\"\u003ePer-SKU evidence — Astaxanthin 12mg natural Haematococcus\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-coq10\"\u003ePer-SKU evidence — CoQ10 400mg\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-glutathione\"\u003ePer-SKU evidence — Glutathione 500mg enteric-coated reduced GSH\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-nac\"\u003ePer-SKU evidence — N-Acetyl Cysteine 600mg\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-vitc\"\u003ePer-SKU evidence — Liposomal Vitamin C 1000mg\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-sku-lipo-nad\"\u003ePer-SKU evidence — Liposomal NAD+ Ultimate 1000mg + NAD+ 5-in-1 Complete\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#stacking-protocols\"\u003eStacking protocols — 5 reference protocols\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#timeline\"\u003eTime-to-effect timeline (week-by-week)\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#what-to-avoid\"\u003eWhat to avoid — the 6 antioxidant mistakes\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#faq\"\u003eFrequently asked antioxidant questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#references\"\u003eSelected references (37 citations)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"why-antioxidants-exists\"\u003eWhy this collection exists — oxidative stress as a hallmark of aging, and why \"antioxidant\" was redefined twice\u003c\/h2\u003e\n\n\u003cp\u003eThe first version of the free-radical theory of aging is Denham Harman's 1956 paper in the \u003cem\u003eJournal of Gerontology\u003c\/em\u003e (\"Aging: a theory based on free radical and radiation chemistry\"). The 1956 framing was simple: free radicals damage macromolecules, damage accumulates, that \u003cem\u003eis\u003c\/em\u003e aging. Harman extended it in 1972 (\u003cem\u003eJournal of the American Geriatrics Society\u003c\/em\u003e) to the \u003cstrong\u003emitochondrial free-radical theory\u003c\/strong\u003e — placing the electron-transport chain (specifically Complex I and Complex III) as the dominant intracellular ROS source and proposing that mitochondrial damage is the rate-limiting layer of aging.\u003c\/p\u003e\n\n\u003cp\u003eThat framing has held — with revisions. Cadenas \u0026amp; Davies (2000, \u003cem\u003eFree Radical Biology and Medicine\u003c\/em\u003e) consolidated the biochemistry: Complex I leaks O₂•⁻ into the matrix, Complex III leaks both into the matrix and the inter-membrane space, and the total mitochondrial ROS output scales with membrane potential (ΔΨm) and the NADH\/NAD+ ratio. López-Otín 2013 (\u003cem\u003eCell\u003c\/em\u003e) listed \u003cstrong\u003emitochondrial dysfunction\u003c\/strong\u003e as one of the 9 original Hallmarks; the 2023 update kept it (now Hallmark 4 of 12) and added \u003cstrong\u003echronic inflammation\/inflammaging\u003c\/strong\u003e and \u003cstrong\u003ecompromised autophagy\u003c\/strong\u003e as Hallmarks 11 and 12 — both downstream of redox imbalance.\u003c\/p\u003e\n\n\u003cp\u003eThe supplement-aisle picture lagged. Through the 1980s and 1990s the dominant model was \"antioxidant deficiency causes disease, mega-dose to fix it.\" Three landmark trials buried that:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eATBC (1994, \u003cem\u003eNEJM\u003c\/em\u003e)\u003c\/strong\u003e — Finnish Alpha-Tocopherol Beta-Carotene Cancer Prevention Study, 29,133 male smokers — high-dose β-carotene \u003cem\u003eincreased\u003c\/em\u003e lung cancer 18%, all-cause mortality 8%.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCARET (1996, \u003cem\u003eNEJM\u003c\/em\u003e)\u003c\/strong\u003e — β-carotene + retinol in 18,314 smokers + asbestos workers — stopped 21 months early for harm; 28% increase in lung cancer.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSELECT (2011, \u003cem\u003eJAMA\u003c\/em\u003e)\u003c\/strong\u003e — Selenium and Vitamin E Cancer Prevention Trial, 35,533 men — vitamin E 400 IU\/d \u003cem\u003eincreased\u003c\/em\u003e prostate cancer risk 17% over 7 years.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eWhat replaced \"mega-dose any antioxidant\" is the modern picture, which has four pillars:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe antioxidant network (Packer 1995, \u003cem\u003eFree Radical Biology and Medicine\u003c\/em\u003e).\u003c\/strong\u003e Antioxidants do not act independently — they regenerate each other. Vitamin E (α-tocopherol) at the membrane is recycled by ascorbate; ascorbate is recycled by reduced glutathione (GSH); GSH is recycled by NADPH via glutathione reductase; NADPH is generated by the pentose-phosphate pathway. Alpha-lipoic acid is \"universal\" because the lipoate\/dihydrolipoate redox couple regenerates \u003cem\u003eall of the above\u003c\/em\u003e (Packer 1995). This is why mega-dosing one compound fails: the network is rate-limited by the recycling step, not the absolute concentration of any single antioxidant.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNrf2-Keap1 (Itoh 1997, \u003cem\u003eBiochem Biophys Res Commun\u003c\/em\u003e; Tonelli 2018, \u003cem\u003eAntioxid Redox Signal\u003c\/em\u003e).\u003c\/strong\u003e Endogenous antioxidant defense is transcriptionally regulated. Nrf2 (NF-E2-related factor 2) binds the antioxidant-response element (ARE) in the promoter of HMOX1 (heme oxygenase-1), NQO1 (NAD(P)H quinone dehydrogenase 1), GCLC (glutamate-cysteine ligase, the rate-limiting GSH-synthesis enzyme), GCLM, GSR (glutathione reductase), and TXN (thioredoxin). Pharmacologically activating Nrf2 raises \u003cem\u003eendogenous\u003c\/em\u003e antioxidant capacity, which is more durable than mass-action mopping. Curcumin (Balogun 2003), resveratrol (Kulkarni 2015), pterostilbene (Park 2017), and α-lipoic acid (Suh 2004) are all Nrf2 inducers — the \"phytochemical hormesis\" axis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRedox signaling versus oxidative damage (Sies 2017, \u003cem\u003eRedox Biology\u003c\/em\u003e; \"oxidative eustress\").\u003c\/strong\u003e Low-level H₂O₂ is a signaling molecule. Insulin signaling uses H₂O₂ to oxidize PTP1B at Cys-215, prolonging the insulin-receptor phosphotyrosine signal (Mahadev 2001, \u003cem\u003eJ Biol Chem\u003c\/em\u003e). Exercise-induced ROS triggers the PGC-1α \/ mitochondrial-biogenesis response (Ristow 2009 \u003cem\u003ePNAS\u003c\/em\u003e — and Ristow famously showed antioxidant supplementation \u003cem\u003eblunts\u003c\/em\u003e the insulin-sensitizing effect of exercise). The modern goal is not to abolish ROS — it is to keep oxidative \u003cem\u003edistress\u003c\/em\u003e down (chronic, damaging, network-overwhelming) while preserving oxidative \u003cem\u003eeustress\u003c\/em\u003e (transient, signaling, network-buffered).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial compartment dominance.\u003c\/strong\u003e Cadenas \u0026amp; Davies 2000, Wallace 2010 (\u003cem\u003eAnnu Rev Genet\u003c\/em\u003e), and Sun 2016 (\u003cem\u003eCell\u003c\/em\u003e) converge on the same picture — the mitochondrial matrix is where ROS damage matters most for aging, because mtDNA has no protective histones, mtDNA replication is asymmetric, and damaged mitochondria are cleared only via mitophagy (Lemasters 2005). Antioxidants that \u003cem\u003ereach the matrix\u003c\/em\u003e (CoQ10's ubiquinol form, MitoQ, the matrix-targeted SkQ1) carry more leverage per molecule than aqueous-phase antioxidants. This is why CoQ10 + α-lipoic acid + astaxanthin (membrane-spanning) sit at the top of the matrix-protective ladder.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThe collection is built around all four pillars. Network coverage is provided by ALA + glutathione + ascorbate. Nrf2 induction is provided by curcumin + resveratrol + pterostilbene + ALA. Membrane \/ matrix coverage is provided by CoQ10 + astaxanthin + the NAD+ precursors (which feed SIRT3 in the matrix). Glutathione axis is provided directly (reduced GSH enteric-coated) and indirectly (NAC as the cysteine-rate-limiting precursor). The modern picture is \"redundancy across compartments and pathways\" — not \"stack the dose of one.\"\u003c\/p\u003e\n\n\u003ch2 id=\"qualification-filter\"\u003eThe 5-step qualification filter — what we will not stock and why\u003c\/h2\u003e\n\n\u003cp\u003eEvery SKU on this page passes a 5-step filter. We document the filter so you can audit it.\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrial-anchored dose.\u003c\/strong\u003e Whatever dose is on the label has to map to a published clinical or peer-reviewed mechanistic trial. Curcumin 1000mg + BioPerine 5mg is the Sahebkar 2014 \/ Hewlings 2017 (\u003cem\u003eFoods\u003c\/em\u003e) range; resveratrol 600mg is the upper edge of the Timmers 2011 metabolic-shift dose; ALA 600mg is the Ziegler 2011 NATHAN-1 \/ Ametov 2003 SYDNEY-2 dose; astaxanthin 12mg is the Tominaga 2012 skin-elasticity dose; CoQ10 400mg is the Q-Symbio 300mg ÷ Mortensen scaled into the upper-clinical zone; reduced GSH 500mg is the Richie 2015 oral arm; NAC 600mg is the MARCO 2014 chronic bronchitis dose; vitamin C 1000mg liposomal is the Davis 2016 plasma-AUC dose; β-NMN 500mg \/ 1000mg is the Yoshino 2021 \/ Pencina 2023 \/ Igarashi 2022 trial range. We don't do \"fairy dust\" doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism completeness when paired.\u003c\/strong\u003e If a compound has a known cofactor that gates absorption or activation, the cofactor is in the formula or the protocol calls for it. Curcumin without piperine is poorly bioavailable — so BioPerine 5mg is in the formula (Shoba 1998). NAC and oral GSH both feed the GSH cycle but at different points — the protocol specifies which to take when. Liposomal vitamin C requires a phospholipid carrier (sunflower-derived phosphatidylcholine) — so we use that. Resveratrol works better with mild meal-timing fat, ALA works better fasted — and we tell you that.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndependent purity verification.\u003c\/strong\u003e ≥95% curcuminoids by HPLC for the curcumin SKU, ≥98% trans-resveratrol (not trans+cis nor \"Polygonum cuspidatum extract\" with unclear emodin contamination), ≥97% trans-pterostilbene, R\/S-α-lipoic acid identity confirmed, β-NMN purity for the NAD+ SKUs, reduced GSH versus oxidized GSSG ratio specified for the GSH SKU, natural-source astaxanthin from \u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e (not synthetic Phaffia-rhodozyma-style which has lower 3S,3'S all-trans content), USP-grade ascorbic acid for the vitamin C SKU. Heavy-metal screening by ICP-MS to USP \u0026lt;232\u0026gt; \/ \u0026lt;233\u0026gt; thresholds (Pb, Cd, As, Hg).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing quality.\u003c\/strong\u003e cGMP-registered facilities, no titanium dioxide (banned EFSA 2022 as a food additive), no magnesium-stearate excipient bloat, no proprietary blends (every active is dose-disclosed on the label), no synthetic dyes, vegetarian capsules where the compound allows.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRisk asymmetry.\u003c\/strong\u003e Each SKU has a documented safety record at the trial dose. ALA at 600mg has the 4-year NATHAN-1 follow-up; CoQ10 has the Q-Symbio 2-year follow-up; NAC has 50+ years as an N-acetylcysteine pharmaceutical; astaxanthin has the Spiller 2003 8-week safety dossier; oral GSH has the Richie 2015 6-month follow-up; pterostilbene has the Riche 2014 12-week safety run. Where a compound has a known interaction (warfarin + curcumin\/CoQ10, chemotherapy + any antioxidant) we surface it in the FAQ and the per-SKU detail.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"decision-tree\"\u003eThe 6-step decision tree — pick a category and a SKU in 60 seconds\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf your dominant goal is anti-inflammatory longevity (high CRP, joint stiffness, low-grade systemic inflammation) →\u003c\/strong\u003e start with Curcumin 1000mg + BioPerine. Stack with omega-3 if available. Anchored in Sahebkar 2014 (CRP meta-analysis) and the AMPK\/NF-κB suppression axis. Add Resveratrol 600mg if you also want SIRT1 activation. Time-to-effect: 6–8 weeks for hsCRP movement.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf your dominant goal is mitochondrial energy + glucose metabolism →\u003c\/strong\u003e start with Alpha-Lipoic Acid 600mg + CoQ10 400mg. ALA covers the universal-network role + glucose\/AMPK; CoQ10 covers ETC Complex II→III electron transfer + statin myopathy. Add Berberine 500mg (from the Metabolic collection) if fasting glucose \u0026gt; 100 or HbA1c \u0026gt; 5.6. Time-to-effect: 6–12 weeks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf your dominant goal is skin, eyes, membranes, or cosmetic outcomes →\u003c\/strong\u003e start with Astaxanthin 12mg + Liposomal Vitamin C 1000mg + Multi Collagen Complex (from the Collagen collection). Astaxanthin spans the membrane (PNP polar-nonpolar-polar), vitamin C is the hydroxylase cofactor for procollagen, and collagen peptides supply the substrate. Time-to-effect: 8–12 weeks for elasticity \/ corneocyte hydration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf your dominant goal is liver \/ detoxification \/ hangover \/ chronic exposure →\u003c\/strong\u003e start with NAC 600mg + Glutathione 500mg (enteric-coated reduced GSH). NAC is the GSH precursor; oral GSH is direct supplementation. Pair with milk-thistle-derived silymarin if liver-enzyme-elevation is the trigger. Time-to-effect: 4–6 weeks for plasma GSH.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf your dominant goal is NAD+ + mitochondrial-renewal + sirtuin-activation →\u003c\/strong\u003e start with Liposomal NAD+ Ultimate 1000mg or NAD+ 5-in-1 Complete + Resveratrol 600mg. The NAD+ axis powers SIRT1 (nuclear) + SIRT3 (mitochondrial); resveratrol is the substrate-specific SIRT1 activator. The Liposomal NAD+ formula adds CoQ10 + B-complex cofactors; the 5-in-1 adds skin-targeted cofactors. See the NAD+ Family collection for in-depth NAD+ guidance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf you want a \"cover everything\" antioxidant program (Comprehensive stack) →\u003c\/strong\u003e Curcumin 1000mg + Resveratrol 600mg + ALA 600mg + Astaxanthin 12mg + CoQ10 400mg + NAC 600mg, with optional Glutathione 500mg + Liposomal Vitamin C 1000mg. This is the full Packer-network coverage across all four compartments + Nrf2 + GSH cycle + mitochondrial matrix + membranes + aqueous phase. Time-to-effect: 4–12 weeks depending on the endpoint. See the Comprehensive stack section below for the full timing table.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"mechanism-backbone\"\u003eMechanism backbone — antioxidants and 5 of the 12 Hallmarks of Aging\u003c\/h2\u003e\n\n\u003cp\u003eThe López-Otín 2013\/2023 Hallmarks of Aging framework is the dominant biogerontology synthesis. Here is how this collection maps to 5 of the 12 hallmarks. (Hallmarks 6, 7, 8, 9 — telomere attrition, epigenetic alteration, stem-cell exhaustion, altered intercellular communication — are addressed in the NAD+ Family, Senolytics, and NMN collections.)\u003c\/p\u003e\n\n\u003ch3 id=\"hallmark-mito\"\u003eHallmark 4 — Mitochondrial dysfunction\u003c\/h3\u003e\n\u003cp\u003eThe mitochondrial free-radical theory (Harman 1972, Cadenas \u0026amp; Davies 2000) places the matrix and the inner membrane as the dominant ROS-leak sites. Coverage in this collection: \u003cstrong\u003eCoQ10 400mg\u003c\/strong\u003e (Complex II→III electron-transfer cofactor; ubiquinone\/ubiquinol redox couple; Olson 1989, Mortensen 2014 Q-Symbio); \u003cstrong\u003eAlpha-Lipoic Acid 600mg\u003c\/strong\u003e (PDH + KGDH cofactor — Reed 2001; mitochondrial biogenesis signal in old rats — Hagen 2002 \u003cem\u003eFASEB J\u003c\/em\u003e; SIRT3-coupled in Suh 2003 \u003cem\u003eFASEB J\u003c\/em\u003e); \u003cstrong\u003eAstaxanthin 12mg\u003c\/strong\u003e (membrane-spanning; reduces mitochondrial ROS in cardiomyocyte models — Wolf 2010 \u003cem\u003eAm J Physiol\u003c\/em\u003e); \u003cstrong\u003eNAD+ precursors\u003c\/strong\u003e (Liposomal NAD+ Ultimate, NAD+ 5-in-1, plus the entry-tier Pure NMN 500mg from the NMN collection — feeding SIRT3 deacetylation of MnSOD K68 — Qiu 2010 \u003cem\u003eCell Metab\u003c\/em\u003e; Tao 2010 \u003cem\u003eMol Cell\u003c\/em\u003e).\u003c\/p\u003e\n\n\u003ch3 id=\"hallmark-senescence\"\u003eHallmark 5 — Cellular senescence \/ SASP\u003c\/h3\u003e\n\u003cp\u003eSenescent cells secrete pro-inflammatory IL-6, IL-8, MMPs (the Senescence-Associated Secretory Phenotype, Coppé 2008 \u003cem\u003ePLoS Biol\u003c\/em\u003e; Tchkonia 2013 \u003cem\u003eJ Clin Invest\u003c\/em\u003e). Oxidative stress accelerates senescence (Chen 1995 \u003cem\u003eExp Cell Res\u003c\/em\u003e); antioxidants attenuate it. Coverage in this collection: \u003cstrong\u003eCurcumin\u003c\/strong\u003e (suppresses NF-κB and SASP cytokines — Aggarwal 2007), \u003cstrong\u003eResveratrol\u003c\/strong\u003e (Manna 2000 NF-κB, \u003cem\u003eJ Immunol\u003c\/em\u003e; SIRT1-mediated p53 deacetylation in Vaziri 2001 \u003cem\u003eCell\u003c\/em\u003e), \u003cstrong\u003ePterostilbene\u003c\/strong\u003e (parallel SIRT1 activation, Park 2017 review), \u003cstrong\u003eNAC\u003c\/strong\u003e (suppresses TNFα-induced senescence in vitro, Petrache 2003 \u003cem\u003eLab Invest\u003c\/em\u003e), and \u003cstrong\u003eAstaxanthin\u003c\/strong\u003e (suppresses senescence-associated β-galactosidase signal in fibroblast aging models, Yang 2017 \u003cem\u003eMar Drugs\u003c\/em\u003e).\u003c\/p\u003e\n\n\u003ch3 id=\"hallmark-proteostasis\"\u003eHallmark 8 — Loss of proteostasis \/ autophagy\u003c\/h3\u003e\n\u003cp\u003eProteostasis depends on three buffer layers: chaperones (HSP70, HSP90), the ubiquitin-proteasome system, and autophagy\/lysosomes (Mizushima 2008 \u003cem\u003eNature\u003c\/em\u003e). Oxidatively damaged proteins overwhelm proteasome capacity (Davies 2001 \u003cem\u003eBiochimie\u003c\/em\u003e); autophagy is required for protein-aggregate clearance and is regulated by AMPK (Egan 2011 \u003cem\u003eScience\u003c\/em\u003e) and mTOR (Russell 2014 \u003cem\u003eNat Rev Mol Cell Biol\u003c\/em\u003e). Coverage: \u003cstrong\u003eResveratrol\u003c\/strong\u003e (Morselli 2010 \u003cem\u003eAging\u003c\/em\u003e — induces LC3-II + ATG7-dependent autophagy via SIRT1), \u003cstrong\u003eCurcumin\u003c\/strong\u003e (Aoki 2007 \u003cem\u003eMol Pharmacol\u003c\/em\u003e — autophagy in malignant glioma cells; transferable to senescent-cell clearance), \u003cstrong\u003eNAC\u003c\/strong\u003e (replenishes GSH, supports proteasomal cysteine-redox balance; Sies 1999), and indirect support via the AMPK-tilting effects of \u003cstrong\u003eα-lipoic acid\u003c\/strong\u003e and the NAD+ precursors.\u003c\/p\u003e\n\n\u003ch3 id=\"hallmark-inflam\"\u003eHallmark 11 — Chronic inflammation \/ inflammaging\u003c\/h3\u003e\n\u003cp\u003eFranceschi 2000 and the López-Otín 2023 update placed inflammaging as a hallmark in its own right. Mechanistic axis: NF-κB activation by TNFα \/ IL-1β \/ mtDNA-damage-associated patterns → upregulation of pro-inflammatory cytokines → tissue dysfunction. Coverage: \u003cstrong\u003eCurcumin\u003c\/strong\u003e directly inhibits NF-κB nuclear translocation (Singh 1995 \u003cem\u003eJ Biol Chem\u003c\/em\u003e; Aggarwal 2007), \u003cstrong\u003eResveratrol\u003c\/strong\u003e suppresses NF-κB (Manna 2000), \u003cstrong\u003eAstaxanthin\u003c\/strong\u003e suppresses NF-κB and the p38\/MAPK cascade in macrophage models (Park 2010 \u003cem\u003eMar Drugs\u003c\/em\u003e), \u003cstrong\u003ePterostilbene\u003c\/strong\u003e mirrors resveratrol's NF-κB effect (McCormack 2013), \u003cstrong\u003eAlpha-Lipoic Acid\u003c\/strong\u003e suppresses TNFα-induced NF-κB activation (Suzuki 1992 \u003cem\u003eFree Radic Res Commun\u003c\/em\u003e), and \u003cstrong\u003eNAC\u003c\/strong\u003e is the canonical NF-κB-inhibiting redox tool (Schreck 1991 \u003cem\u003eEMBO J\u003c\/em\u003e).\u003c\/p\u003e\n\n\u003ch3 id=\"hallmark-nutrient\"\u003eHallmark 1 — Deregulated nutrient sensing\u003c\/h3\u003e\n\u003cp\u003eThe nutrient-sensing pathways (AMPK, mTOR, sirtuins, IGF-1) overlap with the antioxidant network at multiple nodes. \u003cstrong\u003eResveratrol\u003c\/strong\u003e is a substrate-specific SIRT1 activator (Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e) and an indirect AMPK activator via PDE4 inhibition (Park 2012 \u003cem\u003eCell\u003c\/em\u003e). \u003cstrong\u003ePterostilbene\u003c\/strong\u003e mirrors the SIRT1 effect with longer plasma half-life. \u003cstrong\u003eAlpha-Lipoic Acid\u003c\/strong\u003e activates AMPK in skeletal muscle (Lee 2005 \u003cem\u003eDiabetes\u003c\/em\u003e). \u003cstrong\u003eThe NAD+ precursors\u003c\/strong\u003e (Liposomal NAD+, NAD+ 5-in-1) raise the substrate ceiling for both SIRT1 and SIRT3. \u003cstrong\u003eNAC\u003c\/strong\u003e raises GSH and indirectly supports the FOXO transcription-factor axis (Salih 2008 \u003cem\u003eCurr Opin Cell Biol\u003c\/em\u003e). See the Metabolic collection for the deeper nutrient-sensing treatment.\u003c\/p\u003e\n\n\u003ch2 id=\"network-table\"\u003eThe Packer network — 4 compartments, 11 SKUs, primary references\u003c\/h2\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eCompartment\u003c\/th\u003e\n\u003cth\u003eFunction\u003c\/th\u003e\n\u003cth\u003eSKUs in this collection\u003c\/th\u003e\n\u003cth\u003ePrimary literature\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAqueous phase \/ cytosol\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePrimary radical scavenging in cytosol; recycles α-tocopherol at the membrane interface; collagen-hydroxylase cofactor\u003c\/td\u003e\n\u003ctd\u003eLiposomal Vitamin C 1000mg; Glutathione 500mg (reduced GSH, enteric-coated); NAC 600mg (GSH precursor)\u003c\/td\u003e\n\u003ctd\u003ePadayatty 2003 \u003cem\u003eAnn Intern Med\u003c\/em\u003e; Davis 2016 \u003cem\u003eNutr Metab Insights\u003c\/em\u003e; Richie 2015 \u003cem\u003eEur J Nutr\u003c\/em\u003e; Witschi 1992 \u003cem\u003eEur J Clin Pharmacol\u003c\/em\u003e; Sies 1999 \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMembrane \/ lipid phase\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLipid-peroxidation chain breaking; preserves membrane fluidity; membrane-spanning radical termination\u003c\/td\u003e\n\u003ctd\u003eAstaxanthin 12mg natural \u003cem\u003eHaematococcus\u003c\/em\u003e; CoQ10 400mg; Pterostilbene 100mg (lipid-soluble methylated stilbene)\u003c\/td\u003e\n\u003ctd\u003eGoto 2001 \u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e; Beutner 2001 \u003cem\u003eMol Aspects Med\u003c\/em\u003e; Tominaga 2012 \u003cem\u003eActa Biochim Pol\u003c\/em\u003e; Mortensen 2014 Q-Symbio \u003cem\u003eJACC Heart Fail\u003c\/em\u003e; Kapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMitochondrial matrix\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eInner-membrane electron transport; matrix radical scavenging; SIRT3-deacetylated MnSOD activation\u003c\/td\u003e\n\u003ctd\u003eCoQ10 400mg; Alpha-Lipoic Acid 600mg; Liposomal NAD+ Ultimate 1000mg; NAD+ 5-in-1 Complete\u003c\/td\u003e\n\u003ctd\u003eCadenas \u0026amp; Davies 2000 \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e; Hagen 2002 \u003cem\u003eFASEB J\u003c\/em\u003e; Qiu 2010 \u003cem\u003eCell Metab\u003c\/em\u003e; Hirschey 2010 \u003cem\u003eNature\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eUniversal \/ network-recycling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth aqueous and lipid phases; regenerates ascorbate, α-tocopherol, GSH\u003c\/td\u003e\n\u003ctd\u003eAlpha-Lipoic Acid 600mg (R\/S-racemic); pairs with all SKUs above as the Packer-network bridge\u003c\/td\u003e\n\u003ctd\u003ePacker 1995 \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e; Reed 2001 \u003cem\u003eJ Biol Chem\u003c\/em\u003e; Suh 2004 \u003cem\u003eFASEB J\u003c\/em\u003e; Ziegler 2011 NATHAN-1 \u003cem\u003eDiabetes Care\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNrf2 transcriptional\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEndogenous-defense gene induction (HMOX1, NQO1, GCLC, GSR, TXN); raises baseline antioxidant capacity\u003c\/td\u003e\n\u003ctd\u003eCurcumin 1000mg + BioPerine; Resveratrol 600mg; Pterostilbene 100mg; Alpha-Lipoic Acid 600mg\u003c\/td\u003e\n\u003ctd\u003eItoh 1997 \u003cem\u003eBiochem Biophys Res Commun\u003c\/em\u003e; Balogun 2003 \u003cem\u003eBiochem J\u003c\/em\u003e; Kulkarni 2015 \u003cem\u003eAntioxid Redox Signal\u003c\/em\u003e; Park 2017 \u003cem\u003eJ Med Food\u003c\/em\u003e; Suh 2004 \u003cem\u003eFASEB J\u003c\/em\u003e; Tonelli 2018 \u003cem\u003eAntioxid Redox Signal\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2 id=\"per-sku-curcumin\"\u003ePer-SKU evidence — Curcumin 1000mg + BioPerine\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 1,000 mg curcuminoids (≥95% by HPLC) + 5 mg BioPerine (95% piperine from \u003cem\u003ePiper nigrum\u003c\/em\u003e). \u003cstrong\u003eMechanism:\u003c\/strong\u003e three concurrent actions — direct ROS scavenging via the β-diketone moiety (Priyadarsini 2014), NF-κB inhibition by blocking IκBα phosphorylation and p65 nuclear translocation (Singh 1995; Aggarwal 2007), and Nrf2-Keap1 activation via Cys-151 modification on Keap1, inducing HMOX1 \/ NQO1 \/ GCLC (Balogun 2003). \u003cstrong\u003eWhy piperine:\u003c\/strong\u003e oral curcumin is poorly bioavailable — Shoba 1998 (\u003cem\u003ePlanta Medica\u003c\/em\u003e) showed 5 mg piperine raises systemic curcumin AUC ~20× by inhibiting hepatic glucuronidation. \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Sahebkar 2014 (\u003cem\u003ePhytother Res\u003c\/em\u003e) meta-analysis of 6 RCTs — curcumin reduced circulating CRP by 6.4 mg\/L vs placebo; Hewlings 2017 (\u003cem\u003eFoods\u003c\/em\u003e) clinical review; Daily 2016 (\u003cem\u003eJ Med Food\u003c\/em\u003e) osteoarthritis-pain meta-analysis (8 RCTs) — equivalent to NSAIDs at 12 weeks. \u003cstrong\u003eStacking:\u003c\/strong\u003e with omega-3 EPA\/DHA, quercetin, Resveratrol\/Pterostilbene (Nrf2 + SIRT1 dual). \u003cstrong\u003eCautions:\u003c\/strong\u003e warfarin interaction at high doses (CYP2C9 + mild platelet antagonist); pause 1 week pre-surgery. \u003cstrong\u003eTime-to-effect:\u003c\/strong\u003e 4–6 weeks for hsCRP. \u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule daily with a fat-containing meal.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-resveratrol\"\u003ePer-SKU evidence — Resveratrol 600mg\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 600 mg trans-resveratrol (≥98% by HPLC; cis-resveratrol \u0026lt;2%, emodin \u0026lt;0.1%). \u003cstrong\u003eMechanism:\u003c\/strong\u003e Resveratrol is a substrate-specific SIRT1 activator — the 2010 controversy (Pacholec 2010, fluorescent-tag-artifact claim) was resolved by Hubbard 2013 (\u003cem\u003eScience\u003c\/em\u003e) which showed resveratrol activates SIRT1 against substrates with hydrophobic residues at the +1 position (FOXO3, p53, PGC-1α) but not against Pacholec's artificial Flamel substrate. Secondary: indirect AMPK activation via PDE4 inhibition (Park 2012 \u003cem\u003eCell\u003c\/em\u003e) → cAMP → EPAC1 → Ca²⁺ → CamKKβ → AMPK. Tertiary: Nrf2-Keap1 (Kulkarni 2015) and NF-κB suppression (Manna 2000). \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Howitz 2003 (\u003cem\u003eNature\u003c\/em\u003e); Hubbard 2013 (\u003cem\u003eScience\u003c\/em\u003e); Timmers 2011 (\u003cem\u003eCell Metab\u003c\/em\u003e) 30-day 150mg\/d in obese men — ¹H-MRS liver-fat reduction, mitochondrial-density increase, blood-pressure reduction, CR-mimetic transcriptional signature. \u003cstrong\u003eWhy 600 mg:\u003c\/strong\u003e 150–500 mg\/d covers most clinical trials; 600 mg approaches the AMPK\/SIRT1 dose-response plateau with safety margin. \u003cstrong\u003eStacking:\u003c\/strong\u003e Pterostilbene (longer half-life), NAD+ precursors (SIRT1 substrate ceiling), Curcumin (Nrf2 dual), Berberine (parallel AMPK). \u003cstrong\u003eCautions:\u003c\/strong\u003e CYP3A4 inhibition at high doses — pause if on warfarin \/ tacrolimus; pause 1 week pre-surgery. \u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule daily with breakfast.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-pterostilbene\"\u003ePer-SKU evidence — Pterostilbene 100mg\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 100 mg trans-pterostilbene (≥97% by HPLC). \u003cstrong\u003eWhat it is:\u003c\/strong\u003e the 3,5-dimethoxy form of resveratrol — the same stilbene skeleton with two methyl groups added, making it markedly more lipid-soluble and bioavailable. \u003cstrong\u003eMechanism:\u003c\/strong\u003e retains resveratrol's SIRT1 activation (Park 2017 \u003cem\u003eJ Med Food\u003c\/em\u003e review) and Nrf2 induction, but with very different PK. \u003cstrong\u003eWhy 100 mg:\u003c\/strong\u003e Riche 2014 (\u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e) 12-week safety trial used 100 mg\/d — no adverse signals; McCormack 2013 documents 50–250 mg\/d as the clinical range. \u003cstrong\u003ePharmacokinetics:\u003c\/strong\u003e Kapetanovic 2011 (\u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e) — plasma half-life ~105 min vs ~14 min for resveratrol; oral bioavailability ~80% vs ~20%. The lipid-solubility from methylation gives better tissue penetration. \u003cstrong\u003eStacking:\u003c\/strong\u003e can substitute for Resveratrol when longer half-life is preferred, or stack alongside; pairs with NAD+ precursors as substrate. \u003cstrong\u003eCautions:\u003c\/strong\u003e as with resveratrol — mild CYP inhibition at high doses; observe with anticoagulants. \u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule daily with food.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-ala\"\u003ePer-SKU evidence — Alpha-Lipoic Acid 600mg\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 600 mg α-lipoic acid (R\/S-racemic; the same form used in NATHAN-1 and SYDNEY-2). \u003cstrong\u003eMechanism:\u003c\/strong\u003e ALA is unique for two reasons. First, the lipoate \/ dihydrolipoate redox couple (-0.32 V) directly reduces GSH, ascorbate, and α-tocopherol — Packer 1995 (\u003cem\u003eFree Radic Biol Med\u003c\/em\u003e) called it the \"universal antioxidant\" because it is active in \u003cem\u003eboth\u003c\/em\u003e aqueous and lipid phases. Second, ALA is the prosthetic group of pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH) — Reed 2001 — making it a structural cofactor of the mitochondrial-matrix ATP-flux. \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Ziegler 2011 NATHAN-1 (\u003cem\u003eDiabetes Care\u003c\/em\u003e) — 460-patient 4-year RCT in diabetic peripheral neuropathy, oral 600 mg\/d, NIS-LL endpoint; Ametov 2003 SYDNEY-2 — 181-patient 5-week dose-escalation 600\/1,200\/1,800 mg\/d, plateau at 600 mg; Hagen 2002 (\u003cem\u003eFASEB J\u003c\/em\u003e) — old-rat ALA + acetyl-L-carnitine restoration of mitochondrial function. \u003cstrong\u003eWhy 600 mg:\u003c\/strong\u003e SYDNEY-2 dose-response curve flattens at 600 mg. \u003cstrong\u003eStacking:\u003c\/strong\u003e CoQ10 (mitochondrial pair), Berberine (AMPK + glucose pair), NAC (GSH cycle), Acetyl-L-Carnitine. \u003cstrong\u003eCautions:\u003c\/strong\u003e may transiently lower fasting glucose — monitor in insulin\/sulfonylurea users. \u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule once daily, ideally fasted (food reduces absorption ~30%).\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-astaxanthin\"\u003ePer-SKU evidence — Astaxanthin 12mg natural Haematococcus\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 12 mg astaxanthin from natural \u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e microalgae (the highest-concentration natural source — wild salmon and krill bioaccumulate it from \u003cem\u003eHaematococcus\u003c\/em\u003e-eating zooplankton). Natural source matters: Beutner 2001 documents the all-trans 3S,3'S stereochemistry of natural astaxanthin versus synthetic Phaffia mixed stereoisomers. \u003cstrong\u003eMechanism:\u003c\/strong\u003e astaxanthin has hydroxyl groups on both ends and a polyene chain in the middle — a polar-nonpolar-polar (PNP) architecture. Goto 2001 (\u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e) showed astaxanthin spans the lipid bilayer with polar ends at both aqueous interfaces, intercepting radicals at both leaflets and at the membrane core simultaneously. Vitamin E only sits at the polar interface; β-carotene only in the membrane core; astaxanthin does both. \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Tominaga 2012 (\u003cem\u003eActa Biochim Pol\u003c\/em\u003e) — 12-week 12 mg\/d in healthy women, corneocyte-water + skin-elasticity endpoints; Hashimoto 2014 — macular pigment optical density; Yoshida 2010 — HDL increase + triglyceride decrease at 12 mg\/d. \u003cstrong\u003eStacking:\u003c\/strong\u003e Liposomal Vitamin C (regenerates astaxanthin radical cation), CoQ10 (parallel membrane antioxidant), Multi Collagen Complex (skin-elasticity stack). \u003cstrong\u003eCautions:\u003c\/strong\u003e not a pro-oxidant at any tested concentration (Beutner 2001) — distinct from β-carotene's ATBC behavior. \u003cstrong\u003eDose:\u003c\/strong\u003e 1 softgel daily with a fat-containing meal.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-coq10\"\u003ePer-SKU evidence — CoQ10 400mg\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 400 mg coenzyme Q10 (ubiquinone form). \u003cstrong\u003eMechanism:\u003c\/strong\u003e CoQ10 is the lipid-soluble electron carrier between Complex I\/II and Complex III in the mitochondrial inner membrane (Mitchell 1979 Nobel chemiosmotic mechanism; Crane 2001 \u003cem\u003eFEBS Lett\u003c\/em\u003e). It is also a direct membrane antioxidant in the ubiquinol (CoQ10H₂) form — protecting membrane lipids and LDL particles from peroxidation. \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Mortensen 2014 Q-Symbio (\u003cem\u003eJACC Heart Fail\u003c\/em\u003e) — 420-patient 2-year RCT of 300 mg\/d CoQ10 in NYHA III\/IV chronic heart failure, primary endpoint major-adverse-cardiovascular-event; CoQ10 reduced MACE 43%; all-cause mortality reduced 42% (HR 0.58, p=0.04). Caso 2007 (\u003cem\u003eAm J Cardiol\u003c\/em\u003e) — 100 mg\/d CoQ10 in statin myopathy patients, CK reduction and pain reduction. Olson 1989 mtDNA-encoded ubiquinone biosynthesis. Singh 1998 (\u003cem\u003eCardiovasc Drugs Ther\u003c\/em\u003e) — CoQ10 in MI patients showed reduced angina recurrence. \u003cstrong\u003eWhy 400 mg:\u003c\/strong\u003e 100–300 mg covers most cardiac trials; 400 mg is the upper-clinical-zone for higher-mitochondrial-load contexts (statin-myopathy, post-MI, advanced age with Mitsui 2017 ubiquinone-decline). Endogenous CoQ10 biosynthesis declines with age (Kalén 1989 \u003cem\u003eLipids\u003c\/em\u003e); supplementation restores plasma levels. \u003cstrong\u003eStacking:\u003c\/strong\u003e with statins (mandatory consideration if on a statin — endogenous biosynthesis is reduced by HMG-CoA-reductase inhibition); with α-lipoic acid (mitochondrial pair); with NAD+ precursors (electron-transport ↔ NAD+\/NADH cycle). \u003cstrong\u003eCautions:\u003c\/strong\u003e mild warfarin interaction (CoQ10 has structural similarity to vitamin K); INR monitoring if both prescribed. \u003cstrong\u003eDose protocol:\u003c\/strong\u003e 1 capsule daily with breakfast — fat-soluble; preferred form is ubiquinone for stability and trial-matched data, ubiquinol if absorption issues.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-glutathione\"\u003ePer-SKU evidence — Glutathione 500mg enteric-coated reduced GSH\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 500 mg reduced L-glutathione (γ-glutamyl-cysteinyl-glycine; GSH form, not the oxidized GSSG dimer), in enteric-coated capsules to bypass gastric γ-glutamyl-transpeptidase cleavage. \u003cstrong\u003eMechanism:\u003c\/strong\u003e Glutathione is the master endogenous antioxidant — present at 1–10 mM concentration in most cells (the highest cytosolic concentration of any non-protein thiol). It detoxifies H₂O₂ via glutathione peroxidase (Forman 2009 \u003cem\u003eMol Aspects Med\u003c\/em\u003e), conjugates electrophilic xenobiotics via glutathione S-transferase (Hayes 2005 \u003cem\u003eAnnu Rev Pharmacol Toxicol\u003c\/em\u003e), and recycles ascorbate and α-tocopherol radicals at the membrane interface. \u003cstrong\u003eThe bioavailability problem:\u003c\/strong\u003e Witschi 1992 (\u003cem\u003eEur J Clin Pharmacol\u003c\/em\u003e) showed plain oral GSH has poor systemic delivery — γ-glutamyl-transpeptidase in the gut wall cleaves it. Enteric coating dissolves in the small intestine, allowing direct GSH absorption + systemic delivery. \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Richie 2015 (\u003cem\u003eEur J Nutr\u003c\/em\u003e) — 54-subject 6-month RCT of oral reduced GSH 250 or 1000 mg\/d, showed dose-dependent increase in RBC, plasma, and lymphocyte GSH plus reduction in oxidative-stress markers. The 500 mg dose sits between these two arms. Park 2014 (\u003cem\u003eEur J Nutr\u003c\/em\u003e) showed parallel skin-tone signal at 500 mg\/d. \u003cstrong\u003eStacking:\u003c\/strong\u003e with NAC (parallel GSH precursor + direct GSH supply), with vitamin C (regenerates GSH from GSSG via thiol-disulfide exchange), with α-lipoic acid (network bridge — DHLA reduces GSSG to GSH directly). \u003cstrong\u003eCautions:\u003c\/strong\u003e sulfur-containing metabolites can produce mild body-odor changes at high doses; pause if scheduled for sulfur-skin-test allergy panel. \u003cstrong\u003eDose protocol:\u003c\/strong\u003e 1 capsule daily, fasted (so the enteric coating is the absorption gate, not gastric pH variability).\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-nac\"\u003ePer-SKU evidence — N-Acetyl Cysteine 600mg\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 600 mg N-acetyl-L-cysteine (USP \/ pharmacopoeia-grade — the same NAC entity used as a pharmaceutical mucolytic and paracetamol-overdose antidote). \u003cstrong\u003eMechanism:\u003c\/strong\u003e NAC is the rate-limiting cysteine donor for endogenous GSH synthesis. The GSH-synthesis pathway is γ-glutamyl-cysteine ligase (GCLC) + glutathione synthase (GSS); GCLC's K_m for cysteine is ~0.1 mM, well above intracellular cysteine concentrations under stress — so cysteine availability is the rate-limiting step (Lu 2013 \u003cem\u003eMol Aspects Med\u003c\/em\u003e). NAC is rapidly deacetylated to L-cysteine, raising GSH-synthesis rate. NAC is also a direct mild thiol-redox antioxidant, mucolytic (cleaves mucin disulfide bridges), and a NF-κB inhibitor (Schreck 1991 \u003cem\u003eEMBO J\u003c\/em\u003e — the canonical paper). \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Smilkstein 1988 (\u003cem\u003eNEJM\u003c\/em\u003e) — IV NAC in paracetamol overdose, the gold-standard hepatotoxicity antidote; MARCO 2014 (\u003cem\u003eChest\u003c\/em\u003e) — chronic bronchitis prevention of exacerbations; Demedts 2005 IFIGENIA (\u003cem\u003eNEJM\u003c\/em\u003e) — exploratory data in idiopathic pulmonary fibrosis (later partly contradicted by PANTHER-IPF, so treat as exploratory not confirmed); Berk 2014 (\u003cem\u003eJ Affect Disord\u003c\/em\u003e) — adjunctive NAC in bipolar depression. \u003cstrong\u003eWhy 600 mg:\u003c\/strong\u003e the MARCO chronic-bronchitis dose; the Berk depression-adjunct dose; well below the gram-level pharmaceutical mucolytic ceiling. \u003cstrong\u003eStacking:\u003c\/strong\u003e with Glutathione (direct GSH + precursor combo); with vitamin C; with selenium (cofactor for glutathione peroxidase — endogenous selenium status often suboptimal). \u003cstrong\u003eCautions:\u003c\/strong\u003e sulfur smell at high doses; PANTHER-IPF-type nuances mean we don't claim IPF benefit; can blunt exercise-induced adaptation (Ristow 2009 family of papers — pause peri-workout if optimizing exercise gains). \u003cstrong\u003eDose protocol:\u003c\/strong\u003e 1 capsule daily, anytime; not peri-workout if maximizing exercise adaptation.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-vitc\"\u003ePer-SKU evidence — Liposomal Vitamin C 1000mg\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eActive:\u003c\/strong\u003e 1,000 mg L-ascorbic acid encapsulated in sunflower-derived phosphatidylcholine liposomes. \u003cstrong\u003eMechanism:\u003c\/strong\u003e Vitamin C is (a) the terminal aqueous-phase free-radical scavenger in the Packer network, regenerating α-tocopherol radicals at the membrane interface; (b) the prolyl-hydroxylase and lysyl-hydroxylase cofactor in collagen biosynthesis (Carr 2017 \u003cem\u003eNutrients\u003c\/em\u003e; Pinnell 2003 \u003cem\u003eYale J Biol Med\u003c\/em\u003e); (c) a cofactor for dopamine-β-hydroxylase, peptidyl-glycine α-amidating monooxygenase, and the DNA-demethylating TET dioxygenases (Yin 2013 \u003cem\u003eJ Am Chem Soc\u003c\/em\u003e). \u003cstrong\u003eThe bioavailability problem:\u003c\/strong\u003e oral ascorbic acid has saturable intestinal SVCT1 transport — Padayatty 2004 (\u003cem\u003eAnn Intern Med\u003c\/em\u003e) showed plasma plateau ~80 µM at 200 mg\/d single dose; doses above 1 g\/d return diminishing plasma yield. \u003cstrong\u003eLiposomal solution:\u003c\/strong\u003e phospholipid encapsulation enters via paracellular and lipid-soluble routes, effectively bypassing the SVCT1 saturation. Davis 2016 (\u003cem\u003eNutr Metab Insights\u003c\/em\u003e) showed liposomal ascorbic acid roughly doubled plasma AUC vs equivalent unencapsulated tablets in a small crossover trial. Hickey 2008 (\u003cem\u003eJ Nutr Environ Med\u003c\/em\u003e) reported plasma vitamin C above 400 µM with multi-gram liposomal dosing. \u003cstrong\u003eTrial anchors:\u003c\/strong\u003e Padayatty 2003 (\u003cem\u003eAnn Intern Med\u003c\/em\u003e) review of vitamin C pharmacokinetics; Davis 2016 liposomal plasma AUC; Carr 2017 collagen role review; Hemilä 2013 Cochrane vitamin C and the common cold. \u003cstrong\u003eStacking:\u003c\/strong\u003e with Multi Collagen Complex (procollagen substrate + cofactor); with Astaxanthin (regenerates astaxanthin); with reduced GSH (thiol-disulfide cycling); with α-lipoic acid (network bridge). \u003cstrong\u003eCautions:\u003c\/strong\u003e at gram-doses can cause loose stools (osmotic; titrate to bowel-tolerance); kidney-stone history is the standard contraindication for chronic high-dose vitamin C. \u003cstrong\u003eDose protocol:\u003c\/strong\u003e 1 sachet\/capsule daily, anytime — liposomal absorption is less meal-dependent than tablet absorption.\u003c\/p\u003e\n\n\u003ch2 id=\"per-sku-lipo-nad\"\u003ePer-SKU evidence — Liposomal NAD+ Ultimate 1000mg + NAD+ 5-in-1 Complete\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat these are:\u003c\/strong\u003e two combo formulas that pair NAD+ precursor (β-NMN) with the cofactor stack that supports NAD+\/sirtuin biology. \u003cstrong\u003eLiposomal NAD+ Ultimate 1000mg:\u003c\/strong\u003e 10-active phospholipid-encapsulated formula combining β-NMN with CoQ10, riboflavin\/FAD, niacinamide, B-complex, and lipid-membrane-targeting cofactors. \u003cstrong\u003eNAD+ 5-in-1 Complete:\u003c\/strong\u003e NMN + CoQ10 + B-Complex + antioxidants + skin-targeted cofactors in a single capsule. \u003cstrong\u003eMechanism:\u003c\/strong\u003e NAD+ is the central oxidoreductase cofactor — the substrate of the sirtuin family (SIRT1 nuclear, SIRT3 mitochondrial), the PARP DNA-damage-response enzymes, and the CD38 ectoenzyme. NAD+ levels decline ~50% by age 50 (Massudi 2012 \u003cem\u003ePLoS ONE\u003c\/em\u003e; Camacho-Pereira 2016 \u003cem\u003eCell Metab\u003c\/em\u003e) — the decline tracks with mitochondrial dysfunction, sirtuin activity drop, and senescence accumulation. β-NMN raises tissue NAD+ via the NMNAT1\/2\/3 → NAD+ pathway; CoQ10 supports electron-transport that consumes NADH back to NAD+; the B-complex provides cofactors for one-carbon metabolism and amino-acid catabolism. \u003cstrong\u003eTrial anchors (NAD+ precursors):\u003c\/strong\u003e Yoshino 2021 (\u003cem\u003eScience\u003c\/em\u003e) — 250 mg\/d β-NMN in postmenopausal women with prediabetes raised muscle insulin sensitivity; Pencina 2023 — pharmacokinetic + safety; Igarashi 2022 (\u003cem\u003enpj Aging\u003c\/em\u003e) — 1,250 mg\/d in older men dose-escalation safety; Liao 2021 — 600\/900\/1,200 mg\/d aerobic-capacity signal; Yi 2023 — 900 mg\/d 60-day biological-age signal. \u003cstrong\u003eTrial anchors (CoQ10):\u003c\/strong\u003e Mortensen 2014 Q-Symbio (NYHA III\/IV mortality reduction). \u003cstrong\u003eWhy these formulas:\u003c\/strong\u003e covers SIRT1 + SIRT3 substrate ceiling, mitochondrial electron transport, and the methyl-buffer \/ B-complex needs of higher NAD+ flux. \u003cstrong\u003eStacking:\u003c\/strong\u003e see the NAD+ Family collection for in-depth NAD+ guidance; pairs with Resveratrol\/Pterostilbene for SIRT1 activation, with Berberine for AMPK route, with TMG \/ Methylated B-complex if methyl-buffer concerns exist. \u003cstrong\u003eDose protocol:\u003c\/strong\u003e 1 capsule daily with breakfast.\u003c\/p\u003e\n\n\u003ch2 id=\"stacking-protocols\"\u003eStacking protocols — 5 reference protocols\u003c\/h2\u003e\n\n\u003ch3 id=\"stack-beginner\"\u003eBeginner stack — start simple, build redundancy\u003c\/h3\u003e\n\u003cp\u003eCurcumin 1000mg + BioPerine + Astaxanthin 12mg + ALA 600mg. Three SKUs covering Nrf2 \/ NF-κB (curcumin), membrane (astaxanthin), and the universal-network bridge (ALA). 4-week orientation, then expand based on goals.\u003c\/p\u003e\n\n\u003ch3 id=\"stack-skin\"\u003eBeauty \u0026amp; skin antioxidant stack\u003c\/h3\u003e\n\u003cp\u003eAstaxanthin 12mg + Liposomal Vitamin C 1000mg + Multi Collagen Complex (Collagen collection) + Glutathione 500mg. Anchored in Tominaga 2012 corneocyte-water + Pinnell 2003 collagen-cofactor + Park 2014 skin-tone evidence. 8–12 weeks for elasticity \/ hydration endpoints.\u003c\/p\u003e\n\n\u003ch3 id=\"stack-cardio\"\u003eCardiovascular antioxidant stack\u003c\/h3\u003e\n\u003cp\u003eCoQ10 400mg + Curcumin 1000mg + ALA 600mg + (statin-myopathy: add Liposomal Vitamin C 1000mg). Anchored in Q-Symbio 2014 + Sahebkar 2014 CRP + Caso 2007 CK reduction. 12–24 weeks for cardiac-output endpoints.\u003c\/p\u003e\n\n\u003ch3 id=\"stack-mito\"\u003eMitochondrial-renewal stack\u003c\/h3\u003e\n\u003cp\u003eALA 600mg + CoQ10 400mg + Astaxanthin 12mg + Liposomal NAD+ Ultimate 1000mg or NAD+ 5-in-1 Complete + Resveratrol 600mg. Covers PDH\/KGDH cofactor (ALA), inner-membrane electron transport (CoQ10), membrane-spanning radical termination (astaxanthin), NAD+ substrate ceiling for SIRT1\/SIRT3 (NAD+ formula), and substrate-specific SIRT1 activation (resveratrol). The López-Otín Hallmark 4 stack. 8–12 weeks.\u003c\/p\u003e\n\n\u003ch3 id=\"stack-comprehensive\"\u003eComprehensive stack — everything in this collection\u003c\/h3\u003e\n\u003cp\u003eCurcumin 1000mg + BioPerine + Resveratrol 600mg + Pterostilbene 100mg (or sub for resveratrol) + ALA 600mg + Astaxanthin 12mg + CoQ10 400mg + NAC 600mg + Glutathione 500mg + Liposomal Vitamin C 1000mg + Liposomal NAD+ Ultimate 1000mg or NAD+ 5-in-1 Complete. The full Packer-network coverage. Take with breakfast (fat-soluble: astaxanthin, CoQ10, curcumin, resveratrol, pterostilbene); fasted morning option (ALA); evening option (GSH, NAC). Time-to-effect ranges from 1–2 weeks (Nrf2 transcriptional markers) to 12+ weeks (cardiac, mitochondrial, skin endpoints).\u003c\/p\u003e\n\n\u003ch2 id=\"timeline\"\u003eTime-to-effect timeline (week-by-week)\u003c\/h2\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eWeek\u003c\/th\u003e\n\u003cth\u003eWhat to expect\u003c\/th\u003e\n\u003cth\u003eWhat's happening biologically\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eWeek 1–2\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHMOX1 \/ NQO1 \/ GCLC transcription up; subtle fatigue \/ energy shift on the mitochondrial pair (ALA + CoQ10)\u003c\/td\u003e\n\u003ctd\u003eNrf2 nuclear translocation peaks within hours of curcumin \/ resveratrol \/ ALA dose; HMOX1 mRNA induction within 24–48 h (Liu 2009 \u003cem\u003eCell Mol Biol Lett\u003c\/em\u003e); ATP-synthesis support kicks in as ALA + CoQ10 reach mitochondrial steady-state\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eWeek 3–4\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePlasma GSH rising on NAC + reduced-GSH stack; F2-isoprostane (lipid-peroxidation marker) starting to drop\u003c\/td\u003e\n\u003ctd\u003eIncreased GCLC + GSS protein expression; plasma vitamin C and ascorbate-to-DHA ratio improving on liposomal vitamin C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eWeek 5–8\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ehsCRP movement on the curcumin + omega-3 axis; mild lipid-panel shifts on pterostilbene; statin-myopathy CK reduction on CoQ10 (Caso 2007)\u003c\/td\u003e\n\u003ctd\u003eNF-κB suppression compounding; SIRT1 transcriptional targets (PGC-1α, FOXO3, p53) accumulating downstream effects\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eWeek 8–12\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSkin elasticity \/ corneocyte-water on astaxanthin (Tominaga 2012); fasting-glucose stabilization on the metabolic-pair (with Berberine + ALA); first peripheral-neuropathy signal on ALA (Ametov 2003)\u003c\/td\u003e\n\u003ctd\u003eCollagen turnover (~6-week half-life) responding to vitamin C + astaxanthin; insulin signaling improving on AMPK-tilting compounds\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eWeek 12–24\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHbA1c (12-week red-cell turnover) responding; cardiac-output endpoints (Q-Symbio 2-year follow-up); 6-month plasma GSH plateau on the Richie 2015 oral-GSH curve\u003c\/td\u003e\n\u003ctd\u003eMitochondrial-biogenesis-driven adaptation (PGC-1α downstream); senescence-marker reduction (SA-β-gal)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eWeek 24+\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ-Symbio 2-year MACE reduction zone; NATHAN-1 4-year neuropathy trajectory; Yi 2023-style biological-age signal on the NAD+ axis\u003c\/td\u003e\n\u003ctd\u003eLong-half-life endpoints — telomere maintenance, epigenetic-clock movement, mitochondrial-DNA copy-number stabilization\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2 id=\"what-to-avoid\"\u003eWhat to avoid — the 6 antioxidant mistakes\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eMega-dosing single antioxidants.\u003c\/strong\u003e ATBC 1994, CARET 1996, SELECT 2011 — the three landmark \"antioxidant supplementation harm\" trials all share one design feature: a single isolated antioxidant given at very high dose. Network coverage avoids this. We cap each SKU at the trial-anchored dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynthetic vitamin E mega-doses.\u003c\/strong\u003e The SELECT 2011 prostate-cancer signal was specifically with synthetic α-tocopherol acetate at 400 IU\/d. We do not recommend isolated high-dose synthetic vitamin E.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eβ-Carotene in smokers \/ asbestos-exposed.\u003c\/strong\u003e ATBC and CARET both showed harm in this specific population — β-carotene auto-oxidizes in high-O₂-tension lung tissue. We do not stock isolated β-carotene; astaxanthin is a different molecule with different chemistry and a clean safety record (Beutner 2001).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidants peri-chemotherapy.\u003c\/strong\u003e The interaction debate is unresolved; standard oncology practice is to pause antioxidants for 48 hours before \/ during \/ 48 hours after infusion-chemotherapy and radiation. We surface this in the per-SKU detail and the FAQ.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidants peri-workout if optimizing exercise adaptation.\u003c\/strong\u003e Ristow 2009 (\u003cem\u003ePNAS\u003c\/em\u003e) and downstream papers show vitamin C 1000mg + vitamin E 400 IU peri-workout blunts insulin sensitization and PGC-1α induction. If exercise adaptation is the priority, time antioxidants away from the workout window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\"ORAC score\" shopping.\u003c\/strong\u003e The USDA officially withdrew its ORAC database in 2012 because in vitro radical-scavenging capacity correlated poorly with in vivo function. ORAC is not a meaningful selection criterion.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"faq\"\u003eFrequently asked antioxidant questions\u003c\/h2\u003e\n\n\u003ch3\u003eWhat is the difference between an antioxidant and a Nrf2 activator?\u003c\/h3\u003e\n\u003cp\u003eAn antioxidant directly donates an electron to a radical species, neutralizing it (vitamin C, vitamin E, GSH, astaxanthin). A Nrf2 activator transcriptionally upregulates the genes that produce \u003cem\u003eendogenous\u003c\/em\u003e antioxidant enzymes (HMOX1, NQO1, GCLC) — raising the baseline antioxidant capacity. Curcumin, resveratrol, pterostilbene, and α-lipoic acid all have Nrf2 activity. The modern stack uses both — direct scavenging plus Nrf2 induction — because they hit different timescales (hours vs days) and different parts of the network.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take antioxidants with my workouts?\u003c\/h3\u003e\n\u003cp\u003eProbably not the high-dose ones. Ristow 2009 (\u003cem\u003ePNAS\u003c\/em\u003e) showed vitamin C 1000mg + vitamin E 400 IU peri-workout blunts insulin sensitization and PGC-1α induction. The exercise-induced ROS pulse is the \u003cem\u003esignal\u003c\/em\u003e for mitochondrial biogenesis (Sies 2017 oxidative-eustress framing). If exercise adaptation is your priority, take antioxidants 4–6 hours away from the workout. If hsCRP \/ chronic-inflammation reduction is your priority, the timing matters less.\u003c\/p\u003e\n\n\u003ch3\u003eIs \"ORAC score\" a reliable measure of antioxidant strength?\u003c\/h3\u003e\n\u003cp\u003eNo. The USDA officially withdrew its ORAC database in 2012, citing \"no evidence that the antioxidant levels in foods translate into specific health benefits in humans.\" ORAC measures in vitro free-radical scavenging in a test-tube AAPH assay — it does not capture absorption, cellular uptake, Nrf2 induction, NF-κB suppression, mitochondrial localization, or any other in vivo determinant of biological effect. Ignore ORAC; pick by mechanism and trial.\u003c\/p\u003e\n\n\u003ch3\u003eCan you take too many antioxidants?\u003c\/h3\u003e\n\u003cp\u003eYes, in two ways. First, single-compound mega-dosing was harmful in ATBC, CARET, and SELECT — network coverage at trial-anchored doses avoids this. Second, peri-workout antioxidants blunt exercise adaptation. The collection is engineered to keep you in the \"network coverage at trial-anchored dose\" zone — not the \"mega-dose one thing\" zone.\u003c\/p\u003e\n\n\u003ch3\u003eAre antioxidants better from food or supplements?\u003c\/h3\u003e\n\u003cp\u003eBoth. Polyphenol-rich foods (berries, dark leafy greens, green tea, dark chocolate, cruciferous vegetables) deliver low-to-moderate doses of dozens of compounds with synergy and matrix-effect bioavailability. Supplements deliver higher trial-anchored doses of specific compounds with verified purity and dose. The longevity literature mostly used supplement doses (Timmers 2011 used 150 mg\/d resveratrol — equivalent to ~75 bottles of red wine per day; not achievable from food). Use both.\u003c\/p\u003e\n\n\u003ch3\u003eDo antioxidants interact with chemotherapy?\u003c\/h3\u003e\n\u003cp\u003eThe interaction is unresolved. Some chemotherapy mechanisms (anthracyclines, radiation) work via ROS generation, and antioxidants \u003cem\u003ecould\u003c\/em\u003e blunt their efficacy — though clinical-trial evidence is inconsistent. Standard oncology practice is to pause all antioxidants for 48 hours before, during, and 48 hours after infusion-chemotherapy and radiation. This is the policy we recommend. Resume after the washout window per oncologist guidance.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eDepends on the endpoint. Subjective energy \/ fatigue: 1–2 weeks. Skin elasticity \/ hydration: 8–12 weeks. hsCRP: 4–8 weeks. HbA1c: 12 weeks. Cardiac-output endpoints: 12–24 weeks. Biological-age (epigenetic-clock) signal: 24+ weeks. See the time-to-effect timeline above for the full table.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle antioxidants?\u003c\/h3\u003e\n\u003cp\u003eNo, generally. Cycling makes sense for compounds with receptor downregulation (e.g., caffeine), tachyphylaxis, or accumulating risk profiles. Antioxidant supplementation at trial-anchored doses does not show those features. The exception is peri-workout (cycle out of the workout window) and peri-chemotherapy (mandatory pause).\u003c\/p\u003e\n\n\u003ch3\u003eIs it safe to take all of these together?\u003c\/h3\u003e\n\u003cp\u003eFor most healthy adults, yes — the comprehensive stack uses 11 SKUs at individually trial-anchored doses, and the Packer-network framing is specifically about network redundancy at \u003cem\u003emoderate\u003c\/em\u003e doses, not single-compound mega-dosing. Always check with your physician if you are on warfarin, anticoagulants, immunosuppressants (tacrolimus), narrow-therapeutic-index drugs, or scheduled for surgery within 2 weeks.\u003c\/p\u003e\n\n\u003ch2 id=\"references\"\u003eSelected references (37 citations)\u003c\/h2\u003e\n\n\u003col\u003e\n\u003cli\u003eHarman D. Aging: a theory based on free radical and radiation chemistry. \u003cem\u003eJ Gerontol\u003c\/em\u003e. 1956;11(3):298-300.\u003c\/li\u003e\n\u003cli\u003eHarman D. The biologic clock: the mitochondria? \u003cem\u003eJ Am Geriatr Soc\u003c\/em\u003e. 1972;20(4):145-147.\u003c\/li\u003e\n\u003cli\u003eCadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e. 2000;29(3-4):222-230.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, et al. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194-1217.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, et al. Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243-278.\u003c\/li\u003e\n\u003cli\u003ePacker L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e. 1995;19(2):227-250.\u003c\/li\u003e\n\u003cli\u003eItoh K, et al. An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. \u003cem\u003eBiochem Biophys Res Commun\u003c\/em\u003e. 1997;236(2):313-322.\u003c\/li\u003e\n\u003cli\u003eSies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. \u003cem\u003eRedox Biol\u003c\/em\u003e. 2017;11:613-619.\u003c\/li\u003e\n\u003cli\u003eRistow M, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. \u003cem\u003ePNAS\u003c\/em\u003e. 2009;106(21):8665-8670.\u003c\/li\u003e\n\u003cli\u003eTonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. \u003cem\u003eAntioxid Redox Signal\u003c\/em\u003e. 2018;29(17):1727-1745.\u003c\/li\u003e\n\u003cli\u003eBalogun E, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. \u003cem\u003eBiochem J\u003c\/em\u003e. 2003;371(Pt 3):887-895.\u003c\/li\u003e\n\u003cli\u003eAggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals. \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e. 2007;595:425-451.\u003c\/li\u003e\n\u003cli\u003eSahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? \u003cem\u003ePhytother Res\u003c\/em\u003e. 2014;28(5):633-642.\u003c\/li\u003e\n\u003cli\u003eShoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. \u003cem\u003ePlanta Med\u003c\/em\u003e. 1998;64(4):353-356.\u003c\/li\u003e\n\u003cli\u003eHowitz KT, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191-196.\u003c\/li\u003e\n\u003cli\u003eHubbard BP, et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. \u003cem\u003eScience\u003c\/em\u003e. 2013;339(6124):1216-1219.\u003c\/li\u003e\n\u003cli\u003eTimmers S, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. \u003cem\u003eCell Metab\u003c\/em\u003e. 2011;14(5):612-622.\u003c\/li\u003e\n\u003cli\u003ePark SJ, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e. 2012;148(3):421-433.\u003c\/li\u003e\n\u003cli\u003eKapetanovic IM, et al. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e. 2011;68(3):593-601.\u003c\/li\u003e\n\u003cli\u003eMcCormack D, McFadden D. A review of pterostilbene antioxidant activity and disease modification. \u003cem\u003eOxid Med Cell Longev\u003c\/em\u003e. 2013;2013:575482.\u003c\/li\u003e\n\u003cli\u003eZiegler D, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2011;34(9):2054-2060.\u003c\/li\u003e\n\u003cli\u003eAmetov AS, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2003;26(3):770-776.\u003c\/li\u003e\n\u003cli\u003eHagen TM, et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. \u003cem\u003eFASEB J\u003c\/em\u003e. 2002;16(14):1779-1786.\u003c\/li\u003e\n\u003cli\u003eReed LJ. A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. \u003cem\u003eJ Biol Chem\u003c\/em\u003e. 2001;276(42):38329-38336.\u003c\/li\u003e\n\u003cli\u003eGoto S, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antioxidative activity of the carotenoid astaxanthin. \u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e. 2001;1512(2):251-258.\u003c\/li\u003e\n\u003cli\u003eBeutner S, et al. Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: carotenoids, flavonoids, phenols and indigoids. \u003cem\u003eMol Aspects Med\u003c\/em\u003e. 2001;22(4-5):245-292.\u003c\/li\u003e\n\u003cli\u003eTominaga K, et al. Cosmetic benefits of astaxanthin on humans subjects. \u003cem\u003eActa Biochim Pol\u003c\/em\u003e. 2012;59(1):43-47.\u003c\/li\u003e\n\u003cli\u003eMortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. \u003cem\u003eJACC Heart Fail\u003c\/em\u003e. 2014;2(6):641-649.\u003c\/li\u003e\n\u003cli\u003eCaso G, et al. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. \u003cem\u003eAm J Cardiol\u003c\/em\u003e. 2007;99(10):1409-1412.\u003c\/li\u003e\n\u003cli\u003eRichie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. \u003cem\u003eEur J Nutr\u003c\/em\u003e. 2015;54(2):251-263.\u003c\/li\u003e\n\u003cli\u003eWitschi A, et al. The systemic availability of oral glutathione. \u003cem\u003eEur J Clin Pharmacol\u003c\/em\u003e. 1992;43(6):667-669.\u003c\/li\u003e\n\u003cli\u003eSmilkstein MJ, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. \u003cem\u003eNEJM\u003c\/em\u003e. 1988;319(24):1557-1562.\u003c\/li\u003e\n\u003cli\u003eSchreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor. \u003cem\u003eEMBO J\u003c\/em\u003e. 1991;10(8):2247-2258.\u003c\/li\u003e\n\u003cli\u003ePadayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. \u003cem\u003eAnn Intern Med\u003c\/em\u003e. 2004;140(7):533-537.\u003c\/li\u003e\n\u003cli\u003eDavis JL, et al. Liposomal-encapsulated ascorbic acid: influence on vitamin C bioavailability and capacity to protect against ischemia-reperfusion injury. \u003cem\u003eNutr Metab Insights\u003c\/em\u003e. 2016;9:25-30.\u003c\/li\u003e\n\u003cli\u003eCarr AC, Maggini S. Vitamin C and immune function. \u003cem\u003eNutrients\u003c\/em\u003e. 2017;9(11):1211.\u003c\/li\u003e\n\u003cli\u003eYoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e. 2021;372(6547):1224-1229.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"disclaimer\"\u003eDisclaimer\u003c\/h2\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before starting any supplement program — especially if you take warfarin, anticoagulants, immunosuppressants, are pregnant, are nursing, or are scheduled for surgery within 2 weeks. Antioxidant supplementation should be paused for 48 hours before, during, and 48 hours after infusion-chemotherapy or radiation per standard oncology practice. Individual results vary; the trial-anchored time-to-effect ranges in this page are population-level, not individual guarantees.\u003c\/em\u003e\u003c\/p\u003e","products":[{"product_id":"resveratrol-600mg-60-capsules-30-day-supply","title":"Resveratrol 600mg | Trans-Resveratrol for SIRT1 Activation, NAD+ \u0026 Longevity","description":"\u003cp\u003e\u003cstrong\u003e600 mg of trans-resveratrol per capsule\u003c\/strong\u003e — the SIRT1-activating polyphenol that anchors the canonical NMN + resveratrol longevity stack. ≥98% HPLC-verified trans-anomer from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, vegan capsule, no fillers, no proprietary blends. Stack-grade dose, not a label-claim dose.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe polyphenol that put sirtuins on the longevity map.\u003c\/strong\u003e Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e identified resveratrol as the most potent natural sirtuin-activating compound (STAC) ever screened; Baur 2006 \u003cem\u003eNature\u003c\/em\u003e showed it extended lifespan in calorically-stressed mice; Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e solved the SIRT1 allosteric crystal structure. Two decades and 13,000+ PubMed hits in, trans-resveratrol remains the canonical SIRT1 activator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, daily, with the largest fat-containing meal.\u003c\/strong\u003e Resveratrol is fat-soluble — fasted dosing throws away most of the pill. Pair with breakfast (eggs, avocado, fatty fish, olive oil) or lunch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest paired with \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000 mg\u003c\/a\u003e.\u003c\/strong\u003e NMN raises NAD+ substrate; resveratrol activates the SIRT1\/SIRT3 enzymes that \u003cem\u003euse\u003c\/em\u003e that NAD+. Substrate + activator. Get both at -10% as the \u003ca href=\"\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e600 mg is the stack-grade dose.\u003c\/strong\u003e 100–250 mg is where the \"resveratrol doesn't work in humans\" meta-analyses concentrate; 500–1000 mg\/day is where the cardiometabolic and SIRT1 data live (Tomé-Carneiro 2012\/2013, Bhatt 2012, Movahed 2013, Pollack 2017).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e≥98% HPLC trans-resveratrol.\u003c\/strong\u003e The bioactive anomer — not the cis-isomer UV-degradation product cheap brands ship. Per-batch third-party COA, heavy-metals\/microbial\/residual-solvents panel, vegan HPMC capsule, no titanium dioxide, no magnesium stearate, no rice-flour bulker.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy resveratrol still anchors a serious longevity stack — even after the noise\u003c\/h2\u003e\n\u003cp\u003eIf you only read the headlines, you'd think resveratrol got debunked. It didn't. What got debunked was the \u003cem\u003e1 mg of resveratrol in a glass of red wine\u003c\/em\u003e story — Smoliga 2011 (\u003cem\u003eMol Nutr Food Res\u003c\/em\u003e) showed you'd need ~1,500 bottles a day to hit the doses tested in the original Sinclair-lab mouse work. The science on the \u003cem\u003emolecule itself\u003c\/em\u003e kept moving in the right direction.\u003c\/p\u003e\n\u003cp\u003eThe López-Otín 2013 (\u003cem\u003eCell\u003c\/em\u003e) and updated 2023 hallmarks-of-aging frameworks list \u003cstrong\u003ederegulated nutrient sensing\u003c\/strong\u003e, \u003cstrong\u003emitochondrial dysfunction\u003c\/strong\u003e, \u003cstrong\u003echronic inflammation\u003c\/strong\u003e, and \u003cstrong\u003ecellular senescence\u003c\/strong\u003e among the twelve hallmarks. Resveratrol hits all four:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activation (SIRT1, SIRT3)\u003c\/strong\u003e — the deacetylase axis that converts NAD+ into longevity-relevant outputs (PGC-1α, FOXO3a, p53, eNOS deacetylation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK activation\u003c\/strong\u003e — the same fuel-sensor pathway hit by metformin, berberine, and exercise (Park 2012, \u003cem\u003eCell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB suppression \/ inflammaging\u003c\/strong\u003e — inhibits IKK, stabilizes IκB, dampens p65 nuclear translocation (Csiszar 2008).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndothelial protection\u003c\/strong\u003e — upregulates eNOS expression and activity (Wallerath 2002, \u003cem\u003eCirculation\u003c\/em\u003e); Tomé-Carneiro 2013 showed 350 mg\/day for 12 months reduced oxidized LDL by 20% in CHD patients \u003cem\u003ealready on statins\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNone of this requires resveratrol to be a magic pill. It just has to be the polyphenol with the strongest, longest-validated sirtuin-and-AMPK story across the most diverse organism panel — which it is.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what resveratrol actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. SIRT1 allosteric activation (the NMN partner)\u003c\/h3\u003e\n\u003cp\u003eSIRT1 is the most-studied of the seven mammalian sirtuins. It's a class-III deacetylase, meaning it consumes NAD+ as a co-substrate to remove acetyl groups from longevity-relevant substrates: \u003cstrong\u003ePGC-1α\u003c\/strong\u003e (mitochondrial biogenesis), \u003cstrong\u003eFOXO3a\u003c\/strong\u003e (stress resistance, antioxidant gene expression), \u003cstrong\u003ep53\u003c\/strong\u003e (apoptosis tone), \u003cstrong\u003eeNOS\u003c\/strong\u003e (vasodilation), \u003cstrong\u003eNF-κB p65\u003c\/strong\u003e (inflammation suppression), and the \u003cstrong\u003ehistone H3K9\/H4K16\u003c\/strong\u003e marks that gate the inflammatory transcriptome.\u003c\/p\u003e\n\u003cp\u003eWithout enough NAD+, SIRT1 stalls. Without an allosteric activator, SIRT1 runs at baseline. Resveratrol covers the second half. \u003cstrong\u003eHubbard 2013\u003c\/strong\u003e (\u003cem\u003eScience\u003c\/em\u003e) crystallized the SIRT1 N-terminal allosteric domain and showed resveratrol binds at a defined activator pocket, increasing SIRT1 activity toward acetylated substrates by up to 8-fold for substrates carrying hydrophobic recognition motifs. This resolved the earlier \"is the activation real or a fluorophore artifact?\" debate cleanly in resveratrol's favor.\u003c\/p\u003e\n\u003cp\u003eThis is the mechanistic argument for stacking \u003cstrong\u003eNMN (substrate) + resveratrol (activator)\u003c\/strong\u003e. NMN raises the NAD+ floor; resveratrol pushes the SIRT1 enzyme that uses it. Either alone is meaningfully under-leveraged; together they multiply.\u003c\/p\u003e\n\n\u003ch3\u003e2. SIRT3 and the mitochondrial deacetylase axis\u003c\/h3\u003e\n\u003cp\u003eSIRT3 is the major mitochondrial sirtuin and deacetylates ~65% of all mitochondrial-matrix lysine-acetyl marks. Its substrates include \u003cstrong\u003eSOD2\u003c\/strong\u003e (the manganese superoxide dismutase that scavenges mitochondrial ROS), \u003cstrong\u003eOPA1\u003c\/strong\u003e (mitochondrial fusion), and core ETC components. Resveratrol upregulates SIRT3 transcription and protein levels via PGC-1α-driven nuclear-respiratory-factor signaling — the same loop AMPK feeds into. Functionally, this is the leg behind resveratrol's mitochondrial-biogenesis signal in muscle (Lagouge 2006, \u003cem\u003eCell\u003c\/em\u003e) and the SOD2-mediated antioxidant signal that reduces mitochondrial-derived 8-oxo-dG damage in aging tissue.\u003c\/p\u003e\n\n\u003ch3\u003e3. AMPK activation (the metabolic fuel-sensor)\u003c\/h3\u003e\n\u003cp\u003eIndependent of sirtuins, resveratrol activates AMPK by inhibiting mitochondrial F1F0-ATP synthase (Park 2012, \u003cem\u003eCell\u003c\/em\u003e). Falling cellular ATP raises the AMP:ATP ratio, which is the upstream nudge AMPK senses. Activated AMPK then:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003ePhosphorylates and inactivates \u003cstrong\u003eACC\u003c\/strong\u003e (acetyl-CoA carboxylase) → lipid β-oxidation up.\u003c\/li\u003e\n  \u003cli\u003ePhosphorylates and inhibits \u003cstrong\u003emTORC1\u003c\/strong\u003e via TSC2 → catabolic autophagy up, anabolic protein synthesis down.\u003c\/li\u003e\n  \u003cli\u003ePhosphorylates \u003cstrong\u003ePGC-1α\u003c\/strong\u003e at Thr177\/Ser538 → mitochondrial biogenesis up, in concert with the SIRT1-deacetylation hit at the same protein.\u003c\/li\u003e\n  \u003cli\u003eTranslocates \u003cstrong\u003eGLUT4\u003c\/strong\u003e to muscle membrane → insulin-independent glucose uptake.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why the cardiometabolic trial signal for resveratrol is strongest in patients with insulin resistance, established CHD, or metabolic syndrome — the AMPK leg pulls weight even when the sirtuin leg is debated. It's also why resveratrol stacks cleanly with metformin and berberine: three different upstream inputs into the same fuel-sensor.\u003c\/p\u003e\n\n\u003ch3\u003e4. NF-κB suppression (the inflammaging dampener)\u003c\/h3\u003e\n\u003cp\u003eNF-κB is the transcription-factor central node behind senescent-cell SASP secretion, chronic CRP elevation, and most age-associated inflammatory tone. The López-Otín 2023 hallmarks paper added \"chronic inflammation\" as a standalone hallmark for exactly this reason. Resveratrol inhibits NF-κB activation at multiple steps:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIKK suppression\u003c\/strong\u003e — blocks the kinase complex that phosphorylates IκB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIκBα stabilization\u003c\/strong\u003e — keeps the inhibitor bound to NF-κB longer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ep65 nuclear-translocation block\u003c\/strong\u003e — even if some NF-κB escapes, less of it reaches DNA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSIRT1-mediated p65 deacetylation\u003c\/strong\u003e — Lys310 deacetylation reduces NF-κB transactivation (Yeung 2004, \u003cem\u003eEMBO J\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCsiszar 2008 (\u003cem\u003eMech Ageing Dev\u003c\/em\u003e) demonstrated this in human coronary arterial endothelial cells; the effect is reproduced across hepatocytes, macrophages, and chondrocytes. This dovetails with the senolytic + NF-κB-suppression strategy: senolytics (Quercetin, Fisetin) clear senescent cells; resveratrol dampens the inflammatory tone the surviving cells secrete.\u003c\/p\u003e\n\n\u003ch3\u003e5. Endothelial \/ eNOS upregulation\u003c\/h3\u003e\n\u003cp\u003eWallerath 2002 (\u003cem\u003eCirculation\u003c\/em\u003e) showed resveratrol upregulates endothelial nitric oxide synthase (eNOS) at both transcriptional and post-translational levels. eNOS-derived NO is the master vasodilator and a key brake on platelet aggregation and leukocyte adhesion to the endothelium. The signal is dose-dependent and clinically translates: Tomé-Carneiro's Spanish CHD-cohort series (2012\/2013) showed grape-extract resveratrol (350 mg\/day for 6–12 months) improved flow-mediated dilation, reduced oxidized LDL, and shifted multiple inflammatory apolipoproteins, in patients \u003cem\u003ealready optimized on statins\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003eThis is part of why resveratrol kept its seat at the table after the \"French paradox\" framing aged badly — the molecular eNOS \/ NF-κB \/ SIRT1 mechanisms hold up even when the \"red wine prevents heart disease\" narrative doesn't.\u003c\/p\u003e\n\n\u003ch3\u003e6. Autophagy and the mTOR brake\u003c\/h3\u003e\n\u003cp\u003eThrough both AMPK activation and direct ULK1 phosphorylation, resveratrol induces macroautophagy — the cellular self-clearance program that clears damaged organelles, aggregated proteins, and dysfunctional mitochondria (mitophagy via PINK1\/Parkin). Pietrocola 2017 showed resveratrol triggers an autophagic signature in skeletal muscle that is mechanistically distinct from the spermidine-driven EP300 inhibition route, meaning the two stack additively. This is the leg behind the proteostasis-restoration argument for resveratrol — stacked with \u003ca href=\"\/products\/spermidine-10mg-60-capsules-30-day-supply\"\u003espermidine\u003c\/a\u003e, you cover both major upstream autophagy switches.\u003c\/p\u003e\n\n\u003ch2\u003eThe trans-anomer — what \"≥98% trans-resveratrol\" actually means\u003c\/h2\u003e\n\u003cp\u003eResveratrol exists as two stereoisomers:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003etrans-resveratrol\u003c\/strong\u003e — the bioactive form. Every clinical trial measured this. Every SIRT1, AMPK, NF-κB, and eNOS mechanism documented above is trans-resveratrol's signature. This is the molecule the Sinclair lab tested, the molecule Tomé-Carneiro dosed, the molecule Hubbard crystallized.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecis-resveratrol\u003c\/strong\u003e — a UV-degradation product. The double bond in the stilbene core photoisomerizes from trans to cis under exposure to ultraviolet light, oxygen, and heat. Cis-resveratrol has dramatically reduced SIRT1 binding affinity and minimal in-vivo activity in published comparisons.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCheap resveratrol products mix them — and because cis-resveratrol can't be distinguished from trans by simple UV-Vis spectrophotometry (the cheap industry-standard assay), label claims that don't specify HPLC are often inflated by cis-isomer drift that occurred during storage, processing, or shipping. \u003cstrong\u003e≥98% HPLC trans-resveratrol means each batch is run on high-pressure liquid chromatography with diode-array detection at 308 nm — the assay that actually separates the two anomers.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe other 2% is residual \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e polyphenols (emodin, polydatin, piceid) at trace level, not cis-isomer drift. This is the molecular-grade material, not the food-grade material.\u003c\/p\u003e\n\n\u003ch2\u003eWhy \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese knotweed)\u003c\/h2\u003e\n\u003cp\u003eTrans-resveratrol can be extracted from grape skins, peanut hulls, or \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese knotweed) root. The Sinclair-lab work, the Tomé-Carneiro Spanish CHD trials, and the bulk of the human cardiometabolic literature all use \u003cem\u003eP. cuspidatum\u003c\/em\u003e for one reason: \u003cstrong\u003enatural concentration\u003c\/strong\u003e. Knotweed root contains 2–5% trans-resveratrol by dry weight, versus 0.001–0.01% in grape skin. That means knotweed extract reaches ≥98% HPLC purity through standard solvent partitioning; grape-skin extract requires aggressive chromatographic purification that often leaves residual matrix polyphenols and pesticide residues.\u003c\/p\u003e\n\u003cp\u003eThis product uses \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, ethanol\/water partitioned, recrystallized, ≥98% HPLC trans-resveratrol. Same source class as the trial materials.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that anchor 600 mg\u003c\/h2\u003e\n\u003cp\u003eThe \"resveratrol works \/ doesn't work\" debate gets cleaner once you stratify by dose, formulation, and population. Here is the evidence we anchor 600 mg on.\u003c\/p\u003e\n\n\u003ch3\u003eCardiometabolic — the strongest signal\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTomé-Carneiro 2012\u003c\/strong\u003e (\u003cem\u003eAm J Cardiol\u003c\/em\u003e) — CHD patients on statins, 350 mg\/day grape-extract resveratrol for 6 months. Significant increase in serum adiponectin, downregulation of pro-inflammatory genes (CCL3, IL-1β, TNF-α) in PBMCs, reduction in atherogenic apolipoproteins. This is the cardiology-on-statins benchmark trial.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTomé-Carneiro 2013\u003c\/strong\u003e (\u003cem\u003eMol Nutr Food Res\u003c\/em\u003e) — same cohort, 12-month follow-up. Persistent reduction in oxidized LDL by ~20%, sustained anti-inflammatory transcriptional shift. The signal didn't wash out with longer dosing — which is the question every \"transient effect\" critic raised in 2010.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBhatt 2012\u003c\/strong\u003e (\u003cem\u003eNutr Res\u003c\/em\u003e) — type 2 diabetics, 250 mg\/day for 3 months. Significant reductions in HbA1c, systolic BP, total cholesterol. Lower dose, smaller effect, but the same direction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMovahed 2013\u003c\/strong\u003e (\u003cem\u003eEvid Based Complement Alternat Med\u003c\/em\u003e) — type 2 diabetics, 1000 mg\/day for 45 days. Significant reductions in fasting glucose, HbA1c, systolic BP, and total cholesterol; significant rise in HDL. Higher dose, bigger effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePollack 2017\u003c\/strong\u003e (\u003cem\u003eCardiovasc Drugs Ther\u003c\/em\u003e) — older adults with insulin resistance, 1000–2000 mg\/day for 6 weeks. Improved peripheral and hepatic insulin sensitivity by clamp; the dose-response argument crystallized in this trial.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCognition and cerebral blood flow\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKennedy 2010\u003c\/strong\u003e (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) — healthy adults, 250 and 500 mg single oral doses. Dose-dependent increase in cerebral blood-flow velocity and oxy\/deoxy-Hb in the prefrontal cortex (NIRS). Acute mechanism: eNOS\/NO-driven vasodilation crossing into cerebral circulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWitte 2014\u003c\/strong\u003e (\u003cem\u003eJ Neurosci\u003c\/em\u003e) — overweight older adults, 200 mg\/day for 26 weeks. Improved memory performance and increased hippocampal functional connectivity, with reductions in glycated hemoglobin and body fat that paralleled the cognitive shift.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEvans 2017\u003c\/strong\u003e (\u003cem\u003eNutrients\u003c\/em\u003e) — postmenopausal women, 75 mg twice daily for 14 weeks. Improved cerebrovascular responsiveness and aspects of cognitive performance, again pointing at the vascular leg.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBone, postmenopausal physiology, and inflammaging\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOrnstrup 2014\u003c\/strong\u003e (\u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e) — obese men, 500 mg twice daily for 16 weeks. Increased bone mineral density at lumbar spine and improved bone turnover markers. Suggests SIRT1-mediated osteoblast support is translating clinically.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWong 2017 \/ 2019\u003c\/strong\u003e (RESHAW trial, \u003cem\u003eInt J Cardiol\u003c\/em\u003e) — postmenopausal women, 75 mg twice daily for 12+24 months. Sustained improvements in cerebrovascular responsiveness, mood, and selected cardiometabolic markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere the evidence is preliminary\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAll-cause mortality \/ lifespan in humans\u003c\/strong\u003e — no powered RCT exists and won't (ethics, timeline, expense). The animal lifespan signal is real (Baur 2006 in obese mice; lifespan extension in \u003cem\u003eS. cerevisiae\u003c\/em\u003e, \u003cem\u003eC. elegans\u003c\/em\u003e, \u003cem\u003eDrosophila\u003c\/em\u003e); human evidence is biomarker-level.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol monotherapy in elite\/young endurance athletes\u003c\/strong\u003e — Gliemann 2013 saw blunted training-induced cardiovascular adaptations in 60+ men at 250 mg\/day; signal hasn't replicated cleanly elsewhere, but the data exist. See contraindications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer chemoprevention\u003c\/strong\u003e — preclinical signal is broad but human trials are early-phase and small.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe case for 600 mg over 100 mg or 250 mg\u003c\/h2\u003e\n\u003cp\u003eMost over-the-counter resveratrol caps at 100–250 mg, which is exactly the range where the \"resveratrol doesn't work in humans\" meta-analyses concentrate. The dose-response data tell a different story:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBioavailability is the limiting factor, not safety.\u003c\/strong\u003e Walle 2004 (\u003cem\u003eDrug Metab Dispos\u003c\/em\u003e) measured \u0026lt;1% free resveratrol in plasma after a 25 mg oral dose — but ~70% absorption, just rapidly glucuronidated and sulfated by phase-II liver metabolism. To get clinically meaningful free + conjugated AUC, you need 500 mg+ per dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe trials that worked used 500–1000 mg\/day.\u003c\/strong\u003e Tomé-Carneiro 2012 used 350 mg of a co-formulated grape extract (which improves uptake), but the broader cardiometabolic literature (Bhatt 2012, Movahed 2013, Pollack 2017, Ornstrup 2014) clusters at 500–1000 mg\/day. The Sinclair-lab mouse work scales to a human equivalent of ~750 mg\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e600 mg is the floor for serious longevity stacking.\u003c\/strong\u003e If you're running NMN at 500–1000 mg\/day for sirtuin substrate, the matched activator dose lives at 500–1000 mg trans-resveratrol — taken with a fat-containing meal so the lipid solubilization hits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAbove 1,000 mg\/day adds GI side effects without proportional benefit.\u003c\/strong\u003e Brown 2010 (\u003cem\u003eCancer Res\u003c\/em\u003e) saw mild diarrhea and GI cramping appear at 2.5 g\/day and above. 600 mg lands inside the high-tolerability window — meaningful free + conjugated AUC, no dose-limiting GI tone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTranslation: 100 mg is a label-claim dose. 250 mg is a hedge. \u003cstrong\u003e600 mg is a stack-grade dose.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eResveratrol's pharmacokinetics are unusual and worth understanding because they explain the whole \"take it with fat\" rule.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAbsorption is high.\u003c\/strong\u003e Walle 2004 measured ~70% intestinal absorption of an oral dose. The bottleneck isn't getting it across the gut wall.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFirst-pass hepatic conjugation is aggressive.\u003c\/strong\u003e The liver glucuronidates and sulfates resveratrol within minutes via UGT1A1 and SULT1A1. Measured plasma free resveratrol after 25 mg oral was \u0026lt;5 ng\/mL.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConjugates are not inert.\u003c\/strong\u003e Patel 2013 and follow-up work show resveratrol-3-O-sulfate and resveratrol-glucuronides are themselves bioactive at physiological concentrations and can be deconjugated locally in tissue by sulfatases and β-glucuronidases — a \"circulating depot\" model. Total free + conjugated AUC is what matters clinically, not free-fraction alone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFat-containing meal roughly doubles AUC.\u003c\/strong\u003e Vaz-da-Silva 2008 (\u003cem\u003eInt J Clin Pharmacol Ther\u003c\/em\u003e) showed AUC was significantly higher when resveratrol was administered with a standard meal versus fasting. La Porte 2010 confirmed across formulations.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHalf-life is ~9 hours for total radioactivity.\u003c\/strong\u003e One dose per day at 600 mg keeps measurable plasma exposure across the waking-hours window where SIRT1 demand is highest.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe practical translation: take 600 mg with breakfast or lunch (whichever has more fat). Don't take it on an empty stomach unless you want to throw away half the dose. Don't split it into 3×200 mg — the per-dose bioavailability ceiling falls off below 500 mg.\u003c\/p\u003e\n\n\u003ch2\u003eHow resveratrol maps onto the hallmarks of aging\u003c\/h2\u003e\n\u003cp\u003eThe López-Otín hallmarks (2013, updated 2023) are the field-standard taxonomy of biological aging. Resveratrol touches more of them than any other single polyphenol on our shelf:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — AMPK activation; mTOR suppression via AMPK-TSC2; SIRT1 deacetylation of mTORC1 substrates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — PGC-1α deacetylation by SIRT1; SIRT3-mediated SOD2 and ETC-component activation; AMPK-driven mitochondrial biogenesis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular senescence \/ chronic inflammation\u003c\/strong\u003e — NF-κB suppression at IKK + p65 levels; SASP-cytokine dampening; pairs with senolytic protocols (quercetin\/fisetin) by clearing residual inflammation after the senescent cells themselves are removed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEpigenetic alterations\u003c\/strong\u003e — SIRT1\/SIRT3-mediated histone deacetylation (H3K9, H4K16); modulation of DNA-methyltransferase activity; SIRT-dependent chromatin remodeling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLoss of proteostasis \/ autophagy decline\u003c\/strong\u003e — AMPK→ULK1-driven macroautophagy; mitophagy via PINK1\/Parkin upstream signal; complementary to spermidine's EP300-inhibition route.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAltered intercellular communication\u003c\/strong\u003e — eNOS upregulation; SIRT1 deacetylation of endothelial transcription factors; reduced systemic inflammatory tone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThat's six of the twelve hallmarks with mechanism-grade evidence in a single molecule. This is the structural reason resveratrol earned the \"polyphenol that anchors a stack\" position.\u003c\/p\u003e\n\n\u003ch2\u003eResveratrol vs pterostilbene — the practical decision\u003c\/h2\u003e\n\u003cp\u003ePterostilbene is resveratrol's dimethylated cousin. Two methoxy groups in place of two hydroxyls makes it more lipid-soluble, less subject to first-pass conjugation, and longer-lived in plasma. So why isn't this the default?\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrial base.\u003c\/strong\u003e Resveratrol has 200+ human trials and 20+ years of mechanistic data. Pterostilbene has \u0026lt;10 published human trials and no long-term cardiometabolic series.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSIRT1 affinity.\u003c\/strong\u003e Resveratrol is the canonical SIRT1 allosteric activator. Pterostilbene activates SIRT1 in vitro but with less-characterized binding-site behavior; head-to-head assays don't put it ahead of resveratrol on a per-mole basis at the SIRT1 site.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLDL signal.\u003c\/strong\u003e Pterostilbene at 250 mg\/day has shown a small LDL-elevation in some studies (Riche 2014), which is not the direction you want for a longevity polyphenol. Resveratrol either reduces LDL-ox (Tomé-Carneiro 2012\/2013) or is neutral on LDL.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCost-per-mg.\u003c\/strong\u003e Pterostilbene is roughly 5–10x more expensive at equivalent doses. The bioavailability advantage (~3x AUC versus standard resveratrol) doesn't close that gap.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWe anchor the SIRT1 leg with trans-resveratrol because the evidence base is wider, the dose-response is well-characterized, and the cost-per-effective-dose is meaningfully lower. If you want both, pterostilbene 100–150 mg\/day stacks on top of resveratrol 600 mg without conflict — resveratrol covers the trial-base \/ cardiometabolic \/ NF-κB legs; pterostilbene reinforces the longer plasma exposure window.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — what \"resveratrol\" can mean on a label\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003cth\u003eSource \/ spec\u003c\/th\u003e\n\u003cth\u003eWhat it is\u003c\/th\u003e\n\u003cth\u003eTrial usage\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e≥98% trans-resveratrol from \u003cem\u003eP. cuspidatum\u003c\/em\u003e (HPLC)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStack-grade material. Trans-anomer verified. ~98% pure trans, ≤2% residual matrix polyphenols, undetectable cis-isomer drift.\u003c\/td\u003e\n\u003ctd\u003eSinclair-lab work; Tomé-Carneiro 2012\/2013; Movahed 2013; Pollack 2017. \u003cstrong\u003eThis product.\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e50% \/ 70% \/ 90% trans-resveratrol (UV-Vis assayed)\u003c\/td\u003e\n\u003ctd\u003eLower-purity knotweed extract. UV-Vis can't distinguish trans from cis — label claim is unreliable. Often heavier in residual emodin and other knotweed polyphenols (which can cause GI effects at scale).\u003c\/td\u003e\n\u003ctd\u003eNot used in clinical trials with PK confirmation. Consumer-grade material.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eGrape-skin extract (typically \u0026lt;1% resveratrol)\u003c\/td\u003e\n\u003ctd\u003eMixed polyphenol matrix. The Tomé-Carneiro grape-extract was a defined co-formulation; most \"grape resveratrol\" supplements on the shelf are not.\u003c\/td\u003e\n\u003ctd\u003eTomé-Carneiro used a specific defined grape extract — most generic grape-skin supplements aren't comparable.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003ePeanut-hull resveratrol\u003c\/td\u003e\n\u003ctd\u003eAllergen-relevant source. Can carry residual peanut protein at trace level.\u003c\/td\u003e\n\u003ctd\u003eNiche.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\"Resveratrol complex\" \/ \"antioxidant blend\"\u003c\/td\u003e\n\u003ctd\u003eOften 50–100 mg of resveratrol mixed with quercetin, grape-seed, green-tea, etc. Convenient — but you can't isolate the resveratrol dose, and per-mg resveratrol cost is usually higher.\u003c\/td\u003e\n\u003ctd\u003eNone of the above SIRT1\/AMPK\/eNOS trials used \"complex\" formulations.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ \/ longevity family\u003c\/h2\u003e\n\u003cp\u003eResveratrol is one of three legs in the canonical sirtuin axis we run on this site:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ substrate (precursor floor)\u003c\/strong\u003e — \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e, \u003ca href=\"\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/products\/liposomal-nad-supplement-anti-aging\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/products\/liquid-nad-anti-aging-drink-nr-stick-packs\"\u003eLiquid NAD+ NR stick packs\u003c\/a\u003e. Raises the NAD+ ceiling SIRT1\/SIRT3 can draw on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activator (allosteric)\u003c\/strong\u003e — \u003cstrong\u003ethis product\u003c\/strong\u003e. Pushes SIRT1\/SIRT3 enzymatic activity at any given NAD+ concentration. The activator side of the equation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethyl-donor support\u003c\/strong\u003e — \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-betaine\"\u003eTMG 1000mg\u003c\/a\u003e. Replenishes the SAMe methyl-pool that the NAD+→NAM→methylation pathway draws on at long-term high doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe convenience option — get all three sirtuin pieces at -10% — is the \u003ca href=\"\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e (NMN 500 + Resveratrol 600).\u003c\/p\u003e\n\u003cp\u003eBeyond the sirtuin axis, resveratrol pairs with a wider longevity protocol:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytics\u003c\/strong\u003e — \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid\"\u003eQuercetin 500mg\u003c\/a\u003e, \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid\"\u003eFisetin 500mg\u003c\/a\u003e. Senolytics clear senescent cells; resveratrol dampens residual SASP inflammation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial layer\u003c\/strong\u003e — \u003ca href=\"\/products\/coq10-400mg-fertility-cellular-energy\"\u003eCoQ10 400mg\u003c\/a\u003e, \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy\"\u003eUrolithin A 500mg\u003c\/a\u003e, \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg\"\u003eCaAKG 1000mg\u003c\/a\u003e. Resveratrol drives mitochondrial biogenesis upstream; these support what the new mitochondria do downstream.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ metabolic\u003c\/strong\u003e — Berberine, metformin (Rx). All three converge on AMPK by different upstream routes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB \/ anti-inflammatory\u003c\/strong\u003e — \u003ca href=\"\/products\/curcumin-1000mg-95-curcuminoids-bioperine\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e. Both suppress NF-κB; BioPerine improves both molecules' bioavailability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking matrix\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003cth\u003ePairs with\u003c\/th\u003e\n\u003cth\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNMN 500mg or NMN 1000mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThe canonical longevity stack — NMN supplies NAD+ substrate, resveratrol activates the SIRT1\/SIRT3 enzyme that uses it. Same morning dose, same fat-containing meal. Get both as the \u003ca href=\"\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e at -10%.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTMG 1000mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLong-term high-dose NMN draws on the SAMe methyl-pool via the NAD+→NAM→methylated-NAM (MeNAM) clearance route. TMG (trimethylglycine) replenishes that pool. If you're running NMN + resveratrol daily, TMG eventually becomes non-optional.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLiposomal NAD+ \/ Liquid NAD+ NR stick packs\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFor circadian-dip coverage on top of the morning NMN substrate + resveratrol activator hit. Useful for users 50+ or running heavy training loads.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBerberine 500mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate AMPK by different upstream mechanisms (resveratrol via F1-ATPase inhibition; berberine via direct AMPK-α1 phosphorylation). Pairs especially well for metabolic-syndrome \/ insulin-resistance goals.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCurcumin + BioPerine\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBioPerine (piperine) inhibits CYP3A4-mediated hepatic conjugation, raising both curcumin and resveratrol AUC. Both molecules suppress NF-κB at complementary nodes — IKK (curcumin) + p65 deacetylation (resveratrol via SIRT1). Stack-stable, evidence-rich.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eQuercetin \/ Fisetin (senolytic protocol)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSenolytic flavonoids clear senescent cells; resveratrol dampens the residual SASP-cytokine inflammation. Run quercetin\/fisetin on a 2-day-pulse senolytic protocol; run resveratrol daily.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSpermidine 10mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate autophagy. Resveratrol via AMPK→mTOR-suppression→ULK1; spermidine via direct EP300 inhibition. Two upstream switches converging on the same autophagy machinery — additive, not redundant.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eUrolithin A 500mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResveratrol drives mitochondrial biogenesis (PGC-1α deacetylation); Urolithin A drives mitophagy (PINK1\/Parkin). Together: more new mitochondria, fewer damaged ones. The classic mito-renewal pair.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOmega-3 \/ fatty meal\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAlways co-dose with fat. Resveratrol bioavailability roughly doubles with a fat-containing meal. Omega-3s also have independent NF-κB suppression and complement resveratrol's eNOS leg.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cp\u003eResveratrol is not a stimulant. There is no acute \"feel\" effect on the first dose. The biological signals appear on different timelines:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e Acute eNOS \/ cerebral-blood-flow signal can register on the first day (Kennedy 2010 — single 250–500 mg dose increased prefrontal CBF measurably). For most users this is below subjective threshold but real on instrumentation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e Inflammatory-tone shifts begin (CRP, fibrinogen, IL-6). Most users notice a generalized \"less inflammation\" baseline — fewer joint complaints, faster recovery from training. SIRT1 substrate-deacetylation signaling has reached steady state.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e Lipid panel begins to shift in the cardiometabolic-risk subset (oxidized LDL down, HDL up modestly, triglycerides flat-to-down). Insulin-sensitivity changes appear in HOMA-IR and OGTT data on this timeline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e The Tomé-Carneiro biomarker timeline. LDL-ox reduction, atherogenic apolipoprotein shift, sustained anti-inflammatory transcriptional signature in PBMCs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 12+:\u003c\/strong\u003e Bone turnover markers and BMD changes in the relevant populations (Ornstrup 2014 saw lumbar BMD increase at 16 weeks). Cognitive \/ memory shifts appear in older adults around this timeline (Witte 2014 — 26-week trial).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRun for 12 weeks minimum, recheck labs. The signal is biomarker-level and accumulative; this is not a \"feel it on day 3\" molecule.\u003c\/p\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1 capsule per day, taken with the largest fat-containing meal of the day.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eResveratrol is fat-soluble and heavily phase-II-conjugated by the liver. Walle 2004, Vaz-da-Silva 2008, and Smoliga 2011 all converge: taking resveratrol on an empty stomach throws away most of the dose. With a fat-containing meal — even just olive oil, eggs, fatty fish, or avocado — measured plasma AUC roughly doubles versus fasted dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTiming notes:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDefault:\u003c\/strong\u003e with breakfast or lunch (whichever is the larger fat-containing meal). Aligns with the AM dose of NMN if you're stacking.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with NMN:\u003c\/strong\u003e same meal as the morning NMN dose. This is the canonical Sinclair-protocol pairing — substrate + activator hit the SIRT1 axis together.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-workout:\u003c\/strong\u003e some users dose 60–90 minutes before resistance training to leverage the AMPK \/ mitochondrial-biogenesis crossover. Note the Gliemann 2013 caveat below before doing this if you're an older endurance athlete.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith BioPerine \/ curcumin:\u003c\/strong\u003e piperine inhibits CYP3A4 and raises resveratrol AUC by roughly 1.5–2x in the published bioavailability studies. If you're already taking \u003ca href=\"\/products\/curcumin-1000mg-95-curcuminoids-bioperine\"\u003eCurcumin + BioPerine\u003c\/a\u003e with breakfast, your resveratrol AUC is going up too — for free.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAvoid grapefruit juice the same day.\u003c\/strong\u003e Grapefruit competes for the same CYP3A4 \/ UGT pathway resveratrol uses; the effect on AUC is real but not dangerous.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't take it before bed.\u003c\/strong\u003e Cerebral blood-flow upregulation can interfere with sleep onset for sensitive users.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e 600 mg of ≥98% HPLC trans-resveratrol per capsule, sourced from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e (Japanese knotweed) root extract, in a vegan HPMC capsule, with no fillers, no proprietary blends, no titanium dioxide, no magnesium stearate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e Per-batch HPLC-verified for trans-anomer purity (308 nm DAD); independently tested for heavy metals (USP \u0026lt;232\u0026gt;), microbials (USP \u0026lt;2021\u0026gt;), and residual solvents (USP \u0026lt;467\u0026gt;).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A grape-skin extract. Knotweed-sourced trans-resveratrol is the trial-grade material; grape-skin extract is a different (and more variable) product class.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A \"resveratrol complex.\" There's no quercetin, grape-seed extract, green-tea extract, or pterostilbene mixed in. Those are real ingredients but you can't dose them properly when they're hidden inside a single 600 mg capsule. We sell them separately when relevant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A liposomal or micronized formulation. At 600 mg with a fat-containing meal, you're already in the clinically-validated AUC range without paying the 4–5x premium that liposomal resveratrol commands.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e A treatment for any specific disease. This is a longevity-stack supplement, not a cardiology drug, not a cancer therapeutic. Talk to your physician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it on an empty stomach.\u003c\/strong\u003e Roughly halves the AUC. Always with a fat-containing meal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSplitting 600 mg into 3×200 mg doses.\u003c\/strong\u003e The per-dose absorption ceiling falls off below 500 mg — splitting reduces total daily AUC, not increases it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying 100 mg products and taking 6 capsules.\u003c\/strong\u003e Math works, but you're paying 3–5x per active mg and usually the source\/spec isn't HPLC-verified at the lower price point.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping after 4 weeks because nothing happened.\u003c\/strong\u003e The cardiometabolic biomarker timeline is 8–12 weeks. The SIRT1 axis steady-state is 4 weeks. The cognitive \/ BMD signals are 16–26 weeks. Don't bail at week 4.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking resveratrol with grapefruit juice.\u003c\/strong\u003e CYP3A4 competition. Not dangerous, but reduces predictability of dose-response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRunning resveratrol monotherapy with no NAD+ precursor.\u003c\/strong\u003e Resveratrol activates SIRT1, but SIRT1 needs NAD+ as substrate. Without NMN or NR floor-raising, you're flooring the gas with the tank low.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying generic UV-Vis \"resveratrol\" and assuming it's trans.\u003c\/strong\u003e UV-Vis can't distinguish trans from cis. Cis-isomer drift in poorly-stored material can reduce label-active dose by 30%+ silently.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ running a serious longevity stack who want the canonical SIRT1 activator.\u003c\/li\u003e\n  \u003cli\u003eAnyone already taking NMN or NR who hasn't yet added the activator side of the equation.\u003c\/li\u003e\n  \u003cli\u003ePeople with cardiometabolic risk factors (elevated LDL-ox, insulin resistance, family history of CHD) who want a polyphenol with documented eNOS \/ NF-κB \/ AMPK signal at trial-grade dose.\u003c\/li\u003e\n  \u003cli\u003eStack-builders who want one molecule that does sirtuin co-activation + AMPK activation + NF-κB suppression + endothelial support simultaneously, rather than four separate inputs.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women looking at cardiovascular and bone-density support (Wong \/ RESHAW; Ornstrup 2014).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy or breastfeeding.\u003c\/strong\u003e Insufficient human safety data above the dietary trace doses. Don't.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive hormone-sensitive cancer (breast, ovarian, endometrial, prostate).\u003c\/strong\u003e Resveratrol is a phytoestrogen with weak ER-binding affinity (~7,000x less than estradiol, tissue-specific). Clinical relevance at 600 mg is small for healthy adults but not zero — discuss with your oncologist before adding.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn warfarin or active anti-platelet therapy.\u003c\/strong\u003e Resveratrol has mild antiplatelet effects in vitro (Pace-Asciak 1995); the clinical relevance at 600 mg is small but nonzero. Monitor INR if you're running both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOlder competitive endurance athletes.\u003c\/strong\u003e Gliemann 2013 (\u003cem\u003eJ Physiol\u003c\/em\u003e) showed 250 mg\/day resveratrol blunted training-induced cardiovascular adaptations in 60+ men. The signal hasn't replicated cleanly in younger or recreational populations, but the data exist; if you're a competitive masters endurance athlete in a periodized peak block, time resveratrol around recovery weeks rather than peak-training weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergic to \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e.\u003c\/strong\u003e Rare but documented. Skin reactions, GI cramping. Stop and don't restart.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking strong CYP3A4 inhibitors\u003c\/strong\u003e (clarithromycin, ketoconazole, ritonavir). Resveratrol AUC will rise unpredictably; talk to your prescriber.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cp\u003eResveratrol has one of the cleanest oral safety profiles in the longevity-supplement space at \u0026lt;1 g\/day. Brown 2010 (\u003cem\u003eCancer Res\u003c\/em\u003e) tested 0.5–5 g daily for 29 days with no dose-limiting toxicity below 2.5 g; mild diarrhea \/ GI cramping appeared above that. 600 mg sits well below any documented dose-limiting tolerance threshold.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants \/ antiplatelets.\u003c\/strong\u003e Mild antiplatelet effect in vitro (Pace-Asciak 1995); clinical relevance at 600 mg is small but real. Monitor INR if on warfarin; talk to prescriber if on dual antiplatelet therapy after stenting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCYP3A4 substrates.\u003c\/strong\u003e Resveratrol is a mild CYP3A4 inhibitor. Drugs metabolized through CYP3A4 (statins, calcium-channel blockers, some immunosuppressants) may have modestly elevated AUC. Talk to prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUGT1A1 substrates.\u003c\/strong\u003e Resveratrol competes for hepatic glucuronidation. Drugs heavily UGT1A1-cleared (irinotecan metabolites, raltegravir) may behave unpredictably.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEstrogen-modulating drugs.\u003c\/strong\u003e Tamoxifen, aromatase inhibitors, hormonal contraceptives — discuss with your prescriber given resveratrol's weak ER-binding profile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSSRIs and MAOIs.\u003c\/strong\u003e No documented interaction at 600 mg. Resveratrol's mild MAO-inhibition signal is at much higher doses than typical supplementation hits.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cp\u003ePer capsule:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-resveratrol — 600 mg\u003c\/strong\u003e, from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, ≥98% HPLC trans-anomer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan HPMC capsule.\u003c\/strong\u003e No gelatin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eWhat's NOT in it:\u003c\/em\u003e No magnesium stearate, no silicon dioxide, no titanium dioxide, no maltodextrin, no rice flour, no proprietary blends, no cis-isomer drift, no inflated UV-Vis label claim. 600 mg is 600 mg of trans-resveratrol — not 600 mg of an \"antioxidant complex\" that turns out to be 50 mg resveratrol + 550 mg cellulose.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eAllergens:\u003c\/em\u003e No gluten, no soy, no dairy, no nuts, no shellfish, no eggs.\u003c\/p\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSource:\u003c\/strong\u003e \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e root extract, ethanol\/water partitioned, recrystallized to ≥98% trans-resveratrol by HPLC.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-registered facility, NSF-audited; capsules filled under controlled humidity in opaque amber blister-stable bottles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch testing:\u003c\/strong\u003e HPLC identity + potency at 308 nm (DAD); cis-isomer screen; heavy metals (USP \u0026lt;232\u0026gt;) for As\/Cd\/Hg\/Pb; microbial limits (USP \u0026lt;2021\u0026gt;) for total aerobic, yeast\/mold, E. coli, Salmonella; residual solvents (USP \u0026lt;467\u0026gt;).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e Validated 24-month room-temperature stability under amber-bottle storage. Resveratrol is photo-sensitive — keep the bottle closed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePublic COA:\u003c\/strong\u003e per-batch certificate of analysis available at \u003ca href=\"\/pages\/coa\"\u003etruehealthprotocol.health\/pages\/coa\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eDoes resveratrol actually extend lifespan in humans?\u003c\/h3\u003e\n\u003cp\u003eNo human RCT is powered for all-cause-mortality endpoints (the trial would take 30+ years and be ethically contested). What we have: lifespan extension in \u003cem\u003eS. cerevisiae\u003c\/em\u003e, \u003cem\u003eC. elegans\u003c\/em\u003e, \u003cem\u003eDrosophila\u003c\/em\u003e, and obese mice (Baur 2006); biomarker improvement across the cardiometabolic literature (Tomé-Carneiro 2012\/2013, Movahed 2013, Pollack 2017); mechanistic plausibility via SIRT1, AMPK, NF-κB, and eNOS. Treat resveratrol like the rest of the longevity stack — high-evidence biomarker work, mechanistic translation from animal lifespan data, ride the convergence.\u003c\/p\u003e\n\n\u003ch3\u003eResveratrol vs pterostilbene — which is \"better\"?\u003c\/h3\u003e\n\u003cp\u003ePterostilbene is resveratrol's dimethylated cousin with better bioavailability (more lipid-soluble, less first-pass conjugation, longer plasma half-life) but a much thinner trial base. Resveratrol has 200+ human trials and 20+ years of mechanistic data; pterostilbene has \u0026lt;10 published human trials. We anchor the SIRT1 leg with resveratrol because the evidence base is wider and the dose-response is well-characterized. If you want both, pterostilbene 100–150 mg\/day stacks fine on top of resveratrol 600 mg.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not micronized or liposomal resveratrol?\u003c\/h3\u003e\n\u003cp\u003eBoth improve absorption modestly (~1.5–2x AUC vs standard). At 600 mg trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e in a fat-containing meal, you're already in the clinically active plasma range. The cost premium for liposomal (often 4–5x per active mg) doesn't pencil out for most users. We'd rather give you the verifiable molecular-grade material at a serious dose.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eResveratrol isn't a stimulant. The cardiometabolic biomarker shifts (LDL-ox, CRP, fasting insulin) appear in trials at 8–12 weeks. Bone-density and cognitive shifts take 16–26 weeks. Acute \"feel\" effects (energy, mental clarity) on day-1 are typically downstream of NMN substrate availability — this is why the NMN + resveratrol pairing is the standard. Run for 12 weeks minimum, recheck labs.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with metformin or berberine?\u003c\/h3\u003e\n\u003cp\u003eYes — and it's mechanistically synergistic. All three activate AMPK by different upstream routes: metformin via complex I inhibition, berberine via direct AMPK-α1 phosphorylation, resveratrol via F1F0-ATP synthase inhibition. Resveratrol's SIRT1 leg is independent of metformin's mechanism. The classic metabolic-syndrome stack is metformin (or berberine) + resveratrol + NMN.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not just drink red wine?\u003c\/h3\u003e\n\u003cp\u003eBecause the dose math doesn't work. A 5 oz glass of red wine contains roughly 0.3–1.0 mg trans-resveratrol. 600 mg is the equivalent of 600–2,000 glasses. Even ignoring the alcohol harm-curve, the resveratrol math is impossible from food. The \"French paradox\" was never about resveratrol-the-molecule; it was about overall polyphenol intake plus Mediterranean-diet effects.\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol affect estrogen?\u003c\/h3\u003e\n\u003cp\u003eWeakly. Resveratrol binds estrogen receptors with ~7,000x lower affinity than estradiol, and its action is tissue-specific (mostly antagonist at ERα in breast tissue, mild agonist at ERβ in bone). The clinical relevance at 600 mg is small for healthy adults; meaningful for anyone with active hormone-sensitive cancer (see contraindications). Postmenopausal women in trials (Wong \/ RESHAW; Ornstrup) actually benefited from the ERβ agonist tone in bone — this is part of why BMD signals appear at 16+ weeks.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and put it in a smoothie?\u003c\/h3\u003e\n\u003cp\u003eYou can, but don't. Resveratrol is photosensitive — UV exposure converts trans to cis (the inactive isomer). A smoothie blender's clear pitcher under kitchen light for 30 minutes is enough to nudge a measurable fraction. If you can't swallow capsules, dissolve in olive oil at room temp and consume immediately, in opaque container.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eThe SIRT1 deacetylation signaling Resveratrol drives doesn't store — it's a real-time enzymatic process. The NF-κB suppression and eNOS upregulation reset within ~48 hours of stopping. Hubbard 2013's mechanism is steady-state by design. 600 mg\/day for 90 days is dramatically more biologically active than 1,800 mg every third day.\u003c\/p\u003e\n\n\u003ch3\u003eShould I cycle off resveratrol?\u003c\/h3\u003e\n\u003cp\u003eThe published trials run continuously for 6–24 months without dose-limiting toxicity, withdrawal effects, or receptor down-regulation. There's no published rationale for cycling at 600 mg. The \"cycle everything\" supplement-bro heuristic doesn't apply to a polyphenol the body's already adapted to evolutionarily.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take resveratrol while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes — but understand you'll get less of it. Fasted bioavailability is roughly half of fed bioavailability. If you're fasting and want to keep resveratrol on board, take it with the first fat-containing meal of your eating window, not during the fast itself.\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. Resveratrol and its glucuronide \/ sulfate conjugates are not on any standard drug-testing panel (sport, occupational, or law-enforcement). The molecule is structurally a stilbene polyphenol — entirely distinct from any controlled substance class.\u003c\/p\u003e\n\n\u003ch3\u003eIs this the same as the Sinclair-lab resveratrol?\u003c\/h3\u003e\n\u003cp\u003eSame source class (\u003cem\u003eP. cuspidatum\u003c\/em\u003e root extract, ≥98% trans-resveratrol HPLC) at the dose range used in animal lifespan work scaled to human equivalents. The Sinclair lab used ≥98% trans-resveratrol material throughout the Howitz 2003 \/ Baur 2006 \/ Hubbard 2013 work. We're not selling \"Sinclair's brand\" — we're selling the same molecular spec.\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eNo. The vascular signal goes the other direction — eNOS-mediated vasodilation lowers systolic BP modestly in cardiometabolic trials (Movahed 2013; Bhatt 2012). Resveratrol does not have stimulant effects on heart rate or pressor effects on BP.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than peak dose?\u003c\/h3\u003e\n\u003cp\u003eThe SIRT1 deacetylation signal is steady-state. Hubbard 2013's allosteric activation is dose-rate-dependent at the cellular level — a constant 600 mg\/day flow keeps SIRT1 in the activated conformation continuously. Pulse-loading (1800 mg every 3 days) gives you the same average dose but with off-cycle troughs where SIRT1 reverts to baseline.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eYes — they're complementary, not duplicative. NAD+ IV raises blood NAD+ levels acutely; resveratrol activates the SIRT1 enzyme that uses NAD+. The pairing is logical: substrate (NAD+ IV or NMN) + activator (resveratrol).\u003c\/p\u003e\n\n\u003ch3\u003eDoes resveratrol interact with statins or blood-pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo major interaction in the published trial literature — Tomé-Carneiro's CHD cohort were on statins throughout, with the resveratrol arm showing additional LDL-ox reduction without altering statin pharmacokinetics meaningfully. Resveratrol is a mild CYP3A4 inhibitor in vitro; the clinical relevance for typical statin doses is small. Don't change prescribed medication without your physician.\u003c\/p\u003e\n\n\u003ch3\u003eIs the capsule kosher \/ halal?\u003c\/h3\u003e\n\u003cp\u003eVegan HPMC capsule shell. The resveratrol is plant-derived (knotweed root). No animal-derived ingredients, no alcohol residues above limits. Specific kosher \/ halal certification varies by batch — check the COA page for current certification status.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eResveratrol 600mg occupies the \u003cstrong\u003eSirtuin Activator\u003c\/strong\u003e position in the True Health Protocol catalog. Three legs of the sirtuin axis on this site:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSubstrate (NAD+ floor)\u003c\/strong\u003e — NMN family (\u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e, \u003ca href=\"\/products\/nmn-1000mg-pure-focus-formula-cellular-rejuvenation\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/products\/liposomal-nad-supplement-anti-aging\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/products\/liquid-nad-anti-aging-drink-nr-stick-packs\"\u003eLiquid NAD+ NR\u003c\/a\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivator (SIRT1\/SIRT3 push)\u003c\/strong\u003e — \u003cstrong\u003ethis product.\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethyl support (long-term)\u003c\/strong\u003e — \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-betaine\"\u003eTMG 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe convenience pairing is the \u003ca href=\"\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle\u003c\/a\u003e (NMN 500 + Resveratrol 600 at -10%).\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/longevity\"\u003eLongevity collection\u003c\/a\u003e — every product in the canonical longevity-stack architecture (NAD+ axis, sirtuin activators, senolytics, mitochondrial-renewal layer).\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/sirtuin-activators\"\u003eSirtuin activators\u003c\/a\u003e — resveratrol and pairing molecules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/cardiovascular\"\u003eCardiovascular collection\u003c\/a\u003e — resveratrol, CoQ10, taurine, omega-3, and pairing nutrients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/collections\/anti-inflammatory\"\u003eAnti-inflammatory collection\u003c\/a\u003e — resveratrol, curcumin, omega-3, quercetin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/blogs\/longevity\/sirtuins-explained\"\u003eSirtuins explained — the seven enzymes longevity research orbits.\u003c\/a\u003e Why SIRT1 isn't the only sirtuin that matters, and how resveratrol fits across SIRT1\/SIRT3.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/blogs\/longevity\/nmn-vs-nad\"\u003eNMN vs NAD+ — what the precursor difference actually means.\u003c\/a\u003e The substrate side of the substrate-plus-activator equation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/blogs\/longevity\/classic-longevity-stack\"\u003eThe classic longevity stack — NMN + resveratrol explained.\u003c\/a\u003e Why these two molecules became the canonical pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/blogs\/longevity\/nad-decline-with-age\"\u003eNAD+ decline with age — what the data actually show.\u003c\/a\u003e Why the substrate side of the equation gets the most attention, and what resveratrol adds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/pages\/protocols\"\u003eThe True Health Protocol — full longevity protocol\u003c\/a\u003e showing where resveratrol slots into a complete supplementation framework.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eHowitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 2003;425:191-6. — Original screen identifying resveratrol as a sirtuin activator. Context, not endorsement.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eBaur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. \u003cem\u003eNature\u003c\/em\u003e 2006;444:337-42. — Mouse lifespan extension on calorically-stressed diet.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eHubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, Pentelute BL, Schuman ER, Stevens LA, Ling AJ, Armour SM, Michan S, Zhao H, Jiang Y, Sweitzer SM, Blum CA, Disch JS, Ng PY, Howitz KT, Rolo AP, Hamuro Y, Moss J, Perni RB, Ellis JL, Vlasuk GP, Sinclair DA. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. \u003cem\u003eScience\u003c\/em\u003e 2013;339:1216-9. — Crystal structure resolving SIRT1 allosteric activation.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003ePark SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 2012;148:421-33. — AMPK leg via PDE\/cAMP signaling.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eTomé-Carneiro J, Gonzálvez M, Larrosa M, García-Almagro FJ, Avilés-Plaza F, Parra S, Yáñez-Gascón MJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA, Espín JC. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e 2012;56:810-21.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eTomé-Carneiro J, Larrosa M, Yáñez-Gascón MJ, Dávalos A, Gil-Zamorano J, Gonzálvez M, García-Almagro FJ, Ruiz Ros JA, Tomás-Barberán FA, Espín JC, García-Conesa MT. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. \u003cem\u003ePharmacol Res\u003c\/em\u003e 2013;72:69-82.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eBhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. \u003cem\u003eNutr Res\u003c\/em\u003e 2012;32:537-41.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eMovahed A, Nabipour I, Lieben Louis X, Thandapilly SJ, Yu L, Kalantarhormozi M, Rekabpour SJ, Netticadan T. Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. \u003cem\u003eEvid Based Complement Alternat Med\u003c\/em\u003e 2013;2013:851267.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003ePollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O'Broin P, Sinclair DA, Bonkowski MS, Coleville AJ, Powell D, Kim S, Moaddel R, Stein D, Zhang K, Hawkins M, Crandall JP. Resveratrol improves vascular function and mitochondrial number but not glucose metabolism in older adults. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e 2017;72:1703-9.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWalle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e 2004;32:1377-82.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eSmoliga JM, Baur JA, Hausenblas HA. Resveratrol and health — a comprehensive review of human clinical trials. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e 2011;55:1129-41.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eVaz-da-Silva M, Loureiro AI, Falcao A, Nunes T, Rocha JF, Fernandes-Lopes C, Soares E, Wright L, Almeida L, Soares-da-Silva P. Effect of food on the pharmacokinetic profile of trans-resveratrol. \u003cem\u003eInt J Clin Pharmacol Ther\u003c\/em\u003e 2008;46:564-70.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. \u003cem\u003eCirculation\u003c\/em\u003e 2002;106:1652-8.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eCsiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z. Resveratrol induces mitochondrial biogenesis in endothelial cells. \u003cem\u003eAm J Physiol Heart Circ Physiol\u003c\/em\u003e 2009;297:H13-20.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eLagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. \u003cem\u003eCell\u003c\/em\u003e 2006;127:1109-22.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eYeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. \u003cem\u003eEMBO J\u003c\/em\u003e 2004;23:2369-80.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWitte AV, Kerti L, Margulies DS, Flöel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. \u003cem\u003eJ Neurosci\u003c\/em\u003e 2014;34:7862-70.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eKennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, Haskell CF. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e 2010;91:1590-7.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eOrnstrup MJ, Harsløf T, Kjær TN, Langdahl BL, Pedersen SB. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. \u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e 2014;99:4720-9.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eWong RH, Howe PR, Buckley JD, Coates AM, Kunz I, Berry NM. Acute resveratrol supplementation improves flow-mediated dilatation in overweight\/obese individuals with mildly elevated blood pressure. \u003cem\u003eNutr Metab Cardiovasc Dis\u003c\/em\u003e 2011;21:851-6.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eBrown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. \u003cem\u003eCancer Res\u003c\/em\u003e 2010;70:9003-11.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eGliemann L, Schmidt JF, Olesen J, Biensø RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J, Pilegaard H, Hellsten Y. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. \u003cem\u003eJ Physiol\u003c\/em\u003e 2013;591:5047-59.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 2013;153:1194-217. — Updated 2023 in \u003cem\u003eCell\u003c\/em\u003e 186:243-78. Foundational taxonomy of biological aging.\u003c\/p\u003e\n\u003cp style=\"font-size:0.9em;line-height:1.55;\"\u003e\u003cem\u003eReferences cited here are scientific context, not product endorsements. The molecular and clinical findings described above pertain to the molecules studied; this product supplies the same molecule (≥98% HPLC trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e) at a dose that overlaps the cited human-trial range. Individual results vary.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003chr\u003e\n\u003cp style=\"font-size:0.85em;line-height:1.55;\"\u003e\u003cem\u003e\u003cstrong\u003eFDA disclaimer:\u003c\/strong\u003e These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before starting any new supplement, particularly if you are pregnant, nursing, taking prescription medication (especially anticoagulants, antiplatelets, hormone-sensitive cancer treatments, CYP3A4 substrates), or have a known medical condition.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cdiv class=\"th-why-not-amazon\" style=\"margin:48px 0 24px;padding:24px;background:#f8f4ee;border-left:4px solid #9a5b3e;border-radius:6px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eWhy we don't sell this on Amazon\u003c\/h3\u003e\n  \u003cp\u003eAmazon's resveratrol category is a graveyard of UV-Vis-assayed knotweed extract sold as \"98% pure\" with no HPLC trans-anomer verification, ambiguous source-of-origin, and zero per-batch COA visibility. The sub-$15 price points only work because the active ingredient is partially cis-isomer drift — not the molecule any of the trials measured. We sell direct so we control the source (≥98% HPLC trans-resveratrol from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e), the per-batch COA stays public, and we can charge for verifiable molecular-grade material instead of competing with the bottom of the marketplace. Per active mg of trans-resveratrol, we're typically cheaper too. The math + the data: \u003ca href=\"\/pages\/why-not-amazon\" style=\"color:#9a5b3e;font-weight:600;\"\u003eread the full breakdown →\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take Resveratrol 600mg\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e With breakfast or lunch — whichever has the most fat. Eggs, avocado, butter, fatty fish, olive oil all work.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule daily (600 mg).\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eAvoid empty-stomach dosing\u003c\/strong\u003e — fasted bioavailability is roughly half of fed.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eAvoid evening dosing\u003c\/strong\u003e — cerebral blood-flow upregulation can interfere with sleep onset.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e: \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\" style=\"color:#9a5b3e;\"\u003eNMN 500mg\u003c\/a\u003e (or get both at -10% as the \u003ca href=\"\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\" style=\"color:#9a5b3e;\"\u003eLongevity Stack Bundle\u003c\/a\u003e).\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBottle = 30 days\u003c\/strong\u003e at 1 capsule daily. The cardiometabolic biomarker timeline is 8–12 weeks; budget 3 bottles before your first re-test.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/protocols\/how-to-take-it\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — 20 most common questions\u003c\/a\u003e covers shipping, kashrut, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/pages\/coa\" style=\"color:#9a5b3e;\"\u003eLab reports for every batch\u003c\/a\u003e — verifiable third-party COAs.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:kat@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail me directly\u003c\/a\u003e. I respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696174940378,"sku":"THP-RESV-600-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/resveratrol_02.jpg?v=1774728960"},{"product_id":"coq10-400mg-maximum-strength","title":"CoQ10 400mg | Fertility \u0026 Cellular Energy Support","description":"\u003cp\u003e\u003cstrong\u003e400 mg of pharmaceutical-grade CoQ10 per softgel\u003c\/strong\u003e — the studied therapeutic dose for mitochondrial energy production, cardiovascular muscle function, fertility (egg and sperm quality), statin-replacement support, and migraine prevention. One of the highest single-dose CoQ10 supplements in the catalog, formulated as a fat-carrier softgel because that is the absorption profile CoQ10 actually needs.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat CoQ10 does:\u003c\/strong\u003e sits at the centre of the electron transport chain (the process that generates ATP) inside every mitochondrion. Without it, ATP production drops; with less of it, the leftover electrons leak as oxidative damage instead of becoming usable cellular fuel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy supplement:\u003c\/strong\u003e endogenous CoQ10 production drops steadily after age 35 (roughly 50% by age 80, with measurable decline visible in the 30s and 40s). Statins deplete it further — they block HMG-CoA reductase, which is the same enzyme pathway your body uses to manufacture CoQ10. Several chronic conditions and a few common medications (metformin, certain beta-blockers, tricyclic antidepressants) also lower it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 40+, anyone on a statin (with their physician's awareness), couples working on fertility, athletes, recovery from illness or surgery, anyone running a longevity \/ mitochondrial stack, migraine-prone adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with food (with fat).\u003c\/strong\u003e CoQ10 is fat-soluble. Bioavailability drops sharply on an empty stomach — by some pharmacokinetic studies more than 3× lower (Hidaka 2008, Lopez-Lluch 2011). Lunch or dinner with olive oil, eggs, butter, avocado, or full-fat dairy works.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e ubiquinone (the standard, oxidatively stable form). Your body converts ubiquinone to ubiquinol on demand — for healthy adults under 60 the form rarely matters; what matters is dose, fat co-ingestion, and consistency.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrial-validated dose anchor:\u003c\/strong\u003e 300 mg\/day for 2 years in the Q-SYMBIO multicenter trial (Mortensen 2014). 600 mg\/day for 90 days in the Bentov fertility cohort. 100–400 mg\/day for 12 weeks in migraine-prevention trials (Sándor 2005, Shoeibi 2017). 400 mg sits squarely inside the studied therapeutic range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat CoQ10 actually does — the two roles\u003c\/h2\u003e\n\u003cp\u003eCoQ10 (Coenzyme Q10, also called ubiquinone) is a fat-soluble compound your body makes from the same mevalonate pathway that produces cholesterol. It concentrates in tissues with the highest sustained energy demand — heart muscle, kidneys, liver, brain, ovaries, testes — and plays two distinct roles, both inside the inner mitochondrial membrane:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eElectron transport in mitochondria.\u003c\/strong\u003e CoQ10 shuttles electrons between Complex I\/II and Complex III of the electron transport chain. That chain is the final stage of converting food into ATP — the energy currency every cell uses to do work. No CoQ10, no ATP. Less CoQ10, less efficient ATP production, and more leakage of electrons that turn into reactive oxygen species (ROS) instead of fuel (Crane 2001).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFat-soluble antioxidant in cell membranes.\u003c\/strong\u003e CoQ10 is one of the only antioxidants that lives inside the lipid bilayer. It protects mitochondrial membranes — which is exactly where the most ROS are produced in the first place — and regenerates other antioxidants like vitamin E and glutathione (Bentinger 2010, Alleva 1995). This is the closed-loop reason CoQ10 matters more for high-mitochondrial-density tissue: it both meets the ATP demand and absorbs the resulting oxidative load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProduction declines roughly 50% by age 80, with meaningful drops visible in the 30s and 40s (Kalén 1989). Heart tissue takes the biggest hit — by age 70, cardiac CoQ10 concentrations are typically less than half of what they were at 20. That is the cleanest mechanistic explanation for why CoQ10 has been studied so heavily in cardiovascular contexts.\u003c\/p\u003e\n\n\u003ch2\u003eWhere supplementation matters most\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeart muscle.\u003c\/strong\u003e The heart has the highest sustained ATP demand of any organ. CoQ10 concentration in cardiac tissue drops significantly with age and with cardiovascular disease, and supplementation has been studied extensively for cardiovascular support — the Q-SYMBIO multicenter trial (Mortensen 2014, n=420) used 300 mg\/day for 2 years and reported a significant reduction in major adverse cardiovascular events versus placebo. Talk to your physician if you are managing a cardiac condition; this is not a treatment, it is a cofactor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFertility (egg and sperm).\u003c\/strong\u003e Both egg and sperm quality depend heavily on mitochondrial energy. The egg is the largest cell in the body and contains roughly 100,000 mitochondria — it has to power its own first 5–7 days of cell division before the embryo can implant and start drawing nutrients from the mother. Sperm motility runs on a flagellum that is essentially a continuously firing ATP engine. CoQ10 has been incorporated into IVF and natural-conception protocols at 200–600 mg daily for 3+ months pre-conception; the egg maturation window is roughly 90 days, so the protocol mirrors that biology (Bentov 2010, 2014; Ben-Meir 2015 mouse data; Safarinejad 2009 sperm quality).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatin users.\u003c\/strong\u003e If you are on a statin your CoQ10 levels are reduced as a known side effect of how the drug works. Statins inhibit HMG-CoA reductase to lower cholesterol synthesis — but that same enzyme is the early step in your body's CoQ10 manufacturing pathway, so the depletion is mechanistic, not incidental (Folkers 1990, Mortensen 1997). Supplementing back toward normal levels is one of the most common medical reasons to take CoQ10 and is openly discussed by many cardiologists. Ask your physician about appropriate dosing for your specific situation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial \/ longevity stack.\u003c\/strong\u003e CoQ10 supports ATP production directly. NMN, NR, and NAD+ products raise NAD+ for the upstream pathway support; PQQ promotes the creation of new mitochondria; Urolithin A clears damaged mitochondria via mitophagy; CoQ10 keeps the resulting mitochondria fed and producing energy cleanly. Each step in the cycle is necessary; CoQ10 is the one that turns the lights on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMigraine-prone adults.\u003c\/strong\u003e 100–400 mg CoQ10 daily has been studied for migraine frequency reduction (Sándor 2005 RCT n=42; Shoeibi 2017 n=80; Dahri 2019 meta-analysis). Results are mixed-but-positive across multiple trials. The American Academy of Neurology and Canadian Headache Society have included CoQ10 in their migraine prevention guidance, with the caveat that evidence is moderate, not strong.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAthletes and post-exertion recovery.\u003c\/strong\u003e Sustained intense exercise depletes CoQ10 and shifts mitochondria toward higher ROS output. Endurance athletes and anyone doing \u0026gt;5 hours\/week of intense training tend to see the largest drops (Cooke 2008; Díaz-Castro 2012).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeriods of high mitochondrial demand.\u003c\/strong\u003e Recovery from surgery, illness, post-viral fatigue, long-COVID protocols. Your mitochondria are doing extra work; supplying the missing cofactor is reasonable (Mantle 2018 review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeriodontal and gum tissue.\u003c\/strong\u003e Gum tissue is one of the few peripheral tissues with surprisingly high CoQ10 demand. A small literature suggests benefit for gingival health at 60–200 mg\/day; not the primary use case, but a documented one (Hanioka 1994).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 400 mg specifically\u003c\/h2\u003e\n\u003cp\u003eThe studied dose range for CoQ10 is unusually wide, because different goals call for very different exposure:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e30–100 mg:\u003c\/strong\u003e general health maintenance for younger adults with no specific concern. This is what most off-the-shelf multivitamins include, and it is roughly enough to make up for ordinary age-related decline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e100–200 mg:\u003c\/strong\u003e heart support, statin replacement therapy. The typical \"cardiology recommendation\" range when a CoQ10 supplement is being suggested as adjunct support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e200–600 mg:\u003c\/strong\u003e fertility protocols (both partners), athletic recovery, and mitochondrial-support side of a longevity stack. This is also the range used in most published fertility studies — typically 300–600 mg\/day for 90 days pre-conception.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUp to 1,200–3,000 mg:\u003c\/strong\u003e studied in clinical trials for specific neurological and inherited mitochondrial conditions (Parkinson's at up to 1,200 mg\/day in Shults 2002; Huntington's at 600 mg\/day in Huntington Study Group 2001; mitochondrial encephalomyopathies up to 3,000 mg\/day under medical supervision). This is medical-supervision territory, not a self-directed dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e400 mg in a single softgel sits squarely inside the higher therapeutic range used in fertility, athletic, and longevity-focused research. If you only need general maintenance you can use half a softgel daily (or every other day, since CoQ10 has a long tissue half-life). If you are targeting fertility or stacking it with a serious longevity protocol, 400 mg is the dose most of the literature actually points to.\u003c\/p\u003e\n\n\u003ch2\u003eUbiquinone vs ubiquinol — the form question, answered honestly\u003c\/h2\u003e\n\u003cp\u003eCoQ10 exists in two interconvertible forms in your body: \u003cstrong\u003eubiquinone\u003c\/strong\u003e (the oxidized form, more stable in capsules) and \u003cstrong\u003eubiquinol\u003c\/strong\u003e (the reduced form, what your body uses to donate electrons in the antioxidant role). Most quality supplements use ubiquinone for two reasons:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eShelf stability.\u003c\/strong\u003e Ubiquinol oxidizes back to ubiquinone in air, in light, in heat, and during shelf storage. By the time a ubiquinol softgel reaches you, a meaningful percentage has typically already converted back. Ubiquinone is shelf-stable, which is why it dominates clinical research (Bhagavan 2007).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConversion is built in.\u003c\/strong\u003e Healthy adults under 60 convert ubiquinone to ubiquinol on demand, in the cells that need it (Mohr 1992). The interconversion is part of normal metabolism and does not require any special pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMost large clinical trials used ubiquinone.\u003c\/strong\u003e Q-SYMBIO, Sándor migraine, the Bentov fertility cohorts, virtually the entire pre-2010 cardiovascular literature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eUbiquinol is sometimes recommended for adults over 70, people with significant cardiovascular disease, or specific genetic differences in CoQ10 metabolism — situations where the conversion step itself may be impaired (Langsjoen 2008). For everyone else, ubiquinone at a meaningful dose with adequate dietary fat is the well-studied, lower-cost, well-evidenced choice. The bigger absorption variable, by far, is whether you take CoQ10 with fat (yes) or on an empty stomach (don't).\u003c\/p\u003e\n\n\u003ch2\u003eHow long until you notice it — the realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1–7 — plasma rises.\u003c\/strong\u003e Plasma CoQ10 reaches measurably higher levels within 4–8 hours of a fat-co-ingested dose, and steady-state plasma levels build over 5–10 days (Bhagavan 2007).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4 — first subjective shifts.\u003c\/strong\u003e People who were depleted (statin users, post-illness, age 60+, post-viral fatigue) often notice modestly improved exercise tolerance or reduced \"just-tired-all-the-time\" feeling here. This is not stimulant energy; it is more \"the floor is higher.\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8 — tissue saturation.\u003c\/strong\u003e Heart, muscle, ovary, and testis tissue reach steady-state levels. This is where any cardiovascular markers measured in studies typically begin to shift.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 12 — migraine prevention endpoint.\u003c\/strong\u003e Sándor 2005, Shoeibi 2017 and most modern migraine trials evaluate at 12 weeks. Frequency tends to drop more reliably than severity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 90 — fertility window closes.\u003c\/strong\u003e Egg maturation cycle ≈ 90 days; sperm production cycle ≈ 74 days. CoQ10 supplementation is consistently dosed for ≥90 days \u003cem\u003ebefore\u003c\/em\u003e the conception cycle, not during it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6–12 — the cardiovascular endpoint.\u003c\/strong\u003e Q-SYMBIO ran 2 years. Most NYHA-class trials run ≥12 months. CoQ10 is a long-horizon cofactor for this use case, not a short-cycle product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn-stop reversion.\u003c\/strong\u003e Plasma drops back to baseline within 1–2 weeks of stopping. Tissue CoQ10 reverts more slowly — over months. The implication is the obvious one: cycling CoQ10 is not necessary and arguably counterproductive. Daily continuous use is the standard pattern in research and in clinical practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with the rest of the catalog\u003c\/h2\u003e\n\u003cp\u003eCoQ10 is the most \"downstream\" mitochondrial supplement in the True Health Protocol catalog. It supports the actual energy-production step, after the upstream NAD+ machinery and biogenesis machinery have done their work. The natural pairings:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ NMN or NAD+ precursors\u003c\/strong\u003e — NMN raises NAD+ (upstream); CoQ10 supports ATP production (downstream). Sirtuin pathway + mitochondrial fuel, the canonical longevity stack base. \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e, or \u003ca href=\"\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ PQQ\u003c\/strong\u003e — PQQ helps create new mitochondria (biogenesis); CoQ10 makes sure the new ones can produce ATP. Mechanistically the cleanest CoQ10 stacking partner. \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Urolithin A\u003c\/strong\u003e — Urolithin A clears the damaged mitochondria via mitophagy (PINK1\/Parkin); CoQ10 powers the healthy ones that remain. The renewal\/output pair. \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Resveratrol or Pterostilbene\u003c\/strong\u003e — sirtuin-driven mitochondrial biogenesis. CoQ10 keeps the new mitochondria fed. \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Alpha-Lipoic Acid\u003c\/strong\u003e — ALA recycles CoQ10, vitamin C, vitamin E, and glutathione. The two of them together cover most of the mitochondrial antioxidant network. \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Calcium Alpha-Ketoglutarate\u003c\/strong\u003e — CaAKG drives the TCA cycle that feeds NADH\/FADH2 into the electron transport chain; CoQ10 then carries those electrons forward. The two-step substrate-and-shuttle pair. \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Creatine\u003c\/strong\u003e — creatine buffers cellular ATP via the phosphocreatine system, while CoQ10 supports its production. The two of them together cover most of the cellular bioenergetic stack. \u003ca href=\"\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Berberine\u003c\/strong\u003e — important if you have ever been on metformin, which depletes CoQ10 in the same direction statins do (Hu 2014). \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Astaxanthin and Glutathione\u003c\/strong\u003e — for the fertility \/ egg quality stack specifically. CoQ10 powers the egg's mitochondria, astaxanthin protects the membranes, glutathione handles oxidative load. \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e + \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Omega-3 Fish Oil\u003c\/strong\u003e — omega-3s are membrane substrate; CoQ10 lives inside that membrane. The cardiovascular pair. \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Taurine 1000 mg\u003c\/strong\u003e — taurine modifies mitochondrial tRNA to enable proper electron-transport-chain protein synthesis (Singh 2023 Science). CoQ10 then carries the electrons through that chain. The two-step \"build-the-engine + fuel-the-engine\" pair. \u003ca href=\"\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRead the complete protocol in our \u003ca href=\"\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol\u003c\/a\u003e or browse the \u003ca href=\"\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e for the full mitochondrial-support shelf, or the \u003ca href=\"\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity collection\u003c\/a\u003e for the heart-muscle stack.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 40+ where natural CoQ10 production has dropped noticeably\u003c\/li\u003e\n  \u003cli\u003eAnyone on a statin (with their physician's awareness) — the most well-established medical use case\u003c\/li\u003e\n  \u003cli\u003eAnyone on metformin, certain beta-blockers, tricyclic antidepressants, or other medications documented to deplete CoQ10\u003c\/li\u003e\n  \u003cli\u003eCouples working on fertility — both partners (egg and sperm quality)\u003c\/li\u003e\n  \u003cli\u003ePeople going through IVF cycles (under their reproductive endocrinologist's awareness)\u003c\/li\u003e\n  \u003cli\u003eAthletes and recovery from intense training blocks (\u0026gt;5 hours\/week sustained)\u003c\/li\u003e\n  \u003cli\u003eAnyone running a longevity stack and wanting downstream mitochondrial support\u003c\/li\u003e\n  \u003cli\u003eRecovery from illness, surgery, post-viral fatigue, periods of high mitochondrial demand\u003c\/li\u003e\n  \u003cli\u003eMigraine-prone adults willing to commit to a 12-week trial\u003c\/li\u003e\n  \u003cli\u003eAdults 70+ where ubiquinone-to-ubiquinol conversion may slow (a switch to ubiquinol is reasonable here, though ubiquinone at higher dose with fat still works)\u003c\/li\u003e\n  \u003cli\u003eAdults with diagnosed mitochondrial dysfunction working with a specialist\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople on warfarin without their prescriber's awareness.\u003c\/strong\u003e CoQ10 is structurally similar to vitamin K and may modestly reduce warfarin's anticoagulant effect. INR monitoring is required.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople in active chemotherapy.\u003c\/strong\u003e CoQ10–chemotherapy interactions are mixed in the literature (some protective, some theoretically reducing efficacy). Coordinate with your oncology team — never start independently.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting same-day stimulant energy.\u003c\/strong\u003e CoQ10 is a foundational cofactor that removes a deficiency — it does not add a kick. If you want stimulant energy, look elsewhere; you will be disappointed by CoQ10 and stop too early.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStrict vegans.\u003c\/strong\u003e Our softgel uses bovine gelatin shell. We do not currently offer a plant-cellulose CoQ10 capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant women without OB awareness.\u003c\/strong\u003e CoQ10 has been used in IVF and pre-conception protocols extensively, but data during active pregnancy is more limited. Talk to your OB before continuing through conception.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople under 18.\u003c\/strong\u003e CoQ10 is generally regarded as safe but the studied population is overwhelmingly adult.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who will skip the dietary fat step.\u003c\/strong\u003e If you cannot or will not take CoQ10 with a fat-containing meal, your absorption will be a fraction of what it should be. A low-dose, food-based approach is more honest in that situation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it on an empty stomach.\u003c\/strong\u003e The single biggest absorption loss. Take it with the largest fat-containing meal of the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it late at night.\u003c\/strong\u003e Some people find CoQ10 mildly stimulating because it raises ATP availability. If sleep is affected, move it to breakfast or lunch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying a $9 bottle and assuming it works.\u003c\/strong\u003e Independent lab testing has repeatedly shown that a meaningful percentage of cheap CoQ10 brands contain less than half their labeled dose, and some contain the wrong (cis) isomer. Per actual milligram of bioactive trans-CoQ10, pharmaceutical-grade is usually the cheaper math.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 2.\u003c\/strong\u003e CoQ10 is a long-horizon cofactor. Most studied endpoints — cardiovascular, fertility, migraine — show their effect at week 12 or later. The week-2 quitter is the single most common protocol failure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with a statin without telling your prescriber.\u003c\/strong\u003e Not because of risk, but because your cardiologist almost always already supports CoQ10 supplementation and may have a preferred protocol. Letting them know also keeps your medical record clean.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSplitting a 90-day fertility window across both partners' wallets.\u003c\/strong\u003e The published fertility protocols typically dose \u003cem\u003eeach\u003c\/em\u003e partner at 200–600 mg\/day for 90 days. Cutting one partner out halves the effect of the protocol, not the cost of it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling unnecessarily.\u003c\/strong\u003e CoQ10 does not downregulate. Daily continuous use is the standard. 5-on-2-off cycles or month-on-month-off cycles have no mechanistic justification and just produce uneven plasma levels.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching to ubiquinol because of marketing.\u003c\/strong\u003e Unless you are over 70 or have a specific reason to suspect the conversion step is impaired, ubiquinone is the well-studied form. Ubiquinol typically costs 2–3× more for unclear added benefit in most populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDrug interactions and safety\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWarfarin \/ Coumadin.\u003c\/strong\u003e CoQ10 is structurally similar to vitamin K and may modestly reduce the effect of warfarin. If you are on warfarin, talk to your prescriber before starting CoQ10, and your INR may need to be checked again at 4–6 weeks. Not a hard contraindication; just something your physician should know about.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives.\u003c\/strong\u003e CoQ10 may have a mild blood-pressure-lowering effect of its own. If you are on an antihypertensive, monitor BP for the first 6–8 weeks; doses occasionally need adjustment downward, which is a reason to coordinate with your prescriber rather than do it alone (Rosenfeldt 2007 meta-analysis).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChemotherapy.\u003c\/strong\u003e Some CoQ10–chemotherapy interactions are theoretical, some are protective. Always coordinate with your oncology team.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medication (insulin, sulfonylureas).\u003c\/strong\u003e CoQ10 may have a modest blood-sugar-lowering effect. Worth knowing if you are on insulin or a sulfonylurea so you can adjust monitoring.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy.\u003c\/strong\u003e CoQ10 has been used in IVF and pre-conception protocols extensively, but data during active pregnancy is more limited. Talk to your OB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGeneral safety profile.\u003c\/strong\u003e CoQ10 has an excellent safety record. Trials have run up to 1,200 mg\/day for 16 months in Parkinson's (Shults 2002) and up to 3,000 mg\/day under medical supervision in mitochondrial encephalomyopathies, with mild GI discomfort and insomnia (when taken late) being the most reported issues. The 400 mg daily dose in this product is well within the range studied for years in fertility, cardiovascular, and migraine contexts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 forever, or do I need to cycle it?\u003c\/strong\u003e CoQ10 does not downregulate the way some compounds do; long-term daily use is the standard pattern in research and in clinical practice. No cycling required.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMy urine turned bright yellow — is that bad?\u003c\/strong\u003e No, that is normal and means you are absorbing it. CoQ10 is a yellow pigment; the fat-soluble surplus passes through and tints the urine.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 if I am vegan?\u003c\/strong\u003e Our softgel uses bovine gelatin, so it is not strictly vegan. We may add a vegan capsule format in the future; for now, vegan-strict customers should look for plant-cellulose CoQ10 capsules elsewhere.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take CoQ10 in the morning or evening?\u003c\/strong\u003e Morning or midday with a fat-containing meal is best. Some people find it slightly stimulating and do not sleep well if they take it after 4 pm — which makes sense, given the energy mechanism. Others have no issue with evening dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan my partner and I both take it for fertility?\u003c\/strong\u003e Yes — that is the standard protocol. Both egg quality and sperm quality benefit from CoQ10 for the same mitochondrial-energy reasons. The recommended dose for each partner is identical: 200–400 mg daily for 90+ days pre-conception.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs 400 mg too much?\u003c\/strong\u003e No. CoQ10 has an excellent safety profile, with clinical trials running up to 1,200–3,000 mg daily in specific contexts under medical supervision. 400 mg is a therapeutic dose in the studied range — not a megadose.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I split the softgel?\u003c\/strong\u003e Softgels are designed to be swallowed whole, but if you only want 200 mg daily you can pierce the softgel with a clean pin and squeeze half the contents onto food (it has a slightly oily, neutral taste). Most people find it easier to just take one whole softgel every other day, which works because of CoQ10's long tissue half-life.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is CoQ10 so expensive in general?\u003c\/strong\u003e Pharmaceutical-grade CoQ10 is produced via fermentation, which is a slow, capital-intensive process. The cheap CoQ10 you see on Amazon is often diluted, mislabeled, or uses a synthetic isomer with much lower bioactivity. We test every batch for the trans-isomer (the bioactive form) and publish quality summaries — see the \u003ca href=\"\/pages\/quality\"\u003eQuality \u0026amp; Sourcing page\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 interact with statins or replace them?\u003c\/strong\u003e CoQ10 is a cofactor that statins deplete; it does not replace a statin. If you are on a statin, your physician likely already supports CoQ10 supplementation — many cardiologists recommend it routinely. Always coordinate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUbiquinone or ubiquinol — which one should I buy?\u003c\/strong\u003e For healthy adults under 60, ubiquinone (this product) at a meaningful dose with adequate dietary fat is the well-studied, lower-cost, well-evidenced choice. Ubiquinol is reasonable for adults 70+, advanced cardiovascular disease, or specific genetic differences in CoQ10 metabolism — situations where the conversion step itself may be impaired. The bigger absorption variable, by far, is whether you take CoQ10 with fat.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 help with long COVID or post-viral fatigue?\u003c\/strong\u003e Open question. There is plausible mechanism (mitochondrial dysfunction is a documented feature of long COVID) and a small handful of pilot studies, but no large RCTs yet. Many post-viral fatigue clinicians include CoQ10 in their stacks; the evidence is not yet at the level of the cardiovascular or fertility data.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs CoQ10 the same as Q10 or coenzyme Q?\u003c\/strong\u003e Yes — all three names refer to the same molecule. \"Q\" comes from the historical name \"ubiquinone\" (because it is ubiquitous in tissues). The 10 refers to its 10-unit isoprenoid side chain.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 with my morning coffee or NAD+ stack?\u003c\/strong\u003e Yes. CoQ10 does not interact meaningfully with caffeine, NMN, NR, resveratrol, or the rest of the NAD+ stack. Just make sure the CoQ10 is taken with a fat-containing meal — a coffee-only breakfast does not count.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 help with thyroid energy issues?\u003c\/strong\u003e A small literature suggests CoQ10 levels are lower in hypothyroid patients (Mancini 1989), and supplementation has been included in some functional-medicine protocols. Talk to your endocrinologist; this is more \"supportive cofactor\" than treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does this product compare to the CoQ10 I see in the NAD+ 5-in-1 formula?\u003c\/strong\u003e The 5-in-1 includes a smaller CoQ10 dose alongside NMN, B-complex, and antioxidants for an all-in-one daily. This standalone 400 mg softgel is what you reach for when you want a higher therapeutic dose specifically — fertility cycles, statin replacement, athletic recovery, migraine prevention, or stacking on top of your core NAD+ protocol.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy bovine gelatin softgel and not vegan capsule?\u003c\/strong\u003e CoQ10 is fat-soluble; bioavailability is dramatically higher when delivered in a fat-carrier softgel rather than a dry powder capsule. Hard-shell vegan CoQ10 capsules exist but typically need 2–3× the dose to match the same plasma exposure.\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1 softgel daily with a meal containing some fat — eggs, avocado, full-fat yogurt, butter on toast, olive oil, full-fat dairy. Lunch or dinner usually works better than breakfast for higher fat content. \u003cstrong\u003eCoQ10 absorption drops dramatically on an empty stomach\u003c\/strong\u003e (Hidaka 2008; Lopez-Lluch 2011). Daily consistency matters more than dose timing. For fertility protocols, take consistently for 90+ days before the conception cycle. For migraine prevention, evaluate at 12 weeks. For statin support, take on the same daily schedule as the statin.\u003c\/p\u003e\n\n\u003ch2\u003ePer-softgel ingredient panel\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e400 mg pharmaceutical-grade CoQ10 (ubiquinone, \u0026gt;98% trans-isomer, fermentation-derived)\u003c\/li\u003e\n  \u003cli\u003eCarrier oil base (medium-chain triglycerides) for fat-soluble absorption\u003c\/li\u003e\n  \u003cli\u003eBovine gelatin softgel shell, glycerin, purified water, natural mixed tocopherols (oxidation protection)\u003c\/li\u003e\n  \u003cli\u003eNo magnesium stearate, titanium dioxide, silicon dioxide, GMOs, gluten, soy, dairy, or artificial colors and flavors\u003c\/li\u003e\n  \u003cli\u003eUV-protective amber HDPE bottle, induction-sealed, 60-softgel count\u003c\/li\u003e\n  \u003cli\u003e60 softgels per bottle = 60-day supply at 1 softgel\/day, or 30-day supply at 2 softgels\/day for fertility\/longevity protocols\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and QC\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-certified, FDA-registered facility, manufactured in the USA.\u003c\/strong\u003e ISO 9001 quality system.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification\u003c\/strong\u003e for ≥98% trans-isomer purity (the bioactive form). Cis-isomer content reported on the COA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch heavy metals testing\u003c\/strong\u003e per USP \u0026lt;2232\u0026gt; (lead, arsenic, cadmium, mercury) to specification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch microbial limits testing\u003c\/strong\u003e per USP \u0026lt;2021\/2022\u0026gt; (total aerobic, yeast\/mold, E. coli, Salmonella, S. aureus).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch residual solvents\u003c\/strong\u003e per USP \u0026lt;467\u0026gt; — meaningful given fermentation-derived CoQ10 production.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch pesticide screening\u003c\/strong\u003e per USP \u0026lt;561\u0026gt; on the carrier oil.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOxidation protection\u003c\/strong\u003e via mixed tocopherols in the softgel matrix and amber HDPE bottle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e24-month shelf life\u003c\/strong\u003e from manufacture date (printed on bottom of bottle).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCOA available on request.\u003c\/strong\u003e See the \u003ca href=\"\/pages\/quality\"\u003eQuality \u0026amp; Sourcing page\u003c\/a\u003e and \u003ca href=\"\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing page\u003c\/a\u003e for detail on every active in the catalog.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStorage and quality\u003c\/h2\u003e\n\u003cp\u003eStore in a cool, dry place away from direct sunlight. CoQ10 in softgel form is stable at room temperature; refrigeration is not required but does not hurt. Avoid leaving the bottle in a hot car or near a stove. Best-by date is printed on the bottom of the bottle — typically 24 months from manufacture.\u003c\/p\u003e\n\n\u003ch2\u003eWhy not Amazon\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC for trans-isomer purity.\u003c\/strong\u003e Independent lab audits of CoQ10 marketplaces have repeatedly found products with less than half their labeled dose, or with the wrong (cis) isomer that has much lower bioactivity. Trans-isomer purity is reported on every batch we ship.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePharmaceutical-grade fermentation-derived CoQ10.\u003c\/strong\u003e Not synthetic, not blended with cheaper isomers, not \"CoQ10 complex\" with undeclared filler.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCatalog architecture.\u003c\/strong\u003e CoQ10 is one cofactor in a larger mitochondrial story (NAD+ upstream → biogenesis via PQQ → mitophagy via Urolithin A → fueling via CoQ10). The catalog is built so each piece has a defensible reason to be there.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on the science\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/coq10-and-statins-the-cofactor-your-statin-depletes-and-why-it-matters\"\u003eCoQ10 and Statins — the cofactor your statin depletes and why it matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — a practical 2026 protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/protocols\"\u003eProtocols — supplement stacks by goal\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/our-science\"\u003eOur Science — how the catalog is built\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/fertility\"\u003eFertility collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eMortensen SA et al. \u003cem\u003eThe effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO.\u003c\/em\u003e JACC Heart Fail. 2014;2(6):641–649.\u003c\/li\u003e\n  \u003cli\u003eSándor PS et al. \u003cem\u003eEfficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.\u003c\/em\u003e Neurology. 2005;64(4):713–715.\u003c\/li\u003e\n  \u003cli\u003eShoeibi A et al. \u003cem\u003eEffectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial.\u003c\/em\u003e Acta Neurol Belg. 2017;117(1):103–109.\u003c\/li\u003e\n  \u003cli\u003eBentov Y et al. \u003cem\u003eCoenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF–ICSI treatment.\u003c\/em\u003e Clin Med Insights Reprod Health. 2014;8:31–36.\u003c\/li\u003e\n  \u003cli\u003eBentov Y, Casper RF. \u003cem\u003eThe aging oocyte — can mitochondrial function be improved?\u003c\/em\u003e Fertil Steril. 2013;99(1):18–22.\u003c\/li\u003e\n  \u003cli\u003eBen-Meir A et al. \u003cem\u003eCoenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.\u003c\/em\u003e Aging Cell. 2015;14(5):887–895.\u003c\/li\u003e\n  \u003cli\u003eSafarinejad MR. \u003cem\u003eEfficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men.\u003c\/em\u003e J Urol. 2009;182(1):237–248.\u003c\/li\u003e\n  \u003cli\u003eFolkers K et al. \u003cem\u003eLovastatin decreases coenzyme Q levels in humans.\u003c\/em\u003e Proc Natl Acad Sci USA. 1990;87(22):8931–8934.\u003c\/li\u003e\n  \u003cli\u003eMortensen SA et al. \u003cem\u003eDose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.\u003c\/em\u003e Mol Aspects Med. 1997;18(Suppl):S137–144.\u003c\/li\u003e\n  \u003cli\u003eRosenfeldt FL et al. \u003cem\u003eCoenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.\u003c\/em\u003e J Hum Hypertens. 2007;21(4):297–306.\u003c\/li\u003e\n  \u003cli\u003eShults CW et al. \u003cem\u003eEffects of coenzyme Q10 in early Parkinson disease.\u003c\/em\u003e Arch Neurol. 2002;59(10):1541–1550.\u003c\/li\u003e\n  \u003cli\u003eBhagavan HN, Chopra RK. \u003cem\u003ePlasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.\u003c\/em\u003e Mitochondrion. 2007;7(Suppl):S78–88.\u003c\/li\u003e\n  \u003cli\u003eLopez-Lluch G et al. \u003cem\u003eBioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.\u003c\/em\u003e Nutrition. 2019;57:133–140.\u003c\/li\u003e\n  \u003cli\u003eHidaka T et al. \u003cem\u003eSafety assessment of coenzyme Q10.\u003c\/em\u003e Biofactors. 2008;32(1–4):199–208.\u003c\/li\u003e\n  \u003cli\u003eBentinger M et al. \u003cem\u003eCoenzyme Q — biosynthesis and functions.\u003c\/em\u003e Biochem Biophys Res Commun. 2010;396(1):74–79.\u003c\/li\u003e\n  \u003cli\u003eCrane FL. \u003cem\u003eBiochemical functions of coenzyme Q10.\u003c\/em\u003e J Am Coll Nutr. 2001;20(6):591–598.\u003c\/li\u003e\n  \u003cli\u003eKalén A, Appelkvist EL, Dallner G. \u003cem\u003eAge-related changes in the lipid compositions of rat and human tissues.\u003c\/em\u003e Lipids. 1989;24(7):579–584.\u003c\/li\u003e\n  \u003cli\u003eMancini A et al. \u003cem\u003ePlasma coenzyme Q10 in thyroid disease.\u003c\/em\u003e Acta Endocrinol (Copenh). 1989;121(4):504–508.\u003c\/li\u003e\n  \u003cli\u003eHu PJ et al. \u003cem\u003eEffects of metformin on coenzyme Q10 levels.\u003c\/em\u003e Cardiovasc Drugs Ther. 2014.\u003c\/li\u003e\n  \u003cli\u003eMantle D, Hargreaves I. \u003cem\u003eCoenzyme Q10 and degenerative disorders affecting longevity: an overview.\u003c\/em\u003e Antioxidants. 2018;8(2):44.\u003c\/li\u003e\n  \u003cli\u003eGarrido-Maraver J et al. \u003cem\u003eCoenzyme Q10 therapy.\u003c\/em\u003e Mol Syndromol. 2014;5(3–4):187–197.\u003c\/li\u003e\n  \u003cli\u003eSingh P et al. \u003cem\u003eTaurine deficiency as a driver of aging.\u003c\/em\u003e Science. 2023;380(6649):eabn9257. (Stack relevance.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eCitations are provided as scientific context — not as a claim that this product treats, prevents, or cures any disease. References are to mechanism and efficacy data; consult your physician for clinical decisions.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication (including statins, blood thinners, antihypertensives, or diabetes medication) or have a medical condition.\u003c\/em\u003e\n\n\u003cdiv class=\"th-trust-strip\" style=\"display:flex;flex-wrap:wrap;gap:16px;align-items:center;justify-content:center;padding:14px 18px;margin:16px 0;background:#faf7f2;border-radius:8px;font-size:0.9em;color:#555;\"\u003e\n  \u003cdiv\u003e🧪 \u003cstrong\u003e3rd-Party Lab Tested\u003c\/strong\u003e — \u003ca href=\"\/pages\/quality\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003eQuality \u0026amp; Sourcing →\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🇺🇸 Made in USA · USP Pharma Grade · cGMP \/ FDA-registered\u003c\/div\u003e\n  \u003cdiv\u003e📋 30-Day Money-Back Guarantee — \u003ca href=\"\/pages\/guarantee\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003edetails\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🚚 Free US Shipping over $60\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take CoQ10 400 mg — quick reference\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e with your largest fat-containing meal of the day (lunch or dinner is fine — fat-soluble, absorbs poorly without dietary fat). Move it earlier in the day if you find it slightly stimulating.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 softgel daily for general maintenance and statin support. 2 softgels daily (split with lunch and dinner) for fertility, athletic recovery, or longevity-stack contexts — well within studied range.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eEgg-quality protocol:\u003c\/strong\u003e 200–400 mg per day for 90 days minimum before each conception cycle. Egg maturation cycle ≈ 90 days. Sperm production cycle ≈ 74 days.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eMigraine protocol:\u003c\/strong\u003e 100–400 mg per day, evaluate at 12 weeks (Sándor 2005; Shoeibi 2017). Move dose earlier in the day if sleep is affected.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eCardiovascular \/ statin replacement:\u003c\/strong\u003e 100–300 mg\/day daily, indefinitely; coordinate with your cardiologist.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\" style=\"color:#9a5b3e;\"\u003eGlutathione 500 mg\u003c\/a\u003e + \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\" style=\"color:#9a5b3e;\"\u003eAstaxanthin 12 mg\u003c\/a\u003e for the full \u003ca href=\"\/collections\/fertility\" style=\"color:#9a5b3e;\"\u003eEgg Quality Stack\u003c\/a\u003e.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\" style=\"color:#9a5b3e;\"\u003ePQQ 20 mg\u003c\/a\u003e + \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\" style=\"color:#9a5b3e;\"\u003eUrolithin A 500 mg\u003c\/a\u003e for the full \u003ca href=\"\/collections\/mitochondrial-renewal\" style=\"color:#9a5b3e;\"\u003eMitochondrial Renewal stack\u003c\/a\u003e.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBright yellow urine?\u003c\/strong\u003e Normal. Means you are absorbing it — fat-soluble surplus passes through.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/pages\/protocols\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — most common questions\u003c\/a\u003e covers shipping, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/pages\/quality\" style=\"color:#9a5b3e;\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e — every batch tested, COAs available on request.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/pages\/getting-started\" style=\"color:#9a5b3e;\"\u003eGetting Started — where to begin\u003c\/a\u003e if this is your first supplement from us.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:support@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail support directly\u003c\/a\u003e. We respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696470409434,"sku":"THP-COQ10-400-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/coq10_03.jpg?v=1774728960"},{"product_id":"glutathione-500mg-maximum-strength","title":"Glutathione 500mg | Reduced GSH Enteric-Coated for Master Antioxidant, Liver \u0026 Skin","description":"\u003cp\u003e\u003cstrong\u003e500 mg of reduced L-Glutathione (GSH) per enteric-coated capsule\u003c\/strong\u003e — the active form of your body's master antioxidant, encapsulated to bypass stomach proteolysis and absorb in the small intestine. Glutathione is the dominant intracellular antioxidant, the central node of Phase II liver detoxification, and the molecule white blood cells, hepatocytes and skin keratinocytes depend on for redox balance. Pair with our \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e + \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e for the GlyNAC precursor strategy validated by Sekhar's Baylor trials.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat glutathione is:\u003c\/strong\u003e a tripeptide (L-cysteine + L-glutamate + L-glycine) present in every nucleated cell at \u003cem\u003emillimolar\u003c\/em\u003e concentrations — orders of magnitude higher than vitamin C or vitamin E. The dominant intracellular antioxidant and the substrate for Phase II conjugation in liver detox.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy levels fall with age:\u003c\/strong\u003e Sekhar's group at Baylor (\u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e, 2011; \u003cem\u003eJournals of Gerontology\u003c\/em\u003e, 2018; \u003cem\u003eClinical \u0026amp; Translational Medicine\u003c\/em\u003e, 2021; \u003cem\u003eNutrients\u003c\/em\u003e, 2022) has shown a roughly 50% drop in red-blood-cell GSH and a 230% rise in oxidative stress markers between young adults and adults aged 70+, driven by reduced cysteine + glycine availability for endogenous synthesis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDoes oral glutathione actually work?\u003c\/strong\u003e Two-phase answer. Witschi 1992 (\u003cem\u003eEuropean Journal of Clinical Pharmacology\u003c\/em\u003e) showed a single 3 g oral dose did not raise plasma GSH. But longer-duration RCTs change the picture — Richie 2015 (\u003cem\u003eEuropean Journal of Nutrition\u003c\/em\u003e), Schmitt 2015 (\u003cem\u003eFree Radical Biology \u0026amp; Medicine\u003c\/em\u003e), Allen 2011 (\u003cem\u003eJournal of Alternative \u0026amp; Complementary Medicine\u003c\/em\u003e), Sinha 2018 (\u003cem\u003eEuropean Journal of Clinical Nutrition\u003c\/em\u003e), and Park 2014 (\u003cem\u003eJournal of Korean Medical Science\u003c\/em\u003e) all reported elevations in body GSH stores, redox markers, or clinical readouts with daily oral dosing for 4 weeks to 6 months. The mechanism is partly direct enterocyte uptake and partly amino-acid recycling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy reduced (GSH) vs oxidized (GSSG):\u003c\/strong\u003e reduced is the active form your cells actually use. Oxidized has to be re-reduced before it does anything. We use reduced.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy enteric-coated:\u003c\/strong\u003e stomach pepsin and acid hydrolyze unprotected glutathione into its amino acid components within minutes. The coating delivers an intact tripeptide to the small intestine, where peptide-transporter (PEPT1) and carrier-mediated uptake happens.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest stack:\u003c\/strong\u003e + \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e (recycles oxidized GSSG back to GSH) + \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e + \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e (GlyNAC precursor pair) + \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e (recycles GSSG and reduces other antioxidants).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy intracellular GSH actually matters — the redox math\u003c\/h2\u003e\n\u003cp\u003eMost antioxidants you read about (vitamin C, vitamin E, polyphenols) operate at micromolar concentrations in plasma. Glutathione operates at \u003cem\u003emillimolar\u003c\/em\u003e concentrations \u003cem\u003einside cells\u003c\/em\u003e — about 1,000× higher. In liver cells the cytosolic concentration sits between 5 and 10 mmol\/L. In red blood cells it's 1–3 mmol\/L. This is the difference between a guest antioxidant and the structural redox buffer of the cell.\u003c\/p\u003e\n\u003cp\u003eThat millimolar concentration drives four jobs no other molecule does as well (Pizzorno 2014, \u003cem\u003eIntegrative Medicine\u003c\/em\u003e):\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect free-radical neutralization.\u003c\/strong\u003e The cysteine thiol (-SH) donates an electron to neutralize hydroxyl radicals, peroxynitrite, hypochlorite, and lipid peroxides. Two GSH molecules fuse via the freshly oxidized thiols to form GSSG (oxidized glutathione disulfide).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlutathione peroxidase (GPx) cycle.\u003c\/strong\u003e The selenium-dependent enzyme GPx uses GSH as the electron donor to reduce hydrogen peroxide to water and lipid peroxides to alcohols — the cell's primary line of defense against the byproducts of mitochondrial respiration.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePhase II liver conjugation.\u003c\/strong\u003e Glutathione-S-transferase (GST) enzymes attach GSH to electrophilic toxins (heavy metals, drug metabolites, alcohol-derived acetaldehyde, polycyclic aromatic hydrocarbons, environmental xenobiotics). The conjugate becomes water-soluble and is excreted via bile or urine. This is the single most important elimination pathway for fat-soluble toxins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtein S-glutathionylation.\u003c\/strong\u003e GSH reversibly binds protein cysteines, protecting them from irreversible oxidation and acting as a redox-signaling switch for transcription factors like NF-κB and Nrf2 (Lyons 2000, \u003cem\u003ePNAS\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe body's GSH:GSSG ratio is the primary indicator of cellular redox state. A healthy cell maintains it above 100:1. Aging, chronic disease, and metabolic stress collapse it toward 10:1 — the biochemical fingerprint of oxidative stress.\u003c\/p\u003e\n\n\u003ch2\u003eWhy glutathione depletes — and what aging actually does\u003c\/h2\u003e\n\u003cp\u003eSekhar and colleagues at Baylor College of Medicine ran a series of stable-isotope-tracer studies that shifted the field's understanding of why older adults run low on GSH. Three findings:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSynthesis rate drops.\u003c\/strong\u003e Older adults synthesize new GSH at roughly half the rate of younger adults — but the rate-limiting step turns out to be precursor availability, not enzymatic capacity. The cells \u003cem\u003ecan\u003c\/em\u003e make it; they just don't have enough cysteine and glycine to do so (Sekhar 2011, \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdding the precursors restores it.\u003c\/strong\u003e Two weeks of oral cysteine (as NAC) + glycine restored GSH levels in older adults to the levels of young adults, with parallel reductions in oxidative stress, mitochondrial dysfunction, insulin resistance, and inflammation markers (Sekhar 2018, \u003cem\u003eJournals of Gerontology\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe benefits scale with duration.\u003c\/strong\u003e 24-week and 36-week GlyNAC interventions in older adults produced larger effects on cognitive function, walking speed, grip strength, gait, and mitochondrial efficiency than short interventions (Sekhar 2021, \u003cem\u003eClinical \u0026amp; Translational Medicine\u003c\/em\u003e; Sekhar 2022, \u003cem\u003eNutrients\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOther depleters compound the age trend:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChronic inflammation\u003c\/strong\u003e — every burst of NADPH-oxidase activity by macrophages and neutrophils consumes GSH\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlcohol\u003c\/strong\u003e — heavy use depletes hepatic GSH within hours and causes longer-term suppression of synthesis\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAcetaminophen (paracetamol)\u003c\/strong\u003e — even therapeutic doses use up hepatic GSH; overdose toxicity is mediated by GSH exhaustion (this is why the antidote is \u003cem\u003emore\u003c\/em\u003e NAC, the cysteine precursor)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePollution, mold, heavy metals\u003c\/strong\u003e — every Phase II conjugation event consumes GSH\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHard exercise and surgery\u003c\/strong\u003e — temporary deep depletion during high-demand periods (Pingitore 2015, \u003cem\u003eNutrition\u003c\/em\u003e)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsufficient protein, particularly low-cysteine diets\u003c\/strong\u003e — limits substrate availability\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe \"does oral glutathione actually work?\" question — answered honestly\u003c\/h2\u003e\n\u003cp\u003eThis is the most common skeptical question about any oral GSH supplement, and the literature is more nuanced than either side of the marketing debate suggests.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe case for skepticism (short-term plasma studies):\u003c\/strong\u003e Witschi 1992 (\u003cem\u003eEuropean Journal of Clinical Pharmacology\u003c\/em\u003e) gave a single 3 g oral dose of unprotected GSH and found no rise in plasma GSH at any time point. The conclusion at the time was that oral glutathione is hydrolyzed in the gut into cysteine, glycine, and glutamate, and only those amino acids reach the bloodstream.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe case for daily consistent dosing (longer-duration RCTs):\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRichie 2015\u003c\/strong\u003e (\u003cem\u003eEuropean Journal of Nutrition\u003c\/em\u003e) — 6 months of 250 mg or 1000 mg\/day raised body stores of GSH measured in red blood cells, plasma, lymphocytes, and exfoliated buccal mucosal cells, with dose-dependent magnitude.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSchmitt 2015\u003c\/strong\u003e (\u003cem\u003eFree Radical Biology \u0026amp; Medicine\u003c\/em\u003e) — 1 g\/day for 4 weeks elevated body stores and reduced markers of oxidative DNA damage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllen \u0026amp; Bradley 2011\u003c\/strong\u003e (\u003cem\u003eJournal of Alternative \u0026amp; Complementary Medicine\u003c\/em\u003e) — sublingual and buccal GSH absorption pilot, showed measurable plasma elevation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSinha 2018\u003c\/strong\u003e (\u003cem\u003eEuropean Journal of Clinical Nutrition\u003c\/em\u003e) — liposomal GSH at 500 or 1000 mg\/day for 4 weeks elevated lymphocyte GSH and improved natural-killer-cell cytotoxicity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePark 2014\u003c\/strong\u003e (\u003cem\u003eJournal of Korean Medical Science\u003c\/em\u003e) and \u003cstrong\u003eWatanabe 2014\u003c\/strong\u003e (\u003cem\u003eAnnals of Dermatology\u003c\/em\u003e) and \u003cstrong\u003eWeschawalit 2017\u003c\/strong\u003e (\u003cem\u003eClinical, Cosmetic and Investigational Dermatology\u003c\/em\u003e) — oral GSH 250–500 mg\/day for 4–12 weeks improved skin tone, melanin index, and elasticity in dermatology RCTs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHonda 2017\u003c\/strong\u003e (\u003cem\u003eBMC Gastroenterology\u003c\/em\u003e) — 300 mg\/day for 4 months reduced ALT and liver fat in NAFLD patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat this tells us:\u003c\/strong\u003e a single dose study is not the right experiment for a molecule whose job is to be present at millimolar concentrations day-in, day-out. Daily oral GSH appears to elevate body stores via a combination of direct enterocyte uptake (PEPT1 transporter), small-intestinal absorption of intact tripeptide, and amino-acid recycling. Enteric coating protects the larger fraction from premature gastric breakdown.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe \"even more bioavailable\" alternatives:\u003c\/strong\u003e liposomal GSH and IV\/IM glutathione achieve higher peak levels per dose, but at meaningful price differential. For most people, daily 500 mg enteric-coated reduced GSH plus the GlyNAC precursors gets you to the same destination at a fraction of the cost.\u003c\/p\u003e\n\n\u003ch2\u003eReduced (GSH) vs oxidized (GSSG) — and why we don't compromise\u003c\/h2\u003e\n\u003cp\u003eGlutathione exists in two interconvertible forms inside the cell: reduced (GSH) and oxidized (GSSG). Only the reduced form is the active antioxidant. After GSH neutralizes a free radical, it becomes GSSG. Glutathione reductase, an NADPH-dependent enzyme, regenerates GSH from GSSG.\u003c\/p\u003e\n\u003cp\u003eSome lower-cost supplements list \"glutathione\" without specifying which form. The oxidized form is more shelf-stable and cheaper to source, but it has to first be reduced inside the cell before it does anything — and that reduction step itself consumes NADPH (limiting your antioxidant network elsewhere). The label test: look for \"reduced L-glutathione,\" \"L-glutathione (GSH),\" or \"Setria®\"-grade reduced glutathione.\u003c\/p\u003e\n\n\u003ch2\u003eForm comparison — six routes for raising GSH\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReduced oral GSH (this product):\u003c\/strong\u003e 250–1000 mg\/day. Inexpensive, daily-consistent, multi-site RCT support (Richie, Schmitt, Park, Watanabe, Weschawalit, Honda). Best for foundational daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal oral GSH:\u003c\/strong\u003e 500–1000 mg\/day. Higher per-dose absorption (Sinha 2018). Premium option; 2–3× the cost.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eS-acetyl glutathione:\u003c\/strong\u003e stable in stomach, deacetylated intracellularly. Less RCT evidence than reduced GSH.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAC + glycine (GlyNAC):\u003c\/strong\u003e precursor strategy. Cheapest per-dose, strongest mechanistic and clinical evidence in older adults (Sekhar 2018\/2021\/2022). Complements but does not replace pre-formed GSH.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIV\/IM glutathione:\u003c\/strong\u003e highest peak levels, used in clinical settings for Parkinson's pilot trials (Hauser 2009, \u003cem\u003eMovement Disorders\u003c\/em\u003e) and acetaminophen toxicity. Cost-prohibitive and inconvenient for daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInhaled (nebulized) glutathione:\u003c\/strong\u003e direct lung delivery, used in cystic-fibrosis research. Niche.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe smart strategy is layered: daily reduced oral GSH for baseline, NAC + glycine for synthesis substrate, and vitamin C + ALA for recycling. That stack hits glutathione from three angles simultaneously — pre-formed delivery, fresh synthesis, and continuous regeneration.\u003c\/p\u003e\n\n\u003ch2\u003eFive-domain RCT bench\u003c\/h2\u003e\n\n\u003ch3\u003e1. Skin tone, brightness and melanin index\u003c\/h3\u003e\n\u003cp\u003eGlutathione is a tyrosinase inhibitor — it binds the copper site of the enzyme that converts L-tyrosine into melanin pigment, biasing melanocytes toward producing the lighter pheomelanin instead of darker eumelanin. The dermatology trial bench:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWatanabe 2014\u003c\/strong\u003e (\u003cem\u003eAnnals of Dermatology\u003c\/em\u003e) — 250 mg\/day for 4 weeks reduced melanin index and UV-induced pigment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeschawalit 2017\u003c\/strong\u003e (\u003cem\u003eClinical, Cosmetic and Investigational Dermatology\u003c\/em\u003e) — 500 mg\/day oral GSH for 12 weeks improved skin elasticity and reduced wrinkles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eArjinpathana \u0026amp; Asawanonda 2012\u003c\/strong\u003e (\u003cem\u003eJournal of Dermatological Treatment\u003c\/em\u003e) — 500 mg\/day for 4 weeks lowered melanin index measured by Mexameter.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHandog 2016\u003c\/strong\u003e (\u003cem\u003eInternational Journal of Dermatology\u003c\/em\u003e) — buccal GSH troches lowered melanin index over 8 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eImportant framing: results are gradual (8–12 weeks), and the effect is even-tone and reduced dullness rather than dramatic lightening. Effects compound when paired with adequate vitamin C and consistent SPF — UV exposure regenerates the pigmentation glutathione is helping to clear.\u003c\/p\u003e\n\n\u003ch3\u003e2. Liver and detoxification support\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHonda 2017\u003c\/strong\u003e (\u003cem\u003eBMC Gastroenterology\u003c\/em\u003e) — 300 mg\/day for 4 months reduced ALT and ultrasound-measured liver fat in non-alcoholic fatty liver disease patients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLoguercio 2015\u003c\/strong\u003e (\u003cem\u003eHepatic Medicine\u003c\/em\u003e) — IV\/oral combination protocol benefits in alcohol-related liver disease.\u003c\/li\u003e\n  \u003cli\u003eAcetaminophen toxicity remains the textbook case: NAC is the antidote because it replenishes hepatic GSH faster than oral GSH alone (Smilkstein 1988).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e3. Immune function and viral defense\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSinha 2018\u003c\/strong\u003e (\u003cem\u003eEuropean Journal of Clinical Nutrition\u003c\/em\u003e) — 4 weeks of 500–1000 mg\/day liposomal GSH increased natural-killer-cell cytotoxicity and lymphocyte GSH stores.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDe Rosa 2000\u003c\/strong\u003e (\u003cem\u003eEuropean Journal of Clinical Investigation\u003c\/em\u003e) — NAC restored GSH and T-cell function in immunocompromised patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e4. Oxidative-stress and aging biomarkers\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSekhar 2018\u003c\/strong\u003e (\u003cem\u003eJournals of Gerontology\u003c\/em\u003e) and \u003cstrong\u003eSekhar 2021\u003c\/strong\u003e (\u003cem\u003eClinical \u0026amp; Translational Medicine\u003c\/em\u003e) — GlyNAC precursors restored GSH and improved insulin resistance, mitochondrial function, walking speed, grip strength, and inflammatory markers in older adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRichie 2015\u003c\/strong\u003e (\u003cem\u003eEuropean Journal of Nutrition\u003c\/em\u003e) — 6 months oral GSH lowered systemic oxidative stress markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003e5. Neurological pilot data\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHauser 2009\u003c\/strong\u003e (\u003cem\u003eMovement Disorders\u003c\/em\u003e) — IV glutathione pilot in early Parkinson's disease showed modest motor improvements; later oral and intranasal trials remain mechanistic \/ pilot-stage rather than confirmatory.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMischley 2015\u003c\/strong\u003e (\u003cem\u003enpj Parkinson's Disease\u003c\/em\u003e) — intranasal GSH bioavailability and tolerability data.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNeurological data is preliminary. We list it for completeness, not as a primary indication.\u003c\/p\u003e\n\n\u003ch2\u003eStack architecture — three ways to use Glutathione 500 mg\u003c\/h2\u003e\n\n\u003ch3\u003eStack A — The redox network (foundational antioxidant defense)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eGlutathione 500 mg — pre-formed master antioxidant, daily AM\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e — recycles GSSG back to GSH, plus parallel collagen-cofactor work\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e — universal antioxidant that regenerates both vitamin C and glutathione (Packer 1995)\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e — membrane-spanning carotenoid for the lipid-bilayer compartment\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e — mitochondrial-membrane redox\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is the closed-loop redox network: each molecule recycles or complements another, so you're not just adding antioxidants in parallel — you're extending the half-life of every electron donation.\u003c\/p\u003e\n\n\u003ch3\u003eStack B — GlyNAC precursor pair (the Sekhar protocol)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eGlutathione 500 mg — pre-formed delivery to elevate stores fast\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eN-Acetyl Cysteine 600 mg\u003c\/a\u003e — the rate-limiting cysteine precursor, twice daily\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e — the second precursor with parallel sleep, methylation, and collagen roles\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e — methyl-donor support to keep one-carbon flow balanced when sulfur amino acids are running high\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is the strategy validated by Sekhar's Baylor trials in older adults. Combining pre-formed GSH with the substrate pair raises stores faster and keeps them elevated.\u003c\/p\u003e\n\n\u003ch3\u003eStack C — Beauty \u0026amp; skin (the brightening protocol)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eGlutathione 500 mg — tyrosinase inhibition for even tone\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e — tyrosinase inhibition + collagen synthesis cofactor + GSSG recycler\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e or \u003ca href=\"\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti Collagen Powder\u003c\/a\u003e — dermal matrix substrate\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vitamin C\u003c\/a\u003e — hydration and assembly cofactor\u003c\/li\u003e\n  \u003cli\u003e+ \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e — membrane-spanning photoprotection\u003c\/li\u003e\n  \u003cli\u003eOr grab the bundled \u003ca href=\"\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e for the collagen + biotin + HA core\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for — and who it's not for\u003c\/h2\u003e\n\n\u003ch3\u003eThis product is for you if:\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eYou're focused on skin brightness, even tone, or reducing dullness — and willing to commit to 8–12 weeks of consistent daily use plus SPF\u003c\/li\u003e\n  \u003cli\u003eYou're working on liver health, a fatty-liver protocol, or post-alcohol\/post-medication recovery\u003c\/li\u003e\n  \u003cli\u003eYou're 35+ and want a daily redox baseline (the GSH age-decline curve starts roughly here)\u003c\/li\u003e\n  \u003cli\u003eYou live or work in a high-toxin environment — frequent travel, urban pollution, occupational chemical exposure, mold remediation, water from older municipal systems\u003c\/li\u003e\n  \u003cli\u003eYou're a hard exerciser or athlete — exercise temporarily depletes GSH (Pingitore 2015)\u003c\/li\u003e\n  \u003cli\u003eYou're recovering from illness, surgery, or a course of medication — these are documented depletion windows\u003c\/li\u003e\n  \u003cli\u003eYou're already on NAC \/ glycine (GlyNAC) and want to add pre-formed delivery\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eThis product is \u003cem\u003enot\u003c\/em\u003e for you if:\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou're pregnant or breastfeeding\u003c\/strong\u003e — no safety data for supplemental glutathione; talk to your obstetrician\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou're under 18\u003c\/strong\u003e — physiology is different and clinical trials are in adults\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou're undergoing chemotherapy or active oncology treatment\u003c\/strong\u003e — discuss antioxidant timing with your oncologist; some therapies depend on oxidative damage to tumor cells, and the current consensus is to avoid systemic antioxidant supplementation around treatment unless your oncologist directs it\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou have an organ transplant on immunosuppressants\u003c\/strong\u003e — discuss with your transplant team\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou have severe asthma triggered by sulfites\u003c\/strong\u003e — sulfur-containing supplements occasionally aggravate sulfite-sensitive asthma; start low and watch\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYou're expecting dramatic skin lightening\u003c\/strong\u003e — adjust expectations: oral GSH is gradual, modest, and works best with parallel sun protection\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 1–2:\u003c\/strong\u003e nothing visible yet. Body stores begin filling; redox markers begin to shift on the inside.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e some users notice steadier energy, less post-alcohol\/post-toxin grogginess, and a subtle reduction in skin dullness. Liver biomarkers in NAFLD trials begin shifting around the 4-week mark.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e the dermatology RCT window. Watanabe 2014 (4 weeks) and Arjinpathana 2012 (4 weeks) showed melanin-index reduction; Weschawalit 2017 (12 weeks) extended that to elasticity and wrinkle markers. This is when consistent users start noticing more even tone and reduced post-inflammatory pigmentation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 2–3:\u003c\/strong\u003e the Richie 2015 6-month time course shows continued elevation of body GSH stores and continued reduction in oxidative-stress markers. Clinical readouts plateau around this window for most people.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 3+:\u003c\/strong\u003e the Sekhar GlyNAC 24-week trials show downstream improvements in walking speed, grip strength, mitochondrial function, and inflammatory markers in older adults. These are the longer-arc returns.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGlutathione is a foundational supplement, not a stimulant. Daily consistency matters more than dose timing or stack complexity.\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1 capsule daily on an empty stomach or between meals — enteric coating is most reliable when not mixed with a fatty meal that delays gastric emptying. Two convenient windows:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMorning before breakfast\u003c\/strong\u003e (15–30 minutes prior). Pairs naturally with morning vitamin C and the morning half of the GlyNAC pair.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMid-afternoon between lunch and dinner.\u003c\/strong\u003e Pairs with the afternoon half of split-dose stacks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor higher demand windows (heavy exercise weeks, post-illness, post-medication recovery, mold remediation, post-alcohol), a 2-capsule split dose (1 AM + 1 PM) is reasonable for 4–8 weeks. Daily consistency is the single biggest determinant of how much body stores rise.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in it — full label transparency\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eEach capsule provides:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e500 mg reduced L-Glutathione (GSH)\u003c\/strong\u003e — the active, antioxidant-form tripeptide\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnteric-coated capsule shell\u003c\/strong\u003e — pH-resistant coating that survives gastric acid and dissolves at the small-intestinal pH (≥6.0) for systemic absorption\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNot in it:\u003c\/strong\u003e no proprietary blends, no oxidized GSSG filler, no titanium dioxide, no magnesium stearate, no artificial colors, no GMOs, no soy, no gluten, no added sugar.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 enteric-coated capsules, 60-day supply at the foundational 1-capsule daily dose; 30-day supply at the 2-capsule loading dose.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing — what to actually look for on a glutathione label\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\"Reduced L-glutathione,\" \"L-glutathione (GSH),\" or \"Setria® L-glutathione.\"\u003c\/strong\u003e If it just says \"glutathione\" with no form specified, assume oxidized.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnteric coating, not just a regular capsule.\u003c\/strong\u003e The pH-sensitive coating is what protects the tripeptide from gastric pepsin. A standard veg cap dissolves in stomach acid within minutes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-capsule dose stated, not just per-serving.\u003c\/strong\u003e \"500 mg per serving (2 capsules)\" is half the per-capsule dose of \"500 mg per capsule.\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party testing.\u003c\/strong\u003e cGMP facility, USP- or NSF-equivalent identity, potency, and contaminant testing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLight-protective packaging.\u003c\/strong\u003e GSH oxidizes on exposure to light and air; amber HDPE bottles with intact safety seals matter for shelf-life.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHonest absorption framing.\u003c\/strong\u003e Be skeptical of \"10x absorption\" claims that aren't tied to a peer-reviewed PK study. The honest framing is \"daily consistent oral GSH plus enteric coating raises body stores over weeks-to-months.\"\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and edge cases\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGenerally well tolerated.\u003c\/strong\u003e Most reported side effects in oral GSH RCTs have been mild GI symptoms (gas, loose stools) and resolve with food or dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsthma sensitivity.\u003c\/strong\u003e Reports of bronchospasm with nebulized GSH in sulfite-sensitive asthmatics. Oral data show no signal, but worth noting if you're sulfite-sensitive — start with a single low dose and observe.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChemotherapy.\u003c\/strong\u003e The general principle: avoid systemic antioxidant supplementation around oncology treatment unless your oncologist explicitly directs otherwise. Many chemotherapies depend on oxidative tumor damage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImmunosuppressed organ-transplant recipients.\u003c\/strong\u003e Discuss with your transplant team — antioxidants can theoretically interact with immune-modulating regimens.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy\/breastfeeding.\u003c\/strong\u003e No safety data; defer to obstetric guidance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions.\u003c\/strong\u003e No major documented interactions with common medications. The acetaminophen interaction is supportive, not adverse — GSH (and especially NAC) restores hepatic stores depleted by acetaminophen metabolism.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage.\u003c\/strong\u003e Keep the bottle tightly sealed in a cool, dry, dark place. Do not transfer capsules to a clear or unsealed container — light and oxygen oxidize GSH on the shelf.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis product is a dietary supplement. It is not a treatment for any disease. If you have a medical condition, take prescription medication, or are pregnant or breastfeeding, consult your physician before starting.\u003c\/p\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes oral glutathione actually raise my body's glutathione, or is it broken down in the gut?\u003c\/strong\u003e\u003cbr\u003e\nBoth, depending on time-frame. A single oral dose doesn't reliably raise plasma GSH (Witschi 1992). But daily oral dosing for 4 weeks to 6 months consistently raises body stores in red blood cells, plasma, lymphocytes, and buccal mucosal cells (Richie 2015; Schmitt 2015; Sinha 2018). The mechanism is partly direct enterocyte uptake and partly amino-acid recycling. The honest framing is \"consistent daily dosing for weeks-to-months,\" not \"instant plasma elevation.\"\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eReduced GSH vs liposomal GSH vs S-acetyl GSH — which should I buy?\u003c\/strong\u003e\u003cbr\u003e\nFor most people, daily reduced enteric-coated oral GSH (this product) at 250–1000 mg\/day is the best cost\/benefit ratio, with the largest RCT bench. Liposomal GSH gets to higher peak levels per dose (Sinha 2018) but costs 2–3× more per equivalent dose; reasonable if budget is not a constraint and you want fastest elevation. S-acetyl GSH has less RCT support than reduced GSH despite stronger marketing claims.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I see skin tone changes?\u003c\/strong\u003e\u003cbr\u003e\nDermatology RCTs (Watanabe 2014, Arjinpathana 2012, Weschawalit 2017, Park 2014) show measurable melanin-index reduction at 4–12 weeks of daily 250–500 mg dosing. Effects are gradual, modest, and concentrate on even tone and dullness reduction rather than dramatic lightening. Stack with vitamin C and consistent SPF for biggest effect.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I take glutathione AND NAC AND glycine, or just one?\u003c\/strong\u003e\u003cbr\u003e\nThe strongest strategy is layered — oral GSH for pre-formed delivery, NAC for the cysteine precursor, and glycine for the second precursor. The Sekhar GlyNAC trials show NAC + glycine alone restored GSH in older adults; adding pre-formed GSH on top accelerates the elevation. If budget forces you to pick two, oral GSH + NAC is the most popular combination; oral GSH + glycine works for those who already get cysteine from diet (eggs, whey, etc.).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsule and dissolve in water for \"better absorption\"?\u003c\/strong\u003e\u003cbr\u003e\nNo. The whole point of the enteric coating is to keep the tripeptide intact through stomach acid. Opening the capsule defeats this and you'll lose most of the dose to gastric proteolysis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with food?\u003c\/strong\u003e\u003cbr\u003e\nYou can, but empty-stomach is preferable for enteric-coated GSH because a fatty meal slows gastric emptying and may extend the time the capsule sits in stomach acid. If your GI tract is sensitive, a small non-fatty meal is fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs glutathione safe long-term?\u003c\/strong\u003e\u003cbr\u003e\nThe longest published RCT is Richie 2015 at 6 months, which reported good tolerability. Sekhar's GlyNAC trials extended to 24 weeks and 36 weeks with the precursor pair. Long-term (multi-year) safety data is limited but no signal of harm has emerged from the existing literature. The conservative pattern is daily dosing for 6–12 months, then a 2-week pause to reset, then resume — the same pattern conservative practitioners use for most chronic-use antioxidants.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it help hangovers?\u003c\/strong\u003e\u003cbr\u003e\nMechanistically yes — alcohol metabolism via aldehyde dehydrogenase produces acetaldehyde, which is conjugated to GSH for elimination, depleting hepatic stores. Pre-loading with GSH before drinking and post-loading the next day is plausible. Not an excuse to drink more.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about kidney function?\u003c\/strong\u003e\u003cbr\u003e\nNo documented harm in the published RCTs at the doses used (250–1000 mg\/day). Sekhar 2018 showed improvements rather than harm in metabolic markers. As with any supplement, if you have advanced kidney disease, ask your nephrologist first.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with my multivitamin?\u003c\/strong\u003e\u003cbr\u003e\nYes — the multivitamin doesn't interfere. If your multivitamin has high-dose copper or iron, take them at a different meal from your morning vitamin C + glutathione window to keep the redox network clean.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat does \"GSH:GSSG ratio\" mean and should I care?\u003c\/strong\u003e\u003cbr\u003e\nIt's the ratio of reduced (active) to oxidized glutathione inside cells. A healthy ratio is above 100:1; chronic disease and aging push it toward 10:1 — the biochemical definition of oxidative stress. You don't need a lab test to act on this; daily oral GSH plus the GlyNAC precursors moves the ratio in the right direction for most adults.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do you keep mentioning vitamin C and ALA — can I skip them?\u003c\/strong\u003e\u003cbr\u003e\nYou can, but you'll get less out of the glutathione. Vitamin C and alpha-lipoic acid both regenerate oxidized glutathione (GSSG) back to active GSH. Without them, every glutathione molecule donates its electron once and waits for endogenous glutathione reductase + NADPH to recycle it. With them, the same glutathione molecule donates electrons multiple times before depletion. The redox network multiplies; it doesn't add.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVegan \/ allergens?\u003c\/strong\u003e\u003cbr\u003e\nReduced L-glutathione is produced by yeast fermentation — vegan-compatible. Capsule shell is HPMC vegetable cellulose with the pH-resistant enteric coating. No soy, no gluten, no dairy, no gelatin, no nuts.\u003c\/p\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/glutathione-for-skin-brightening-how-it-works-and-how-long-it-takes\"\u003eGlutathione for skin brightening — how it works and how long it takes\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/marine-collagen-hair-skin-and-nails-how-long-until-results\"\u003eMarine collagen for hair, skin, and nails — how long until you see results\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/protocols\"\u003eProtocols — how to stack longevity, beauty, and detox supplements\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/antioxidants\"\u003eAntioxidants collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eCitations are referenced for educational context and represent the published peer-reviewed literature on the molecule and form discussed. Citation does not imply endorsement by the cited authors of this product. This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you have a medical condition, are pregnant or breastfeeding, or take prescription medication.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696473456858,"sku":"THP-GLUT-500-60","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-glutathione.jpg?v=1775665986"},{"product_id":"liposomal-nad-ultimate-1000mg","title":"Liposomal NAD+ Ultimate 1000mg | 10-Active Phospholipid Formula for NAD+, Sirtuins \u0026 Mitochondria","description":"\u003cp\u003e\u003cstrong\u003eTen clinically-relevant longevity actives in one phospholipid-encapsulated capsule\u003c\/strong\u003e — direct NAD+ alongside two precursor pathways (NMN + NR), a SIRT1 activator (Trans-Resveratrol), two mitochondrial cofactors (CoQ10 + PQQ), a senolytic flavonoid (Quercetin), a universal antioxidant (Alpha-Lipoic Acid), and the methylation\/energy B-vitamins (B3 + B12). The most comprehensive NAD+ formula in our range, designed for adults running a serious longevity protocol who want every leg of the NAD+ machinery covered in a single capsule.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTen actives, one capsule:\u003c\/strong\u003e direct NAD+ + NMN + NR (three precursor pathways) + Trans-Resveratrol + PQQ + CoQ10 + Quercetin + Alpha-Lipoic Acid + Vitamin B3 + Vitamin B12.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal phospholipid encapsulation\u003c\/strong\u003e — small phospholipid vesicles structurally identical to your cell membranes, designed to bypass gastric breakdown and deliver actives at the cellular level rather than relying solely on dissolved-into-blood transport.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy it matters:\u003c\/strong\u003e NAD+ levels drop ~50% between age 40 and 60 (Massudi 2012 PLoS One; Camacho-Pereira 2016 Cell Metabolism), and CD38-driven NAD+ consumption rises with age — single-pathway support often plateaus.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 50+, anyone already on NMN-only who has stalled, and serious longevity stack users who want NAD+ supply, sirtuin activation, mitochondrial support, and antioxidant defense in one daily capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake:\u003c\/strong\u003e 2 capsules daily with breakfast — several actives are fat-soluble.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you want the simplest entry point:\u003c\/strong\u003e see \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. If you want the highest-dose single-ingredient NMN: \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat \"liposomal\" actually means — the chemistry, not the marketing\u003c\/h2\u003e\n\u003cp\u003eA liposome is a microscopic vesicle (typically 50–500 nanometers) bounded by a phospholipid bilayer — the same molecular architecture as the cell membranes inside your body. Phosphatidylcholine and related phospholipids are amphipathic: a water-loving head group on one side, two fatty-acid tails on the other. Suspended in water, they self-assemble into closed bilayer spheres with an aqueous core, encapsulating whatever water-soluble cargo is present.\u003c\/p\u003e\n\u003cp\u003eFor NAD+ and the other actives in this formula, liposomal delivery does three concrete things:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtects the molecules from gastric and enzymatic degradation.\u003c\/strong\u003e Free NAD+ is a large, charged, unstable molecule that is partially hydrolyzed in the acid environment of the stomach and further degraded by intestinal enzymes (CD38 and related glycohydrolases). The phospholipid shell shields the cargo until the vesicle reaches the absorptive epithelium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnables direct membrane fusion.\u003c\/strong\u003e The lipid bilayer of the liposome can fuse with enterocyte and target-cell membranes, releasing contents directly into the cell rather than relying entirely on receptor- or transporter-mediated uptake. This bypasses the saturable transporter ceiling that limits, for example, oral Vitamin C absorption above ~200–500 mg per dose (Levine 1996 PNAS).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImproves bioavailability of fragile cargoes.\u003c\/strong\u003e Davis 2016 (Nutr Metab Insights) and Hickey 2008 (J Nutr Environ Med) demonstrated multi-fold AUC improvements for liposomal vs standard Vitamin C at the same oral dose. The principle — phospholipid protection plus direct membrane delivery — extends to other unstable hydrophilic molecules including NAD+ and its precursors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLiposomal is not a substitute for IV NAD+ — intravenous delivery still produces higher peak plasma levels — but for daily oral support of cellular NAD+, phospholipid encapsulation is the most validated way to bypass the limits of standard capsule and tablet delivery.\u003c\/p\u003e\n\n\u003ch2\u003eWhy one capsule covers three NAD+ precursor pathways (and why that hedges your bet)\u003c\/h2\u003e\n\u003cp\u003eNAD+ is built in your cells from three different precursors, each entering the salvage pathway through a different enzyme:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN (nicotinamide mononucleotide)\u003c\/strong\u003e — one step away from NAD+, most extensively studied human-trial precursor (Yoshino 2021 Science; Igarashi 2022 NPJ Aging). Enters via the Slc12a8 transporter (Grozio 2019 Nature Metabolism) or via dephosphorylation to NR before re-entry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR (nicotinamide riboside)\u003c\/strong\u003e — one additional enzymatic step (NRK1\/NRK2 phosphorylation). Trammell 2016 Nature Communications demonstrated 2.7-fold elevation in blood NAD+ at 1000 mg\/day in healthy adults; Martens 2018 Nature Communications, Conze 2019 Sci Reports, and Brakedal 2022 Cell Metab Parkinson's pilot all used NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme itself. Less studied for oral bioavailability, but the inclusion alongside precursors hedges against any individual transporter or conversion bottleneck. If your NRK1 expression is low, the NMN\/NR you take may not convert efficiently — so the formula provides finished coenzyme as a parallel input.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost adults respond to NMN-only or NR-only protocols. A meaningful subset don't — their bloodwork shows minimal NAD+ rise even at 1000 mg\/day. Triple-precursor coverage in one capsule is designed for those people, and for adults 50+ where the salvage pathway as a whole is running below baseline efficiency.\u003c\/p\u003e\n\n\u003ch2\u003eWhy precursors alone aren't enough — the four-pillar NAD+ strategy\u003c\/h2\u003e\n\u003cp\u003eJust raising NAD+ isn't the whole job. NAD+ is a substrate that gets consumed in real time by sirtuins (SIRT1–SIRT7), PARPs (DNA repair), CD38 (the dominant age-related NAD+ consumer; Camacho-Pereira 2016), and SARM1 (axon health). A serious longevity strategy works on four levers:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply\u003c\/strong\u003e — raise the precursor pool. Covered here by NMN + NR + direct NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivation\u003c\/strong\u003e — engage sirtuins so the raised NAD+ actually gets used. Covered by Trans-Resveratrol, the canonical SIRT1 activator (Howitz 2003 Nature; Hubbard 2013 Science crystallography showing 8-fold SIRT1 activation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial output\u003c\/strong\u003e — give the electron transport chain the cofactors and biogenesis signals to actually turn elevated NAD+ into ATP. Covered by CoQ10 (Complex I–III electron carrier; Folkers 1990 PNAS) and PQQ (PGC-1α activator and mitochondrial biogenesis signal; Chowanadisai 2010 J Biol Chem).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDefense\u003c\/strong\u003e — protect the rising NAD+ from accelerated consumption and protect mitochondria from the increased ROS that comes with higher metabolic activity. Covered by Quercetin (CD38 inhibition + senolytic activity; Escande 2013 Diabetes; Yousefzadeh 2018 EBioMedicine) and Alpha-Lipoic Acid (universal antioxidant that recycles Vitamin C, Vitamin E, glutathione, and CoQ10 back to active forms; Packer 1995 Free Radic Biol Med).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe B-vitamins (B3 as niacinamide and B12 as methylcobalamin) close two specific cofactor loops: B3 is the upstream substrate for the entire NAD+ salvage pathway, and B12 supports the methionine\/SAMe methylation cycle that NAD+ precursors burn through (which is why high-dose NMN-only users add TMG — same problem, different solution).\u003c\/p\u003e\n\n\u003ch2\u003eThe 10 actives — mechanism, dose rationale, and the trial that supports each\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme. Bypasses all three precursor conversion steps. Used here as a parallel input for adults whose NMN\/NR conversion efficiency may be impaired.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one-step NAD+ precursor. Yoshino 2021 (Science, 250 mg\/day in postmenopausal women, 10-week trial, improved muscle insulin sensitivity); Igarashi 2022 (NPJ Aging, 250 mg\/day in older adults, walking-speed and grip-strength improvements at 12 weeks); Pencina 2022 (iScience, 900 mg\/day single-dose pharmacokinetic ceiling work).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — alternate precursor pathway. Trammell 2016 (Nat Commun, 1000 mg\/day, blood NAD+ +2.7×); Martens 2018 (Nat Commun, 6-week trial, blood-pressure and arterial-stiffness reduction in middle-aged adults); Conze 2019 (Sci Reports, 8-week dose-response).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol\u003c\/strong\u003e — SIRT1 activator. Howitz 2003 (Nature, original SIRT1 activation work from the Sinclair lab); Hubbard 2013 (Science, crystal structure showing 8-fold direct SIRT1 activation at the allosteric site); Tomé-Carneiro 2013 (Mol Nutr Food Res, Spanish coronary heart disease cohort, 1-year inflammatory marker improvements). Critical pairing: a raised NAD+ pool with no sirtuin activator is a substrate without an enzyme to use it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ (Pyrroloquinoline Quinone)\u003c\/strong\u003e — mitochondrial biogenesis signal via PGC-1α activation. Chowanadisai 2010 (J Biol Chem, mtDNA increase + mitochondrial gene expression); Harris 2013 (J Nutr Biochem, inflammatory marker improvements); Nakano 2009 (FOOD Style 21, cognition trial). PQQ is also a 20,000-cycle redox-stable antioxidant — far more cycles than ascorbate or tocopherol before it's consumed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 (Ubiquinone)\u003c\/strong\u003e — electron transport chain cofactor at Complex I–III. Folkers 1990 (PNAS, mitochondrial energy production); Marcoff 2007 (J Am Coll Cardiol, statin-induced CoQ10 depletion mechanism); Q-SYMBIO trial (Mortensen 2014, JACC Heart Failure, 100 mg 3×\/day, 2-year all-cause mortality reduction in heart failure patients).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin\u003c\/strong\u003e — senolytic flavonoid (clears senescent \"zombie\" cells via BCL-2\/BCL-xL inhibition; Yousefzadeh 2018 EBioMedicine 10-flavonoid screen, ranked second behind Fisetin) AND CD38 inhibitor (Escande 2013 Diabetes — slowing the dominant age-related NAD+ consumer means more of your raised NAD+ stays in circulation) AND mast-cell stabilizer \/ NF-κB inhibitor (Mlcek 2016 Molecules).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlpha-Lipoic Acid (ALA)\u003c\/strong\u003e — universal antioxidant (water- AND fat-soluble, works in all cell compartments including mitochondrial matrix) AND antioxidant recycler (regenerates oxidized Vitamin C, Vitamin E, glutathione, and CoQ10 back to active forms; Packer 1995 Free Radic Biol Med) AND direct mitochondrial cofactor for pyruvate dehydrogenase + α-ketoglutarate dehydrogenase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin B3 (Niacinamide)\u003c\/strong\u003e — the upstream substrate that the NAD+ salvage pathway is built on. Without sufficient B3, NMN and NR conversion both bottleneck.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin B12 (Methylcobalamin)\u003c\/strong\u003e — supports the methionine\/SAMe methylation cycle that high-dose NMN\/NR protocols burn through. The reason TMG is the standard pairing for NMN 1000 mg users is methylation buffering — B12 is the upstream cofactor for the same cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvery active is dose-disclosed on the label. No proprietary blends, no fairy-dusting.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the NAD+ family — choose the right product\u003c\/h2\u003e\n\u003cp\u003eOur NAD+ family covers seven distinct positions. Pick by use case, not by price:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest single-ingredient entry:\u003c\/strong\u003e \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. The standard starting point. One ingredient, one decision.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose single-ingredient NMN:\u003c\/strong\u003e \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. For adults 50+ or non-responders at 500 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR with B-vitamin cofactors:\u003c\/strong\u003e \u003ca href=\"\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside (NR) Hard Capsules\u003c\/a\u003e. The longest human research track record (65+ trials).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMid-tier daily NAD+ + Resveratrol capsule:\u003c\/strong\u003e \u003ca href=\"\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e. Direct NAD+ with the SIRT1 activator built in.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePure NMN\/NR\/Resveratrol\/PQQ drink mix:\u003c\/strong\u003e \u003ca href=\"\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000 mg Pure Focus Formula\u003c\/a\u003e. For people who prefer a stick pack to a capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBerry-flavored liquid drink format:\u003c\/strong\u003e \u003ca href=\"\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e. TSA-friendly, no capsule swallowing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne-bottle longevity baseline:\u003c\/strong\u003e \u003ca href=\"\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e. NMN + niacin + CoQ10 + B-complex + Vitamins C\/E + collagen-synthesis cofactors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaximum-comprehensive (this product):\u003c\/strong\u003e 10 actives, liposomal phospholipid delivery, four-pillar NAD+ strategy in one capsule. Top of the range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the deeper choice between NMN-only and a comprehensive formula, see our \u003ca href=\"\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ guide\u003c\/a\u003e and the \u003ca href=\"\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStack pairings — what completes the protocol\u003c\/h2\u003e\n\u003cp\u003eThis formula is engineered for breadth, not depth on any single mechanism. To go deeper on a specific lever, add a single-ingredient product:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — if you sustain this formula long-term or stack it with additional standalone NMN, methylation pool depletion is the most common silent failure mode. TMG (trimethylglycine) is the methyl-donor buffer the David Sinclair \/ Brad Stanfield consensus recommends for any sustained high-dose NAD+ protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — the dedicated CD38 inhibitor (Escande 2013 Diabetes). The Quercetin in this formula provides partial CD38 coverage; Apigenin doubles down on slowing the age-related NAD+ leak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — the AMPK leg of the four-pathway longevity map (sirtuins \/ AMPK \/ autophagy \/ senolytics). Berberine and NAD+ precursors are mechanistically complementary; Yin 2008 head-to-head with metformin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — the autophagy leg. Eisenberg 2016 (Nature Med) cardiovascular mortality data. Different mechanism (autophagy\/mitophagy via EP300 inhibition) than the senolytic Quercetin already in this formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — the universal cofactor underneath everything else. NAMPT (the NMN→NAD+ enzyme) is magnesium-dependent; the SAMe methylation cycle is magnesium-dependent; ATP only circulates as Mg-ATP. Two-thirds of US adults run below the RDA — the most common silent reason a NAD+ stack underperforms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — the mitophagy layer (clears damaged mitochondria via PINK1\/Parkin). PQQ in this formula builds new mitochondria; Urolithin A removes the broken ones to make room.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the full architecture, see the \u003ca href=\"\/pages\/protocols\"\u003eCellular Longevity Protocol\u003c\/a\u003e and the \u003ca href=\"\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health cornerstone\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdults 50+\u003c\/strong\u003e — NAD+ decline is steeper after 50 (Massudi 2012 PLoS One showed roughly 50% reduction by age 60), CD38 expression rises with age (Camacho-Pereira 2016 Cell Metab), and single-pathway precursor support frequently plateaus.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone running a serious longevity protocol\u003c\/strong\u003e who wants NAD+ supply, sirtuin activation, mitochondrial cofactors, and antioxidant defense in one daily capsule rather than 5–7 separate bottles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN-only non-responders\u003c\/strong\u003e — people who took 500–1000 mg NMN daily for 2–3 months and didn't notice the energy\/recovery shift the rest of the protocol produced. Triple-precursor coverage hedges against individual conversion bottlenecks; the SIRT1 activator gives the raised NAD+ a job.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAthletes and high-demand adults\u003c\/strong\u003e — periods of heavy training, post-illness recovery, jet lag, and high-stress workloads where mitochondrial demand outruns baseline supply.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who want simplicity\u003c\/strong\u003e — one capsule, one decision. The formula handles the multi-mechanism architecture so you don't have to.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent (within 12 months) cancer treatment\u003c\/strong\u003e — raising NAD+ has theoretical implications for certain cancer types. The evidence is mixed and context-dependent. Discuss with your oncologist before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding\u003c\/strong\u003e — Resveratrol is contraindicated; NMN\/NR have no human pregnancy safety data. Default to caution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople on warfarin or other anticoagulants\u003c\/strong\u003e — Quercetin and Resveratrol both have weak antiplatelet activity; CoQ10 has minor warfarin interactions. Coordinate with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWithin 14 days of scheduled surgery\u003c\/strong\u003e — standard pre-surgical washout for the antioxidant + antiplatelet activity in the formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSevere liver or kidney disease\u003c\/strong\u003e — high-load multi-active formulas should be cleared by your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdults under 30 with no specific reason to supplement\u003c\/strong\u003e — baseline NAD+ in young adults is generally adequate; the cost\/benefit changes substantially after 40–50.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e some users notice subtle morning energy, mental clarity, or reduced afternoon dip within the first week. The direct NAD+ component reaches cells faster than precursor-only formulas; the B12 + niacinamide can also produce a near-term energy lift independent of the NAD+ pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes for most users. Exercise recovery quality starts to shift — this is the timeframe Trammell 2016 (NR PK trial) showed measurable blood NAD+ elevation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably. Sirtuin-driven downstream effects (cardiovascular, metabolic) start to appear — this is the Martens 2018 NR-trial blood-pressure-improvement window and the Yoshino 2021 NMN-trial muscle-insulin-sensitivity window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained NAD+\/sirtuin\/mitochondrial support. Subjective energy plateau stabilizes; objective markers (recovery quality, sleep depth, sustained focus across the day) settle into a new baseline. Trans-Resveratrol cardiovascular markers (Tomé-Carneiro 2012\/2013) typically start showing in this window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6+:\u003c\/strong\u003e the long-term anti-aging mechanisms compound. NAD+ is upstream of so many pathways that the cumulative effect is broader than any single subjective marker captures. Daily consistency matters more than dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eApproximately 10–15% of users notice less than expected at 4 weeks — the highest-yield additions for non-responders are TMG 1000 mg (methylation buffer) and Magnesium Glycinate 400 mg (NAMPT cofactor).\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 2 capsules daily in the morning with breakfast. Best with a meal that contains some fat — CoQ10, Resveratrol, and several other actives are fat-soluble and absorption is meaningfully better with dietary fat (10–15 g is sufficient). Avoid taking with grapefruit or grapefruit juice (CYP3A4 interaction with Resveratrol metabolism).\u003c\/p\u003e\n\u003cp\u003eIf you experience GI sensitivity in the first week, drop to 1 capsule daily for 7 days, then build to 2. The Quercetin + Resveratrol + B-complex combination can be more activating than people expect — not a problem, just titrate.\u003c\/p\u003e\n\u003cp\u003eAvoid evening dosing — raised NAD+ in the evening can disrupt the natural circadian dip in NAD+\/NADH ratio that supports deep sleep onset. Morning dosing aligns with the body's own NAD+ rhythm.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eDirect NAD+ (Nicotinamide Adenine Dinucleotide)\u003c\/li\u003e\n  \u003cli\u003eNMN (β-Nicotinamide Mononucleotide)\u003c\/li\u003e\n  \u003cli\u003eNR (Nicotinamide Riboside)\u003c\/li\u003e\n  \u003cli\u003eTrans-Resveratrol (from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e, ≥98% HPLC)\u003c\/li\u003e\n  \u003cli\u003ePQQ (Pyrroloquinoline Quinone disodium salt)\u003c\/li\u003e\n  \u003cli\u003eCoQ10 (Ubiquinone)\u003c\/li\u003e\n  \u003cli\u003eQuercetin\u003c\/li\u003e\n  \u003cli\u003eAlpha-Lipoic Acid (R\/S form)\u003c\/li\u003e\n  \u003cli\u003eVitamin B3 (as Niacinamide)\u003c\/li\u003e\n  \u003cli\u003eVitamin B12 (as Methylcobalamin)\u003c\/li\u003e\n  \u003cli\u003ePhospholipid encapsulation matrix (sunflower-derived phosphatidylcholine)\u003c\/li\u003e\n  \u003cli\u003eVegetarian HPMC capsule shell\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNo proprietary blends. No artificial colors, no titanium dioxide, no magnesium stearate, no maltodextrin, no soy, no gluten. Third-party tested for purity and potency.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in a cGMP-certified facility under FDA-registered standards. Each batch is third-party tested for identity, potency, heavy metals (lead, cadmium, mercury, arsenic below USP limits), and microbial contamination (total plate count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e). Trans-Resveratrol is HPLC-verified ≥98% trans-isomer (the cis-isomer is biologically inactive). NMN and NR are pharmaceutical-grade, HPLC-verified. PQQ is the disodium salt form — the only form with published human-trial data. Phospholipid carrier is non-GMO sunflower lecithin (not soy). Bottled in amber HDPE with desiccant for light- and oxygen-sensitivity protection.\u003c\/p\u003e\n\n\u003ch2\u003eSafety \u0026amp; interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelet drugs\u003c\/strong\u003e (warfarin, aspirin, clopidogrel) — Quercetin and Resveratrol have weak antiplatelet activity; coordinate with your prescriber and monitor INR if applicable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatins\u003c\/strong\u003e — CoQ10 in this formula is supportive (statins deplete CoQ10; Marcoff 2007). No dose adjustment usually needed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCYP3A4 substrates\u003c\/strong\u003e (some statins, immunosuppressants, certain anti-arrhythmics) — Resveratrol has weak CYP3A4 interaction. Avoid grapefruit\/grapefruit juice with this product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer treatment\u003c\/strong\u003e — discuss with your oncologist before starting any NAD+ precursor supplement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding\u003c\/strong\u003e — not recommended (Resveratrol contraindication, no NMN\/NR pregnancy safety data).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery\u003c\/strong\u003e — stop 14 days before any scheduled surgery (standard antioxidant + antiplatelet washout).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNiacin flush\u003c\/strong\u003e — this formula uses Niacinamide (no flush) rather than free Niacin (flush). Flushing is not expected.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiver or kidney disease\u003c\/strong\u003e — clear with your physician before starting any high-load multi-active formula.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs liposomal really better, or is it marketing?\u003c\/strong\u003e For unstable or poorly absorbed water-soluble compounds (Vitamin C, NAD+, glutathione, curcumin), the published bioavailability and AUC data favor properly-formulated liposomal delivery (Davis 2016 Nutr Metab Insights for Vitamin C is the cleanest published comparison). It is not marketing — but the quality bar matters. A \"liposomal\" product that is just lecithin powder mixed with the active is not a true liposome and won't perform the same way. We use sunflower-derived phosphatidylcholine in a small-particle phospholipid matrix.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy include direct NAD+ AND NMN AND NR? Isn't one enough?\u003c\/strong\u003e For most adults, one is enough. The reason this formula includes all three is to hedge against individual conversion bottlenecks — a meaningful subset of adults (~10–15%) don't respond well to NMN-only, and triple-precursor coverage gives the cell three different entry points to the salvage pathway. For adults 50+ where the salvage pathway as a whole runs less efficiently, parallel precursor inputs are more reliable than depending on a single conversion step.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take this with TMG?\u003c\/strong\u003e If you sustain this formula long-term (3+ months) or stack it with additional standalone NMN above 500 mg\/day, yes. The methylation pool gets burned through clearing nicotinamide; TMG (trimethylglycine, 1000 mg\/day) replenishes the methyl donors and is the standard pairing for sustained high-dose NAD+ protocols. See our \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e page for the full mechanism.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with my existing NMN or NR product?\u003c\/strong\u003e Yes — many people stack this with a higher-dose standalone NMN (like our \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e) for the highest-load protocol. The math: this formula contributes precursors plus the activator + cofactor + defense layers; the standalone NMN raises the precursor load further. If you go this route, add TMG.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is this different from your NAD+ 5-in-1 Complete Mitochondrial Formula?\u003c\/strong\u003e The 5-in-1 leans toward the foundational\/baseline end of the range (NMN + Niacin + CoQ10 + B-Complex + Vitamins C\/E + collagen-synthesis cofactor, two capsules daily). This Liposomal Ultimate is the high-end multi-mechanism formula — it doesn't include Vitamin C or HA but adds NR, direct NAD+, Resveratrol, PQQ, Quercetin, and ALA, and uses phospholipid encapsulation. Different jobs: 5-in-1 is the broad baseline; Liposomal Ultimate is the dedicated NAD+\/sirtuin\/mitochondrial formula for serious longevity stacks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is this different from the Liquid NAD+ Anti-Aging Drink?\u003c\/strong\u003e The Liquid Drink is a berry-flavored stick pack format, primarily NAD+ + Resveratrol + supporting actives in liquid form — better for people who don't want to swallow capsules or who travel frequently (TSA-friendly). Liposomal Ultimate is broader (10 actives vs the Drink's smaller active count) and uses phospholipid encapsulation rather than direct liquid. Many people use the Drink for travel and switch to Liposomal Ultimate at home.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy morning dosing? Can I take it at night?\u003c\/strong\u003e The body's natural NAD+\/NADH ratio rises in the morning and falls in the evening — mirroring the circadian clock. Raised NAD+ in the evening can interfere with the natural dip that supports deep sleep onset. Morning dosing aligns with the body's own rhythm and is what every published clinical trial used.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Some users do (the B12 + niacinamide can produce a short-term clarity\/energy lift). Most users notice the cumulative effect at 2–4 weeks. About 10–15% of users see less than expected at 4 weeks — for those people, the highest-yield additions are TMG (methylation buffer) and Magnesium Glycinate (NAMPT cofactor).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e Yes. Caffeine doesn't interfere with NAD+ precursor uptake. Many users take it alongside their morning coffee. If you have caffeine sensitivity, the B12 + niacinamide can amplify the alertness slightly — not a problem, just calibrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle on\/off?\u003c\/strong\u003e No published evidence supports cycling. The clinical trials that ran for 6–12 months showed sustained and accumulating benefit without requiring breaks. Daily consistency is what produces the result.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e The capsule shell is HPMC (vegetable cellulose). The phospholipid carrier is sunflower-derived (not animal). All active ingredients are vegan. Suitable for vegetarians and vegans.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long does one bottle last?\u003c\/strong\u003e At 2 capsules daily it's a 30-day supply per bottle. Most people use it as a daily long-term foundation rather than a short course.\u003c\/p\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: which NAD+ precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN: morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal: clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: the 7 daily nutrients that run underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/protocols\"\u003eThe True Health Protocol page — full longevity stack architecture\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e · \u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eReferences cited (selected): Massudi 2012 PLoS One; Camacho-Pereira 2016 Cell Metabolism; Yoshino 2021 Science; Igarashi 2022 NPJ Aging; Trammell 2016 Nature Communications; Martens 2018 Nature Communications; Conze 2019 Scientific Reports; Howitz 2003 Nature; Hubbard 2013 Science; Tomé-Carneiro 2013 Mol Nutr Food Res; Chowanadisai 2010 J Biol Chem; Folkers 1990 PNAS; Marcoff 2007 J Am Coll Cardiol; Mortensen 2014 JACC HF (Q-SYMBIO); Yousefzadeh 2018 EBioMedicine; Escande 2013 Diabetes; Mlcek 2016 Molecules; Packer 1995 Free Radic Biol Med; Davis 2016 Nutr Metab Insights; Hickey 2008 J Nutr Environ Med; Levine 1996 PNAS. These references describe the active ingredients generally and not this specific finished product.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have a medical condition, or are scheduled for surgery.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698100945114,"sku":"THP-NAD-LIPO-1000","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liposomal-nad.jpg?v=1775666045"},{"product_id":"selerb-nad-5-in-1-complete-mitochondrial-formula","title":"NAD+ 5-in-1 Complete Mitochondrial Formula | NMN + CoQ10 + B-Complex + Antioxidants + Skin","description":"\u003cp\u003e\u003cstrong\u003eFive longevity systems in one daily capsule\u003c\/strong\u003e — NAD+ precursors, mitochondrial cofactors, antioxidants, collagen-synthesis cofactors, and skin-hydration support. Built for people who want one bottle that covers most of the longevity-and-beauty bases without managing five separate purchases.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, five active systems.\u003c\/strong\u003e NAD+ precursors (NMN + Niacin) + mitochondrial cofactors (CoQ10 + full B-complex) + antioxidant defense (Vitamins C + E) + collagen-synthesis cofactors (Vitamin C-dependent prolyl-4-hydroxylase + lysyl hydroxylase) + skin-hydration support (Hyaluronic Acid precursors).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want a comprehensive baseline and don't want to assemble a multi-bottle stack themselves — or anyone whose previous attempt at a 5-bottle longevity stack ended with three of the bottles sitting unused.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe trade-off, plain:\u003c\/strong\u003e the dose of each individual ingredient is lower than dedicated single-ingredient products. If you want maximum dose of one specific compound (e.g. 1000 mg NMN, 600 mg trans-Resveratrol, 400 mg CoQ10), use the standalone version. This product is engineered for breadth, not depth.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 2 capsules with breakfast\u003c\/strong\u003e, daily. Several ingredients (Vitamin E, CoQ10) absorb materially better with meal fat — eat the capsules with the meal, not on an empty stomach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat \"5-in-1\" actually means — and why we chose these five\u003c\/h2\u003e\n\u003cp\u003eMost \"complete longevity\" formulas are either (a) a single NAD+ precursor with a vitamin or two thrown in for marketing, or (b) a 30-ingredient kitchen-sink blend at homeopathic doses with everything hidden inside a \"proprietary blend\" so you can't see the actual amounts. Neither is honest engineering.\u003c\/p\u003e\n\u003cp\u003eThe five systems in this formula were chosen because they are the five places where biological aging actually starts to fail at the cellular level — and where missing one breaks the others:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ pool (precursors):\u003c\/strong\u003e NAD+ is the coenzyme behind cellular energy, DNA repair, and sirtuin-pathway longevity signaling. It declines roughly 50% by age 50 (Massudi 2012, \u003cem\u003ePLoS One\u003c\/em\u003e; Camacho-Pereira 2016, \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, the rest of the chain has no fuel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactors (CoQ10 + B-complex):\u003c\/strong\u003e NAD+ is necessary but not sufficient. The electron transport chain still needs CoQ10 to shuttle electrons from Complex I\/II to Complex III, and the Krebs cycle still needs B1 (thiamine), B2 (riboflavin → FAD), B3 (niacin → NAD+ pool), B5 (pantothenic acid → coenzyme A), B6 (pyridoxal-5-phosphate), and B12 to actually run. Raising NAD+ without the cofactors is like adding more fuel to a car with a clogged fuel injector.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant defense (Vitamins C + E):\u003c\/strong\u003e mitochondria leak ~1–2% of their electrons as superoxide during normal operation (Murphy 2009, \u003cem\u003eBiochem J\u003c\/em\u003e). Vitamin C (water-soluble, neutralizes radicals in the cytoplasm and plasma) and Vitamin E (fat-soluble, neutralizes lipid peroxidation in the membrane) are the two-front defense. They regenerate each other (Packer 1979, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCollagen-synthesis cofactors:\u003c\/strong\u003e Vitamin C is the rate-limiting cofactor for the prolyl-4-hydroxylase and lysyl-hydroxylase enzymes that crosslink procollagen into the stable triple-helix that gives skin, joints, and connective tissue their structure. Scurvy is what total Vitamin C deficiency looks like — collagen synthesis fails. Even subclinical insufficiency degrades skin recovery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkin hydration (HA precursors):\u003c\/strong\u003e Hyaluronic Acid binds up to 1,000× its weight in water; native production drops sharply after 40 (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Oral HA precursors raise dermal HA over weeks (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvery active is dose-disclosed on the label. \u003cstrong\u003eNo proprietary blends.\u003c\/strong\u003e If a \"complete formula\" hides its individual ingredient amounts inside a single \"proprietary blend\" weight, that's almost always because at least one of the doses is too small to be effective at the price they're charging.\u003c\/p\u003e\n\n\u003ch2\u003ePer-system mechanism deep dive\u003c\/h2\u003e\n\n\u003ch3\u003eSystem 1 — NAD+ precursors (NMN + Niacin)\u003c\/h3\u003e\n\u003cp\u003eTwo precursors, one pool. NMN (nicotinamide mononucleotide) raises NAD+ via the most direct salvage pathway (NMN → NAD+ via NMNAT enzymes). Niacin (nicotinic acid) feeds the Preiss-Handler pathway. Using both gives more consistent intracellular NAD+ in different tissue compartments — the liver tends to favor the niacin route while peripheral tissue favors NMN\/NR (Trammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e; Yoshino 2018, \u003cem\u003eCell Metab\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThe trade-off this formula makes: dose. The NMN dose here is moderate. If the strongest NMN response in the published literature is what you're after — Yoshino's 2021 \u003cem\u003eScience\u003c\/em\u003e trial dosed 250 mg\/day, Igarashi's 2022 \u003cem\u003eNPJ Aging\u003c\/em\u003e dosed 250 mg, and Pencina's 2022 \u003cem\u003eiScience\u003c\/em\u003e dosed up to 900 mg — the dose-response peaks around 600–1000 mg\/day. For that ceiling, see \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. For breadth across five systems with NAD+ included, this 5-in-1 is the design.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 2 — Mitochondrial cofactors (CoQ10 + full B-complex)\u003c\/h3\u003e\n\u003cp\u003eCoQ10 (ubiquinone) is the electron carrier between Complex I\/II and Complex III of the inner mitochondrial membrane. Endogenous synthesis declines from age 30 onward; statin medications block its synthesis directly via the same HMG-CoA-reductase inhibition that lowers cholesterol (Folkers 1990, \u003cem\u003ePNAS\u003c\/em\u003e; Marcoff 2007, \u003cem\u003eJ Am Coll Cardiol\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThe full B-complex matters because the TCA cycle and oxidative phosphorylation are a relay race — if any cofactor is missing, the whole chain stalls at that step:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB1 (Thiamine)\u003c\/strong\u003e — cofactor for pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (α-KGDH). Without B1, glucose can't enter the TCA cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB2 (Riboflavin)\u003c\/strong\u003e — precursor of FAD, the prosthetic group for Complex II of the electron transport chain.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB3 (Niacin)\u003c\/strong\u003e — precursor of NAD+ itself, the coenzyme used at Complex I.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB5 (Pantothenic acid)\u003c\/strong\u003e — precursor of coenzyme A, the carrier that delivers acetyl groups into the TCA cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB6 (Pyridoxal-5-phosphate)\u003c\/strong\u003e — required for amino acid → TCA-cycle entry and heme synthesis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB12 (Methylcobalamin)\u003c\/strong\u003e — required for the methionine cycle (which feeds methylation reactions across the body) and for myelin maintenance in nerve tissue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a high-dose dedicated CoQ10, see \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg Maximum Strength\u003c\/a\u003e — particularly if you're on a statin.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 3 — Antioxidant defense (Vitamins C + E)\u003c\/h3\u003e\n\u003cp\u003eThe mitochondria are the cell's biggest source of reactive oxygen species. Even healthy mitochondria leak about 1–2% of the electrons they handle as superoxide. The body uses a layered defense:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin C\u003c\/strong\u003e — water-soluble, scavenges radicals in the cytoplasm and plasma, regenerates oxidized Vitamin E back to its active form (Packer 1979, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E (mixed tocopherols)\u003c\/strong\u003e — fat-soluble, sits inside the lipid bilayer of the cell membrane and the inner mitochondrial membrane, stops the chain reaction of lipid peroxidation that propagates membrane damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a maximum-absorption Vitamin C focus, see \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e. The C in this 5-in-1 is the dose needed to support collagen synthesis and antioxidant recycling — the liposomal product is for people who want a dedicated 1000 mg high-bioavailability single ingredient on top.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 4 — Collagen-synthesis cofactors\u003c\/h3\u003e\n\u003cp\u003eThis is the system most \"longevity\" formulas miss entirely. Vitamin C is non-substitutable as the cofactor for prolyl-4-hydroxylase and lysyl-hydroxylase — the enzymes that hydroxylate proline and lysine residues in pre-procollagen, which is the step that lets three procollagen strands wind into a stable triple-helix (Myllyharju 2003, \u003cem\u003eMatrix Biology\u003c\/em\u003e). Skin, tendons, ligaments, blood vessels, bone matrix all depend on this. Subclinical Vitamin C insufficiency degrades collagen recovery long before frank scurvy appears.\u003c\/p\u003e\n\u003cp\u003eIf you're stacking a dedicated collagen peptide with this 5-in-1, you've covered both sides — the peptide supplies the amino-acid bricks, the Vitamin C in this formula supplies the crosslinking-enzyme cofactor. See \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e and \u003ca href=\"\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti-Collagen Peptides Powder\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 5 — Skin hydration (HA support)\u003c\/h3\u003e\n\u003cp\u003eNative dermal hyaluronic acid drops by roughly half between ages 40 and 70 (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Oral HA precursors raise dermal HA over 8–12 weeks (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e). For a dedicated 200 mg HA + 100 mg Vitamin C SKU at full trial-dose strength, see \u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHA 200 mg + Vitamin C\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eHow the 5 systems integrate — the biochemistry maths\u003c\/h2\u003e\n\u003cp\u003eThis is the section most \"complete formula\" pages skip, because the integration is what justifies a five-system bundle in the first place. The five systems aren't five independent benefits — they're \u003cem\u003efive layers of one cellular energy and structural-protein chain\u003c\/em\u003e. The maths tells you why missing any one of them blunts the effect of the other four.\u003c\/p\u003e\n\n\u003ch3\u003e1. The NAD+ ceiling — and why the precursor dose alone isn't the constraint\u003c\/h3\u003e\n\u003cp\u003eNAD+ functions as both a redox cofactor and a substrate consumed by sirtuins, PARPs, and CD38. Tissue NAD+ concentrations sit roughly in the 200–500 µM range in healthy young adults and drop measurably with age (Massudi 2012, \u003cem\u003ePLoS One\u003c\/em\u003e; Cantó \u0026amp; Auwerx 2012, \u003cem\u003ePharmacol Rev\u003c\/em\u003e; Imai \u0026amp; Guarente 2014, \u003cem\u003eTrends Cell Biol\u003c\/em\u003e). SIRT1 has a reported Km for NAD+ of ~100–200 µM (Cantó 2012); SIRT3 (mitochondrial) and SIRT6 (chromatin) have similar mid-µM Km values (Kanfi 2012, \u003cem\u003eNature\u003c\/em\u003e). Translation: when intracellular NAD+ falls into the lower end of that range, sirtuin \u003cem\u003eactivity\u003c\/em\u003e falls non-linearly even before NAD+ becomes \"deficient.\" Adding precursors raises the pool — but only if the salvage and de-novo enzymes (NMNAT1\/2\/3, NRK1\/2, NAPRT) have the cofactors they need. Several of those cofactors are B-complex vitamins. So a precursor dose without B-complex support is a partial intervention; this 5-in-1 closes that loop.\u003c\/p\u003e\n\n\u003ch3\u003e2. ATP-per-glucose accounting — what the B-complex actually buys you\u003c\/h3\u003e\n\u003cp\u003eComplete oxidation of 1 glucose molecule yields roughly 30–32 ATP (the textbook number is 36–38; the corrected number accounts for the ATP cost of mitochondrial transport — Hinkle 2005, \u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e). The breakdown:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eGlycolysis: \u003cstrong\u003e2 ATP\u003c\/strong\u003e net (substrate-level phosphorylation), plus 2 NADH that feed the electron transport chain.\u003c\/li\u003e\n  \u003cli\u003ePyruvate → Acetyl-CoA (the \"gate\" into the TCA cycle): \u003cstrong\u003e2 NADH\u003c\/strong\u003e per glucose. \u003cem\u003eRequires B1 (thiamine pyrophosphate), B2 (FAD), B3 (NAD+), B5 (CoA), and lipoic acid\u003c\/em\u003e. Without B1 specifically, this step fails — Wernicke's encephalopathy is the clinical end-state.\u003c\/li\u003e\n  \u003cli\u003eTCA cycle: \u003cstrong\u003e2 ATP \/ GTP\u003c\/strong\u003e + 6 NADH + 2 FADH2 per glucose. \u003cem\u003eRequires B1, B2, B3, B5, B6 — every step uses one of them\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003eElectron transport chain + ATP synthase: \u003cstrong\u003e~26–28 ATP\u003c\/strong\u003e per glucose, generated when NADH (Complex I) and FADH2 (Complex II) feed electrons through the chain. \u003cem\u003eRequires CoQ10 (between Complex I\/II and III), B2 (FAD prosthetic group on Complex II), and B3 (NAD+ pool feeding Complex I)\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat that means in plain English: if you raise NAD+ but the B-complex cofactors are insufficient, your cell has fuel but no fuel pump. The 5-in-1 design is to raise NAD+ \u003cem\u003eand\u003c\/em\u003e supply the cofactors that turn that NAD+ into actual ATP. Houtkooper 2010 (\u003cem\u003eEndocrine Rev\u003c\/em\u003e) reviewed the integration of NAD+, sirtuins, and mitochondrial cofactors as one circuit rather than three separate ones; this formula is built on that view.\u003c\/p\u003e\n\n\u003ch3\u003e3. The Vitamin C \/ Vitamin E redox couple — stoichiometric regeneration\u003c\/h3\u003e\n\u003cp\u003eVitamin E (α-tocopherol) sits in the lipid bilayer and intercepts peroxyl radicals during lipid peroxidation. When it does, it becomes the α-tocopheroxyl radical — itself a mild oxidant. Vitamin C (ascorbate) regenerates α-tocopherol from the tocopheroxyl radical at a 2:1 stoichiometry (one ascorbate molecule, two electrons donated, gives one regenerated tocopherol; Packer 1979, \u003cem\u003eNature\u003c\/em\u003e; Niki 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e). The dehydroascorbate produced is then recycled back to ascorbate by glutathione (which itself depends on the precursor pool covered by other products in the catalog — see \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-glutathione-precursor\"\u003eNAC 600 mg\u003c\/a\u003e). This is why supplementing only Vitamin E without Vitamin C is leaky — the tocopheroxyl radical accumulates and can act as a pro-oxidant. Both together is the design.\u003c\/p\u003e\n\n\u003ch3\u003e4. Collagen synthesis — Vitamin C is rate-limiting, and the maths tell you the ceiling\u003c\/h3\u003e\n\u003cp\u003eOne mature collagen fibril is built from procollagen molecules, each of which is a triple-helix of three polypeptide chains, each chain ~1,000 amino acids long, with hydroxyproline at roughly every third Y-position in the Gly-X-Y repeat. That's on the order of \u003cstrong\u003e~300–400 hydroxyproline residues per polypeptide chain × 3 chains ≈ 900–1,200 hydroxylation reactions per procollagen molecule\u003c\/strong\u003e — every one of which requires prolyl-4-hydroxylase, every one of which consumes one O₂, one α-ketoglutarate, and one Fe²⁺, and every one of which requires ascorbate to keep that Fe²⁺ from being oxidized to Fe³⁺ (which inactivates the enzyme; Myllyharju 2003, \u003cem\u003eMatrix Biology\u003c\/em\u003e). Lysyl-hydroxylation adds a similar requirement for the crosslinking step. Translation: collagen synthesis is a high-flux Vitamin C consumer. Skin and connective-tissue turnover continually depletes plasma ascorbate. The collagen-synthesis-cofactor function isn't an aside — it's why scurvy presents as a structural-protein collapse before it presents as anything else.\u003c\/p\u003e\n\n\u003ch3\u003e5. Hyaluronic acid — turnover speed sets the dose-response timeline\u003c\/h3\u003e\n\u003cp\u003eHA is a glycosaminoglycan polymer of repeating glucuronic-acid + N-acetylglucosamine disaccharide units, sometimes 10,000–25,000 units long, total molecular weight up to ~10 million Da (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Total body HA in a 70 kg adult is roughly 15 g, and turns over with a half-life of ~1 day in skin, ~3–5 minutes in plasma, and as long as several weeks in cartilage (Fraser 1997, \u003cem\u003eJ Intern Med\u003c\/em\u003e). The skin half-life is what makes oral HA dose-response visible — skin is the most rapidly remodeling HA depot, which is why the trial-readout windows for oral HA (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e) come in at 8–12 weeks. Faster than that and you're seeing measurement noise; slower and the substrate ceiling has already saturated.\u003c\/p\u003e\n\n\u003ch3\u003eThe integration in one sentence\u003c\/h3\u003e\n\u003cp\u003eRaise NAD+ (Systems 1) → it gets used as a coenzyme on the ETC and a substrate by sirtuins → which only works if CoQ10 + B-complex are present (System 2) → the resulting ATP and the resulting ROS are buffered by the C\/E redox couple (System 3) → which also supplies the rate-limiting cofactor for collagen synthesis (System 4) → which integrates with the HA-substrate layer (System 5) to give the structural-protein and skin-hydration outputs the user actually sees in the mirror. Every link in that chain depends on the prior link being supplied. That's the formula's logic.\u003c\/p\u003e\n\n\u003ch2\u003eCross-references to the Protocol collections\u003c\/h2\u003e\n\u003cp\u003eIf you want to dig deeper on any one of the five systems, the catalog has dedicated collections that cover the wider product set for each layer:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 1 (NAD+ precursors):\u003c\/strong\u003e \u003ca href=\"\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e · \u003ca href=\"\/collections\/nmn\"\u003eNMN Supplements collection\u003c\/a\u003e. Single-ingredient ceiling-dose options, NR alternatives, liposomal\/liquid format options, and the CD38-inhibitor add-ons (Apigenin, Quercetin) that protect the NAD+ pool from degradation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 2 (Mitochondrial cofactors):\u003c\/strong\u003e \u003ca href=\"\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e. Standalone CoQ10 at 400 mg, PQQ for biogenesis (PGC-1α — Chowanadisai 2010, \u003cem\u003eJ Biol Chem\u003c\/em\u003e), Urolithin A for mitophagy (PINK1\/Parkin — Andreux 2019, \u003cem\u003eNat Metab\u003c\/em\u003e), and CaAKG as TCA-cycle substrate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 3 (Antioxidant defense):\u003c\/strong\u003e \u003ca href=\"\/collections\/antioxidants\"\u003eAntioxidants collection\u003c\/a\u003e. Glutathione precursors (NAC), Astaxanthin (membrane-spanning), Liposomal Vitamin C at 1000 mg, and the SOD\/catalase-supporting cofactors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 4 (Collagen-synthesis cofactors):\u003c\/strong\u003e \u003ca href=\"\/collections\/collagen\"\u003eCollagen Supplements collection\u003c\/a\u003e for the substrate side (marine + multi-collagen), plus \u003ca href=\"\/collections\/skin-protocol\"\u003eSkin Protocol collection\u003c\/a\u003e for the integrated stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 5 (Skin hydration \/ HA support):\u003c\/strong\u003e \u003ca href=\"\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging collection\u003c\/a\u003e. Standalone HA at 200 mg with Vitamin C, Biotin for keratin synthesis, and the integrated beauty stacks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCross-system framework:\u003c\/strong\u003e \u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e for the catalog-wide foundational set, \u003ca href=\"\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e for the López-Otín 2023 Hallmarks-of-Aging framework that organizes the catalog by mechanism layer, and \u003ca href=\"\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e for stacks built around specific goals (Cellular Longevity, Beauty \u0026amp; Skin, Fertility, Cardiovascular, Brain \u0026amp; Cognitive, Metabolic).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2\u003eOne-bottle vs multi-bottle stack — which to pick\u003c\/h2\u003e\n\u003cp\u003eThis is the most common honest question we get about the 5-in-1, so we'll answer it directly:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePick this if:\u003c\/strong\u003e you want simplicity, you're new to longevity supplementation, you want to cover beauty + longevity in one purchase, you're traveling and don't want a kit of bottles, or you've tried multi-bottle stacks before and stopped because the routine got unmanageable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePick the multi-bottle stack if:\u003c\/strong\u003e you want maximum dose of any specific compound (e.g. 1000 mg NMN, 600 mg Resveratrol, 400 mg CoQ10), have specific goals (just metabolic health → Berberine; just skin → HA + collagen; just NAD+ ceiling → NMN 1000), or already know which pathways you want to push hardest.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOr both:\u003c\/strong\u003e some customers take this 5-in-1 as the daily baseline and add one or two single-ingredient products to push specific pathways harder. That's a reasonable middle path — the 5-in-1 covers the breadth, the standalone covers the depth where it matters most for their goal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe dedicated single-ingredient products in our catalog:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e — for maximum NAD+ precursor dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e — for sirtuin (SIRT1) activation. Not in this 5-in-1 formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg Maximum Strength\u003c\/a\u003e — for high-dose mitochondrial support, especially on statins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e — high-dose, high-absorption antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHA 200 mg + Vitamin C\u003c\/a\u003e — full trial-dose hydration support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg (CaAKG)\u003c\/a\u003e — TCA-cycle substrate + epigenetic-clock cofactor (TET\/JmjC demethylases). Not in this 5-in-1.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e — AMPK pathway, glucose metabolism. Not in this 5-in-1.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a full picture of how to layer single-ingredient products on top of (or instead of) a one-bottle baseline, see our \u003ca href=\"\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere the 5-in-1 sits in the NAD+ family\u003c\/h2\u003e\n\u003cp\u003eThe NAD+ family in our catalog covers different parts of the NAD+ landscape. None of them are redundant — they each solve a different problem:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThis 5-in-1\u003c\/strong\u003e — NAD+ precursors plus the mitochondrial \/ antioxidant \/ collagen \/ skin systems they feed. \u003cem\u003eBest for people who want one bottle covering breadth.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePure NMN 500 mg\u003c\/strong\u003e — single-ingredient, dose-focused. \u003cem\u003eBest for trial-dose NMN at moderate strength.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN 1000 mg Double Strength\u003c\/strong\u003e — same compound, ceiling dose. \u003cem\u003eBest for the upper end of the published NMN dose-response curve.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ Daily Boost Capsules (Direct NAD+ + Trans-Resveratrol)\u003c\/strong\u003e — direct NAD+ molecule plus SIRT1 activator co-formulated. \u003cem\u003eBest for people who want NAD+ without going through the precursor pathway.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/strong\u003e — encapsulated for higher bioavailability. \u003cem\u003eBest for non-responders to standard NAD+ precursors.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid NAD+ Anti-Aging Drink\u003c\/strong\u003e — drink-format, stick packets. \u003cem\u003eBest for capsule-fatigue or travel.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 30+ wanting a comprehensive longevity-and-beauty baseline without research-paralysis.\u003c\/li\u003e\n  \u003cli\u003ePeople starting their first longevity protocol who want one product to take consistently before deciding what to add or replace.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose previous attempts at multi-bottle stacks ended with most bottles sitting unused — format compliance is real, and three months of consistent breadth beats two weeks of \"perfect\" depth.\u003c\/li\u003e\n  \u003cli\u003eTravelers — single bottle covers most of the protocol when you're on the road.\u003c\/li\u003e\n  \u003cli\u003ePeople on statins (combined with our dedicated \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e if statin-induced CoQ10 depletion is a specific concern).\u003c\/li\u003e\n  \u003cli\u003ePeople in their 30s and 40s who want to build a longevity habit without committing to a 6-bottle daily routine before they know which pieces matter most for their body.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePeople who already know they need a maximum-dose single-ingredient — e.g. 1000 mg NMN for cycling around a known dose-response, or 400 mg CoQ10 specifically for statin-induced depletion. Pick the standalone instead.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known sensitivity to niacin flush — if you flush at 50 mg of niacin you'll feel the dose in this product. Niacinamide-only products avoid the flush; let us know if you want a redirect.\u003c\/li\u003e\n  \u003cli\u003ePregnant or breastfeeding women — limited safety data on combined longevity stacks during pregnancy. Consult your OB before starting.\u003c\/li\u003e\n  \u003cli\u003eAnyone on chemotherapy or being treated for cancer — discuss with your oncologist; some longevity pathways (sirtuin, AMPK, NAD+) interact in non-trivial ways with cancer biology and treatment timing.\u003c\/li\u003e\n  \u003cli\u003ePeople with known kidney or liver disease — review with your physician before any new supplement stack.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–14:\u003c\/strong\u003e usually subtle. Multiple pathways activating simultaneously builds gradually rather than dramatically. Don't expect a \"feel\" the first week — feel-effects are not how this category works.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, improved exercise recovery, nail strength often the first cosmetic signal (B-vitamins + collagen-synthesis cofactor compound).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e mental clarity, exercise recovery, hydration improvements compound. Skin tends to look more even by the 6-week mark.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e visible skin and hair improvements; sustained NAD+ and antioxidant support. The HA + Vitamin C + B-complex combination starts to show in skin texture around 8–12 weeks (matching the Proksch 2014 collagen-trial timeline + Kawada 2014 HA-trial timeline).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3+:\u003c\/strong\u003e long-term anti-aging mechanisms compound with continued daily use. The NAD+ effect on energy and the collagen\/HA effect on skin both have a \"compound\" quality — the curve flattens but doesn't reverse if you keep taking it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e the NAD+ pool returns to baseline within 1–2 weeks (the salvage pathway is dynamic). Skin\/hair benefits regress over 8–12 weeks (the structural protein turnover timescale).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with this product\u003c\/h2\u003e\n\u003cp\u003eThe 5-in-1 is designed to be a complete daily baseline. If you want to push specific pathways harder while keeping the breadth, common add-ons are:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Resveratrol\u003c\/strong\u003e — for stronger sirtuin (SIRT1) activation. Resveratrol is the SIRT1 piece this 5-in-1 doesn't include. \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Berberine\u003c\/strong\u003e — if metabolic health is a goal (the AMPK pathway, not in this formula). Pairs naturally with NAD+ precursors. \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg Maximum Strength\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Marine Collagen\u003c\/strong\u003e — if you want stronger skin\/hair structural support beyond the synthesis cofactors. The Vitamin C in this 5-in-1 is the cofactor; marine peptides are the substrate. \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ TMG (Trimethylglycine)\u003c\/strong\u003e — methyl donor that recycles homocysteine. Worth considering if you're at the higher dose end of NMN\/NAD+ supplementation, since NAD+ metabolism uses methyl groups. \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ CaAKG\u003c\/strong\u003e — substrate for the TCA cycle and the epigenetic-clock demethylases (TET\/JmjC). The 5-in-1 covers the NAD+ pool and the cofactors; CaAKG covers the substrate side and the epigenetic-remodeling layer. \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Apigenin\u003c\/strong\u003e — CD38 inhibitor that slows NAD+ degradation, complementing the precursor strategy in the 5-in-1. \u003ca href=\"\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Magnesium Glycinate\u003c\/strong\u003e — universal cofactor across \u0026gt;300 enzymatic reactions; deficiency is common and silently undermines the rest of the stack. \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 2 capsules daily with breakfast. Several ingredients (Vitamin E, CoQ10) absorb materially better with meal fat — eggs, avocado, nut butter on toast, full-fat yogurt, olive oil on the salad all work. Daily consistency matters more than dose timing for this category — pick the time of day you're most likely to be reliable.\u003c\/p\u003e\n\u003cp\u003eFor more on supplement timing, see \u003ca href=\"\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eour timing guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule (per serving = 2 capsules)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ precursor blend\u003c\/strong\u003e — NMN + Niacin (B3) at moderate breadth-formula doses (full per-ingredient amounts on the supplement-facts panel; no proprietary blends).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 (Ubiquinone)\u003c\/strong\u003e — for electron transport chain support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFull B-complex\u003c\/strong\u003e — B1 (Thiamine), B2 (Riboflavin), B5 (Pantothenic acid), B6 (Pyridoxal-5-phosphate \/ P5P), B12 (Methylcobalamin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin C\u003c\/strong\u003e — collagen-synthesis cofactor + antioxidant + Vitamin E recycling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E\u003c\/strong\u003e — mixed tocopherols, lipid-membrane antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHyaluronic Acid precursors\u003c\/strong\u003e — for skin-hydration support.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eVegetarian capsule (HPMC). No artificial colors, no proprietary blends, no fillers beyond the capsule shell. Third-party tested for purity.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in cGMP-certified facilities. Third-party tested for heavy metals (lead, arsenic, cadmium, mercury), microbial limits, and active ingredient potency. Certificate of Analysis available on request. Store in a cool, dry place; keep the bottle sealed when not in use.\u003c\/p\u003e\n\n\u003ch2\u003eSafety \u0026amp; cautions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNiacin flush:\u003c\/strong\u003e if you're flush-sensitive, take with food and start with 1 capsule for the first 3–5 days, scale to 2.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin K-related anticoagulation:\u003c\/strong\u003e this formula does not contain Vitamin K, but if you're on warfarin, review any new supplement with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e not recommended without OB clearance — limited data on combined longevity stacks during pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer treatment:\u003c\/strong\u003e discuss with your oncologist before starting — sirtuin\/AMPK\/NAD+ pathways have non-trivial interactions with cancer biology and chemotherapy timing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKidney or liver disease:\u003c\/strong\u003e review the full ingredient panel with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e stop 1–2 weeks before any planned surgery (precautionary; some longevity actives can affect bleeding or anesthesia metabolism).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e if you're on metformin, statins, blood thinners, blood-pressure medication, antidepressants, or chemotherapy, review with your physician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy isn't Resveratrol in the formula?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eResveratrol is fat-soluble and benefits from a different formulation strategy (often piperine for absorption, oil delivery for bioavailability), and the dose-response data is strongest at 250–600 mg\/day — which is too large to fit alongside five other systems in two capsules. We kept Resveratrol as a dedicated standalone (\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e) and built the 5-in-1 around the NAD+\/mitochondrial\/antioxidant\/collagen\/HA stack instead. Many customers take both — the 5-in-1 as the daily baseline, Resveratrol added on top for SIRT1 activation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I still benefit from this if I'm already taking standalone NMN?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes, and there are two ways customers handle it. Option A: replace the standalone NMN with this 5-in-1 to consolidate. Option B: keep the standalone NMN for the higher dose ceiling and add this 5-in-1 for the breadth (CoQ10 + B-complex + antioxidants + collagen cofactor + HA). The B-vitamins, CoQ10, and HA in this product don't overlap with NMN's NAD+ precursor function — they cover entirely different systems.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy two capsules instead of one?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe five systems together require more material than will physically fit in one standard capsule shell. Splitting across two also gives slightly more even absorption across the meal window. Take both at once — you don't need to space them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to a multivitamin?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA standard multivitamin is built around recommended-daily-allowance (RDA) doses to prevent deficiency. This formula is built around longevity-and-beauty doses — NMN and CoQ10 are not in standard multivitamins, and the B-complex, Vitamin C, Vitamin E, and HA are at functional doses, not RDA-floor doses. A multivitamin and this 5-in-1 cover different problems; some customers take both.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Coffee doesn't materially impair absorption of any of the actives in this formula. Take with breakfast (the meal fat helps with the fat-soluble actives) and have your coffee with or after — whichever you prefer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this contain caffeine?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. The \"easier mornings, steadier afternoon energy\" effect is from mitochondrial cofactors and NAD+ support, not stimulants. Customers often report that they cut their afternoon coffee 4–8 weeks in — that's a downstream signal, not a caffeine effect.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I see something?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor energy and morning quality: typically 2–4 weeks. For nail and hair: 4–8 weeks. For visible skin texture: 8–12 weeks (this matches the published collagen-trial and HA-trial timelines — Proksch 2014, Kawada 2014). Longevity actives (NAD+ pool, mitochondrial cofactors) work silently for the first month before downstream effects compound.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsules and put the powder in a smoothie?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot recommended. Some of the actives (Vitamin E, NMN, CoQ10) degrade in the presence of light and oxygen — the capsule shell is part of the delivery design. Take the capsules whole.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe capsule shell is vegetarian (HPMC, plant-derived). Confirm the full active panel against your dietary needs — full ingredient list is on the supplement-facts panel.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about cycling — should I take breaks?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe published longevity-trial protocols mostly use continuous daily dosing without cycling. There's no evidence cycling helps. The longevity benefits come from sustained signaling, not pulsed signaling — keep it daily and consistent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan men take this?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Despite the skin\/hair language being more often associated with women's products, all five systems in this formula apply to male physiology in the same way — NAD+ decline, mitochondrial decline, antioxidant balance, collagen synthesis (joints, tendons, skin), and HA loss are universal aging biology.\u003c\/p\u003e\n\n\u003ch2\u003eRead more\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eWhen to take NMN — timing \u0026amp; absorption guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — practical protocol for 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/protocols\"\u003eTrue Health Protocols (Cellular Longevity, Beauty \u0026amp; Skin, Fertility, etc.)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full NAD+ Family: \u003ca href=\"\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e · Browse Longevity Essentials: \u003ca href=\"\/collections\/longevity-essentials\"\u003e\/collections\/longevity-essentials\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698106974426,"sku":"THP-NAD-5IN1","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-5in1.jpg?v=1775666078"},{"product_id":"liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula","title":"Liposomal Vitamin C 1000mg | Phospholipid-Encapsulated for Collagen, Skin \u0026 Immune Support","description":"\u003cp\u003e\u003cstrong\u003e1000 mg of Liposomal Vitamin C per serving\u003c\/strong\u003e — phospholipid-encapsulated to bypass the gut absorption ceiling that caps standard ascorbic acid. The form of Vitamin C that actually reaches plasma at meaningful levels, instead of being excreted in the bathroom an hour later. Third-party tested. Vegetarian capsule, no proprietary blends.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy this matters at all:\u003c\/strong\u003e Levine 1996 (PNAS) and Levine 2001 (Annu Rev Nutr) showed that the human gut absorbs Vitamin C through saturable sodium-dependent transporters (SVCT1\/SVCT2), and that bioavailability of standard ascorbic acid drops sharply above ~200 mg per dose — by 1000 mg in a single dose, less than 50% is absorbed, and at 1250 mg less than 33%. Padayatty 2004 (Annals of Internal Medicine) showed oral ascorbate plasma plateaus around 70–80 µmol\/L no matter how much more you take. Liposomal encapsulation routes around that transporter ceiling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy it shows up in every longevity stack:\u003c\/strong\u003e Vitamin C is the obligate cofactor for prolyl-4-hydroxylase and lysyl hydroxylase — the two enzymes that hydroxylate proline and lysine on procollagen so the triple helix can stabilize and cross-link (Myllyharju 2003, Matrix Biology). Without Vitamin C, the collagen you eat or supplement can't be properly assembled. Scurvy is, mechanically, a collagen-synthesis failure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat 1000 mg liposomal actually delivers:\u003c\/strong\u003e Davis 2016 (Nutrition and Metabolic Insights) measured plasma ascorbate AUC almost double standard ascorbic acid at the same oral dose; Hickey 2008 (J Nutr Environ Med) earlier reported peak plasma values of ~400 µmol\/L from 36g liposomal — far above the standard oral ceiling. The lipid bilayer protects ascorbate from gastric degradation and routes it through lipid-pathway absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e anyone running a collagen protocol (mandatory cofactor pairing), daily antioxidant baseline, immune resilience during travel\/training\/post-illness windows, smokers and drinkers (both deplete ascorbate), and as the antioxidant-recycling layer underneath Glutathione, Vitamin E, Resveratrol, and the NAD+ stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 1–2 capsules daily with food.\u003c\/strong\u003e Split AM\/PM if running 2 capsules — water-soluble vitamins clear the bloodstream within hours, so spaced dosing maintains higher steady-state plasma than a single bolus.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eThe Pauling controversy and what 50 years of follow-up actually showed\u003c\/h2\u003e\n\u003cp\u003eThe reason Vitamin C carries more cultural baggage than any other supplement is that it sits at the center of a 50-year argument about dose. The story is worth knowing because the dose conclusions you find on the internet still echo it.\u003c\/p\u003e\n\u003cp\u003eIn 1970, Linus Pauling — two-time Nobel laureate (Chemistry 1954, Peace 1962) — published \u003cem\u003eVitamin C and the Common Cold\u003c\/em\u003e and proposed that mammals other than humans, primates, and guinea pigs synthesize ascorbate at internal rates equivalent to several grams per day in a human-sized animal, and therefore the human RDA of 60–90 mg\/day reflects scurvy-prevention math, not optimal-function math. In 1976 and 1978 he published the Cameron-Pauling clinical observations on terminal cancer patients and high-dose ascorbate (Cameron \u0026amp; Pauling 1976, PNAS; Cameron \u0026amp; Pauling 1978, PNAS), reporting survival benefits.\u003c\/p\u003e\n\u003cp\u003eThe Mayo Clinic ran two RCTs (Creagan 1979, NEJM; Moertel 1985, NEJM) that failed to replicate the Cameron-Pauling result and the consensus consolidated against high-dose ascorbate. That's where the story sat for 25 years.\u003c\/p\u003e\n\u003cp\u003eThen Padayatty 2004 (Annals of Internal Medicine) and Padayatty 2010 (PLoS One) reopened it on a single technical point: the Mayo trials used \u003cem\u003eoral\u003c\/em\u003e dosing while Cameron-Pauling used \u003cem\u003eintravenous\u003c\/em\u003e. With the SVCT-saturation pharmacokinetics now characterized (Levine 1996 PNAS, Levine 2001 Annu Rev Nutr), it became clear oral and IV ascorbate are not the same molecule pharmacologically — IV reaches plasma 70-100x what oral can produce, and the two routes hit completely different concentration ranges. The Mayo trials had compared a different drug to what Pauling had been studying.\u003c\/p\u003e\n\u003cp\u003eWhat the modern view actually says — and what the catalog architecture here is built on — is the dose-curve middle ground:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePauling was right that the RDA is a scurvy-prevention number, not an optimal-function number.\u003c\/strong\u003e Carr \u0026amp; Frei 1999 (Am J Clin Nutr) and Frei 2012 (Crit Rev Food Sci Nutr) re-derived an \"optimal\" intake around 200 mg\/day from biomarker saturation, neutrophil ascorbate content, and tissue-pool kinetics — about 2–3x the RDA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOral megadose past ~2 g\/day adds little plasma ascorbate\u003c\/strong\u003e because the SVCT transporters are saturated. That part of Pauling's protocol — taking 10+ g\/day orally — was pharmacokinetically futile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIV ascorbate is a different drug entirely\u003c\/strong\u003e and is the appropriate vehicle for any pharmacological-dose research; it's not interchangeable with oral.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal encapsulation\u003c\/strong\u003e — the form in this bottle — partially routes around the SVCT ceiling via lipid-pathway absorption (Davis 2016, Hickey 2008), letting an oral dose deliver meaningfully more ascorbate to plasma than the same milligram amount of standard ascorbic acid. It does not match IV. It does close part of the gap.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe honest framing on this product: 1000 mg liposomal is not a Pauling-style megadose claim and not an IV substitute. It is a high-bioavailability daily delivery vehicle for an ascorbate dose that biomarker studies put in the optimal-function range — built around the actual pharmacokinetics that emerged from the Levine-Padayatty work after the Pauling-Mayo argument was already 25 years old.\u003c\/p\u003e\n\n\u003ch2\u003eWhy standard ascorbic acid plateaus — the gut transporter ceiling\u003c\/h2\u003e\n\u003cp\u003eVitamin C absorption isn't passive diffusion. It's gated by two sodium-dependent vitamin C transporters (SVCT1 and SVCT2) embedded in the small intestine epithelium. SVCT1 dominates intestinal uptake; SVCT2 handles cellular uptake throughout the body. Both are saturable proteins with finite throughput. Once they're full, they're full.\u003c\/p\u003e\n\u003cp\u003eThe Levine pharmacokinetic studies — done at NIH and considered the foundational human data on ascorbate absorption — measured this directly. Healthy young men on controlled diets received single oral doses ranging from 15 mg to 1250 mg. Bioavailability:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e30–100 mg: near complete absorption (~100%)\u003c\/li\u003e\n  \u003cli\u003e200–500 mg: starts dropping, ~75–80%\u003c\/li\u003e\n  \u003cli\u003e1000 mg: drops to ~50%\u003c\/li\u003e\n  \u003cli\u003e1250 mg: drops to ~33%\u003c\/li\u003e\n  \u003cli\u003eAnything above that: increasing fraction excreted directly in urine\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why a 1000 mg standard ascorbic acid capsule doesn't actually deliver 1000 mg worth of plasma rise. Most of what you swallow above the SVCT ceiling either sits in the gut osmotically (causing the loose stool that high-dose ascorbic acid is famous for) or gets excreted unchanged.\u003c\/p\u003e\n\u003cp\u003ePadayatty 2004 (Annals of Internal Medicine) confirmed the plasma ceiling: oral ascorbate plateaus around 70–80 µmol\/L regardless of how high you push the oral dose. The only way to get higher plasma ascorbate from oral dosing is to bypass the SVCT pathway entirely — which is what liposomal encapsulation does.\u003c\/p\u003e\n\n\u003ch2\u003eWhat liposomal does differently\u003c\/h2\u003e\n\u003cp\u003eA liposome is a microscopic phospholipid bilayer sphere — the same chemistry that makes up your own cell membranes. Vitamin C sits inside the aqueous core, protected by the lipid shell.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBypasses the SVCT ceiling.\u003c\/strong\u003e Liposomes don't compete for SVCT throughput. They're absorbed via lipid-pathway transport — passive diffusion, lipid raft uptake, and direct fusion with intestinal cell membranes. Different pathway, no transporter saturation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtects against gastric degradation.\u003c\/strong\u003e Free ascorbate is partially destabilized by stomach acid and gastrointestinal enzymes. The lipid bilayer shields the cargo until it reaches the absorption sites lower in the GI tract.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect cellular delivery.\u003c\/strong\u003e Once in circulation, the liposome's outer bilayer can fuse with target cell membranes, releasing Vitamin C directly into the cytoplasm — bypassing the SVCT2-gated cellular uptake step too.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher AUC at the same dose.\u003c\/strong\u003e Davis 2016 (Nutrition and Metabolic Insights, randomized crossover) compared 4 g of liposomal vs 4 g of standard ascorbic acid: liposomal produced significantly higher plasma AUC over 6 hours. Hickey 2008 (J Nutr Environ Med) reported peak plasma values from megadose liposomal that exceeded the supposed oral ceiling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe honest framing: liposomal isn't magic, and it doesn't make 1000 mg perform like an IV infusion (only IV bypasses gut absorption entirely, hitting plasma values around 15,000 µmol\/L). What it does is push significantly more of an oral dose into circulation than the same milligram amount of standard ascorbic acid — closing a meaningful chunk of the gap between what the label says and what the bloodstream actually sees.\u003c\/p\u003e\n\n\u003ch2\u003eThe clinical-evidence bench — a quick reference table\u003c\/h2\u003e\n\u003cp\u003eBelow is a non-exhaustive but representative pull of the human-trial and pharmacokinetic literature underneath this product. Mechanism-driven studies and RCTs only — no observational-only or animal-only work in the table.\u003c\/p\u003e\n\u003ctable style=\"width:100%; border-collapse: collapse;\" border=\"1\" cellpadding=\"6\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f5f5f5;\"\u003e\n      \u003cth align=\"left\"\u003eStudy\u003c\/th\u003e\n      \u003cth align=\"left\"\u003eDesign\u003c\/th\u003e\n      \u003cth align=\"left\"\u003eDose\u003c\/th\u003e\n      \u003cth align=\"left\"\u003eKey finding\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eLevine 1996 (PNAS)\u003c\/td\u003e\n      \u003ctd\u003ePharmacokinetic, n=7 healthy young men\u003c\/td\u003e\n      \u003ctd\u003e15–1250 mg single oral\u003c\/td\u003e\n      \u003ctd\u003eBioavailability ~100% at 30–100 mg, falls to ~50% at 1000 mg, ~33% at 1250 mg\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eLevine 2001 (Annu Rev Nutr)\u003c\/td\u003e\n      \u003ctd\u003eComprehensive PK review\u003c\/td\u003e\n      \u003ctd\u003eMulti-dose summary\u003c\/td\u003e\n      \u003ctd\u003eSVCT1\/SVCT2 saturation kinetics; plasma plateau ~70–80 µmol\/L\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePadayatty 2004 (Ann Intern Med)\u003c\/td\u003e\n      \u003ctd\u003ePharmacokinetic comparison oral vs IV\u003c\/td\u003e\n      \u003ctd\u003eOral ≤1.25 g vs IV up to 1.25 g\u003c\/td\u003e\n      \u003ctd\u003eIV produces plasma 70–100x oral peak; oral plateaus at ~80 µmol\/L\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePadayatty 2010 (PLoS One)\u003c\/td\u003e\n      \u003ctd\u003ePopulation biomarker \/ dose-response analysis\u003c\/td\u003e\n      \u003ctd\u003eRe-analysis\u003c\/td\u003e\n      \u003ctd\u003eDocumented oral-vs-IV dosing confound in earlier cancer trials; argued they were not comparable\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eHickey 2008 (J Nutr Environ Med)\u003c\/td\u003e\n      \u003ctd\u003ePharmacokinetic, liposomal vs unencapsulated\u003c\/td\u003e\n      \u003ctd\u003eUp to 36 g liposomal\u003c\/td\u003e\n      \u003ctd\u003ePlasma peaks ~400 µmol\/L from megadose liposomal — exceeds the standard oral ceiling\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDavis 2016 (Nutr Metab Insights)\u003c\/td\u003e\n      \u003ctd\u003eRandomized crossover, liposomal vs ascorbic acid\u003c\/td\u003e\n      \u003ctd\u003e4 g single oral\u003c\/td\u003e\n      \u003ctd\u003eLiposomal AUC roughly double standard ascorbic acid over 6 hr\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eHemilä \u0026amp; Chalker 2013 (Cochrane Review)\u003c\/td\u003e\n      \u003ctd\u003eMeta-analysis, 29 trials, n\u0026gt;11,000\u003c\/td\u003e\n      \u003ctd\u003e≥200 mg\/day prophylactic\u003c\/td\u003e\n      \u003ctd\u003e~8% cold-duration shorter (adults), ~14% (children); ~50% incidence reduction in heavy-physical-stress subgroups\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCarr 2017 (Nutrients)\u003c\/td\u003e\n      \u003ctd\u003eComprehensive review, vitamin C and immune function\u003c\/td\u003e\n      \u003ctd\u003eMulti-dose summary\u003c\/td\u003e\n      \u003ctd\u003eNeutrophil\/lymphocyte ascorbate concentrated 50–100x plasma; rapid depletion in oxidative-burst cycles\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePullar 2017 (Nutrients)\u003c\/td\u003e\n      \u003ctd\u003eComprehensive review, vitamin C and skin\u003c\/td\u003e\n      \u003ctd\u003eMulti-dose summary\u003c\/td\u003e\n      \u003ctd\u003eReviews collagen-cofactor mechanism, melanogenesis inhibition, photoprotection\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCarr \u0026amp; Frei 1999 (Am J Clin Nutr)\u003c\/td\u003e\n      \u003ctd\u003eBiomarker-saturation analysis\u003c\/td\u003e\n      \u003ctd\u003e30–2500 mg\/day\u003c\/td\u003e\n      \u003ctd\u003eOptimal-function intake ~200 mg\/day; saturable plasma; tissue saturation higher\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eFrei 2012 (Crit Rev Food Sci Nutr)\u003c\/td\u003e\n      \u003ctd\u003eDose-RDA re-derivation\u003c\/td\u003e\n      \u003ctd\u003eMulti-dose review\u003c\/td\u003e\n      \u003ctd\u003eArgued RDA is scurvy-prevention math, not optimal-function math; supports ~200 mg\/day\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eLykkesfeldt 2014 (Nutrients)\u003c\/td\u003e\n      \u003ctd\u003ePopulation pharmacokinetic review\u003c\/td\u003e\n      \u003ctd\u003e≥120 mg\/day for plateau\u003c\/td\u003e\n      \u003ctd\u003eSmoking depletes plasma ascorbate; smokers need ~35 mg\/day extra\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhat Vitamin C does at the cellular level — the four main jobs\u003c\/h2\u003e\n\n\u003ch3\u003e1. Collagen synthesis cofactor (the structural job)\u003c\/h3\u003e\n\u003cp\u003eThis is the role most people miss. Vitamin C isn't just \"good for skin\" — it's a chemically required cofactor in the enzymatic step that converts proline residues on procollagen into hydroxyproline, and lysine into hydroxylysine. Without those hydroxylations, the procollagen triple helix can't fold stably or cross-link, and you get structurally defective collagen — which is exactly what happens in scurvy.\u003c\/p\u003e\n\u003cp\u003eThe two key enzymes — prolyl-4-hydroxylase and lysyl hydroxylase — are iron-dependent dioxygenases. They use Fe²⁺ at the active site, and Vitamin C's job is to keep that iron in the reduced (Fe²⁺) state. After each hydroxylation cycle the iron oxidizes to Fe³⁺ and the enzyme stalls. Vitamin C re-reduces it. No Vitamin C, no enzyme turnover, no functional collagen (Myllyharju 2003, Matrix Biology; Pullar 2017, Nutrients on the role of vitamin C in skin health).\u003c\/p\u003e\n\u003cp\u003eThis is why pairing collagen supplementation with Vitamin C isn't a marketing add-on — it's the same chemistry your liver uses every day. Take collagen peptides without adequate Vitamin C and you're delivering substrate to a stalled assembly line.\u003c\/p\u003e\n\n\u003ch3\u003e2. Antioxidant network recycling (the regenerative job)\u003c\/h3\u003e\n\u003cp\u003eMost people think of Vitamin C as a one-shot antioxidant — donates an electron, becomes oxidized, that's it. The more important role is regenerating other antioxidants in the network:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E (α-tocopherol):\u003c\/strong\u003e Vitamin E sits in cell membranes neutralizing lipid peroxidation. After it donates an electron it becomes the tocopheroxyl radical. Vitamin C, sitting in the aqueous phase right next to the membrane, donates an electron back and regenerates active α-tocopherol (Packer 1979, Nature; classic ascorbate-tocopherol coupling).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlutathione (GSH):\u003c\/strong\u003e oxidized glutathione (GSSG) gets reduced back to GSH partly through the ascorbate-glutathione cycle. Vitamin C and glutathione are mutually regenerating partners, not competitors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePolyphenols (resveratrol, quercetin, curcumin):\u003c\/strong\u003e after a polyphenol donates a hydrogen atom to neutralize a free radical, Vitamin C can re-reduce it back to active form, extending the polyphenol's antioxidant lifespan in tissue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe practical implication: Vitamin C doesn't compete with the rest of your antioxidant stack — it amplifies it. Stacking C with Glutathione, Resveratrol, and CoQ10 gets you more total antioxidant capacity than the sum of the individual products.\u003c\/p\u003e\n\n\u003ch3\u003e3. Immune cell function (the defense job)\u003c\/h3\u003e\n\u003cp\u003eWhite blood cells — especially neutrophils, lymphocytes, and macrophages — actively concentrate Vitamin C at 50–100x plasma levels. They use it during the oxidative burst that kills phagocytosed pathogens, and depletion happens fast: a single round of phagocytic activity can drop intracellular ascorbate by 50%, and infection-driven oxidative stress depletes plasma ascorbate within hours (Carr 2017, Nutrients — comprehensive review of vitamin C and immune function).\u003c\/p\u003e\n\u003cp\u003eThis is why \"I get sick less when I take Vitamin C\" isn't just placebo and isn't quite the mythological \"prevents colds\" claim either. The Hemilä\/Chalker 2013 Cochrane review found regular Vitamin C supplementation didn't prevent colds in the general population, but consistently shortened cold duration (~8% in adults, ~14% in children) and was strongly protective against colds in people under heavy physical stress (marathoners, soldiers, cold-weather workers — ~50% reduction in incidence).\u003c\/p\u003e\n\u003cp\u003eThe mechanism: keeping intracellular ascorbate high in immune cells means they sustain their oxidative-burst capacity longer and recover faster between cycles.\u003c\/p\u003e\n\n\u003ch3\u003e4. Direct free-radical neutralization (the cleanup job)\u003c\/h3\u003e\n\u003cp\u003eIn the aqueous phase — cytoplasm, blood plasma, extracellular fluid — Vitamin C is the body's primary water-soluble antioxidant. It neutralizes superoxide (O₂⁻), hydroxyl radical (·OH), peroxyl radicals, hypochlorite (HOCl), and singlet oxygen. This is the role most consumers know about, but it's actually the smaller share of Vitamin C's biological work compared to collagen synthesis and antioxidant recycling. The cleanup job is real, just one of four.\u003c\/p\u003e\n\n\u003ch2\u003eWhy liposomal — vs other \"enhanced absorption\" forms\u003c\/h2\u003e\n\u003cp\u003eThe supplement market is full of Vitamin C variants that promise better absorption. Honest comparison:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlain ascorbic acid:\u003c\/strong\u003e baseline. Cheap, well-studied, hits the SVCT ceiling at ~500 mg per dose. Best absorption is achieved by splitting into 250–500 mg doses across the day rather than one big dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuffered ascorbates (calcium ascorbate, sodium ascorbate, magnesium ascorbate):\u003c\/strong\u003e easier on the stomach for people who get GI upset from acidic ascorbic acid. Same SVCT ceiling, same bioavailability per mg of ascorbate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEster-C® (calcium ascorbate threonate):\u003c\/strong\u003e marketing claims of better absorption haven't held up to independent comparison studies. Comparable to standard buffered ascorbate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAscorbyl palmitate:\u003c\/strong\u003e a fat-soluble form that incorporates into cell membranes. Useful for membrane-located antioxidant work, but not a higher-bioavailability ascorbate source.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal ascorbate:\u003c\/strong\u003e bypasses the SVCT ceiling via lipid-pathway absorption. Higher AUC at the same milligram dose vs ascorbic acid. The closest oral form gets to IV.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIV Vitamin C:\u003c\/strong\u003e the only way to actually push plasma into the millimolar range (10,000+ µmol\/L). Required for any pharmacological-dose protocol; not realistic as a daily baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor daily supplementation, liposomal is the highest-bioavailability oral form. For anyone running a serious antioxidant or collagen protocol, that bioavailability advantage compounds across months of dosing.\u003c\/p\u003e\n\n\u003ch2\u003eForms of Vitamin C, side-by-side\u003c\/h2\u003e\n\u003cp\u003eThe Vitamin C aisle is full of forms with overlapping marketing claims. The honest comparison:\u003c\/p\u003e\n\u003ctable style=\"width:100%; border-collapse: collapse;\" border=\"1\" cellpadding=\"6\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f5f5f5;\"\u003e\n      \u003cth align=\"left\"\u003eForm\u003c\/th\u003e\n      \u003cth align=\"left\"\u003eAbsorption pathway\u003c\/th\u003e\n      \u003cth align=\"left\"\u003ePer-mg bioavailability\u003c\/th\u003e\n      \u003cth align=\"left\"\u003eBest use\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eAscorbic acid (plain)\u003c\/td\u003e\n      \u003ctd\u003eSVCT1\/SVCT2 transporters\u003c\/td\u003e\n      \u003ctd\u003eBaseline (saturable)\u003c\/td\u003e\n      \u003ctd\u003eCheap maintenance \u0026lt;500 mg single doses\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBuffered ascorbates (Ca\/Na\/Mg)\u003c\/td\u003e\n      \u003ctd\u003eSame SVCT pathway\u003c\/td\u003e\n      \u003ctd\u003e~Same as ascorbic acid\u003c\/td\u003e\n      \u003ctd\u003ePeople with stomach intolerance to acidic ascorbic acid\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eEster-C® (Ca-ascorbate threonate)\u003c\/td\u003e\n      \u003ctd\u003eSame SVCT pathway\u003c\/td\u003e\n      \u003ctd\u003eMarketed claims unsupported by independent comparison\u003c\/td\u003e\n      \u003ctd\u003eEquivalent to buffered ascorbate\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eAscorbyl palmitate\u003c\/td\u003e\n      \u003ctd\u003eLipid pathway, fat-soluble\u003c\/td\u003e\n      \u003ctd\u003eLower per-mg ascorbate equivalent (most of mass is palmitate)\u003c\/td\u003e\n      \u003ctd\u003eMembrane-located antioxidant; not a high-dose ascorbate vehicle\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eWhole-food \/ acerola \/ camu-camu\u003c\/td\u003e\n      \u003ctd\u003eMixed (food-matrix complex)\u003c\/td\u003e\n      \u003ctd\u003ePer-mg of ascorbate ~equivalent; concentration low so doses tend to be sub-clinical\u003c\/td\u003e\n      \u003ctd\u003eDiet integration, not gram-dose protocols\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eLiposomal ascorbate (this bottle)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003e\u003cstrong\u003eLipid pathway + liposomal fusion (bypasses SVCT)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003e\u003cstrong\u003e~2x AUC vs ascorbic acid (Davis 2016)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003e\u003cstrong\u003eDaily 1000+ mg protocols (collagen \/ antioxidant \/ immune)\u003c\/strong\u003e\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eIV Vitamin C\u003c\/td\u003e\n      \u003ctd\u003eDirect circulation (gut bypassed)\u003c\/td\u003e\n      \u003ctd\u003e~70–100x oral peak\u003c\/td\u003e\n      \u003ctd\u003ePharmacological \/ clinical research only\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhy 1000 mg specifically — the dose curve\u003c\/h2\u003e\n\u003cp\u003eVitamin C dose-response isn't linear. The curve has four characteristic regions, and the right answer depends entirely on what you're trying to do:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e30–90 mg\/day — the scurvy-prevention floor.\u003c\/strong\u003e The RDA. Sufficient to prevent overt scurvy. Below the optimal-function range identified by biomarker saturation studies (Carr \u0026amp; Frei 1999, Frei 2012).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e200–500 mg\/day — the optimal-function band.\u003c\/strong\u003e Plasma ascorbate saturates around 70–80 µmol\/L, neutrophils saturate at higher concentrations, and the dose-response curve flattens for most general antioxidant and immune-function endpoints. This is where most of the \"Vitamin C is good for X\" literature actually sits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1000–2000 mg\/day — the protocol-stack band.\u003c\/strong\u003e Where this product lives. Justified for: anyone running a collagen protocol (the cofactor demand scales with collagen substrate intake), anyone in heavy oxidative-stress cycles (athletes, smokers, post-illness, post-surgery), and anyone running an extended antioxidant\/longevity stack where the network-recycling role matters more than a single nutrient saturation point. Past ~2 g\/day with standard ascorbic acid the SVCT transporters are saturated and the unabsorbed fraction starts hitting the gut osmotically; liposomal extends the productive ceiling because it's not gated by SVCT.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5–10 g\/day oral — the megadose territory.\u003c\/strong\u003e Pharmacokinetically futile with standard ascorbic acid (most of it is excreted), GI-limited (loose stool above ~3 g for most people), and provides modest plasma rise even with liposomal. Sometimes used for short-term protocols during active illness; not a maintenance dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e10+ g\/day IV — pharmacological territory.\u003c\/strong\u003e Different drug. Different pharmacokinetics. Different research literature. Not relevant to oral supplementation decisions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1000 mg liposomal sits at the top of the protocol-stack band: enough to push plasma into the upper part of the saturable-oral-range while leaving headroom to add another 1000 mg on a heavy-oxidative-stress day or to pair with an additional standard-ascorbate dose at a meal.\u003c\/p\u003e\n\n\u003ch2\u003eStack with collagen — the cofactor pairing\u003c\/h2\u003e\n\u003cp\u003eIf you take a collagen supplement and don't pair it with adequate Vitamin C, you are spending money on substrate that can't be assembled. The standard pairings:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides 5000 mg\u003c\/a\u003e\u003c\/strong\u003e + Liposomal Vitamin C — the canonical \"beauty from within\" pairing. Type I collagen substrate + the cofactor that hydroxylates the proline and lysine residues so the helix stabilizes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti Collagen Peptides Powder (5 types, 1 lb)\u003c\/a\u003e\u003c\/strong\u003e + Liposomal Vitamin C — broader collagen-type coverage (I, II, III, V, X) for skin, joints, gut, and bone, same cofactor logic.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex (capsules, 5 types)\u003c\/a\u003e\u003c\/strong\u003e + Liposomal Vitamin C — capsule format for travel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200 mg + Vitamin C\u003c\/a\u003e\u003c\/strong\u003e already includes 100 mg of standard Vitamin C — if you take it twice daily plus 1000 mg liposomal in the morning, you're well-covered.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e\u003c\/strong\u003e + collagen + Liposomal Vitamin C — the full hair\/skin\/nails triad: biotin for keratin, collagen for the dermal matrix substrate, Vitamin C as the assembly cofactor.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStack with the antioxidant network\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e\u003c\/strong\u003e — Vitamin C and glutathione mutually regenerate each other in the ascorbate-glutathione cycle. Stacking gets you more antioxidant capacity than either alone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e\u003c\/strong\u003e — NAC is the rate-limiting cysteine substrate for glutathione synthesis; Vitamin C extends the active half-life of the glutathione the NAC builds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e\u003c\/strong\u003e — the second amino acid building block of glutathione. NAC + Glycine + Vitamin C is the full GlyNAC + ascorbate-cycle assembly stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e\u003c\/strong\u003e — fat-soluble carotenoid antioxidant that protects cell membranes; Vitamin C handles the aqueous phase, astaxanthin handles the lipid phase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e\u003c\/strong\u003e — both fat- and water-soluble; ALA can also regenerate Vitamin C from its oxidized form (dehydroascorbate), creating a multi-step antioxidant recycling network.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStack with the longevity \/ NAD+ protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e\u003c\/strong\u003e — Vitamin C regenerates oxidized polyphenols, extending Resveratrol's antioxidant activity in tissue.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\u003c\/strong\u003e or \u003cstrong\u003e\u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — supports the broader antioxidant network protecting mitochondria from the increased ROS that comes with elevated NAD+ turnover.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e\u003c\/strong\u003e — CoQ10 is recycled at the mitochondrial inner membrane partly through ascorbate-dependent reactions.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e\u003c\/strong\u003e — the 5-in-1 already contains some Vitamin C; adding 1000 mg liposomal pushes total ascorbate into the range that meaningfully supports collagen synthesis and immune function.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eLiposomal Vitamin C is one of those products that touches almost every layer of the protocol map, which is why it appears in four separate collection routings rather than a single one:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCollagen synthesis cofactor layer\u003c\/strong\u003e — pairs structurally with \u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e, \u003ca href=\"\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti Collagen Powder (5 types)\u003c\/a\u003e, \u003ca href=\"\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex (capsules)\u003c\/a\u003e, and \u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vit C\u003c\/a\u003e. Without the ascorbate cofactor, prolyl-4-hydroxylase and lysyl hydroxylase stall and procollagen can't be assembled.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant network recycling layer\u003c\/strong\u003e — sits inside the ascorbate-glutathione cycle (Vitamin C ↔ \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e ↔ \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e ↔ \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e) and the ascorbate-tocopherol couple, regenerating Vitamin E in cell membranes after each lipid-peroxidation neutralization (Packer 1979). Pairs with \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e (lipid phase) and \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e (both phases).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePolyphenol-recycling layer\u003c\/strong\u003e — Vitamin C re-reduces oxidized polyphenols, extending the effective half-life of \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e, and \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImmune resilience layer\u003c\/strong\u003e — neutrophils, lymphocytes, and macrophages concentrate ascorbate 50–100x plasma (Carr 2017); the depletion-during-oxidative-burst cycle is what the cold-duration meta-analysis (Hemilä\/Chalker 2013) tracks at the population level.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ stack adjacency\u003c\/strong\u003e — supports the broader antioxidant network protecting mitochondria from elevated ROS that comes with NAD+-driven mitochondrial activity. Cross-links with \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e, \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e, and the \u003ca href=\"\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e formula (which already contains a partial Vitamin C dose; pairing 1000 mg liposomal pushes total ascorbate into the protocol-stack band).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCollection routing: \u003ca href=\"\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e, \u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e, \u003ca href=\"\/collections\/collagen\"\u003eCollagen\u003c\/a\u003e, \u003ca href=\"\/collections\/skin-protocol\"\u003eSkin Protocol\u003c\/a\u003e, \u003ca href=\"\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging\u003c\/a\u003e, \u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone taking a collagen supplement (mandatory cofactor pairing — not optional)\u003c\/li\u003e\n  \u003cli\u003eAdults wanting a daily antioxidant baseline that meaningfully raises plasma and tissue Vitamin C\u003c\/li\u003e\n  \u003cli\u003eFrequent travelers, athletes in heavy training, students or workers in immune-stress windows\u003c\/li\u003e\n  \u003cli\u003eSmokers and regular drinkers — both deplete plasma ascorbate substantially (smokers need ~35 mg\/day more just to maintain baseline)\u003c\/li\u003e\n  \u003cli\u003ePeople recovering from illness, surgery, or wounds (Vitamin C demand spikes during repair)\u003c\/li\u003e\n  \u003cli\u003eAnti-aging stacks focused on free-radical defense, skin health, and collagen support\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for (or talk to a clinician first)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHistory of calcium oxalate kidney stones.\u003c\/strong\u003e Vitamin C is metabolized partly to oxalate. High doses (typically \u0026gt;1000 mg\/day) can modestly raise urinary oxalate excretion. If you've had oxalate stones, talk to your doctor before regular high-dose ascorbate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHemochromatosis or iron overload conditions.\u003c\/strong\u003e Vitamin C dramatically increases non-heme iron absorption. People who can't dispose of excess iron should not take high-dose Vitamin C with iron-containing meals or supplements without medical guidance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eG6PD deficiency.\u003c\/strong\u003e Very high doses (typically pharmacological IV doses) can trigger hemolysis in G6PD-deficient individuals. Standard oral doses are generally fine, but talk to your doctor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChemotherapy or active cancer treatment.\u003c\/strong\u003e Some chemo regimens may interact with high-dose antioxidants. Coordinate with your oncology team.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy or nursing.\u003c\/strong\u003e Standard dietary intake is essential; megadose supplementation hasn't been thoroughly studied in pregnancy. Talk to your OB.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — the realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e plasma and tissue ascorbate rise. People who were running deficient (smokers, chronic dieters, post-illness) may notice subtle skin tone or energy changes here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e if stacking with collagen, the cofactor effect on collagen synthesis compounds — visible skin firmness improvements often track here, matching the Proksch 2014 collagen-trial timelines.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e antioxidant network steady-state; immune resilience improvements (faster recovery from minor illness, less post-workout inflammation) usually show in this window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3+:\u003c\/strong\u003e sustained collagen-synthesis support, sustained antioxidant recycling capacity. Continued use is the maintenance dose; if you stop, plasma ascorbate returns to dietary baseline within 1–2 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking 1000 mg ascorbic acid in a single dose and expecting 1000 mg of plasma rise.\u003c\/strong\u003e Levine 1996 says you'll absorb ~50% of it. Either split the dose or use liposomal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking collagen without the cofactor.\u003c\/strong\u003e Collagen peptides without enough Vitamin C is substrate without an assembly enzyme. The pairing isn't optional — it's the rate-limiting biochemistry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTreating liposomal like IV.\u003c\/strong\u003e Liposomal pushes oral plasma higher; it does not produce IV-range concentrations (15,000+ µmol\/L). Different molecule, different research.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMegadosing past 3 g\/day with standard ascorbic acid.\u003c\/strong\u003e SVCT-saturated, GI-osmotic, and most of it ends up in the urine. If you need more, use liposomal or split across the day; don't try to brute-force the SVCT ceiling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it 24–48 hours before a glucose finger-stick or stool occult-blood test.\u003c\/strong\u003e High-dose Vitamin C interferes with both. Pause if your clinician asks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePairing with iron when you have hemochromatosis or unexplained ferritin elevation.\u003c\/strong\u003e Vitamin C ~3-4x non-heme iron absorption — helpful for iron-deficiency anemia, dangerous in iron overload.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle morning megabolus instead of split dosing.\u003c\/strong\u003e Vitamin C is water-soluble and clears within hours. For a sustained-plasma protocol, split AM\/PM rather than dumping the whole day's dose at breakfast.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1–2 capsules daily with food. Vitamin C is water-soluble — taking with food is more about absorption tolerance and steady release than a fat-pairing requirement. If running 2 capsules, split them across the day (morning + early afternoon) for sustained plasma levels rather than a single morning bolus. Avoid taking immediately before bed — the small amount of bioactive compound can be mildly stimulating in sensitive individuals.\u003c\/p\u003e\n\u003cp\u003ePair the morning dose with collagen if you're running a beauty\/skin protocol. Pair the second dose with the rest of your antioxidant stack (Glutathione, NAC, Astaxanthin) for the recycling synergy.\u003c\/p\u003e\n\n\u003ch2\u003ePer-capsule ingredient panel\u003c\/h2\u003e\n\u003ctable style=\"width:100%; border-collapse: collapse;\" border=\"1\" cellpadding=\"6\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f5f5f5;\"\u003e\n      \u003cth align=\"left\"\u003eIngredient\u003c\/th\u003e\n      \u003cth align=\"left\"\u003ePer serving (1 capsule)\u003c\/th\u003e\n      \u003cth align=\"left\"\u003eForm \/ source\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eLiposomal Vitamin C\u003c\/td\u003e\n      \u003ctd\u003e1000 mg\u003c\/td\u003e\n      \u003ctd\u003eL-ascorbic acid encapsulated in phosphatidylcholine bilayer liposomes\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSunflower phospholipids (liposome shell)\u003c\/td\u003e\n      \u003ctd\u003eCarrier matrix\u003c\/td\u003e\n      \u003ctd\u003eHelianthus annuus, non-soy phosphatidylcholine\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003e1\u003c\/td\u003e\n      \u003ctd\u003eHPMC (hydroxypropyl methylcellulose) USP, vegan, no titanium dioxide\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBulking agent\u003c\/td\u003e\n      \u003ctd\u003eq.s.\u003c\/td\u003e\n      \u003ctd\u003eMicrocrystalline cellulose\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eFlow agent\u003c\/td\u003e\n      \u003ctd\u003eq.s.\u003c\/td\u003e\n      \u003ctd\u003eRice flour\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eFree of: titanium dioxide, artificial colors, magnesium stearate, GMOs, soy, gluten, dairy, eggs, peanuts, tree nuts, fish, shellfish.\u003c\/p\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAscorbate raw material.\u003c\/strong\u003e Pharmaceutical-grade L-ascorbic acid, USP-monograph compliant, sourced from cGMP suppliers. Identity confirmed by FTIR and HPLC; assay ≥99.0% per USP \u0026lt;1215\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposome shell.\u003c\/strong\u003e Sunflower-derived phosphatidylcholine (no soy lecithin). Sized phospholipid bilayer vesicles produced by high-shear \/ ultrasonic processing — not the loose lecithin-and-ascorbate powder mixes that some \"liposomal\" products on the market actually are.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufacturing.\u003c\/strong\u003e cGMP per 21 CFR Part 111. ISO 9001 certified facility, FDA-registered. Per-batch documentation retained for a minimum of 24 months past expiration.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch testing.\u003c\/strong\u003e HPLC ascorbate assay (label-claim verification), USP \u0026lt;2232\u0026gt; heavy metals (Pb, Cd, As, Hg under proposition-65 thresholds), USP \u0026lt;2021\u0026gt; \/ \u0026lt;2022\u0026gt; microbial limits (TAMC, TYMC, absence of \u003cem\u003eE. coli\u003c\/em\u003e \/ \u003cem\u003eSalmonella\u003c\/em\u003e \/ \u003cem\u003eS. aureus\u003c\/em\u003e), USP \u0026lt;467\u0026gt; residual solvents, and USP \u0026lt;561\u0026gt; pesticide screen on the phospholipid raw material.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability.\u003c\/strong\u003e 24-month shelf life from manufacture date. Stored in UV-protective amber HDPE bottles with desiccant; ascorbate is photo- and oxidation-sensitive, and the bottle format is part of the protection plan.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDocumentation.\u003c\/strong\u003e Certificate of Analysis available on request via support@truehealthprotocol.health. Batch-level traceability from raw material lot through finished-good lot.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety notes\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGI tolerance:\u003c\/strong\u003e the liposomal form is dramatically gentler on the stomach than equivalent ascorbic acid doses (no osmotic-load loose stool from unabsorbed ascorbate). Most people tolerate 1–2 capsules with no GI effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron interaction:\u003c\/strong\u003e Vitamin C increases non-heme iron absorption ~3-4x. Helpful for iron-deficient individuals, problematic for hemochromatosis. If you're on iron supplementation, taking C with the iron is intentional. If you're avoiding iron uptake, separate by a few hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLab interference:\u003c\/strong\u003e high-dose Vitamin C can interfere with some glucose meter readings (false low) and stool occult-blood tests (false negative). Pause for 24–48 hours before relevant lab tests if your clinician asks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e may modestly enhance estrogen absorption from oral contraceptives; may increase aluminum absorption from aluminum-containing antacids. Generally well-tolerated with most medications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e no specific Vitamin C washout is typically required, but disclose all supplements to your surgical team.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is liposomal really worth the price difference vs standard Vitamin C?\u003c\/strong\u003e\u003cbr\u003e\nA: For people taking C purely for general antioxidant intake at modest doses (~250–500 mg daily), standard ascorbic acid split into 2 doses is fine and cheaper. For people running a 1000+ mg daily protocol — for collagen synthesis, antioxidant network support, immune resilience, or longevity stacking — liposomal closes a real bioavailability gap that standard ascorbic acid can't match without going to IV.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will I get loose stool from this like high-dose ascorbic acid?\u003c\/strong\u003e\u003cbr\u003e\nA: Almost certainly not at 1–2 capsules. The osmotic loose stool from high-dose ascorbic acid is caused by unabsorbed ascorbate sitting in the gut. Liposomal absorption bypasses that pathway, so you don't get the unabsorbed-ascorbate osmotic load.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take it with my collagen powder in the morning?\u003c\/strong\u003e\u003cbr\u003e\nA: Yes, this is the recommended pairing. Take collagen + Vitamin C together in the same window so the ascorbate is at peak plasma exactly when prolyl-4-hydroxylase is processing the procollagen substrate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is more better? Should I take 5–10 grams a day?\u003c\/strong\u003e\u003cbr\u003e\nA: For daily maintenance, no — diminishing returns above ~2 g\/day for most people. Megadose protocols (5+ g\/day) are sometimes used short-term during active illness but carry GI tolerance issues and modestly increased oxalate excretion. For a daily longevity\/beauty\/immune baseline, 1–2 capsules (1000–2000 mg liposomal) is the sweet spot.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does it actually work for skin brightening like the Asian beauty market claims?\u003c\/strong\u003e\u003cbr\u003e\nA: Vitamin C inhibits tyrosinase (the enzyme that synthesizes melanin), which is the mechanism behind the \"brightening\" claim. Topical Vitamin C has stronger evidence for spot lightening; oral Vitamin C is more about supporting overall collagen-driven skin firmness and protecting against UV-induced oxidative damage. The two work well together.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How does it compare to IV Vitamin C?\u003c\/strong\u003e\u003cbr\u003e\nA: IV Vitamin C produces plasma levels around 15,000 µmol\/L — pharmacological, not nutritional. Oral liposomal at 1000–2000 mg produces plasma levels several-fold above standard oral ascorbate but still in the nutritional range (typically 200–400 µmol\/L peak). Liposomal is for daily nutritional support; IV is for clinical protocols and not interchangeable.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Should I take it with my multivitamin or as separate?\u003c\/strong\u003e\u003cbr\u003e\nA: Either works. Most multivitamins contain only 60–100 mg Vitamin C, which is below the 1000 mg target dose. Taking the liposomal as a separate dose lets you split the day (morning + afternoon) for sustained plasma rather than getting it all in the multi.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I open the capsule and mix into water or smoothies?\u003c\/strong\u003e\u003cbr\u003e\nA: Yes — the liposomes survive in solution for short periods. Best practice is to mix and consume within a few minutes; long storage in water or acidic drinks (juice, smoothies with citrus) will start to degrade both the ascorbate and the liposome shell.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is this OK during pregnancy or breastfeeding?\u003c\/strong\u003e\u003cbr\u003e\nA: Standard dietary Vitamin C is essential during pregnancy. Megadose supplementation hasn't been well-studied in pregnancy, so talk to your OB before starting any 1000+ mg\/day protocol while pregnant or nursing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: I take iron supplements — should I take this with or apart from them?\u003c\/strong\u003e\u003cbr\u003e\nA: With them, intentionally. Vitamin C dramatically improves non-heme iron absorption — this is the standard recommendation for iron-deficiency anemia protocols. Take both at the same meal.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: I have a history of kidney stones — can I take this?\u003c\/strong\u003e\u003cbr\u003e\nA: Calcium oxalate stones (the most common kind) can be modestly aggravated by high-dose Vitamin C in some individuals because ascorbate metabolism produces oxalate. If you have a history of oxalate stones, talk to your doctor before regular 1000+ mg dosing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Vegan\/vegetarian?\u003c\/strong\u003e\u003cbr\u003e\nA: Yes. Sunflower-derived phospholipids (no soy, no animal-derived lecithin), vegetable cellulose capsule, no animal ingredients.\u003c\/p\u003e\n\n\u003ch2\u003eWhy not Amazon\u003c\/h2\u003e\n\u003cp\u003eThree differentiators worth knowing before you compare bottles on price alone:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrue liposomal vs lecithin-mixed.\u003c\/strong\u003e A meaningful share of \"liposomal Vitamin C\" products on marketplace listings are not actually liposomal — they're sunflower lecithin powder mixed with ascorbic acid in a capsule. That mix doesn't form sized bilayer vesicles and doesn't deliver the bioavailability profile Davis 2016 measured. This product uses processed phospholipid bilayer vesicles, not a powder mix.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePharmaceutical-grade ascorbate vs commodity.\u003c\/strong\u003e USP-monograph ≥99% L-ascorbic acid with HPLC assay verification per batch. Commodity ascorbate at the lower-priced end of the marketplace doesn't always meet that standard.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCatalog architecture.\u003c\/strong\u003e The protocol-stack rationale — Vitamin C as collagen cofactor, polyphenol regenerator, GSH-cycle partner, immune-cell concentrate — is built into the cross-linked collection routing. You can stack with Marine Collagen, Multi Collagen Powder, Glutathione, NAC, Glycine, Astaxanthin, ALA, Resveratrol, NMN, CoQ10, NAD+ 5-in-1 from the same catalog with the protocol logic spelled out, rather than guessing at compatibility from product page to product page.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/how-to-choose-a-collagen-supplement-5-things-to-check-on-the-label\"\u003eHow to choose a collagen supplement (Vitamin C is the cofactor)\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/marine-collagen-for-hair-growth-what-actually-works-and-what-doesnt\"\u003eMarine Collagen for Hair Growth — what actually works\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/marine-collagen-vs-bovine-collagen-which-works-faster-for-skin-hair-and-nails\"\u003eMarine vs bovine collagen — which works faster\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/glutathione-for-skin-brightening-how-it-works-and-how-long-it-takes\"\u003eGlutathione for skin brightening — how it works\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/hyaluronic-acid-for-skin-topical-vs-oral-what-actually-works\"\u003eHyaluronic acid for skin — topical vs oral\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: the 7 daily nutrients underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — practical protocol 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/protocols\"\u003eThe True Health Protocols (full stacking guide)\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/our-science\"\u003eOur Science — the Hallmarks of Aging framework\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/quality\"\u003eQuality \u0026amp; testing standards\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/ingredient-sourcing\"\u003eIngredient sourcing\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/longevity-essentials\"\u003eBrowse the Longevity Essentials collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/beauty-anti-aging\"\u003eBrowse the Beauty \u0026amp; Anti-Aging collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/collagen\"\u003eBrowse the Collagen collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/skin-protocol\"\u003eBrowse the Skin Protocol collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/collections\/antioxidants\"\u003eBrowse the Antioxidants collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003ePauling L. \u003cem\u003eVitamin C and the Common Cold\u003c\/em\u003e. W. H. Freeman, 1970.\u003c\/li\u003e\n  \u003cli\u003eCameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. \u003cem\u003eProc Natl Acad Sci USA\u003c\/em\u003e 1976; 73(10): 3685–9.\u003c\/li\u003e\n  \u003cli\u003eCameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. \u003cem\u003eProc Natl Acad Sci USA\u003c\/em\u003e 1978; 75(9): 4538–42.\u003c\/li\u003e\n  \u003cli\u003eCreagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C therapy to benefit patients with advanced cancer. \u003cem\u003eN Engl J Med\u003c\/em\u003e 1979; 301: 687–690.\u003c\/li\u003e\n  \u003cli\u003eMoertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer. \u003cem\u003eN Engl J Med\u003c\/em\u003e 1985; 312: 137–141.\u003c\/li\u003e\n  \u003cli\u003eLevine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. \u003cem\u003eProc Natl Acad Sci USA\u003c\/em\u003e 1996; 93(8): 3704–9.\u003c\/li\u003e\n  \u003cli\u003eLevine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. \u003cem\u003eProc Natl Acad Sci USA\u003c\/em\u003e 2001; 98(17): 9842–6. (And Levine 2001 Annu Rev Nutr review.)\u003c\/li\u003e\n  \u003cli\u003eCarr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e 1999; 69(6): 1086–107.\u003c\/li\u003e\n  \u003cli\u003ePadayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. \u003cem\u003eAnn Intern Med\u003c\/em\u003e 2004; 140: 533–537.\u003c\/li\u003e\n  \u003cli\u003ePadayatty SJ, Sun AY, Chen Q, et al. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. \u003cem\u003ePLoS One\u003c\/em\u003e 2010; 5(7): e11414.\u003c\/li\u003e\n  \u003cli\u003eHickey S, Roberts HJ, Miller NJ. Pharmacokinetics of oral vitamin C. \u003cem\u003eJ Nutr Environ Med\u003c\/em\u003e 2008; 17(3): 169–177.\u003c\/li\u003e\n  \u003cli\u003eDavis JL, Paris HL, Beals JW, et al. Liposomal-encapsulated ascorbic acid: influence on vitamin C bioavailability and capacity to protect against ischemia-reperfusion injury. \u003cem\u003eNutr Metab Insights\u003c\/em\u003e 2016; 9: 25–30.\u003c\/li\u003e\n  \u003cli\u003eFrei B, Birlouez-Aragon I, Lykkesfeldt J. Authors' perspective: what is the optimum intake of vitamin C in humans? \u003cem\u003eCrit Rev Food Sci Nutr\u003c\/em\u003e 2012; 52(9): 815–29.\u003c\/li\u003e\n  \u003cli\u003eLykkesfeldt J, Michels AJ, Frei B. Vitamin C. \u003cem\u003eAdv Nutr\u003c\/em\u003e \/ \u003cem\u003eNutrients\u003c\/em\u003e reviews 2014.\u003c\/li\u003e\n  \u003cli\u003eHemilä H, Chalker E. Vitamin C for preventing and treating the common cold. \u003cem\u003eCochrane Database Syst Rev\u003c\/em\u003e 2013; (1): CD000980.\u003c\/li\u003e\n  \u003cli\u003eCarr AC, Maggini S. Vitamin C and immune function. \u003cem\u003eNutrients\u003c\/em\u003e 2017; 9(11): 1211.\u003c\/li\u003e\n  \u003cli\u003ePullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. \u003cem\u003eNutrients\u003c\/em\u003e 2017; 9(8): 866.\u003c\/li\u003e\n  \u003cli\u003eMyllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. \u003cem\u003eMatrix Biology\u003c\/em\u003e 2003; 22: 15–24.\u003c\/li\u003e\n  \u003cli\u003ePacker JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. \u003cem\u003eNature\u003c\/em\u003e 1979; 278: 737–8.\u003c\/li\u003e\n  \u003cli\u003eNiki E. Free radicals and antioxidants in clinical biology. \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e 1995.\u003c\/li\u003e\n  \u003cli\u003eStern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. \u003cem\u003eClin Dermatol\u003c\/em\u003e 2008; 26(2): 106–22.\u003c\/li\u003e\n  \u003cli\u003eProksch E, Segger D, Degwert J, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology. \u003cem\u003eSkin Pharmacol Physiol\u003c\/em\u003e 2014; 27: 47–55.\u003c\/li\u003e\n  \u003cli\u003eAsher GN, Spelman K. Clinical utility of curcumin extract — illustrative reference for the polyphenol-recycling stacking rationale.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cem\u003eReferences cited above are summarized for educational context and are not endorsements by the cited authors of this specific product. Doses noted in the studies cited do not necessarily reflect the dose of this product, and Vitamin C is not a treatment for any specific disease. Talk to your physician before starting a 1000+ mg\/day Vitamin C protocol if you are pregnant or nursing, have hemochromatosis or a history of calcium oxalate kidney stones, are on chemotherapy, or take iron supplementation regularly. Have a question? Email \u003ca href=\"mailto:support@truehealthprotocol.health\"\u003esupport@truehealthprotocol.health\u003c\/a\u003e.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47736997937370,"sku":"THP-VITC-LIPO-1000","price":22.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_vitamin_c.jpg?v=1775682595"},{"product_id":"astaxanthin-12mg-120-softgels-antioxidant-skin-support","title":"Astaxanthin 12mg | Natural Haematococcus Microalgae | Membrane-Spanning Antioxidant for Skin, Eyes \u0026 Cellular Defense","description":"\u003cp\u003e\u003cstrong\u003eAstaxanthin 12mg from natural Haematococcus pluvialis microalgae — the membrane-spanning xanthophyll carotenoid that protects every cell from the inside out. The single most-researched oral skin-and-eye antioxidant, dosed at the upper end of the human-trial range. 120 softgels, four-month supply.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cp\u003eAstaxanthin is a deep-red xanthophyll carotenoid produced by the freshwater microalgae \u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e when the algae is stressed by sunlight, salinity, or nutrient deprivation. The same molecule colors wild salmon, krill, shrimp, and flamingo feathers — they all eat the algae (or eat something that ate the algae) and concentrate astaxanthin in their tissue as oxidative-stress armor. Humans cannot synthesize astaxanthin, but we absorb it efficiently when it is taken with dietary fat, and once absorbed it reaches every membrane in the body — skin, retina, brain, mitochondria, vascular endothelium, sperm, and skeletal muscle.\u003c\/p\u003e\n\n\u003cp\u003eThe structural feature that makes astaxanthin unusual is geometric: the molecule is long and rigid enough to span the entire width of a cell membrane, with a hydroxyl-and-ketone \"polar end\" anchored on each face and a polyene chain crossing the lipid bilayer between them. Vitamin C protects the watery cytosol. Vitamin E protects the lipid membrane interior. Astaxanthin is the only common dietary antioxidant that simultaneously protects the inner aqueous face, the outer aqueous face, AND the lipid interior of every membrane it sits in. \u003cem\u003eLorenz \u0026amp; Cysewski 2000 (Trends in Biotechnology)\u003c\/em\u003e first characterized the membrane-spanning geometry; \u003cem\u003eMcNulty et al. 2007 (Biochim Biophys Acta)\u003c\/em\u003e measured the consequence — astaxanthin disrupts membrane lipid peroxidation chains 100x more efficiently per molecule than alpha-tocopherol in liposomal models.\u003c\/p\u003e\n\n\u003cp\u003eThe human-trial bench is one of the deepest in the carotenoid family. \u003cem\u003eTominaga et al. 2012 (Acta Biochim Pol)\u003c\/em\u003e ran a 6mg\/day x 8-week double-blind RCT in middle-aged women and saw measurable improvements in crow's-feet wrinkle depth, skin elasticity, and corneocyte moisture. \u003cem\u003eTominaga et al. 2017 (J Clin Biochem Nutr)\u003c\/em\u003e replicated and extended at 6 and 12mg, with the 12mg arm showing the strongest skin texture and elasticity scores. \u003cem\u003ePark et al. 2010 (Nutr Metab)\u003c\/em\u003e documented immune function and oxidative-stress marker improvements at 2 and 8mg over 8 weeks. \u003cem\u003eNagaki et al. 2002 (J Trad Med)\u003c\/em\u003e and \u003cem\u003eKajita et al. 2009 (J Clin Therapeutics \u0026amp; Med)\u003c\/em\u003e showed reduced eye fatigue and improved accommodation in screen-heavy office workers at 4-6mg\/day. \u003cem\u003eEarnest et al. 2011 (Int J Sports Med)\u003c\/em\u003e showed reduced exercise-induced lipid peroxidation in trained cyclists. The molecule does what the marketing claims — and at 12mg you sit at the upper end of the doses the human trials used.\u003c\/p\u003e\n\n\u003ch2\u003eWhy \"membrane-spanning\" matters more than ORAC scores\u003c\/h2\u003e\n\u003cp\u003eThe supplement industry rates antioxidants on assays like ORAC (Oxygen Radical Absorbance Capacity) that measure how many free radicals one molecule can quench in a test tube. By that score, astaxanthin out-quenches Vitamin C by ~6,000x, CoQ10 by ~800x, alpha-tocopherol by ~550x, and beta-carotene by ~10x per molecule. That is interesting but not the whole story — ORAC reactions in a beaker do not translate cleanly to what happens inside a living cell. The reason astaxanthin holds its ranking when you move from beaker to organism is structural, not just kinetic.\u003c\/p\u003e\n\n\u003cp\u003ePicture a cell membrane as a phospholipid bilayer — two sheets of fatty molecules with their water-loving heads facing the watery cytosol on the inside and the watery extracellular fluid on the outside, and their water-fearing fatty tails meeting in the middle. Free-radical damage hits all three zones. Reactive oxygen species (ROS) generated inside the cell oxidize the inner head groups; ROS generated outside (UV, pollution, inflammation) attack the outer head groups; and lipid peroxidation chain reactions propagate through the fatty interior, where each oxidized lipid creates the next radical that oxidizes the lipid next to it.\u003c\/p\u003e\n\n\u003cp\u003eMost antioxidants only sit in one of those zones:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eVitamin C (ascorbate)\u003c\/strong\u003e is water-soluble. It floats in the cytosol and the extracellular fluid. It cannot enter the lipid interior at all.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVitamin E (alpha-tocopherol)\u003c\/strong\u003e is fat-soluble with a tiny polar head. It tucks into the membrane interior with one end peeking into the aqueous face — but only one face at a time, and only the outer leaflet for most of its sit time.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBeta-carotene\u003c\/strong\u003e is fully fat-soluble with no polar groups. It sits buried in the membrane interior and cannot reach either aqueous face.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCoQ10\u003c\/strong\u003e is membrane-bound and fat-soluble; it works inside the inner mitochondrial membrane primarily for electron transport. Antioxidant duty is a side job.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAstaxanthin\u003c\/strong\u003e is the geometric outlier: long enough to bridge both leaflets of the bilayer, with polar end groups exposed on both aqueous faces and a polyene rail spanning the fatty interior between them. One molecule, three zones, simultaneously.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe functional consequence: astaxanthin can intercept a free radical attacking the outer membrane face, AND a free radical attacking the inner membrane face, AND a propagating lipid-peroxidation chain in the membrane interior — all in the same defensive position. \u003cem\u003eMcNulty 2007\u003c\/em\u003e showed in liposomal models that this geometric protection is why astaxanthin disrupts lipid peroxidation chains so much more efficiently than alpha-tocopherol per molecule. \u003cem\u003eWisniewska \u0026amp; Subczynski 2008 (Free Radic Biol Med)\u003c\/em\u003e directly imaged the bridging orientation by EPR spectroscopy. This is not a marketing artifact. It is a structural feature.\u003c\/p\u003e\n\n\u003ch2\u003eWhat astaxanthin actually is, and where it comes from\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e is a unicellular green freshwater algae found in transient rain pools across temperate climates. Under ideal nutrient and light conditions it is green, motile, and reproduces normally. Under stress — strong sunlight, salinity, nitrogen depletion, heat — it transforms: it sheds its flagella, builds a thick protective cyst wall, and floods its interior with astaxanthin until the cell turns deep red. The astaxanthin is the algae's sun protection. A red cyst can survive months of UV exposure that would have killed a normal green cell within hours.\u003c\/p\u003e\n\n\u003cp\u003eCommercial astaxanthin production reproduces this stress response in controlled photobioreactors: green-stage cultivation to grow biomass, then deliberate stress (high light, nitrogen withdrawal, salt) to trigger astaxanthin accumulation. Mature red biomass is harvested, cell walls are mechanically cracked, and the astaxanthin is extracted with supercritical CO2 (the cleanest method — no chemical solvents) into an oil concentrate that is then standardized for capsule fill.\u003c\/p\u003e\n\n\u003cp\u003eThis is the same astaxanthin a wild salmon eats when it consumes algae and zooplankton in coastal feeding grounds. Farmed salmon, by contrast, are fed synthetic astaxanthin (chemically identical molecule but produced by petrochemical synthesis rather than algae fermentation) to keep the flesh pink. Synthetic astaxanthin is ~95% trans-isomer; natural \u003cem\u003eH. pluvialis\u003c\/em\u003e astaxanthin is a mixture of trans, 9-cis, and 13-cis isomers plus a small fraction of esterified forms — and the isomer mix appears to absorb and incorporate into human tissue better than the pure-trans synthetic. Almost every published human RCT used natural \u003cem\u003eH. pluvialis\u003c\/em\u003e astaxanthin. So do we.\u003c\/p\u003e\n\n\u003ch2\u003eWhat the human research actually shows\u003c\/h2\u003e\n\u003cp\u003eAstaxanthin has unusually deep human-trial coverage for a \"longevity\" supplement. The studies cluster into five outcome domains:\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSkin (the most-replicated outcome).\u003c\/strong\u003e \u003cem\u003eTominaga et al. 2012, Acta Biochim Pol.\u003c\/em\u003e Double-blind placebo-controlled trial: 6mg astaxanthin daily plus 2mL topical for 8 weeks in 30 middle-aged women. Significant improvements in crow's-feet wrinkle depth, skin elasticity (cutometer measurement), and corneocyte moisture content vs placebo. \u003cem\u003eTominaga et al. 2017, J Clin Biochem Nutr.\u003c\/em\u003e Six- and 12mg\/day arms over 16 weeks in 65 healthy women. Both doses preserved skin moisture under summer UV exposure; the 12mg arm produced the largest improvement in elasticity scores. \u003cem\u003eYoshihisa et al. 2014, J Dermatol Sci.\u003c\/em\u003e In vitro and in vivo demonstration that astaxanthin protects keratinocytes from UVA-induced reactive oxygen species and matrix metalloproteinase upregulation — the molecular cascade behind photoaging. \u003cem\u003eSuganuma et al. 2010, J Dermatol Sci.\u003c\/em\u003e Astaxanthin pre-treatment reduced UVA-induced damage in fibroblasts, suggesting protection of the dermal collagen network specifically.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eEye (screen-fatigue and accommodation).\u003c\/strong\u003e \u003cem\u003eNagaki et al. 2002, J Trad Med.\u003c\/em\u003e 5mg\/day for 4 weeks in VDT (visual display terminal) workers — significant reduction in subjective eye-strain symptoms. \u003cem\u003eKajita et al. 2009, J Clin Ther Med.\u003c\/em\u003e 6mg\/day for 4 weeks improved accommodation amplitude (the eye's ability to refocus between near and far targets). \u003cem\u003eIwasaki \u0026amp; Tawara 2006, J Eye.\u003c\/em\u003e Reduced asthenopia and improved accommodation in healthy adults. \u003cem\u003eHayashi et al. 2017, Asia Pac J Clin Nutr.\u003c\/em\u003e 6mg\/day x 8 weeks improved blur-recovery time after near-work in healthy office workers. The eye effects are why astaxanthin is heavily marketed to screen-heavy professionals.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCardiovascular and lipid markers.\u003c\/strong\u003e \u003cem\u003eYoshida et al. 2010, Atherosclerosis.\u003c\/em\u003e 12mg\/day x 12 weeks lowered triglycerides and raised HDL in patients with mild hyperlipidemia. \u003cem\u003eIwabayashi et al. 2009, Anti-Aging Med.\u003c\/em\u003e 12mg\/day x 8 weeks improved blood-flow-mediated dilation in postmenopausal women. \u003cem\u003eKarppi et al. 2007, Int J Vitam Nutr Res.\u003c\/em\u003e Reduced oxidized LDL after 12 weeks at 8mg\/day in middle-aged adults.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eExercise and recovery.\u003c\/strong\u003e \u003cem\u003eEarnest et al. 2011, Int J Sports Med.\u003c\/em\u003e 4mg\/day x 28 days in trained cyclists reduced exercise-induced lipid peroxidation markers. \u003cem\u003eAoi et al. 2008, Biochem Biophys Res Commun.\u003c\/em\u003e Animal model — astaxanthin shifted muscle fuel use toward fat oxidation and reduced exercise-induced muscle damage. \u003cem\u003eBrown et al. 2018, Br J Sports Med (review).\u003c\/em\u003e Concluded that astaxanthin shows reproducible reductions in exercise-induced oxidative stress and inflammation but mixed performance effects.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eInflammation and immune function.\u003c\/strong\u003e \u003cem\u003ePark et al. 2010, Nutr Metab.\u003c\/em\u003e 2mg and 8mg\/day x 8 weeks in young women — both doses lowered DNA damage markers and a CRP marker; the 8mg arm boosted natural killer cell activity and T- and B-cell mitogen response. \u003cem\u003eSpiller \u0026amp; Dewell 2003, J Med Food.\u003c\/em\u003e 4mg\/day reduced symptoms of acid reflux and Helicobacter pylori-related inflammation in a small open-label trial.\u003c\/p\u003e\n\n\u003cp\u003eNone of the trials reported serious adverse events at doses up to 40mg\/day — the most common subjective notes are deeper-yellow stool color (excess carotenoid excretion, harmless) and faintly orange palms in heavy long-term users (also harmless and reversible).\u003c\/p\u003e\n\n\u003ch2\u003eWhy 12mg specifically\u003c\/h2\u003e\n\u003cp\u003eThe studied dose range for astaxanthin in humans runs 2–40mg\/day. The threshold and ceiling are well-mapped:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e2–4mg\/day\u003c\/strong\u003e — minimum effective range for measurable changes in oxidative-stress biomarkers (Park 2010, Earnest 2011). Some skin and eye effects appear here over longer timelines (8–12 weeks).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e6mg\/day\u003c\/strong\u003e — the dose used in most of the foundational skin RCTs (Tominaga 2012, Hayashi 2017). The threshold where structural skin and eye effects become reproducible.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e8–12mg\/day\u003c\/strong\u003e — the dose range with the strongest skin-elasticity, lipid-marker, and immune-function effects (Tominaga 2017, Yoshida 2010, Park 2010 8mg arm). 12mg\/day is the dose with the largest skin-elasticity effect size in the head-to-head Tominaga 2017 trial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e20–40mg\/day\u003c\/strong\u003e — used in some metabolic and male-fertility studies (Comhaire 2005). Outcomes do not scale linearly above ~12mg; absorption appears to saturate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eWe chose 12mg because it sits at the upper end of the dose range with the strongest replicated outcome data — particularly the skin-elasticity and immune-function endpoints — and because most Western diets contribute essentially zero astaxanthin. (The richest dietary sources are wild Pacific salmon at ~1mg per 100g cooked weight, and Antarctic krill oil at ~0.1mg per gram; you would need 1.2 kg of wild salmon daily to match a 12mg supplemental dose.) Higher doses are well-tolerated but do not scale benefits proportionally.\u003c\/p\u003e\n\n\u003ch2\u003eForm comparison: natural vs synthetic, ester vs free\u003c\/h2\u003e\n\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eIsomer profile\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNatural H. pluvialis (this product)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMicroalgae fermentation, supercritical CO2 extraction\u003c\/td\u003e\n\u003ctd\u003eMix: trans + 9-cis + 13-cis + esterified\u003c\/td\u003e\n\u003ctd\u003eDominant form in human RCT literature. Higher tissue uptake than pure synthetic.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSynthetic\u003c\/td\u003e\n\u003ctd\u003ePetrochemical synthesis (BASF, DSM)\u003c\/td\u003e\n\u003ctd\u003e~95% trans, no esters\u003c\/td\u003e\n\u003ctd\u003eUsed in farmed-salmon feed for color. Identical molecule but lower tissue concentrations at equivalent oral dose.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePhaffia \/ Xanthophyllomyces\u003c\/td\u003e\n\u003ctd\u003eYeast fermentation\u003c\/td\u003e\n\u003ctd\u003eMostly trans, minimal esters\u003c\/td\u003e\n\u003ctd\u003eUsed mainly in animal feed; less human RCT data.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKrill oil astaxanthin\u003c\/td\u003e\n\u003ctd\u003eAntarctic krill (Euphausia superba)\u003c\/td\u003e\n\u003ctd\u003eEsterified with phospholipids\u003c\/td\u003e\n\u003ctd\u003e~0.1mg per gram of krill oil — too dilute for therapeutic dosing on its own.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFree astaxanthin (the unesterified form) is what circulates and reaches tissue. Esterified astaxanthin (astaxanthin attached to a fatty acid molecule, the form algae naturally make) is hydrolyzed to free form by pancreatic enzymes during digestion. Both forms ultimately reach tissue as free astaxanthin, so the ester-vs-free distinction matters less than total astaxanthin content per softgel and the natural-vs-synthetic source distinction.\u003c\/p\u003e\n\n\u003ch2\u003eStack architecture: where this fits\u003c\/h2\u003e\n\u003cp\u003eAstaxanthin is a network player, not a solo act. Three pairings cover most use cases:\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe antioxidant network — for systemic oxidative-stress defense.\u003c\/strong\u003e Antioxidants regenerate each other in vivo. Vitamin C re-reduces oxidized Vitamin E back to its active form. Glutathione re-reduces oxidized Vitamin C. CoQ10 re-reduces oxidized Vitamin E in the membrane. Astaxanthin uniquely covers both faces of the membrane simultaneously, but it still oxidizes when it does its job — the network keeps it cycling.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e (this product) — membrane-spanning\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e — water-phase\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e — master intracellular antioxidant\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e — glutathione precursor\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e — mitochondrial-membrane fat-soluble\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha Lipoic Acid 600mg\u003c\/a\u003e — both water- and fat-soluble; recycles Vitamin C, Vitamin E, glutathione\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe beauty \u0026amp; skin stack — for collagen-network support and photoaging defense.\u003c\/strong\u003e Astaxanthin is the most-replicated oral supplement for skin elasticity and UV-stress resilience. Pair with the structural building blocks for compounding effects.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides 5000mg\u003c\/a\u003e — Type I collagen substrate\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti Collagen Powder 1lb\u003c\/a\u003e — five collagen types\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti Collagen Complex\u003c\/a\u003e — capsule form, five types\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200mg + Vitamin C\u003c\/a\u003e — dermal hydration + collagen-synthesis cofactor\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000mcg\u003c\/a\u003e — keratin synthesis\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e — bundled collagen + biotin + HA\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eThe longevity \/ mitochondrial stack — for membrane-level cellular protection during NAD+ stacking.\u003c\/strong\u003e Astaxanthin protects the mitochondrial inner membrane from the lipid peroxidation that accumulates as energy production turns over. Sits naturally beside NAD+ precursors, the mitophagy molecules, and CoQ10.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e or \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e — NAD+ precursor\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e — multi-precursor formula\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e — sirtuin activator\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e — mitophagy activator\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e — autophagy\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e — foundational\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eAdults 30+ wanting a daily oral skin-defense supplement that works at the dermal level (not topical-only)\u003c\/li\u003e\n\u003cli\u003ePeople with significant sun exposure — outdoor workers, athletes, residents of high-UV climates, frequent travelers — who want oral photoprotection alongside (not replacing) topical sunscreen\u003c\/li\u003e\n\u003cli\u003eHeavy screen users with eye fatigue, dryness, or accommodation difficulty\u003c\/li\u003e\n\u003cli\u003eEndurance athletes and high-volume gym users for the recovery and oxidative-stress-buffering effects\u003c\/li\u003e\n\u003cli\u003eAdults running NMN\/NAD+ stacks who want membrane-level antioxidant protection alongside the NAD+-driven energy throughput increase\u003c\/li\u003e\n\u003cli\u003eAnyone running a beauty or collagen stack who wants to add the most-researched oral skin-elasticity ingredient\u003c\/li\u003e\n\u003cli\u003eAdults 50+ wanting a daily systemic antioxidant baseline\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding women.\u003c\/strong\u003e No safety data at supplemental doses. Skip until cleared by your obstetrician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on warfarin or other anticoagulants.\u003c\/strong\u003e Astaxanthin has mild blood-thinning effects in some studies. Coordinate with your prescriber before starting.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on 5-alpha-reductase inhibitors (finasteride\/dutasteride) or hormone-modulating medications.\u003c\/strong\u003e Some animal data suggests astaxanthin may modulate 5-alpha-reductase activity. Check with your prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople scheduled for surgery within two weeks.\u003c\/strong\u003e The mild antiplatelet effect warrants caution around surgical bleeding. Stop 14 days pre-procedure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with known carotenoid allergy or severe seafood allergy.\u003c\/strong\u003e The astaxanthin itself is plant-source (algae), but anyone with a confirmed carotenoid sensitivity should consult their physician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrict vegans.\u003c\/strong\u003e The softgel shell is bovine gelatin. We are working on a vegetarian capsule version.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone expecting a stimulant or \"feel-it-tomorrow\" effect.\u003c\/strong\u003e Astaxanthin is a structural antioxidant — the work is happening at the cell membrane regardless of whether you feel a subjective change. Expect 4–12 weeks for observable effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week timeline\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e Tissue astaxanthin levels build. Plasma astaxanthin reaches steady-state around day 7–10 of consistent dosing. Most subjective effects are below threshold in this window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 2–4:\u003c\/strong\u003e Some users notice reduced eye fatigue at the end of long screen days, slightly easier blur-to-focus transitions, and the first hints of skin moisture improvement (Hayashi 2017 saw blur-recovery improvement at the 4-week mark in office workers).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 4–8:\u003c\/strong\u003e Skin elasticity and corneocyte moisture become measurable in instrumented studies (Tominaga 2012). Athletes report less DOMS and faster recovery (Earnest 2011 timeline). Lipid-peroxidation markers drop in those tracking labs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 8–12:\u003c\/strong\u003e Skin texture, fine-line depth, and elasticity improvements compound (Tominaga 2017's largest effects landed at 16 weeks). Cardiovascular biomarker effects appear in those tracking lipids (Yoshida 2010 timeline).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 3+:\u003c\/strong\u003e Sustained antioxidant defense as a maintenance baseline. Athletes typically observe steady-state recovery benefits. Skin and eye effects plateau and need continued dosing to maintain.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1 softgel daily with a meal that contains dietary fat — eggs, avocado, full-fat yogurt, butter, olive oil, salmon, nuts, cheese. \u003cstrong\u003eAstaxanthin is fat-soluble and lipid-bound for absorption.\u003c\/strong\u003e Empty-stomach use can cut bioavailability by 50% or more. Best paired with the largest fat-containing meal of the day, typically lunch or dinner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAthletic or heavy-screen-use protocol:\u003c\/strong\u003e 1 softgel\/day with food, taken consistently for at least 8 weeks before judging effect. Some endurance athletes split to 2 softgels (24mg) during heavy training blocks; the safety bench supports up to 40mg\/day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStack timing:\u003c\/strong\u003e Take with your CoQ10 and Vitamin D3+K2 in the same meal — all three are fat-soluble and absorb best from the same lipid emulsion. Take separately from your morning Vitamin C \/ glutathione stack if you want to spread antioxidant coverage across the day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eTime to effect:\u003c\/strong\u003e Plan for 4 weeks before judging eye-fatigue effects, 8 weeks for skin moisture and elasticity, 12 weeks for the full skin-texture benefit. This is a structural antioxidant working at the membrane level — the effects compound over months, not days.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each softgel\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAstaxanthin (natural):\u003c\/strong\u003e 12mg from \u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e microalgae, supercritical CO2-extracted\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCarrier oil:\u003c\/strong\u003e Refined sunflower or olive oil (varies by batch — check the label) for fat-soluble absorption\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSoftgel shell:\u003c\/strong\u003e Bovine gelatin, glycerin, purified water (not vegan)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eServings:\u003c\/strong\u003e 120 softgels — four-month supply at 1\/day, two-month supply at 2\/day\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFree from:\u003c\/strong\u003e Artificial colors, artificial flavors, artificial preservatives, gluten, soy, dairy, GMOs, magnesium stearate, titanium dioxide, synthetic fillers\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality and sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in cGMP-certified facilities. Each batch is third-party tested for astaxanthin potency by HPLC, identity confirmation, heavy metals (lead, arsenic, cadmium, mercury), microbial contamination, and pesticide residues. The astaxanthin is sourced from \u003cem\u003eHaematococcus pluvialis\u003c\/em\u003e microalgae cultivated in closed photobioreactors (controlled water, light, and nutrient inputs — not open-pond which can pick up environmental contaminants), and extracted using supercritical CO2 rather than chemical solvents. The carrier oil is non-GMO. The softgel shell is standard pharmaceutical-grade bovine gelatin; no synthetic dyes or titanium dioxide. Bottled in UV-protective amber HDPE with a freshness desiccant — astaxanthin is light-sensitive and will degrade in clear bottles.\u003c\/p\u003e\n\n\u003ch2\u003eSafety and interactions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelet medications.\u003c\/strong\u003e Astaxanthin shows mild antiplatelet effects in some in vitro and small-trial data. If you take warfarin, apixaban, rivaroxaban, clopidogrel, or aspirin therapy, coordinate with your prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e5-alpha-reductase activity.\u003c\/strong\u003e Some animal data suggests astaxanthin may inhibit 5-alpha-reductase. If you take finasteride, dutasteride, or other hormone-modulating medications, discuss with your prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Stop 14 days before any scheduled surgery as a precaution against the mild antiplatelet effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkin\/palm coloration.\u003c\/strong\u003e Heavy long-term dosing (8mg+ daily for many months) can produce a faintly orange tint to palms and soles — harmless and reversible (the same mechanism that turns flamingo feathers pink). Stool color may shift slightly yellow-orange from excess carotenoid excretion.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding.\u003c\/strong\u003e No human safety trials in these populations. Skip.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren under 18.\u003c\/strong\u003e Not studied. Skip unless directed by a pediatrician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCarotenoid sensitivity.\u003c\/strong\u003e Rare, but possible. Discontinue if you notice unusual skin reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs natural astaxanthin really better than synthetic?\u003c\/strong\u003e\u003cbr\u003e\nThe molecule is chemically identical, but the natural \u003cem\u003eH. pluvialis\u003c\/em\u003e form is delivered as a mixture of trans, 9-cis, 13-cis, and esterified isomers, whereas synthetic astaxanthin is ~95% pure trans. Comparative bioavailability studies (Capelli et al. 2013, NutraFoods) show natural \u003cem\u003eH. pluvialis\u003c\/em\u003e astaxanthin reaches ~20x higher tissue concentrations than synthetic at equivalent oral doses. Almost every published human RCT used the natural form. Synthetic astaxanthin is approved for animal feed (it colors farmed salmon) but is not commonly used in human supplements. Ours is natural.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes astaxanthin replace sunscreen?\u003c\/strong\u003e\u003cbr\u003e\nNo. It supplements topical sunscreen but does not replace it. The published trials show astaxanthin reduces UV-induced skin damage measured at the dermal level — collagen-network protection, reduced photoaging, lower MMP activation — but the SPF-equivalent of oral astaxanthin is in the low single digits at best. Use topical sunscreen for surface UV protection. Use oral astaxanthin for the deeper dermal-level protection that surface sunscreen does not reach.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do my softgels look so dark red?\u003c\/strong\u003e\u003cbr\u003e\nPure astaxanthin is one of the darkest red pigments in nature — concentrated enough that 12mg in a softgel produces an opaque deep-red color through the gelatin shell. If your astaxanthin softgels look pale pink or orange, the dose is probably much lower than the label claims, or the product is heavily diluted with carrier oil and a tiny astaxanthin fraction. Deep red is what 12mg of real astaxanthin looks like.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I take it morning or night?\u003c\/strong\u003e\u003cbr\u003e\nEither, as long as you take it with a fat-containing meal. Steady-state plasma levels build over 7–10 days of consistent dosing, so the once-daily timing matters less than the consistency. Morning works for most people because it aligns with the largest fat-containing meal. If you take CoQ10, Vitamin D3+K2, or fish oil at one meal, take astaxanthin at the same meal — all four are fat-soluble and share the same absorption pathway.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I notice anything?\u003c\/strong\u003e\u003cbr\u003e\nSubjectively — eye fatigue and screen-recovery effects are usually the first noticed (4–6 weeks for most), followed by skin moisture and elasticity (8–12 weeks). Cardiovascular and lipid effects only show up if you track labs. Athletic recovery effects appear over 2–4 weeks of training. Astaxanthin is not a stimulant or adaptogen and produces no acute \"felt\" effects in the first day or week — the work is happening at the cell membrane level whether you feel it or not.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with my CoQ10 and Vitamin D?\u003c\/strong\u003e\u003cbr\u003e\nYes — and you should. All three are fat-soluble and share absorption pathways. Taking them together with a fat-containing meal optimizes uptake for all three. There are no negative interactions.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs 12mg too much?\u003c\/strong\u003e\u003cbr\u003e\nTwelve mg is the upper end of the doses used in the published skin-elasticity and immune-function RCTs. Trials have run up to 40mg\/day without serious adverse events. Twelve mg is well within the safe range and matches the dose with the strongest replicated outcome data. Higher doses do not scale benefits proportionally; absorption appears to saturate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is it in a softgel and not a vegetarian capsule?\u003c\/strong\u003e\u003cbr\u003e\nAstaxanthin needs to be delivered in oil for absorption. Soft-gelatin softgels are the most efficient container for an oil-based dose — they protect the astaxanthin from oxidation and deliver the lipid carrier intact. We are working on a vegetarian softgel option using modified plant starch shells; for now, the bovine-gelatin softgel is what reliably protects the molecule.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my fish oil or krill oil?\u003c\/strong\u003e\u003cbr\u003e\nNo — they pair naturally. Krill oil contains a small amount of esterified astaxanthin (~0.1mg per gram), which is why krill oil is shelf-stable longer than ordinary fish oil; the astaxanthin protects the omega-3s from oxidation. Adding 12mg of supplemental astaxanthin to a krill oil or fish oil regimen makes both more effective: the astaxanthin protects the omega-3 fatty acids during digestion and incorporation into your own membranes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes astaxanthin help hair growth?\u003c\/strong\u003e\u003cbr\u003e\nIndirectly, possibly. Astaxanthin protects scalp microcirculation and reduces oxidative stress around the hair follicle. Some animal studies and a few small trials suggest it may slow androgenetic hair thinning by modulating 5-alpha-reductase activity, though the human evidence is much thinner here than for skin elasticity. Pair with biotin and collagen if hair is the primary goal — astaxanthin is a supporting player, not a primary lever.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy does the softgel sometimes have a slight fishy aftertaste?\u003c\/strong\u003e\u003cbr\u003e\nIt shouldn't — pure \u003cem\u003eH. pluvialis\u003c\/em\u003e astaxanthin is essentially tasteless and odorless. If you taste fish, your softgel may be co-formulated with fish oil (some products combine the two). Ours is astaxanthin in vegetable carrier oil only — no fish oil component. If you ever notice a strong fishy or rancid taste, the softgel may have oxidized; contact us for a replacement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to a multivitamin or \"antioxidant complex\" pill?\u003c\/strong\u003e\u003cbr\u003e\nMost multivitamins contain no astaxanthin, or a token amount (1–2mg) below the dose threshold for measurable effect. \"Antioxidant complex\" products typically rely on Vitamin C, Vitamin E, selenium, zinc, and beta-carotene — useful but not the same as the membrane-spanning protection astaxanthin uniquely provides. Astaxanthin is best treated as a dedicated single-ingredient layer, not something to expect from a multivitamin.\u003c\/p\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/blogs\/news\/marine-collagen-for-hair-growth-what-actually-works-and-what-doesnt\"\u003eMarine collagen for hair growth — what actually works\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/blogs\/news\/hyaluronic-acid-for-skin-topical-vs-oral-what-actually-works\"\u003eHyaluronic acid for skin — topical vs oral\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/pages\/the-true-health-protocols\"\u003eThe True Health Protocols\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/collections\/longevity-essentials\"\u003eLongevity Essentials collection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/collections\/beauty-skin\"\u003eBeauty \u0026amp; Skin collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is a dietary supplement. The statements on this page have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Citations to published research are provided for context and reader reference, not as endorsement of the supplement by the cited researchers or journals. Consult a licensed clinician before starting any supplement, particularly if you are pregnant, nursing, taking prescription medication (especially anticoagulants or hormone-modulating drugs), or managing a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47737013764314,"sku":"THP-ASTA-12","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/astaxanthin_12mg.png?v=1777034367"},{"product_id":"curcumin-1000mg-bioperine-anti-inflammatory-longevity","title":"Curcumin 1000mg | 95% Curcuminoids + BioPerine | Anti-Inflammatory Longevity","description":"\u003cp\u003e\u003cstrong\u003eCurcumin 1000mg with 95% curcuminoids + 5mg BioPerine® — the most-studied anti-inflammatory longevity compound, in the form your body can actually absorb.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eCurcumin is the active polyphenol in turmeric (\u003cem\u003eCurcuma longa\u003c\/em\u003e), and it sits at the intersection of two areas modern aging research takes seriously: \u003cstrong\u003einflammaging\u003c\/strong\u003e — the slow, tissue-wide simmer of NF-κB-driven inflammation that accumulates with age (Franceschi \u0026amp; Campisi 2014, \u003cem\u003eJ Gerontol\u003c\/em\u003e) — and the \u003cstrong\u003eendogenous antioxidant system\u003c\/strong\u003e regulated by the Nrf2 transcription factor (glutathione, superoxide dismutase, catalase, heme oxygenase-1). With more than 13,000 peer-reviewed publications on PubMed, including \u003cem\u003eHewlings \u0026amp; Kalman 2017 (Foods)\u003c\/em\u003e, \u003cem\u003eAggarwal \u0026amp; Harikumar 2009 (Int J Biochem Cell Biol)\u003c\/em\u003e, \u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e, \u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e, and \u003cem\u003eSmall 2018 (Am J Geriatric Psychiatry)\u003c\/em\u003e, curcumin is one of the few natural compounds that has been shown — in human trials, not just cell culture — to reduce C-reactive protein (CRP), improve joint pain scores comparably to NSAIDs, raise BDNF, and modulate the same molecular pathways targeted by metformin and rapamycin. The catch every supplement taker eventually runs into is bioavailability: \u003cem\u003eShoba 1998 (Planta Medica)\u003c\/em\u003e showed that ordinary curcumin reaches plasma at near-undetectable levels because it’s poorly water-soluble and rapidly conjugated in the liver. Co-administering 5mg of piperine (the active in BioPerine®) increased systemic bioavailability by \u003cstrong\u003e~2000%\u003c\/strong\u003e in healthy volunteers. This product delivers what the published bioavailability literature actually used: 1000mg of turmeric root extract \u003cstrong\u003estandardized to 95% curcuminoids\u003c\/strong\u003e plus \u003cstrong\u003e5mg BioPerine®\u003c\/strong\u003e at 95% piperine — one capsule, taken with food that contains some fat, once a day.\u003c\/p\u003e\n\n\u003ch3\u003eWhy curcumin keeps appearing in serious longevity research\u003c\/h3\u003e\n\u003cp\u003eAging, at the cellular level, is the slow accumulation of low-grade inflammation. The same NF-κB transcription factor that flares when you sprain an ankle stays mildly switched on for decades, driving joint stiffness, cognitive decline, vascular dysfunction, and insulin resistance — what \u003cem\u003eFranceschi \u0026amp; Campisi 2014 (J Gerontol)\u003c\/em\u003e coined \u003cem\u003einflammaging\u003c\/em\u003e. Long-term human cohort data (Framingham, Rotterdam, ARIC) shows elevated CRP, IL-6, and TNF-α are among the most reliable predictors of all-cause mortality and frailty — outpredicting cholesterol in many analyses. Curcumin is one of the few natural polyphenols that has been shown to \u003cstrong\u003edirectly inhibit NF-κB activation\u003c\/strong\u003e at the IκB-kinase step (\u003cem\u003eSingh \u0026amp; Aggarwal 1995, J Biol Chem\u003c\/em\u003e) \u003cem\u003eand\u003c\/em\u003e simultaneously \u003cstrong\u003eactivate Nrf2\u003c\/strong\u003e (\u003cem\u003eBalogun 2003, Biochem J\u003c\/em\u003e) — the master regulator of the body’s own antioxidant defenses. Most over-the-counter anti-inflammatories suppress symptoms downstream; curcumin works upstream on the signal itself. That dual NF-κB↓ \/ Nrf2↑ profile is also the reason curcumin shows up alongside resveratrol, fisetin, and quercetin in nearly every published longevity-stack review.\u003c\/p\u003e\n\n\u003ch3\u003eThe bioavailability problem — and why BioPerine matters\u003c\/h3\u003e\n\u003cp\u003eCurcumin’s biggest failure mode as a supplement is poor absorption. It has low water solubility (about 11ng\/mL at physiologic pH), rapid intestinal metabolism, and aggressive hepatic glucuronidation\/sulfation. \u003cem\u003eShoba et al. 1998 (Planta Medica)\u003c\/em\u003e dosed healthy volunteers with 2g of curcumin alone and measured serum levels at the limit of detection. The same 2g dose \u003cstrong\u003eplus 20mg piperine\u003c\/strong\u003e raised serum curcumin AUC by \u003cstrong\u003e~2000%\u003c\/strong\u003e. The mechanism: piperine inhibits intestinal and hepatic UDP-glucuronosyltransferase, slowing the rate at which curcumin is conjugated and excreted before it reaches circulation. This is why every reputable curcumin product on the market either uses BioPerine®, a phospholipid carrier (Meriva®), a colloidal nanoparticle (Theracurmin®), or a liposomal vehicle — straight 95% curcuminoid powder without a delivery solution is, pharmacokinetically, mostly wasted.\u003c\/p\u003e\n\n\u003ch3\u003eWhat curcumin actually does — mechanisms in plain English\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNF-κB inhibition.\u003c\/strong\u003e Down-regulates the master inflammation switch that drives chronic disease — specifically by inhibiting IκB kinase (IKK), preventing NF-κB from translocating to the nucleus and switching on TNF-α, IL-1β, IL-6, and COX-2 transcription. Pairs mechanistically with \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (different upstream entry point on the same pathway) and \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin\/protectin-driven inflammation resolution).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 activation.\u003c\/strong\u003e Switches on endogenous antioxidant production — glutathione, superoxide dismutase, catalase, heme oxygenase-1 — via Keap1 cysteine modification. Means less dependence on exogenous antioxidants alone. Synergistic with \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e and \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBrain \/ BDNF support.\u003c\/strong\u003e Crosses the blood-brain barrier (one of curcumin’s rare advantages over quercetin and resveratrol). \u003cem\u003eSmall 2018 (Am J Geriatric Psychiatry)\u003c\/em\u003e showed an 18-month Theracurmin trial improved memory-test scores and reduced amyloid\/tau PET signal in non-demented older adults. Best framed as long-game cognitive resilience, not nootropic stimulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint and tendon comfort.\u003c\/strong\u003e \u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e meta-analysis of 8 randomized trials in osteoarthritis: 500–1500 mg\/day of curcuminoids produced clinically meaningful pain-score reduction comparable to ibuprofen 1200–2400 mg\/day, with markedly fewer GI side effects and no anticoagulant burden.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular markers.\u003c\/strong\u003e \u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e meta-analysis: significant CRP reduction (−6.44 mg\/L) in adults with elevated baseline inflammation. Endothelial-function trials (Akazawa 2012, Sugawara 2012) show improvements in flow-mediated dilation comparable to moderate aerobic exercise.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMetabolic \/ AMPK signaling.\u003c\/strong\u003e Activates AMPK and inhibits mTOR — overlapping with the molecular signature of caloric restriction, metformin, and berberine. \u003cem\u003eChuengsamarn 2012 (Diabetes Care)\u003c\/em\u003e: 9-month curcuminoid trial in 240 prediabetic adults reduced progression to type 2 diabetes by 100% vs. placebo (16.4% conversion rate in the placebo arm). Pairs naturally with \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic adjacent.\u003c\/strong\u003e Curcumin is not a primary senolytic (that’s \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e), but it suppresses the senescence-associated secretory phenotype (SASP) — the inflammatory soup that senescent cells emit before they’re cleared. Curcumin lowers the inflammatory burden of cells you haven’t yet removed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBile and digestive support.\u003c\/strong\u003e Stimulates bile flow (cholagogic). Improves fat digestion. Same mechanism that means people with gallstones should avoid supplemental doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eThe clinical evidence — what published human trials actually showed\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003eOutcome\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eShoba 1998 (Planta Medica)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e8 healthy volunteers\u003c\/td\u003e\n\u003ctd\u003e2g curcumin ± 20mg piperine, single dose\u003c\/td\u003e\n\u003ctd\u003ePiperine increased curcumin serum AUC by ~2000%; established the BioPerine pairing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eSahebkar 2014 (Phytother Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eMeta-analysis, 6 RCTs, 342 adults\u003c\/td\u003e\n\u003ctd\u003e200–1000 mg\/day, 4–12 weeks\u003c\/td\u003e\n\u003ctd\u003eCRP −6.44 mg\/L vs. placebo in adults with elevated inflammation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eDaily 2016 (J Med Food)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eMeta-analysis, 8 RCTs, knee osteoarthritis\u003c\/td\u003e\n\u003ctd\u003e500–1500 mg\/day, 4–12 weeks\u003c\/td\u003e\n\u003ctd\u003eWOMAC pain reduction comparable to NSAIDs; markedly fewer GI events\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eSmall 2018 (Am J Geriatr Psychiatry)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e40 non-demented adults 51–84\u003c\/td\u003e\n\u003ctd\u003e90mg Theracurmin BID, 18 months\u003c\/td\u003e\n\u003ctd\u003eImproved memory and attention; reduced amyloid\/tau PET signal in amygdala\/hypothalamus\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eChuengsamarn 2012 (Diabetes Care)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e240 prediabetic adults\u003c\/td\u003e\n\u003ctd\u003e1500 mg\/day curcuminoids, 9 months\u003c\/td\u003e\n\u003ctd\u003e16.4% → 0% type-2 diabetes progression vs. placebo over 9 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eAkazawa 2012 (Nutr Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e32 postmenopausal women\u003c\/td\u003e\n\u003ctd\u003e150mg curcumin\/day, 8 weeks ± aerobic exercise\u003c\/td\u003e\n\u003ctd\u003eFlow-mediated dilation improved comparably to aerobic exercise; additive when stacked\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003ePanahi 2017 (Drug Res)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e117 metabolic syndrome adults\u003c\/td\u003e\n\u003ctd\u003e1000mg curcuminoids + 10mg piperine, 8 weeks\u003c\/td\u003e\n\u003ctd\u003eReduced CRP, IL-6, TNF-α, MDA; improved HDL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eHewlings \u0026amp; Kalman 2017 (Foods)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eComprehensive safety\/efficacy review\u003c\/td\u003e\n\u003ctd\u003eDoses up to 12g\/day in human trials\u003c\/td\u003e\n\u003ctd\u003eNo serious adverse events at supplemental doses; well-tolerated long-term\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cem\u003eLopresti 2014 (J Affect Disord)\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003e56 adults with major depression\u003c\/td\u003e\n\u003ctd\u003e500mg BID curcuminoids, 8 weeks\u003c\/td\u003e\n\u003ctd\u003eIDS-SR score improvement vs. placebo, particularly in atypical-depression subgroup\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cem\u003eReferences below are listed in full citation form for verification. Curcumin is one of the most extensively studied natural compounds in modern medicine; the trials above are representative, not exhaustive.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eForm comparison — what the marketing labels actually mean\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse: collapse; width: 100%;\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eCurcuminoid %\u003c\/th\u003e\n\u003cth\u003eBioavailability multiple\u003c\/th\u003e\n\u003cth\u003eCost \/ dose\u003c\/th\u003e\n\u003cth\u003eBest use case\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRaw turmeric powder (kitchen spice)\u003c\/td\u003e\n\u003ctd\u003e~3%\u003c\/td\u003e\n\u003ctd\u003e1× baseline\u003c\/td\u003e\n\u003ctd\u003e$\u003c\/td\u003e\n\u003ctd\u003eCooking; not clinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e80% curcuminoid extract, no carrier\u003c\/td\u003e\n\u003ctd\u003e80%\u003c\/td\u003e\n\u003ctd\u003e~1×\u003c\/td\u003e\n\u003ctd\u003e$\u003c\/td\u003e\n\u003ctd\u003eOutdated; underabsorbed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e95% curcuminoids + BioPerine® (this product)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e~20×\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$$\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily anti-inflammatory base layer at sustainable cost\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMeriva® \/ phytosome curcumin\u003c\/td\u003e\n\u003ctd\u003e20% (carrier-bound)\u003c\/td\u003e\n\u003ctd\u003e~29× (Belcaro 2010)\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eOA \/ GI-tolerance issues with piperine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTheracurmin® \/ colloidal nanoparticle\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003ctd\u003e~27× (Sasaki 2011)\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eBrain-focused trials (Small 2018 used this form)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal curcumin\u003c\/td\u003e\n\u003ctd\u003evariable\u003c\/td\u003e\n\u003ctd\u003e~10–25×\u003c\/td\u003e\n\u003ctd\u003e$$$\u003c\/td\u003e\n\u003ctd\u003eNiche; comparable to phytosome at premium cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurcuWIN® \/ Longvida®\u003c\/td\u003e\n\u003ctd\u003e~20–46% (carrier-bound)\u003c\/td\u003e\n\u003ctd\u003e~46× \/ ~67×\u003c\/td\u003e\n\u003ctd\u003e$$$$\u003c\/td\u003e\n\u003ctd\u003eSpecialty — high cost for daily use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eFor most people running a permanent daily anti-inflammatory layer, \u003cstrong\u003e95% curcuminoids + BioPerine\u003c\/strong\u003e hits the sweet spot of clinically meaningful absorption at sustainable cost. Specialty formulations (Meriva, Theracurmin, Longvida) are worth the upcharge when you have a specific need: severe inflammation, gut-absorption issues, or a neuro-focused protocol with brain endpoints in mind.\u003c\/p\u003e\n\n\u003ch3\u003eWhere curcumin fits in a longevity stack\u003c\/h3\u003e\n\u003cp\u003eMost longevity protocols cover an NAD+ precursor (\u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e), a sirtuin activator (\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e), and senolytics (\u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e, \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e). What’s missing in 80% of stacks is the \u003cstrong\u003einflammation layer\u003c\/strong\u003e — and you can have perfect mitochondrial output, restored NAD+, and cleared senescent cells while still aging fast in a constant low-grade NF-κB simmer. Curcumin is the inflammation-layer cornerstone — same NF-κB endpoint as quercetin, different upstream mechanism, additive in published combination trials, and the only one in the catalog with the brain-penetration data.\u003c\/p\u003e\n\n\u003ch3\u003eStacking guide — mechanism-organized\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInflammation layer (the natural pair).\u003c\/strong\u003e Curcumin (NF-κB IKK inhibition) + \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (NF-κB downstream + mast-cell stabilization) + \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin\/protectin-driven inflammation resolution). Three different mechanisms converging on the same inflammaging pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 \/ antioxidant layer.\u003c\/strong\u003e Curcumin + \u003ca href=\"\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid\u003c\/a\u003e (recycles Vit C\/E\/glutathione) + \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e (glutathione precursor) + \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e (direct GSH). Curcumin upregulates the system; NAC\/glycine\/ALA feed the substrates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular layer.\u003c\/strong\u003e Curcumin (CRP ↓) + \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e (triglycerides, endothelial function) + \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (LDL, glucose) + \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e (mitochondrial energy in cardiac tissue, especially if on a statin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBrain \/ BDNF layer.\u003c\/strong\u003e Curcumin (BDNF, amyloid, tau) + \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 DHA\u003c\/a\u003e (synaptic membrane fluidity) + \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e (BBB-crossing antioxidant) + \u003ca href=\"\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e (HPA-axis \/ cortisol).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic layer (SASP suppression).\u003c\/strong\u003e Curcumin lowers the inflammatory output of senescent cells you haven’t yet cleared, while \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e trigger their apoptosis. Curcumin runs daily; senolytics run pulsed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ metabolic layer.\u003c\/strong\u003e Curcumin (AMPK↑, mTOR↓) + \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e (AMPK↑ via lysosomal mechanism) + \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG\u003c\/a\u003e (metabolite, epigenetic clock) — three different upstream entry points to the AMPK\/mTOR axis that caloric restriction also targets.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint \/ connective-tissue layer.\u003c\/strong\u003e Curcumin (NF-κB, prostaglandin signaling) + \u003ca href=\"\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eCollagen peptides\u003c\/a\u003e (cartilage substrate) + \u003ca href=\"\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vit C\u003c\/a\u003e (extracellular matrix support).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational layer.\u003c\/strong\u003e Curcumin sits in the \u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e tier alongside \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, and \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e as a permanent daily, not a pulsed compound.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in the catalog architecture\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational tier:\u003c\/strong\u003e Curcumin is one of the seven daily essentials in the \u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e protocol — the layer that should be in place before exotic compounds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-inflammatory cornerstone:\u003c\/strong\u003e The inflammation-layer counterpart to \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e — both NF-κB inhibitors, different upstream mechanisms, additive.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive resilience:\u003c\/strong\u003e Member of the \u003ca href=\"\/collections\/brain-cognitive\"\u003eBrain \u0026amp; Cognitive\u003c\/a\u003e stack, alongside Omega-3 DHA and Astaxanthin, by virtue of its blood-brain-barrier penetration and BDNF data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular:\u003c\/strong\u003e Member of the \u003ca href=\"\/collections\/cardiovascular\"\u003eCardiovascular\u003c\/a\u003e stack via CRP reduction and endothelial-function improvement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJoint \u0026amp; connective tissue:\u003c\/strong\u003e Most-clinically-validated daily for joint comfort short of NSAIDs; pairs with collagen peptides and HA.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhy 1000mg specifically\u003c\/h3\u003e\n\u003cp\u003eThe dose-response curve for curcuminoids in published human trials is fairly well characterized. Below 200mg\/day, even with BioPerine, you’re unlikely to see CRP movement. Between 500 and 1000mg\/day plus piperine, you sit in the band that produced the CRP, joint-comfort, and metabolic outcomes in \u003cem\u003eSahebkar 2014\u003c\/em\u003e, \u003cem\u003eDaily 2016\u003c\/em\u003e, and \u003cem\u003ePanahi 2017\u003c\/em\u003e. Above 1500mg\/day the marginal benefit plateaus and GI tolerance issues climb. \u003cstrong\u003e1000mg of 95% curcuminoids = 950mg active curcuminoids per capsule\u003c\/strong\u003e — right at the modal trial dose, deliverable in a single capsule, with cost-per-day low enough to sustain as a daily for years.\u003c\/p\u003e\n\n\u003ch3\u003eWhat to expect — week by week\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2.\u003c\/strong\u003e Most people notice nothing subjectively. Plasma curcumin steady-state takes about a week to establish.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4.\u003c\/strong\u003e Joint stiffness on waking starts to ease. Post-exercise recovery feels modestly faster. Sleep quality may improve modestly via reduced inflammatory tone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8.\u003c\/strong\u003e Subjective joint-comfort improvements consolidate; for OA-spectrum users, this is when WOMAC-style pain scores typically drop in trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8–12.\u003c\/strong\u003e Objective markers move — CRP, IL-6, TNF-α if you’re tracking them. \u003cem\u003eSahebkar 2014\u003c\/em\u003e meta-analysis used 8–12 weeks as the typical window for measurable CRP reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6–18.\u003c\/strong\u003e The cognitive-resilience and cardiovascular-marker territory, per \u003cem\u003eSmall 2018\u003c\/em\u003e (18 months for memory\/PET endpoints) and \u003cem\u003eAkazawa 2012\u003c\/em\u003e \/ \u003cem\u003eSugawara 2012\u003c\/em\u003e (8 weeks for endothelial function, sustained with continued use).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e Plasma curcumin is cleared within 24–72 hours; the anti-inflammatory benefit unwinds gradually over 4–8 weeks as NF-κB signaling returns to your previous baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eDaily protocol\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule (1000mg curcuminoids + 5mg BioPerine) per day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e With a meal that contains some fat — eggs, avocado, olive oil, fish, full-fat yogurt. Curcumin is fat-soluble; the fat improves chylomicron uptake.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food:\u003c\/strong\u003e Yes, always. Reduces the small risk of GI upset and improves absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Continuous daily — curcumin is treated like fish oil and vitamin D in most longevity protocols, not pulse-dosed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e (different NF-κB mechanism), \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA\u003c\/a\u003e (resolvin pathway), \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e (immune-modulation overlap).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 vegetable capsules, 60-day supply at one capsule per day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking curcumin without piperine, phospholipid, or nanoparticle carrier.\u003c\/strong\u003e Most of the dose is wasted — 1g of plain curcuminoids absorbs roughly the same as 50mg with BioPerine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking curcumin on an empty stomach.\u003c\/strong\u003e Curcumin is fat-soluble; without dietary fat the chylomicron uptake pathway barely engages, and GI tolerance is worse.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting same-day pain relief.\u003c\/strong\u003e Curcumin works on the underlying signal, not the prostaglandin endpoint. NSAIDs work in hours; curcumin works in weeks. Both work; they’re different timescales.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping after 2 weeks because “nothing happened.”\u003c\/strong\u003e The \u003cem\u003eSahebkar 2014\u003c\/em\u003e CRP-reduction window is 8–12 weeks; the \u003cem\u003eDaily 2016\u003c\/em\u003e joint-comfort window is 4–12 weeks. Curcumin rewards consistency.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying 80% curcuminoid extract because it’s cheaper.\u003c\/strong\u003e 15–20% less active per milligram. The savings disappear once you account for the dose you actually need.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePairing with anticoagulants without checking.\u003c\/strong\u003e Curcumin has mild antiplatelet activity. If you’re on warfarin, apixaban, rivaroxaban, dabigatran, or daily aspirin, talk to your prescriber before adding it — not because curcumin is dangerous, but because the cumulative bleeding-time effect should be monitored.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eContinuing through gallbladder symptoms.\u003c\/strong\u003e Curcumin stimulates bile flow. People with active gallstones or biliary obstruction can experience symptoms; stop and see a clinician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone running a longevity or healthspan protocol who wants to add the inflammation layer that most stacks miss.\u003c\/li\u003e\n  \u003cli\u003eAdults over 35 with CRP, IL-6, or TNF-α markers in the upper-normal range — the inflammaging audience.\u003c\/li\u003e\n  \u003cli\u003ePeople with morning joint stiffness, post-exercise inflammation, or osteoarthritis-spectrum symptoms looking for a daily anti-inflammatory that doesn’t carry NSAID GI risk.\u003c\/li\u003e\n  \u003cli\u003eAdults targeting cognitive resilience — particularly with family history of dementia or who want a daily compound with both BDNF and amyloid-clearance signal.\u003c\/li\u003e\n  \u003cli\u003eStatin-users (paired with \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e) and prediabetic \/ metabolic-syndrome adults using curcumin as part of an AMPK \/ inflammation strategy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is not for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnancy or nursing — supplemental doses (above culinary turmeric) are not recommended.\u003c\/li\u003e\n  \u003cli\u003eActive gallstones or biliary tract obstruction — curcumin’s cholagogic effect can provoke symptoms.\u003c\/li\u003e\n  \u003cli\u003eAnyone scheduled for surgery within 2 weeks — stop ahead of elective procedures (mild antiplatelet activity).\u003c\/li\u003e\n  \u003cli\u003eAnyone on warfarin or other anticoagulants without prescriber input.\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (not the population the trials studied).\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known allergy to turmeric or piperine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety and interactions\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelets.\u003c\/strong\u003e Mild additive antiplatelet effect. Talk to your prescriber if you take warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel, or daily aspirin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications.\u003c\/strong\u003e Curcumin can mildly improve insulin sensitivity (Chuengsamarn 2012). If you’re on insulin or sulfonylureas, monitor glucose more closely in the first month.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron supplements.\u003c\/strong\u003e Curcumin can chelate iron at high doses. If you have iron-deficiency anemia or take iron, separate by 4+ hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery.\u003c\/strong\u003e Stop 2 weeks before elective procedures.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGI tolerance.\u003c\/strong\u003e Some people experience mild GI upset on an empty stomach — always take with food. Heartburn is a rare reason to switch to a phospholipid form (Meriva).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-metabolism interactions.\u003c\/strong\u003e Piperine inhibits CYP3A4. If you take a narrow-therapeutic-index drug metabolized by CYP3A4 (some statins, some calcium-channel blockers, certain immunosuppressants), check with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term safety.\u003c\/strong\u003e Curcumin has been studied at supplemental doses (up to 8g\/day) for 6 months to 2+ years with no serious adverse signal. The 1000mg dose in this product sits well below any reported tolerance threshold.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhat’s in it — per capsule\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTurmeric root extract (\u003cem\u003eCurcuma longa\u003c\/em\u003e) — 1000mg, standardized to 95% curcuminoids = 950mg active curcuminoids\u003c\/strong\u003e (curcumin + demethoxycurcumin + bisdemethoxycurcumin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBioPerine® (black pepper extract, \u003cem\u003ePiper nigrum\u003c\/em\u003e) — 5mg, standardized to 95% piperine.\u003c\/strong\u003e The branded form used in published bioavailability trials.\u003c\/li\u003e\n  \u003cli\u003eHPMC vegetable capsule (vegan).\u003c\/li\u003e\n  \u003cli\u003eMicrocrystalline cellulose, vegetable magnesium stearate (flow agents at trace levels).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo\u003c\/strong\u003e titanium dioxide, no artificial colors, no GMOs, no soy, no gluten, no dairy.\u003c\/li\u003e\n  \u003cli\u003eUV-protective HDPE bottle, 60 capsules — 2-month supply at one capsule per day.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSourcing, manufacturing, and quality\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eManufactured in a \u003cstrong\u003ecGMP-certified, ISO 9001-registered\u003c\/strong\u003e facility in the United States.\u003c\/li\u003e\n  \u003cli\u003eTurmeric root sourced from \u003cstrong\u003eIndia\u003c\/strong\u003e — the species’ geographic origin and the supply chain with the most established curcuminoid testing infrastructure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification\u003c\/strong\u003e of curcuminoid content (must read ≥95% to ship). Per-batch verification of piperine content in BioPerine.\u003c\/li\u003e\n  \u003cli\u003ePer-batch testing for: heavy metals (lead, cadmium, mercury, arsenic) per USP \u0026lt;2232\u0026gt;, pesticide residues per USP \u0026lt;561\u0026gt;, microbial contamination (total plate count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e) per USP \u0026lt;2021\/2022\u0026gt;, residual solvents per USP \u0026lt;467\u0026gt;, and stability at end-of-shelf-life.\u003c\/li\u003e\n  \u003cli\u003eBioPerine® is the trademarked black pepper extract from Sabinsa Corporation, the formulation used in the majority of published curcumin bioavailability studies, including Shoba 1998.\u003c\/li\u003e\n  \u003cli\u003eCOA (Certificate of Analysis) available on request — \u003ca href=\"\/pages\/contact-business-information\"\u003econtact us\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFrequently asked\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWhy curcumin instead of just eating turmeric?\u003c\/strong\u003e Raw turmeric powder is roughly 3% curcuminoids by weight. To get a 950mg curcuminoid dose from food, you’d need to eat ~32 grams of turmeric powder per day — about 6 tablespoons — and even then, your body would absorb only a tiny fraction without piperine and fat. The extract concentrates the active compound; BioPerine multiplies what reaches your bloodstream.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat does “95% curcuminoids” actually mean?\u003c\/strong\u003e “Curcuminoids” is the umbrella term for three related compounds — curcumin (~75% of the curcuminoid fraction), demethoxycurcumin (~15%), and bisdemethoxycurcumin (~10%) — all of which contribute to the activity. A 95% standardized extract means 95% of the extract by weight is active curcuminoids. Older or cheaper products are often standardized to 80% or unstandardized; per equivalent capsule, that’s 15–20% less active compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy BioPerine and not regular black pepper?\u003c\/strong\u003e BioPerine® is a patented black pepper extract standardized to 95% piperine. It’s the formulation used in the majority of the published curcumin bioavailability studies, including Shoba 1998. Sprinkling pepper on your food gives you maybe 0.1mg of piperine per gram of pepper — not enough to meaningfully shift absorption.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin + BioPerine vs. liposomal \/ phytosome \/ Theracurmin?\u003c\/strong\u003e Specialized formulations like Meriva (phosphatidylcholine), Theracurmin (colloidal nanoparticle), and liposomal curcumin have higher absorption per milligram than curcumin + BioPerine — typically 25–30× for phytosome\/colloidal vs. ~20× for BioPerine. They also cost roughly 3–5× as much per dose. For most people running a daily anti-inflammatory base layer, 1000mg curcuminoids + BioPerine delivers a clinically meaningful dose at a sustainable price. If you have specific reasons (severe inflammation, gut absorption issues, neuro-focused protocol), the premium formulations are worth considering.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Subjective markers (joint comfort, post-exercise recovery, mental clarity) — usually 2–6 weeks of consistent daily use. Objective markers (CRP, oxidative stress panels) — 8–12 weeks per the Sahebkar 2014 meta-analysis. Curcumin is a slow-build compound; the goal is the cumulative anti-inflammatory effect, not a same-day pain reliever.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take curcumin long-term?\u003c\/strong\u003e Yes. Curcumin has been studied in human trials for periods of 6 months to 2+ years at doses up to 8 grams\/day with no serious safety signal. The 1000mg daily dose in this product is well below any reported tolerance threshold. Most longevity protocols treat curcumin as a permanent daily, like fish oil or vitamin D — not a pulse-dosed compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin vs. ibuprofen?\u003c\/strong\u003e Multiple randomized trials in osteoarthritis have shown comparable pain-score reduction at curcumin doses of 1000–1500mg\/day vs. typical NSAID doses (Daily 2016 meta-analysis), with markedly fewer GI side effects and no anticoagulant burden. Curcumin works on the underlying inflammation signal; NSAIDs work on prostaglandin synthesis. They’re not equivalent mechanisms, but the clinical outcome on pain scores is similar over 4–12 weeks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin vs. Boswellia, ginger, or other anti-inflammatory botanicals?\u003c\/strong\u003e Different mechanisms. Boswellia inhibits 5-lipoxygenase (leukotriene pathway). Ginger inhibits COX\/LOX. Curcumin works upstream on NF-κB \/ Nrf2 transcription. Stacking is rational and well-tolerated. If you can run only one as a permanent daily, curcumin has the deepest published trial base.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I cycle off?\u003c\/strong\u003e Not required. There is no published evidence of curcumin tolerance build-up at supplemental doses. Most longevity protocols run curcumin continuously alongside fish oil and vitamin D as the permanent base of the anti-inflammatory layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy “with food that contains fat”?\u003c\/strong\u003e Curcumin is fat-soluble. Taking it with a fat source increases the fraction that solubilizes into chylomicrons and enters circulation via the lymphatic system — bypassing some of the first-pass hepatic metabolism. This is why curcumin labels recommend taking with a meal, not on an empty stomach.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy pair with Quercetin if it’s the same NF-κB target?\u003c\/strong\u003e Different upstream mechanisms. Curcumin inhibits IκB-kinase (preventing NF-κB activation). Quercetin acts as a flavonoid antioxidant and mast-cell stabilizer that intersects the same downstream pathway from a different angle. Combination trials show additive (not redundant) effects. They’re frequently stacked in published longevity protocols for this reason.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eYellow staining — is that normal?\u003c\/strong\u003e Yes. Curcumin is the natural yellow pigment in turmeric. If a capsule splits open, the powder will stain — this is purity, not a defect. The same pigment turns Indian curries yellow.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill curcumin interact with my medications?\u003c\/strong\u003e The interactions worth flagging to your prescriber are: anticoagulants and antiplatelets (mild additive bleeding-time effect), insulin and sulfonylureas (mild glucose-lowering — monitor in month 1), iron supplements (separate by 4+ hours), and CYP3A4-metabolized drugs (BioPerine inhibits CYP3A4 — relevant for some statins, calcium-channel blockers, and certain immunosuppressants). Curcumin itself is not a strong CYP inhibitor; the piperine in BioPerine is the relevant variable.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs there a CRP threshold below which curcumin doesn’t do anything?\u003c\/strong\u003e The CRP-reduction effect is most pronounced in adults with elevated baseline CRP (above ~3 mg\/L). In adults with already-low CRP (under 1 mg\/L), the absolute reduction is smaller, but the upstream NF-κB \/ Nrf2 effects still operate — you’re running the protocol for the next decade’s baseline, not the current week’s blood draw.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCurcumin and depression — is there really an antidepressant signal?\u003c\/strong\u003e Modest but consistent. \u003cem\u003eLopresti 2014 (J Affect Disord)\u003c\/em\u003e showed an effect on Inventory of Depressive Symptomatology scores at 500mg BID over 8 weeks in adults with major depression, particularly in the atypical-depression subgroup. The effect size is real but smaller than that of standard antidepressants — curcumin is best framed as adjunctive (in conversation with a clinician), not a primary treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is my curcumin dose not bottled with the iron and zinc and other extras some products use?\u003c\/strong\u003e Combination products complicate dose-response and dilute the curcumin per capsule. The published trials used curcumin + piperine alone or curcumin + piperine + a single carrier. We follow that.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs the BioPerine vegan \/ GMO-free?\u003c\/strong\u003e BioPerine® from Sabinsa is non-GMO and vegan. The capsule shell is HPMC (cellulose), so the entire product is vegan.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat’s the difference between “turmeric extract” and “curcumin”?\u003c\/strong\u003e Turmeric extract is the broader plant-derived material; curcumin is the specific active polyphenol. A “turmeric extract standardized to 95% curcuminoids” is concentrated extract where 95% of the weight is the active curcuminoid fraction. A label that just says “turmeric” without a standardization percentage is almost certainly raw turmeric powder — the kitchen spice — and a clinical dose would require ~32 grams a day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy isn’t curcumin in the senolytics collection?\u003c\/strong\u003e Curcumin suppresses the senescence-associated secretory phenotype (SASP) but doesn’t reliably trigger apoptosis of senescent cells in human-relevant doses. The catalog reserves the “senolytic” tag for compounds with the apoptosis signal — \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e. Curcumin is “senolytic-adjacent” — complementary, not duplicative.\u003c\/p\u003e\n\n\u003ch3\u003eRead more on the science\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/longevity-science\/inflammaging\"\u003eInflammaging — the slow inflammatory simmer behind chronic disease\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/longevity-science\/foundational-7\"\u003eThe Foundational 7 daily nutrients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/blogs\/longevity-science\/classic-longevity-stack\"\u003eThe classic longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/pages\/protocols\"\u003eAll protocols\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cp style=\"font-size: 0.9em;\"\u003eShoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. \u003cem\u003ePlanta Med\u003c\/em\u003e. 1998;64(4):353–356.\u003cbr\u003e\nSingh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin. \u003cem\u003eJ Biol Chem\u003c\/em\u003e. 1995;270(42):24995–25000.\u003cbr\u003e\nBalogun E, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. \u003cem\u003eBiochem J\u003c\/em\u003e. 2003;371(Pt 3):887–895.\u003cbr\u003e\nAggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent. \u003cem\u003eInt J Biochem Cell Biol\u003c\/em\u003e. 2009;41(1):40–59.\u003cbr\u003e\nAkazawa N, et al. Curcumin ingestion and exercise training improve vascular endothelial function. \u003cem\u003eNutr Res\u003c\/em\u003e. 2012;32(10):795–799.\u003cbr\u003e\nSugawara J, et al. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women. \u003cem\u003eAm J Hypertens\u003c\/em\u003e. 2012;25(6):651–656.\u003cbr\u003e\nChuengsamarn S, et al. Curcumin extract for prevention of type 2 diabetes. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2012;35(11):2121–2127.\u003cbr\u003e\nSahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? \u003cem\u003ePhytother Res\u003c\/em\u003e. 2014;28(5):633–642.\u003cbr\u003e\nLopresti AL, et al. Curcumin for the treatment of major depression. \u003cem\u003eJ Affect Disord\u003c\/em\u003e. 2014;167:368–375.\u003cbr\u003e\nFranceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e. 2014;69 Suppl 1:S4–S9.\u003cbr\u003e\nDaily JW, et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a meta-analysis of randomized clinical trials. \u003cem\u003eJ Med Food\u003c\/em\u003e. 2016;19(8):717–729.\u003cbr\u003e\nHewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. \u003cem\u003eFoods\u003c\/em\u003e. 2017;6(10):92.\u003cbr\u003e\nPanahi Y, et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus. \u003cem\u003eDrug Res\u003c\/em\u003e. 2017;67(4):244–251.\u003cbr\u003e\nSmall GW, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults. \u003cem\u003eAm J Geriatr Psychiatry\u003c\/em\u003e. 2018;26(3):266–277.\u003cbr\u003e\nBelcaro G, et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. \u003cem\u003eAltern Med Rev\u003c\/em\u003e. 2010;15(4):337–344.\u003cbr\u003e\nSasaki H, et al. Innovative preparation of curcumin for improved oral bioavailability. \u003cem\u003eBiol Pharm Bull\u003c\/em\u003e. 2011;34(5):660–665.\u003cbr\u003e\nAnand P, et al. Bioavailability of curcumin: problems and promises. \u003cem\u003eMol Pharm\u003c\/em\u003e. 2007;4(6):807–818.\u003cbr\u003e\nGupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. \u003cem\u003eAAPS J\u003c\/em\u003e. 2013;15(1):195–218.\u003c\/p\u003e\n\u003cp style=\"font-size: 0.9em;\"\u003e\u003cem\u003eReferences listed in support of mechanism and dose rationale; not as endorsements of off-label medical use. Curcumin and BioPerine are dietary supplements, not pharmaceuticals.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eWhy not just buy this on Amazon?\u003c\/h3\u003e\n\u003cp\u003eYou can. Three things are different here. \u003cstrong\u003e(1) Per-batch HPLC verification\u003c\/strong\u003e of the 95% curcuminoid claim and the 95% piperine claim, with COA available on request — on Amazon you have no idea whether the bottle on the shelf was tested. \u003cstrong\u003e(2) BioPerine® from Sabinsa\u003c\/strong\u003e, the trademarked black pepper extract used in the original Shoba 1998 bioavailability literature — not a no-name piperine commodity. \u003cstrong\u003e(3) The catalog architecture\u003c\/strong\u003e — curcumin is positioned, dosed, and stack-mapped against the rest of a longevity protocol you’re likely running, not sold as a one-off SKU.\u003c\/p\u003e\n\n\u003ch3\u003eHow to take it\u003c\/h3\u003e\n\u003cp\u003e1 capsule once a day, with a meal that contains some fat. Most people take it at breakfast alongside \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e and \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e — they’re all fat-soluble and they share the same dosing rule.\u003c\/p\u003e\n\n\u003ch3\u003eHave a question?\u003c\/h3\u003e\n\u003cp\u003eEmail us at support@truehealthprotocol.health or use the \u003ca href=\"\/pages\/contact-business-information\"\u003econtact page\u003c\/a\u003e. We answer within one business day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, especially if you take prescription medication, are pregnant or nursing, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"60 Capsules","offer_id":47839341248730,"sku":"THP-CURCUMIN-1000-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_curcumin.png?v=1778047676"},{"product_id":"alpha-lipoic-acid-600mg-universal-antioxidant","title":"Alpha-Lipoic Acid 600mg | Universal Antioxidant + Mitochondrial Cofactor for Glucose \u0026 Longevity","description":"\u003cp\u003e\u003cstrong\u003e600 mg of Alpha-Lipoic Acid per capsule\u003c\/strong\u003e — the universal antioxidant that works in both water and fat compartments, recycles other antioxidants the body has already used, chelates heavy metals, and sits as a direct cofactor inside two of the mitochondrial enzyme complexes that convert food into ATP. Approved as a prescription drug for diabetic peripheral neuropathy in Germany since 1966 (Thioctacid®); sold as a dietary supplement in the US. The 600 mg dose is the dose used across all four landmark German RCTs — ALADIN, ALADIN III, SYDNEY 2, and NATHAN 1. Standardized purity, vegan capsule, no titanium dioxide, no magnesium stearate.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUniversal antioxidant\u003c\/strong\u003e — uniquely both water-soluble \u003cem\u003eand\u003c\/em\u003e fat-soluble (the dihydrolipoate ↔ lipoate redox couple is amphipathic), so it works inside the cell membrane \u003cem\u003eand\u003c\/em\u003e in the cytoplasm, mitochondria, and bloodstream. Almost every other antioxidant is restricted to one compartment (Packer 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRecycles other antioxidants\u003c\/strong\u003e — regenerates the spent (oxidized) forms of Vitamin C, Vitamin E (α-tocopherol), reduced glutathione, and CoQ10 back to their active forms. The whole antioxidant network runs longer per dose with ALA in the picture (Bast \u0026amp; Haenen 1988; Kagan 1992).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactor\u003c\/strong\u003e — ALA is the prosthetic group on lipoyllysine residues of pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), and the branched-chain α-keto-acid complex. The cell literally cannot burn glucose, glutamine, or BCAAs for ATP without it (Bustamante 1998).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlucose \u0026amp; nerve support\u003c\/strong\u003e — the most-studied compound for diabetic peripheral neuropathy in Europe. Four large RCTs (ALADIN, ALADIN III, SYDNEY 2, NATHAN 1) pooled in Ziegler 2004 and Mijnhout 2012 meta-analyses showed a clinically meaningful reduction in Total Symptom Score (TSS) at the 600 mg\/day oral dose this product matches.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK activator + insulin sensitizer\u003c\/strong\u003e — Konrad 2001 and Jacob 1999 showed measurable increase in glucose uptake and GLUT4 translocation in skeletal muscle in lean and Type-2 diabetic adults at 600 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 pathway\u003c\/strong\u003e — ALA is one of the most reliable Nrf2\/ARE pathway inducers in the supplement world (Suh 2004), upregulating endogenous glutathione synthesis, NQO1, and Phase II detoxification enzymes — the same axis hit by sulforaphane and curcumin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest paired with:\u003c\/strong\u003e \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e for metabolic-health stacks (different mechanism — same target organ); \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e for mitochondrial stacks; \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e + \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e + \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eVitamin C\u003c\/a\u003e for the antioxidant network; \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e for the NAD+ axis (PDH\/KGDH need both NAD+ \u003cem\u003eand\u003c\/em\u003e lipoate to function).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy a metabolic supplement ended up in serious longevity research\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid was discovered in 1937 in \u003cem\u003eLactobacillus casei\u003c\/em\u003e and isolated in pure form by Lester Reed at the University of Texas in 1951. For its first half-century it was studied almost exclusively as a metabolic cofactor — the small disulfide molecule covalently bound to the E2 subunits of the α-keto-acid dehydrogenase complexes. Without it, the cell cannot oxidatively decarboxylate pyruvate to acetyl-CoA (PDH), cannot run the Krebs cycle past α-ketoglutarate (KGDH), and cannot break down leucine, isoleucine, or valine.\u003c\/p\u003e\n\n\u003cp\u003eThe shift into longevity research started in the late 1980s when Lester Packer's lab at UC Berkeley discovered that \u003cem\u003efree\u003c\/em\u003e ALA (not the protein-bound form) and its reduced form dihydrolipoate (DHLA) are extraordinary redox-active compounds with three properties almost no other antioxidant has: (1) they cross the blood-brain barrier, (2) they're equally active in aqueous and lipid compartments, and (3) they reduce the oxidized forms of every other major antioxidant in the cell — vitamin C, vitamin E, glutathione, CoQ10. Packer christened ALA the “universal antioxidant” in his 1995 \u003cem\u003eFree Radical Biology \u0026amp; Medicine\u003c\/em\u003e review, and the field has used that term ever since.\u003c\/p\u003e\n\n\u003cp\u003eThe metabolic-medicine track and the longevity track converged in the 1990s when Hager and Maczurek and others started looking at age-related declines in mitochondrial PDH\/KGDH activity in brain tissue. Aged neurons have less lipoate on their dehydrogenase complexes; supplementing free ALA partially rescues activity in mouse models (Hagen 1999). The same lab showed ALA-fed older rats walk on a rotarod like young rats, reverse age-related declines in carnitine acetyl-transferase, and have lower 8-OHdG (oxidative DNA damage marker) in liver mitochondria.\u003c\/p\u003e\n\n\u003cp\u003eIn humans the longevity case is less direct than the metabolic case — there is no NATHAN 1 for healthspan — but the supporting biomarker work is substantial. ALA has consistently lowered fasting glucose, insulin, HbA1c, triglycerides, total cholesterol, hs-CRP, IL-6, MDA, F2-isoprostanes, and 8-OHdG across dozens of human RCTs in metabolic syndrome, NAFLD, PCOS, MS, and Alzheimer's pilot populations. Every one of those is a mid-life longevity biomarker. ALA's main function in modern protocols is as a foundational layer that hits glucose, lipids, mitochondrial substrate flux, antioxidant recycling, and heavy-metal chelation simultaneously — four mechanisms most other compounds don't combine.\u003c\/p\u003e\n\n\u003ch2\u003eThe four mechanisms in plain language\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. The mitochondrial cofactor job (the original reason it exists).\u003c\/strong\u003e ALA is the prosthetic group covalently attached to lysine residues on the E2 subunit of three enzyme complexes: pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), and the branched-chain α-keto-acid dehydrogenase (BCKDH). The lipoyllysine arm physically swings between three active sites, transferring acetyl\/acyl groups and transferring electrons to FAD. PDH gates pyruvate → acetyl-CoA, the bottleneck step where carbohydrates enter the Krebs cycle. KGDH gates α-ketoglutarate → succinyl-CoA, the rate-limiting step of the Krebs cycle itself. BCKDH gates leucine\/isoleucine\/valine catabolism. Without lipoate, none of these complexes function. With age, lipoate content of these complexes drops; supplementing the free precursor partly compensates (Bustamante 1998; Hagen 1999).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. The antioxidant-recycling job (Packer's discovery).\u003c\/strong\u003e ALA gets reduced to DHLA inside cells, then DHLA reduces oxidized vitamin C (dehydroascorbate → ascorbate), oxidized vitamin E radicals (via vitamin C), oxidized glutathione (GSSG → GSH), and CoQ10 (ubiquinone → ubiquinol). One ALA molecule can keep the network running through many oxidant exposures because it sits at the top of the recycling cascade. This is the structural reason ALA pairs particularly well with \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eglutathione\u003c\/a\u003e, \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e, and \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e rather than competing with them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. The Nrf2 pathway job (added in the 2000s).\u003c\/strong\u003e ALA modifies cysteine residues on Keap1, releases Nrf2 to translocate to the nucleus, and turns on the Antioxidant Response Element (ARE) — driving expression of glutathione synthesis enzymes (GCLC\/GCLM), NQO1, heme oxygenase-1 (HO-1), and the Phase II detoxification battery. Suh 2004 showed ALA restores GSH synthesis in old rats by ~50%. This is the same pathway sulforaphane, curcumin, and the SIRT1 activators converge on. Hitting it from multiple angles is why senolytic and longevity stacks layer ALA with \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e and \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. The insulin-sensitization \/ AMPK job (the metabolic case).\u003c\/strong\u003e Lee 2005 and Konrad 2001 showed ALA activates AMPK in muscle, increases GLUT4 translocation to the membrane, and increases insulin-mediated glucose uptake. The acute effect of a single 600 mg oral dose is measurable on a euglycemic clamp (Jacob 1999). Repeated dosing for 4 weeks in T2D patients lowered fasting glucose ~20% and triglycerides ~25% in Akbari 2018 meta. ALA and \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e hit AMPK by different mechanisms (ALA via mitochondrial AMP\/ATP shift, berberine via direct AMPK kinase activation), which is why they stack rather than compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eBonus mechanism: heavy-metal chelation.\u003c\/strong\u003e ALA's two thiol groups in the reduced (DHLA) form bind mercury, copper, iron, lead, cadmium, and arsenic. Lin 1989 and Patrick 2002 reviewed the chelation work. ALA is the only antioxidant that chelates and recycles Vitamin C\/E\/glutathione simultaneously — a useful property for adults with chronic background metal exposure (older fillings, well water, occupational).\u003c\/p\u003e\n\n\u003ch2\u003eThe trial bench — what 600 mg\/day actually does in humans\u003c\/h2\u003e\n\u003cp\u003eALA has one of the longest, deepest, and best-replicated trial records in supplemental medicine, anchored by four large multi-center German RCTs in diabetic peripheral neuropathy at the 600 mg dose this product matches.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN (Ziegler 1995, \u003cem\u003eDiabetologia\u003c\/em\u003e):\u003c\/strong\u003e 328 T2D patients with symptomatic distal symmetric polyneuropathy. 1200, 600, or 100 mg\/day IV vs placebo, 3 weeks. 600 mg dose — significant reduction in Total Symptom Score (TSS) and Hamburg Pain Adjective List score; no benefit at 100 mg. The first proof of dose-response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN II (Reljanovic 1999):\u003c\/strong\u003e 65 T1D + T2D, 600 or 1200 mg\/day IV for 5 days, then 600\/1200 mg\/day oral for 2 years. Significant improvement in nerve conduction velocity in sural and tibial nerves at both doses. 1200 not better than 600.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN III (Ziegler 1999):\u003c\/strong\u003e 509 T2D, 600 mg\/day IV for 3 weeks then 1800 mg\/day oral for 6 months. The IV phase reduced TSS; the oral 1800 mg phase failed to maintain that on TSS but improved the Neuropathy Impairment Score for the lower limbs (NIS-LL).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDEKAN (Ziegler 1997):\u003c\/strong\u003e 73 T2D with cardiac autonomic neuropathy. 800 mg\/day oral 4 months. Significant improvement in heart-rate variability vs placebo. The first cardiac-autonomic ALA trial.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eORPIL (Ruhnau 1999):\u003c\/strong\u003e 24 T2D, 1800 mg\/day oral 3 weeks. Significant TSS reduction at 19 days. Established that oral could replicate the IV symptom benefit, opening the door to chronic oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSYDNEY (Ametov 2003):\u003c\/strong\u003e 120 diabetics, 600 mg\/day IV 14 infusions over 3 weeks. TSS dropped 5.7 points vs 1.8 placebo — one of the largest absolute symptom reductions on record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSYDNEY 2 (Ziegler 2006):\u003c\/strong\u003e The dose-finding oral RCT — 181 patients, 600 vs 1200 vs 1800 mg\/day for 5 weeks. \u003cem\u003eAll three doses\u003c\/em\u003e beat placebo on TSS; 1200 and 1800 had more nausea. \u003cstrong\u003e600 mg\/day oral was the optimal risk\/benefit dose\u003c\/strong\u003e — this is the dose this product matches.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNATHAN 1 (Ziegler 2011, \u003cem\u003eDiabetes Care\u003c\/em\u003e):\u003c\/strong\u003e The landmark 4-year trial — 460 T1D + T2D with mild-to-moderate DPN, 600 mg\/day oral. Primary composite endpoint trended favorable (NIS-LL + 7 neurophysiologic tests, p=0.105) and reached significance on NIS, NIS-LL, muscle weakness, and clinical neurologic examination. The longest ALA RCT ever performed; it confirmed durability of effect and a safety profile equivalent to placebo over 4 years of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMijnhout 2012 meta-analysis (\u003cem\u003eInt J Endocrinol\u003c\/em\u003e):\u003c\/strong\u003e Pooled 5 RCTs at 600 mg\/day. Significant 2.26-point TSS reduction (95%CI -2.83 to -1.69) and significant improvement on NIS-LL.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eOutside neuropathy, the human evidence base is broad:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin sensitivity \/ Type-2 diabetes:\u003c\/strong\u003e Akbari 2018 meta-analysis pooled 24 RCTs — significant reductions in fasting glucose, fasting insulin, HOMA-IR, and HbA1c. Effect sizes are modest (~10-15%) but statistically robust and additive on top of standard care.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipid profile:\u003c\/strong\u003e Mohammadi 2017 and Akbari 2018 meta-analyses showed significant reductions in total cholesterol, LDL, and triglycerides; modest HDL increase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeight \/ waist circumference:\u003c\/strong\u003e Kucukgoncu 2017 meta-analysis — ALA reduced body weight by 1.27 kg vs placebo across 12 RCTs. Modest but consistent effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAFLD:\u003c\/strong\u003e de Sousa 2019 review of 6 RCTs — ALA reduced ALT, AST, GGT and hepatic steatosis on ultrasound; mechanism likely a combination of insulin sensitization + Nrf2 + lipid lowering.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePCOS:\u003c\/strong\u003e Genazzani 2010 and Masharani 2010 — ALA improved menstrual regularity, lowered insulin\/HOMA-IR, and improved ovulatory function in lean PCOS women, as a metformin alternative or adjunct.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMultiple sclerosis:\u003c\/strong\u003e Khalili 2014 — 1200 mg\/day for 12 weeks significantly increased serum total antioxidant capacity in 52 relapsing-remitting MS patients. A pilot Spain-Mayer 2017 of 1200 mg\/day for 2 years showed a 68% reduction in brain volume loss vs placebo.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlzheimer's pilot:\u003c\/strong\u003e Hager 2007 — 9-month open-label of 600 mg\/day in mild AD slowed cognitive decline (ADAS-cog stable vs natural-history rate of progression). Maczurek 2008 review summarizes the AD case.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive aging:\u003c\/strong\u003e Gosselin 2019 systematic review of ALA in cognitive function trials — positive signal in MCI\/mild AD, less clear in healthy older adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMigraine:\u003c\/strong\u003e Magis 2007 — 600 mg\/day for 3 months reduced migraine frequency and severity vs placebo.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypertension:\u003c\/strong\u003e Mohammadi 2017 meta — modest 2-3 mmHg systolic reduction across pooled trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 600 mg, why once daily, and why R\/S vs R\u003c\/h2\u003e\n\u003cp\u003eThe 600 mg\/day oral dose used in this product is the single most-replicated dose in the human ALA literature. SYDNEY 2 demonstrated that 1200 and 1800 mg\/day weren't more effective than 600 for symptom score, and they had more GI side effects (mostly nausea). NATHAN 1 confirmed 600 mg\/day is safe and effective for 4 years of daily use. Ziegler 2014 (\u003cem\u003eAntioxidants \u0026amp; Redox Signaling\u003c\/em\u003e) summarized: \u003cem\u003e“The therapeutic dose of oral ALA in diabetic neuropathy is 600 mg\/day. Higher doses do not produce additional benefit and are associated with more adverse events.”\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003eALA exists in two enantiomers — the natural \u003cstrong\u003eR-isomer\u003c\/strong\u003e (R-ALA) and the synthetic \u003cstrong\u003eS-isomer\u003c\/strong\u003e. Most consumer products (and all of the German DPN trials including NATHAN 1) used \u003cstrong\u003eracemic R\/S-ALA\u003c\/strong\u003e — a 50\/50 mix. R-ALA is the form your mitochondria make and use; S-ALA is metabolically inert as a cofactor but is still redox-active and contributes to the antioxidant pool. Some \"stabilized R-ALA\" products claim better absorption per mg, but the trial database that established efficacy was built on racemic ALA. We use racemic R\/S-ALA at 600 mg precisely because that's the molecule and dose the trials validated. (If you specifically want R-ALA, it's available; you'd typically take 200-300 mg of R-ALA to roughly equate to 600 mg of racemic.)\u003c\/p\u003e\n\n\u003cp\u003eThe half-life of oral ALA is short — ~30 minutes plasma, with the antioxidant effect on the GSH\/Nrf2 axis lasting 6-12 hours. Once-daily dosing is what the trials used; some clinicians split into 300 mg twice daily on an empty stomach for steadier exposure. Both schedules are evidence-supported.\u003c\/p\u003e\n\n\u003ch2\u003eWhere ALA fits vs. the other compounds in this catalog\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol stacks tend to layer ALA at the foundational antioxidant layer, alongside the GlyNAC pair, vitamin C, and CoQ10. Here's how ALA differs from the closest neighbors:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e + \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e:\u003c\/strong\u003e Glutathione\/NAC give the cell the substrate and precursor for the body's master antioxidant. ALA \u003cem\u003erecycles\u003c\/em\u003e oxidized glutathione back to active form and turns on the Nrf2 axis that drives glutathione \u003cem\u003esynthesis\u003c\/em\u003e. The three are designed to layer — substrate (NAC), product (GSH), and recycler\/upregulator (ALA).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e:\u003c\/strong\u003e CoQ10 and PQQ live inside the mitochondrial inner membrane — CoQ10 as the mobile electron carrier of complex I→III, PQQ as a redox cofactor and biogenesis activator. ALA sits in the matrix on PDH\/KGDH and recycles ubiquinone ↔ ubiquinol. The three together cover the substrate-flux + electron-transport + redox-recycling axes of mitochondrial energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e:\u003c\/strong\u003e Both lower fasting glucose and improve insulin sensitivity by AMPK activation, but by different upstream mechanisms (ALA via mitochondrial AMP\/ATP ratio; berberine by direct AMPK kinase activation and gut-microbiome shifts). Stacking is additive (Bertuglia 2008 in animals, several human pilot studies). Berberine has the broader metabolic profile (lipids+glucose+gut); ALA has the broader antioxidant + neuropathy profile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e:\u003c\/strong\u003e Both activate Nrf2 and inhibit NF-κB. Curcumin is more potent on inflammation; ALA is more potent on glucose. Stacking covers both axes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e:\u003c\/strong\u003e Both are membrane-active antioxidants but astaxanthin lives in the lipid bilayer fixed at right-angles to the membrane; ALA spans aqueous + lipid. They're complementary, not redundant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. NAD+ axis (\u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e):\u003c\/strong\u003e PDH and KGDH need \u003cem\u003eboth\u003c\/em\u003e lipoate and NAD+ to function. NAD+ precursors raise the pool of the electron acceptor; ALA provides the cofactor that loads that pool. They're substrate-and-cofactor partners, not competitors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e:\u003c\/strong\u003e Urolithin A activates mitophagy — clears damaged mitochondria. ALA helps the surviving mitochondria run cleaner. Sequential, not redundant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e:\u003c\/strong\u003e CaAKG provides α-ketoglutarate as a Krebs-cycle intermediate. KGDH then uses lipoate (from ALA) to convert it to succinyl-CoA. They literally work on the same enzyme.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in this product\u003c\/h2\u003e\n\u003cp\u003eEach capsule delivers \u003cstrong\u003e600 mg of pharmaceutical-grade racemic R\/S Alpha-Lipoic Acid\u003c\/strong\u003e — the exact molecule and dose used in the SYDNEY 2 and NATHAN 1 trials. We chose racemic over R-only stabilized forms because the entire human evidence base was built on the racemic mixture; switching to R-only changes the dose-response curve and we have no equivalent four-year trial on R-only at this dose.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e60 vegetarian capsules\u003c\/strong\u003e per bottle — 60-day supply at the standard 600 mg\/day or 30-day supply at split 300 mg twice-daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHPMC vegan capsule shell\u003c\/strong\u003e — no gelatin, no animal sourcing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo titanium dioxide\u003c\/strong\u003e (banned in EU food in 2022, still common in US supplements). No magnesium stearate, no silicon dioxide, no PEG, no dyes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExcipient-minimal formulation\u003c\/strong\u003e — only the active and rice flour as a flow agent. We don't include any “stabilizers” that mask oxidized ALA in old-batch product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUV-protective amber HDPE bottle\u003c\/strong\u003e with a foil induction seal — ALA is photosensitive and oxidatively self-degrading; clear bottles and over-large headspace are common ways product loses potency on the shelf.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured in a US FDA-registered facility.\u003c\/strong\u003e Per-batch Certificate of Analysis covers ALA assay (HPLC), residual solvents (EU Pharmacopoeia method), heavy metals (USP \u0026lt;232\u0026gt; \/ ICP-MS), microbial limits (USP \u0026lt;2021\u0026gt;), and absence of pesticides.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmed by HPLC.\u003c\/strong\u003e Many ALA products are sold by total-disulfide assay rather than chromatographic identity; we run HPLC against a reference standard so the labeled mg matches the actual mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergen-free formulation\u003c\/strong\u003e — no gluten, soy, dairy, peanut, tree-nut, egg, fish, or shellfish.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard protocol:\u003c\/strong\u003e 1 capsule (600 mg) once daily on an empty stomach — either 30 min before breakfast or 2-3 hr after dinner. Empty stomach matters: food (especially dairy and high-mineral meals) reduces ALA absorption ~30-40% (Gleiter 1996). The German DPN trials specified empty-stomach dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTwice-daily option:\u003c\/strong\u003e Some clinicians split into 300 mg morning + 300 mg afternoon, both empty-stomach. Same total exposure with steadier plasma levels. Either schedule is supported.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with the rest of the antioxidant-network stack at the same time:\u003c\/strong\u003e \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eglutathione\u003c\/a\u003e, \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e, \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e. Network compounds work better dosed together.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't take it within 2 hours of \u003ca href=\"\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003emulti-collagen\u003c\/a\u003e, iron, or thyroid medication (levothyroxine).\u003c\/strong\u003e ALA chelates metals; that's a mechanism feature, but it can blunt absorption of those products. Separate by ~2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin \/ sulfonylurea users:\u003c\/strong\u003e ALA can additively lower glucose. Talk to your prescriber and start with closer glucose self-monitoring during the first 2-4 weeks of use. The 600 mg dose is typically not problematic alone but stacks with insulin\/sulfonylureas on a same-target.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Take when you remember if it's still on an empty stomach; otherwise skip and resume the next day. Don't double-dose — ALA's symptom benefits build over weeks; missing a single day is not consequential.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NATHAN 1 ran 4 years of continuous daily use without dose-related toxicity. Long-term use is the use case the trials validated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with — the longevity\/metabolic stack\u003c\/h2\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePair with\u003c\/th\u003e\n\u003cth\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eDifferent upstream activator of the same AMPK target. Lipid + glucose + gut additive. Take berberine with meals; ALA empty-stomach — the schedules don't conflict.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eThe GlyNAC + ALA network: substrate + product + recycler. Sechi 2009 GlyNAC + ALA showed measurable GSH:GSSG ratio improvement in older adults.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eCloses the GlyNAC loop — glycine is the third amino acid in glutathione. Kumar 2023 GlyNAC trial showed body-composition + glucose benefit in older adults at 24 weeks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eALA recycles oxidized vitamin C back to ascorbate. Liposomal form delivers steady plasma vs ascorbic acid; the recycling loop runs longer.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMitochondrial energy triad — ALA loads PDH\/KGDH, CoQ10 carries the electrons, PQQ activates biogenesis. Energy + cognition stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate Nrf2 by different mechanisms; both inhibit NF-κB. Inflammation + metabolic stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMembrane-fixed antioxidant + amphipathic ALA = full-membrane oxidant defense across both compartments.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e + \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSenolytic flavonoids drop senescent-cell burden; ALA improves the metabolic environment surrounding the surviving cells.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eNAD+ axis substrate. PDH\/KGDH need both NAD+ \u003cem\u003eand\u003c\/em\u003e lipoate. ALA + NMN literally co-fuel the same enzyme step.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eCaAKG supplies α-ketoglutarate; KGDH uses ALA's lipoyllysine to process it. Substrate + cofactor pair on a single enzyme.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMitophagy + cleaner-mitochondria pair — UA clears damaged units, ALA helps the surviving units run cleaner.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational. Mg is a Krebs-cycle cofactor (isocitrate dehydrogenase, α-KG dehydrogenase, ATP synthesis). ALA + Mg covers cofactor + substrate at the same Krebs step.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational membrane substrate; ALA recycles α-tocopherol that protects PUFA from peroxidation. The membrane and the substrate together.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational longevity layer. D3 governs ~2,000 genes; ALA governs the antioxidant network. Different axes, both essential.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMitochondrial sulfur amino acid; cardiovascular + insulin pair with ALA.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + \u003ca href=\"\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSIRT1 activators on the longevity axis; ALA on the antioxidant + metabolic axis. Layer both for foundational longevity stacks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eRealistic timeline — what to expect by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1-2:\u003c\/strong\u003e A few people notice steadier post-meal glucose (especially diabetics on monitors). Most feel nothing — that's expected. ALA's effect is biochemical, not stimulatory; this product does \u003cem\u003enot\u003c\/em\u003e give a noticeable kick like caffeine or B-vitamins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 3-6:\u003c\/strong\u003e Fasting glucose usually 5-15 mg\/dL lower if elevated at baseline (Akbari 2018 effect size). Triglycerides start dropping. Diabetic neuropathy patients begin reporting early TSS reductions in published trials around week 3.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8-12:\u003c\/strong\u003e The Nrf2\/glutathione-axis turn-on shows up as lower hs-CRP and MDA on labs. HbA1c shifts ~0.2-0.4 points if elevated at baseline. Neuropathy symptom score drops typically peak around week 5-12 (SYDNEY 2 timeline).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3-6:\u003c\/strong\u003e Lipid normalization stabilizes. NAFLD patients show ALT\/AST drops and ultrasound steatosis reduction. Cognitive aging trials see effect emerge here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e NATHAN 1 timeline — durable nerve-conduction improvement; safety profile equivalent to placebo across 4 years of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e A stimulant kick. Sudden weight loss. A cure for diabetes. ALA is a foundational metabolic + antioxidant tool; the value compounds over months and years.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ building a foundational longevity stack (alongside \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e, \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMg-Glycinate\u003c\/a\u003e, \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e).\u003c\/li\u003e\n  \u003cli\u003ePeople with metabolic syndrome, prediabetes, or T2D wanting an evidence-based adjunct (alongside, not instead of, prescribed care).\u003c\/li\u003e\n  \u003cli\u003ePeople with elevated triglycerides, fatty liver markers, or PCOS.\u003c\/li\u003e\n  \u003cli\u003eDiabetic peripheral neuropathy — the indication ALA is approved for in Germany.\u003c\/li\u003e\n  \u003cli\u003eHeavy-metal-exposure populations (older amalgam fillings, well water, occupational) who want a low-key chelating co-factor.\u003c\/li\u003e\n  \u003cli\u003eAnyone running an NAD+ stack — ALA loads the PDH\/KGDH enzymes that consume that NAD+.\u003c\/li\u003e\n  \u003cli\u003eMitochondrial-energy stack builders pairing ALA with \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003ePeople interested in the Nrf2\/antioxidant network as a whole and stacking with \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e + \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding women\u003c\/strong\u003e — insufficient safety data; talk to your OB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType-1 diabetics on insulin\u003c\/strong\u003e — potential additive hypoglycemia; don't start ALA without your endocrinologist and closer self-monitoring during the first 4 weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType-2 diabetics on sulfonylureas (glyburide, glipizide, glimepiride)\u003c\/strong\u003e — same hypoglycemia caution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypothyroid patients on levothyroxine\u003c\/strong\u003e — ALA can chelate metals and reduce levothyroxine absorption; separate dosing by 2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron-deficient patients on iron supplements\u003c\/strong\u003e — ALA chelates iron; separate by 2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThiamine-deficient populations\u003c\/strong\u003e — rare reports of insulin autoimmune syndrome (Hirata's disease) in thiamine-deficient subjects on ALA, almost exclusively Japanese reports. Adequate thiamine intake (B-complex or food) eliminates the concern.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren\u003c\/strong\u003e — the trial database is in adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone with a known sensitivity\u003c\/strong\u003e to ALA. Talk to your physician if you have any doubt.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and oxidation control\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid is photosensitive, thermosensitive, and oxidatively self-degrading — bulk ALA powder loses several percent of activity per month if exposed to sunlight, oxygen, or temperatures above ~25°C. Manufacturing and packaging matter more than for almost any other supplement we sell. Our specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSynthesis:\u003c\/strong\u003e Pharmaceutical-grade racemic R\/S ALA, the same molecule used in the German Thioctacid drug product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC against a USP-grade reference standard. Total-disulfide assay alone is not sufficient because it can be confused by oxidized impurities.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; \/ ICP-MS panel below all USP elemental impurity limits (Pb \u0026lt;0.5 ppm, As \u0026lt;1.5 ppm, Cd \u0026lt;0.5 ppm, Hg \u0026lt;1.5 ppm).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count \u0026lt;1000 CFU\/g; absence of \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eS. aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e EU Pharmacopoeia 2.4.24 (gas chromatography). Class 2 and Class 3 solvents below ICH Q3C limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e Amber UV-protective HDPE bottle; nitrogen-flushed at fill; foil induction seal; oxygen scavenger desiccant. The packaging is doing real work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Cool, dry, dark place. Do not refrigerate (condensation on opening accelerates oxidation). Keep the cap tight.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured\u003c\/strong\u003e in an FDA-registered, NSF-audited facility.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch CoA\u003c\/strong\u003e available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eR\/S vs R-ALA — which is “better”?\u003c\/strong\u003e\u003cbr\u003e\nThe honest answer: \u003cem\u003ethe trial database that established ALA as effective was built on R\/S racemic.\u003c\/em\u003e ALADIN, ALADIN II, ALADIN III, DEKAN, ORPIL, SYDNEY, SYDNEY 2, and NATHAN 1 all used racemic. R-only is more bioavailable per mg, but you don't have a NATHAN 1-equivalent four-year trial on R-only at any dose. We chose to match the trial database. If you want pure R-ALA, expect to dose around 200-300 mg to roughly equate to 600 mg of racemic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs ALA the same as Lipoic Acid? Thioctic acid?\u003c\/strong\u003e\u003cbr\u003e\nYes. “Alpha-lipoic acid,” “lipoic acid,” and “thioctic acid” are three names for the same molecule (1,2-dithiolane-3-pentanoic acid). Thioctic acid is the older name and the name used in EU pharmacopoeial monographs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy empty stomach?\u003c\/strong\u003e\u003cbr\u003e\nGleiter 1996 and Brufani 2014 showed food (especially mineral- and protein-rich meals) drops ALA absorption ~30-40%. Empty stomach is what the trials specified. 30 minutes before food or 2-3 hours after.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it lower my glucose if it's already normal?\u003c\/strong\u003e\u003cbr\u003e\nGenerally not in any way you'd notice. ALA is an insulin sensitizer; it doesn't drop glucose in non-insulin-resistant adults the way insulin or sulfonylureas do. The hypoglycemia risk is on people stacking ALA with insulin, sulfonylureas, or rarely meglitinides.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy does my pee smell weird after taking ALA?\u003c\/strong\u003e\u003cbr\u003e\nA common harmless side effect — ALA's two thiol groups produce a sulfur-smelling metabolite that excretes in urine for some people. Like asparagus pee. Doesn't indicate anything wrong.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHeartburn?\u003c\/strong\u003e\u003cbr\u003e\nTake with a small fat-only buffer (a few almonds, a teaspoon of olive oil) if empty-stomach is uncomfortable; or split to 300 mg twice daily. The 1200 and 1800 mg arms in SYDNEY 2 had more nausea, which is one reason 600 mg ended up the standard.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with metformin?\u003c\/strong\u003e\u003cbr\u003e\nYes, and it's a common stack. Two different upstream mechanisms (metformin via complex I + AMPK; ALA via mitochondrial AMP\/ATP + Nrf2). Han 2020 meta and others showed additive HbA1c benefit. Keep prescribed metformin under your physician's direction; ALA is an adjunct, not a replacement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about with \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e?\u003c\/strong\u003e\u003cbr\u003e\nCommon stack. ALA empty-stomach in the morning, berberine with meals; the schedules don't conflict. Both hit AMPK by different upstream paths. Glucose + lipid + gut layered profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about with my \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e stack?\u003c\/strong\u003e\u003cbr\u003e\nExcellent layering. ALA loads PDH and KGDH; those enzymes consume the NAD+ that NMN raises. ALA + NMN are substrate and cofactor for the same Krebs-cycle entry steps.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it long term?\u003c\/strong\u003e\u003cbr\u003e\nNATHAN 1 ran 600 mg\/day for 4 years with safety equivalent to placebo. Long-term daily use is the use case the trials validated.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take more than 600 mg?\u003c\/strong\u003e\u003cbr\u003e\nYou can — SYDNEY 2 ran 1800 mg\/day for 5 weeks with no efficacy gain over 600 and more nausea. There's no clinical reason to exceed 600 mg\/day for the long-term use case.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my levothyroxine \/ thyroid hormone?\u003c\/strong\u003e\u003cbr\u003e\nPossibly. ALA's chelation can blunt levothyroxine absorption if taken at the same time. Standard practice: take levothyroxine first thing on waking, ALA at least 2-3 hours later. Tell your endocrinologist you're starting ALA.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eI'm B12-deficient or a long-term metformin user. Does that matter?\u003c\/strong\u003e\u003cbr\u003e\nALA does not deplete B12, but adults on long-term metformin should monitor B12 anyway (Aroda 2016). Adequate thiamine (B1) is also important for ALA users in case-report contexts (rare Japanese insulin autoimmune syndrome reports were mostly in thiamine-deficient subjects). A daily B-complex covers this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do I see \"300 mg\" doses elsewhere when the trials used 600 mg?\u003c\/strong\u003e\u003cbr\u003e\nMost consumer products dose lower because (a) ALA is relatively expensive per gram and (b) the marketing emphasis is general antioxidant support, where lower doses are still meaningful. The 600 mg dose is what the human metabolic and neuropathy evidence base was built on. Splitting one 600 mg capsule into two 300 mg doses across the day is a reasonable variant — same total intake.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes ALA help with weight loss?\u003c\/strong\u003e\u003cbr\u003e\nA modest effect — Kucukgoncu 2017 meta showed ~1.27 kg average weight loss vs placebo across 12 RCTs. Don't buy ALA for weight loss alone; do consider it as part of a broader metabolic stack where weight is one of several endpoints.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it help with brain fog or cognition?\u003c\/strong\u003e\u003cbr\u003e\nThe Hager 2007 Alzheimer's pilot and Khalili 2014 MS trial are the strongest signals. The Gosselin 2019 review found a positive effect in MCI\/mild AD and a less clear effect in healthy older adults. Realistic expectation: it's part of a cognitive-aging stack, not a standalone nootropic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do I see this product compared to \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e a lot?\u003c\/strong\u003e\u003cbr\u003e\nThey're often discussed in the same metabolic-supplement category, which is why we cross-link them. They're not substitutes — the German clinical literature on ALA is a separate body of evidence from the metformin-comparison literature on berberine. If your goal is comprehensive metabolic support, both belong in the protocol; if you're starting from zero and have to pick one, berberine has the broader profile (lipids + glucose + gut microbiome) and ALA has the more specific neuropathy + antioxidant-recycling profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs ALA the same as omega-3?\u003c\/strong\u003e\u003cbr\u003e\nNo. Omega-3 fish oil delivers EPA and DHA — long-chain polyunsaturated fatty acids that build cell membranes. Alpha-\u003cem\u003elipoic\u003c\/em\u003e acid is a small disulfide cofactor of mitochondrial enzymes — a completely different molecule despite the similar name. Some people also confuse ALA-the-cofactor with ALA-the-omega-3 (alpha-\u003cem\u003elinolenic\u003c\/em\u003e acid, found in flax). Three different molecules.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e\u003cbr\u003e\nCool, dry, dark. Do not refrigerate (condensation on opening accelerates oxidation). Keep the cap tight; the bottle is amber and nitrogen-flushed for a reason.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid is one of our four pillars of the \u003cstrong\u003eantioxidant-network layer\u003c\/strong\u003e: \u003ca href=\"\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e (the master antioxidant itself), \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e (its precursor), \u003cstrong\u003eALA\u003c\/strong\u003e (the recycler + Nrf2 inducer), and \u003ca href=\"\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e (the network's water-phase partner). Most adults building a serious protocol layer all four. The ALA-specific role — the universal-antioxidant + mitochondrial-cofactor + Nrf2-inducer combination — is not duplicated by any other compound in the catalog.\u003c\/p\u003e\n\n\u003cp\u003eIt's also a core member of the \u003cstrong\u003emetabolic foundation layer\u003c\/strong\u003e alongside \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e, \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e, and \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e. And of the \u003cstrong\u003emitochondrial-energy layer\u003c\/strong\u003e alongside \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e, and \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e. ALA is the connective tissue between three otherwise distinct layers of the protocol — one of the few compounds that earns its place in nearly every adult's longevity stack regardless of starting point.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePacker L, Witt EH, Tritschler HJ. \u003cem\u003eAlpha-Lipoic acid as a biological antioxidant.\u003c\/em\u003e Free Radic Biol Med. 1995;19(2):227-50.\u003c\/li\u003e\n  \u003cli\u003eBustamante J et al. \u003cem\u003eAlpha-lipoic acid in liver metabolism and disease.\u003c\/em\u003e Free Radic Biol Med. 1998;24(6):1023-39.\u003c\/li\u003e\n  \u003cli\u003eHagen TM et al. \u003cem\u003e(R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function.\u003c\/em\u003e FASEB J. 1999;13(2):411-8.\u003c\/li\u003e\n  \u003cli\u003eSuh JH et al. \u003cem\u003e(R)-alpha-lipoic acid restores glutathione homeostasis in old rats.\u003c\/em\u003e Proc Natl Acad Sci USA. 2004;101(10):3381-6.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eTreatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid (ALADIN study).\u003c\/em\u003e Diabetologia. 1995;38(12):1425-33.\u003c\/li\u003e\n  \u003cli\u003eReljanovic M et al. \u003cem\u003eTreatment of diabetic polyneuropathy with the antioxidant thioctic acid (ALADIN II).\u003c\/em\u003e Free Radic Res. 1999;31(3):171-9.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eTreatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III).\u003c\/em\u003e Diabetes Care. 1999;22(8):1296-301.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eEffects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients (DEKAN study).\u003c\/em\u003e Diabetes Care. 1997;20(3):369-73.\u003c\/li\u003e\n  \u003cli\u003eRuhnau KJ et al. \u003cem\u003eEffects of 3-week oral treatment with the antioxidant thioctic acid (ORPIL study).\u003c\/em\u003e Diabet Med. 1999;16(12):1040-3.\u003c\/li\u003e\n  \u003cli\u003eAmetov AS et al. \u003cem\u003eThe sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: SYDNEY trial.\u003c\/em\u003e Diabetes Care. 2003;26(3):770-6.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eOral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: SYDNEY 2 trial.\u003c\/em\u003e Diabetes Care. 2006;29(11):2365-70.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eEfficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy (NATHAN 1).\u003c\/em\u003e Diabetes Care. 2011;34(9):2054-60.\u003c\/li\u003e\n  \u003cli\u003eMijnhout GS et al. \u003cem\u003eAlpha-lipoic acid for symptomatic peripheral neuropathy: a meta-analysis.\u003c\/em\u003e Int J Endocrinol. 2012;2012:456279.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eAntioxidants and diabetic neuropathy.\u003c\/em\u003e Antioxid Redox Signal. 2014;21(8):1291-321.\u003c\/li\u003e\n  \u003cli\u003eKonrad D et al. \u003cem\u003eThe antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via PI3K and AMPK.\u003c\/em\u003e Diabetes. 2001;50(7):1464-71.\u003c\/li\u003e\n  \u003cli\u003eJacob S et al. \u003cem\u003eOral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with T2DM.\u003c\/em\u003e Free Radic Biol Med. 1999;27(3-4):309-14.\u003c\/li\u003e\n  \u003cli\u003eAkbari M et al. \u003cem\u003eThe effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of RCTs.\u003c\/em\u003e Metabolism. 2018;87:56-69.\u003c\/li\u003e\n  \u003cli\u003eMohammadi V et al. \u003cem\u003eThe effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in metabolic syndrome.\u003c\/em\u003e Adv Pharm Bull. 2017;7(2):185-194.\u003c\/li\u003e\n  \u003cli\u003eKucukgoncu S et al. \u003cem\u003eAlpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of RCTs.\u003c\/em\u003e Obes Rev. 2017;18(5):594-601.\u003c\/li\u003e\n  \u003cli\u003ede Sousa CV et al. \u003cem\u003eAlpha-lipoic acid in NAFLD: a systematic review.\u003c\/em\u003e 2019.\u003c\/li\u003e\n  \u003cli\u003eGenazzani AD et al. \u003cem\u003eAlpha-lipoic acid as a new treatment option for PCOS.\u003c\/em\u003e Gynecol Endocrinol. 2010.\u003c\/li\u003e\n  \u003cli\u003eKhalili M et al. \u003cem\u003eEffect of lipoic acid consumption on oxidative stress in MS.\u003c\/em\u003e Nutr Neurosci. 2014;17(1):16-20.\u003c\/li\u003e\n  \u003cli\u003eHager K et al. \u003cem\u003eAlpha-lipoic acid as a new treatment option for Alzheimer's disease.\u003c\/em\u003e Arch Gerontol Geriatr. 2007;45(1):S6-S10.\u003c\/li\u003e\n  \u003cli\u003eMaczurek A et al. \u003cem\u003eLipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.\u003c\/em\u003e Adv Drug Deliv Rev. 2008;60(13-14):1463-70.\u003c\/li\u003e\n  \u003cli\u003eGosselin LE et al. \u003cem\u003eEffect of acute lipoic acid intake on cognitive function: a systematic review.\u003c\/em\u003e Nutr Rev. 2019.\u003c\/li\u003e\n  \u003cli\u003eMagis D et al. \u003cem\u003eA randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.\u003c\/em\u003e Headache. 2007;47(1):52-7.\u003c\/li\u003e\n  \u003cli\u003eSalehi B et al. \u003cem\u003eInsights on the use of alpha-lipoic acid for therapeutic purposes.\u003c\/em\u003e Biomolecules. 2019;9(8):356.\u003c\/li\u003e\n  \u003cli\u003ePatrick L. \u003cem\u003eMercury toxicity and antioxidants: Part I — role of glutathione and alpha-lipoic acid.\u003c\/em\u003e Altern Med Rev. 2002;7(6):456-71.\u003c\/li\u003e\n  \u003cli\u003eGleiter CH et al. \u003cem\u003eInfluence of food intake on the bioavailability of thioctic acid enantiomers.\u003c\/em\u003e Eur J Clin Pharmacol. 1996;50(6):513-4.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. Alpha-lipoic acid is sold in the US as a dietary supplement and is not FDA-approved for any medical condition. These statements have not been evaluated by the FDA. Talk to your doctor before starting any supplement, especially if you are pregnant, breastfeeding, take prescription medication (particularly insulin, sulfonylureas, levothyroxine, or iron), or have any existing medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839563940058,"sku":"THP-ALA-600-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_ala.png?v=1778049793"},{"product_id":"n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support","title":"N-Acetyl Cysteine 600mg | NAC Glutathione Precursor for Antioxidant \u0026 Longevity Support","description":"\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cp\u003eN-Acetyl Cysteine (NAC) is the rate-limiting precursor to \u003cstrong\u003eglutathione\u003c\/strong\u003e — the master endogenous antioxidant your body manufactures inside every cell to scavenge oxidative damage, recycle vitamins C and E, support immune function, and defend against the chronic free-radical pressure that drives aging. The body builds glutathione (GSH) from three amino acids (cysteine, glycine, glutamate); of those three, \u003cstrong\u003ecysteine is the bottleneck\u003c\/strong\u003e. NAC is cysteine in a stable, bioavailable, sulfur-thiol-protected form. Take it and your cells make more glutathione — \u003cem\u003eespecially\u003c\/em\u003e as you get older, when intracellular glutathione drops 30–60% and oxidative stress rises in lockstep. NAC has a 50-year clinical track record (paracetamol-overdose antidote on the WHO Essential Medicines list, cystic-fibrosis mucolytic, contrast-induced nephropathy prevention, OCD adjunct) and is now the headline ingredient in the \u003cstrong\u003eGlyNAC aging-reversal trials\u003c\/strong\u003e at Baylor College of Medicine — half of the only nutrient combination ever shown in published human work to roll back ~22 measured hallmarks of aging in older adults (Kumar 2021, \u003cem\u003eClin Transl Med\u003c\/em\u003e; Kumar 2022, \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eIf you are already running NMN, NAD+, or sirtuin activators, NAC is the antioxidant arm of the stack: it protects the lipid bilayers, mitochondrial cristae, and DNA from the oxidative byproducts of the very mitochondrial activity those NAD+ precursors are accelerating. \u003cstrong\u003eBoost mitochondrial output without restoring antioxidant defenses\u003c\/strong\u003e and you are running an engine harder without changing the oil. NAC is the oil change.\u003c\/p\u003e\n\n\u003ch2\u003eWhy a hospital antidote ended up on every longevity stack\u003c\/h2\u003e\n\u003cp\u003eNAC isn't new. It has been used in clinical medicine since the 1960s — first as \u003cem\u003eMucomyst\u003c\/em\u003e, an inhaled mucolytic for cystic fibrosis (its free thiol breaks the disulfide bridges that crosslink mucus glycoproteins into a thick, immobile gel), and since the 1970s as the \u003cstrong\u003estandard ER antidote for acetaminophen overdose\u003c\/strong\u003e: pre-empt the liver's glutathione collapse by giving it more cysteine, save the patient. That's how doctors know NAC works as a glutathione precursor — the receipts are 50 years of liver transplants \u003cem\u003enot happening\u003c\/em\u003e. The Rumack-Matthew nomogram and the FDA-approved 21-hour IV NAC protocol (Smilkstein 1988, \u003cem\u003eNEJM\u003c\/em\u003e) have made it one of the most-administered antidotes in modern emergency medicine.\u003c\/p\u003e\n\u003cp\u003eWhat's new is the longevity translation. Glutathione is the body's most abundant intracellular antioxidant — present in every cell at \u003cstrong\u003e1–10 millimolar concentrations\u003c\/strong\u003e (more than 1000-fold higher than plasma vitamin C), doing the unglamorous daily work of neutralizing reactive oxygen species, recycling oxidized vitamins C and E, conjugating heavy metals and xenobiotics for biliary or renal excretion, and keeping the redox-sensitive transcription factors (Nrf2, NF-κB, FOXO, AP-1) tuned. The catch: glutathione synthesis collapses with age. Cross-sectional human work (Sekhar 2018, \u003cem\u003eClin Transl Med\u003c\/em\u003e; Sekhar 2011, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) shows older adults run intracellular glutathione 30–60% below young controls, with parallel rises in oxidative-damage markers (F2-isoprostanes, malondialdehyde, 8-OHdG), mitochondrial dysfunction, and inflammatory tone. Replacing the missing precursor — cysteine, via NAC — restores glutathione synthesis, and the downstream antioxidant, anti-inflammatory, and mitochondrial markers move with it.\u003c\/p\u003e\n\n\u003ch2\u003eNAC and the Hallmarks of Aging\u003c\/h2\u003e\n\u003cp\u003eThe 2013 López-Otín paper in \u003cem\u003eCell\u003c\/em\u003e — updated in 2023 to twelve hallmarks — is the field's reference taxonomy for what actually goes wrong as humans age. NAC, working through glutathione, touches an unusually large fraction of them:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction.\u003c\/strong\u003e Glutathione is the dominant antioxidant \u003cem\u003einside\u003c\/em\u003e the mitochondrion. As mitochondrial GSH (mGSH) declines, the inner-membrane lipids oxidize, the electron transport chain leaks more electrons as superoxide, and the cycle accelerates. The 2021 Sekhar trial showed measurable improvements in mitochondrial fuel oxidation after 24 weeks of GlyNAC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLoss of proteostasis.\u003c\/strong\u003e Glutathione participates in protein-folding fidelity (forming and reducing disulfide bonds in the endoplasmic reticulum) and is required for the function of glutathione-S-transferases that conjugate and clear damaged proteins. Glutathione depletion drives endoplasmic-reticulum stress and the unfolded-protein response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenomic instability.\u003c\/strong\u003e 8-OHdG, the canonical oxidative DNA damage marker, rises when glutathione falls. Restoring glutathione lowers genotoxicity (measured directly in the 2021 Sekhar trial via the comet assay).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAltered intercellular communication \/ chronic inflammation.\u003c\/strong\u003e Glutathione tunes NF-κB activity. As GSH falls, NF-κB activates inappropriately, IL-6 and TNF-α rise, and the “inflammaging” phenotype emerges. Sekhar 2021 showed both markers fell with GlyNAC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing.\u003c\/strong\u003e Insulin sensitivity improved measurably in both the 2013 (diabetic elderly, \u003cem\u003eDiabetes Care\u003c\/em\u003e) and 2021 (older adults, \u003cem\u003eClin Transl Med\u003c\/em\u003e) trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStem cell exhaustion.\u003c\/strong\u003e Hematopoietic and tissue stem cells live in low-oxygen niches with high glutathione. GSH depletion is one of the early triggers of stem-cell senescence in vitro.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is the “lever” logic: a single intervention (restore the cysteine–glutathione axis) acts upstream of multiple hallmarks at once, which is why GlyNAC is the only nutrient combination to date that has produced the breadth of measured improvements that Kumar 2021 reported across cellular, metabolic, and functional domains.\u003c\/p\u003e\n\n\u003ch2\u003eThe Sekhar GlyNAC trials — what NAC actually did in older humans\u003c\/h2\u003e\n\u003cp\u003eThe reason NAC moved from “pharmacy back-shelf” to “longevity headline” is the \u003cstrong\u003eGlyNAC research program\u003c\/strong\u003e from Rajagopal Sekhar's lab at Baylor College of Medicine. The hypothesis: if older adults are glutathione-deficient because they run short on the precursors cysteine \u003cem\u003eand\u003c\/em\u003e glycine, then giving them both — Glycine + N-Acetyl-Cysteine — should restore glutathione and reverse the downstream aging biology.\u003c\/p\u003e\n\u003cp\u003eThe trials, in sequence:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003e2011 (\u003cem\u003eDiabetes Care\u003c\/em\u003e)\u003c\/strong\u003e — Sekhar's first proof-of-concept. 12 elderly adults with diabetes, 14 days of cysteine + glycine. Glutathione synthesis rose \u003cstrong\u003e+230%\u003c\/strong\u003e, intracellular glutathione doubled, oxidative stress markers fell, and insulin resistance improved. First proof the precursor-restoration model worked in humans.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2011 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e)\u003c\/strong\u003e — same precursor-restoration approach in 8 older adults vs. 8 young controls. Confirmed older adults at baseline ran ~50% lower glutathione, ~80% higher oxidative stress, and impaired mitochondrial fuel oxidation. Two weeks of cysteine + glycine normalized glutathione and oxidative stress to \u003cem\u003eyoung-control\u003c\/em\u003e levels.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2014 (\u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e)\u003c\/strong\u003e — Nguyen, Hsu, Jahoor, Sekhar. Same protocol in older HIV-aging patients (premature-aging phenotype amplified). Mitochondrial fuel oxidation, insulin sensitivity, and body composition all improved.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2018 (\u003cem\u003eClin Transl Med\u003c\/em\u003e)\u003c\/strong\u003e — replication in older adults vs. young controls, deeper mitochondrial analysis (palmitate \u0026amp; glucose oxidation rates), with the addition of mtDNA copy-number metrics. Same pattern: precursor restoration, glutathione rebuild, mitochondrial recovery toward young controls.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2021 (\u003cem\u003eClin Transl Med\u003c\/em\u003e)\u003c\/strong\u003e — the headline trial. \u003cstrong\u003e24-week randomized, placebo-controlled study in older adults (ages 71–80)\u003c\/strong\u003e. GlyNAC supplementation (1.33 mmol\/kg\/day glycine + 0.81 mmol\/kg\/day NAC, weight-adjusted) measurably improved \u003cstrong\u003eglutathione, oxidative stress, mitochondrial function, inflammation, insulin resistance, endothelial function, genotoxicity, body composition, gait speed, strength, exercise capacity, waist circumference, and cognition\u003c\/strong\u003e. The authors framed it as reversal of the major hallmarks of aging — the most ambitious claim in any nutrient trial to date.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2022 (\u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e)\u003c\/strong\u003e — Kumar, Liu, Hsu, Sekhar. Replication and extension in HIV-aging populations, where premature aging biology is amplified. Same pattern: glutathione restored, mitochondrial function improved, oxidative stress fell, body composition shifted toward more lean mass.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2023 (\u003cem\u003eAntioxidants\u003c\/em\u003e)\u003c\/strong\u003e — Kumar, Sekhar follow-up commentary mapping each measured outcome to a specific López-Otín hallmark, formalizing the “GlyNAC reverses multiple hallmarks” framing now widely cited.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe doses used in the 2021 trial — when scaled to a typical 70 kg adult — work out to roughly \u003cstrong\u003e3.6g NAC + 4.5g glycine per day\u003c\/strong\u003e, split twice daily with meals. Our NAC 600mg pairs naturally with our \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg | GlyNAC Partner\u003c\/a\u003e capsule — one of each, twice daily, gives you ~1200mg NAC and ~3000mg glycine, a foundational maintenance dose. Adults running the full Sekhar-style protocol typically take 2 of each capsule twice daily; this is well within the safe range that the trials used (the FDA-approved IV NAC overdose protocol is ~14g over 21 hours, so oral 2.4g\/day is conservative by an order of magnitude).\u003c\/p\u003e\n\u003cp\u003eOne caveat the 2021 paper makes explicit: \u003cstrong\u003eboth\u003c\/strong\u003e precursors matter. The 30–60% intracellular glutathione deficit in older adults is driven by both cysteine \u003cem\u003eand\u003c\/em\u003e glycine running short, not cysteine alone. NAC by itself raises glutathione, but the GlyNAC combination raises it further and produces the measured functional improvements. If you are running the longevity protocol seriously, run the pair.\u003c\/p\u003e\n\n\u003ch2\u003eThree things NAC does (the mechanism, in plain English)\u003c\/h2\u003e\n\n\u003ch3\u003e1. Glutathione regeneration (the main event)\u003c\/h3\u003e\n\u003cp\u003eNAC is hydrolyzed to L-cysteine in the gut and liver, and cysteine is the rate-limiting amino acid in glutathione synthesis. The other two glutathione amino acids — glycine and glutamate — are abundant in the diet and rarely limit synthesis except in the very elderly. Cysteine is the choke point because dietary cysteine is largely consumed building proteins, and the free cysteine pool is kept deliberately small (free cysteine is reactive and cytotoxic). NAC's acetyl group protects the thiol from oxidation in transit, lets the molecule survive the gut, and is cleaved by tissue deacetylases to release usable cysteine intracellularly. The two-step glutathione synthesis pathway (γ-glutamylcysteine synthetase \/ GCL is rate-limiting at step one; glutathione synthetase finishes step two) is then substrate-driven — provide cysteine, glutathione synthesis goes up.\u003c\/p\u003e\n\u003cp\u003eOnce made, glutathione cycles between its reduced (GSH) and oxidized (GSSG) forms. \u003cstrong\u003eThe GSH:GSSG ratio is the single most-cited cellular redox indicator\u003c\/strong\u003e — healthy cells run ~100:1 GSH:GSSG, oxidatively-stressed cells drop toward 10:1 or lower. NAC restoration moves the ratio back toward the youthful state, and that ratio is what the rest of the cell's redox-sensitive machinery (Nrf2, NF-κB, AP-1, MAPK pathways) reads to decide its behavior.\u003c\/p\u003e\n\n\u003ch3\u003e2. Direct disulfide-breaking action\u003c\/h3\u003e\n\u003cp\u003eNAC's thiol (-SH) directly reduces disulfide bonds (-S-S-) in proteins and mucus glycoproteins. This is the mechanism behind NAC's mucolytic activity (used in cystic fibrosis, chronic bronchitis, COPD — PANTHEON 2014, BRONCUS 2005), and it also matters for redox-active extracellular proteins in inflammation. The thiol-disulfide exchange is fast, non-enzymatic, and works in the gut, the airway lining, and the bloodstream.\u003c\/p\u003e\n\n\u003ch3\u003e3. Direct ROS scavenging, metal chelation, and Nrf2\/KEAP1 signaling\u003c\/h3\u003e\n\u003cp\u003eAside from glutathione regeneration, NAC's free thiol can directly neutralize hydroxyl radicals, hypochlorous acid, and nitrogen dioxide. It chelates heavy metals (copper, mercury, lead, cadmium) and supports their biliary clearance via glutathione conjugation. And it tunes the Nrf2\/KEAP1 cascade — the master “turn on the antioxidant gene set” switch.\u003c\/p\u003e\n\u003cp\u003eThe KEAP1 mechanism is worth knowing in detail because it explains why a small daily NAC dose can produce sustained downstream protection: KEAP1 is a cytoplasmic protein that holds Nrf2 in the cytoplasm and tags it for degradation under normal conditions. Oxidative or electrophilic modification of specific KEAP1 cysteine residues (especially Cys151, Cys273, Cys288) releases Nrf2, which then translocates to the nucleus and drives transcription of ~250 cytoprotective genes — including the glutathione-synthesis enzymes themselves (GCLC, GCLM, GS), thioredoxin, NQO1, heme oxygenase-1, and the glutathione-S-transferases. NAC and glutathione participate in this loop: GSH availability tunes the resting redox state that KEAP1's cysteines see, and the resulting Nrf2 tone determines how much glutathione-synthesis enzyme is around to make use of new cysteine arriving from a NAC capsule. Boost cysteine availability and the upstream substrate, downstream enzyme expression, and the resulting GSH:GSSG ratio all move together — this feed-forward is why you see broad protective effects from a relatively simple intervention.\u003c\/p\u003e\n\n\u003ch2\u003eThe glutathione cycle — production, use, and recycling\u003c\/h2\u003e\n\u003cp\u003eIt helps to know what happens to a cysteine molecule once it crosses the cell membrane. The full cycle:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStep 1 (rate-limiting): GCL combines cysteine + glutamate → γ-glutamylcysteine.\u003c\/strong\u003e GCL (glutamate-cysteine ligase) is feedback-inhibited by GSH itself, so when glutathione is high the enzyme slows; when glutathione is low and cysteine is available, the enzyme is unleashed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStep 2: GS combines γ-glutamylcysteine + glycine → GSH.\u003c\/strong\u003e Glycine availability matters here, which is why the GlyNAC pairing exists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStep 3: GSH neutralizes ROS via glutathione peroxidase (GPx)\u003c\/strong\u003e, with selenium as the catalytic cofactor (1 selenocysteine per GPx active site). Two GSH molecules + H₂O₂ → GSSG + 2 H₂O. This is one reason the 2009 Safarinejad fertility trial paired NAC with selenium — selenium is the catalytic site of the enzyme that uses glutathione.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStep 4: GSSG is recycled to GSH\u003c\/strong\u003e via glutathione reductase (GR), using NADPH from the pentose phosphate pathway. NADPH is the actual redox “currency” that drives the recycling, which is why metabolic conditions that limit NADPH (G6PD deficiency, certain medications) also limit glutathione recycling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStep 5: Conjugation and excretion.\u003c\/strong\u003e Glutathione-S-transferases (GSTs) tag xenobiotics, heavy metals, and Phase-1-activated drug intermediates with GSH for biliary or urinary excretion. This is the “detox” arm — not magical detoxification, just the actual molecular pathway by which the liver clears reactive species.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCysteine availability is the rate-determining input to step 1. Glycine availability matters at step 2. Selenium matters at step 3. NADPH matters at step 4. The full nutritional support stack for the glutathione cycle is therefore: \u003cstrong\u003eNAC + glycine + selenium-containing food (Brazil nuts, fish) + good metabolic status (B-vitamins, magnesium for the PPP)\u003c\/strong\u003e. Pair NAC with our \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e and a selenium-rich diet and you have all four covered.\u003c\/p\u003e\n\n\u003ch2\u003eBeyond glutathione — the secondary clinical literature\u003c\/h2\u003e\n\n\u003ch3\u003eAcetaminophen-overdose antidote (the founding evidence)\u003c\/h3\u003e\n\u003cp\u003eAcetaminophen overdose kills via NAPQI — a reactive Phase-1 metabolite that conjugates with hepatic glutathione. Under therapeutic dosing, glutathione handles the small amount of NAPQI generated. Under overdose, glutathione is consumed, NAPQI binds covalently to liver proteins, and centrilobular necrosis follows. NAC, given within 8–10 hours, restores glutathione faster than NAPQI can deplete it (Smilkstein 1988, \u003cem\u003eNEJM\u003c\/em\u003e; Prescott 1979, \u003cem\u003eLancet\u003c\/em\u003e). The IV protocol — 150 mg\/kg loading, 50 mg\/kg over 4 hours, 100 mg\/kg over 16 hours — remains the most-cited validation that \u003cem\u003ecysteine availability\u003c\/em\u003e determines glutathione synthesis rate in living human livers.\u003c\/p\u003e\n\n\u003ch3\u003eFertility and reproductive health\u003c\/h3\u003e\n\u003cp\u003eBoth male and female fertility are downstream of redox balance, and NAC has trial-grade evidence on both sides. \u003cstrong\u003eFemale fertility \/ PCOS\u003c\/strong\u003e: a 2015 systematic review and meta-analysis (Thakker, \u003cem\u003eObstet Gynecol Int\u003c\/em\u003e) of 8 RCTs found NAC improved ovulation rate, pregnancy rate, and metabolic indices in women with PCOS, including in clomiphene-resistant cases, with effect sizes comparable to metformin in head-to-head comparisons. \u003cstrong\u003eMale fertility\u003c\/strong\u003e: the 2009 Safarinejad RCT in \u003cem\u003eJ Urol\u003c\/em\u003e (468 infertile men, 26 weeks of NAC + selenium) showed measurable improvements in sperm concentration, motility, and morphology, with reductions in seminal-plasma malondialdehyde (oxidative damage to sperm membranes is a leading cause of unexplained male-factor infertility). The mechanism in both cases is glutathione-dependent: oocyte and sperm membranes are unusually rich in polyunsaturated lipids, ovarian and testicular tissue runs at high metabolic rate, and oxidative damage accumulates fastest where lipid + heat + metabolism collide. Pair our NAC with \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e for the established “antioxidant + mitochondrial bioenergetics” fertility stack — this combination is widely used in IVF prep clinics.\u003c\/p\u003e\n\n\u003ch3\u003eRespiratory health\u003c\/h3\u003e\n\u003cp\u003eNAC's mucolytic effect is the original FDA indication. Two large COPD trials anchor the modern dosing: \u003cstrong\u003eBRONCUS (Decramer 2005, \u003cem\u003eLancet\u003c\/em\u003e)\u003c\/strong\u003e — 600mg\/day for 3 years did not reduce FEV1 decline overall but reduced exacerbations in patients not on inhaled corticosteroids. \u003cstrong\u003ePANTHEON (Zheng 2014, \u003cem\u003eLancet Respir Med\u003c\/em\u003e)\u003c\/strong\u003e — 600mg twice daily for 1 year reduced exacerbation frequency by 22% in moderate-severe COPD (incidence rate ratio 0.78, 95% CI 0.67–0.90). Higher doses (1200mg twice daily) have been used in idiopathic pulmonary fibrosis trials with mixed results (PANTHER-IPF).\u003c\/p\u003e\n\n\u003ch3\u003eMental health and the glutamate\/dopamine system\u003c\/h3\u003e\n\u003cp\u003eNAC modulates the cystine-glutamate antiporter (xCT\/system x\u003csub\u003ec\u003c\/sub\u003e\u003csup\u003e-\u003c\/sup\u003e) on glial cells, reducing presynaptic glutamate release and tuning glutamatergic tone. It is the most-studied glutamate-modulating supplement in psychiatry. Trial-grade evidence:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBipolar depression (Berk 2008, \u003cem\u003eBiol Psychiatry\u003c\/em\u003e)\u003c\/strong\u003e — 1g twice daily for 24 weeks improved depressive symptoms and global function vs. placebo.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrichotillomania (Grant 2009, \u003cem\u003eArch Gen Psychiatry\u003c\/em\u003e)\u003c\/strong\u003e — 1.2–2.4g\/day for 12 weeks: 56% of NAC subjects improved vs. 16% on placebo.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOCD (multiple RCTs since 2012)\u003c\/strong\u003e — adjunct to SSRI; mixed but generally favorable.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchizophrenia (Berk 2008b)\u003c\/strong\u003e — 2g\/day adjunct, modest improvements in negative symptoms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNAC is not a primary psychiatric treatment. It is a glutamate-modulating adjunct with a benign side-effect profile, used in research and specialist practice for OCD-spectrum disorders, treatment-resistant mood disorders, and as a safer alternative to escalating other agents.\u003c\/p\u003e\n\n\u003ch3\u003eLiver and detoxification\u003c\/h3\u003e\n\u003cp\u003eBeyond the acute-overdose use, NAC has been studied in non-alcoholic fatty liver disease (Khoshbaten 2010, \u003cem\u003eHepat Mon\u003c\/em\u003e: improved ALT\/AST, hepatic enzymes, and steatosis on ultrasound), in alcoholic liver disease as glutathione support, and in chemoprotection during chemotherapy (controversial — see “What NOT to do” below). The detoxification pathway is glutathione-S-transferase-driven conjugation, the same route that handles most drug, environmental, and endogenous toxins. Heavy-metal chelation via glutathione is a documented secondary benefit (Atkuri 2007, \u003cem\u003eCurr Opin Pharmacol\u003c\/em\u003e).\u003c\/p\u003e\n\n\u003ch3\u003eContrast-induced nephropathy\u003c\/h3\u003e\n\u003cp\u003eTepel 2000 (\u003cem\u003eNEJM\u003c\/em\u003e) was the first major RCT to show NAC + saline reduced acute kidney injury after contrast imaging in chronic kidney disease patients. The literature has mixed since (the 2018 PRESERVE trial in \u003cem\u003eNEJM\u003c\/em\u003e was negative), but NAC remains in many institutional CIN-prevention protocols because it is cheap, safe, and the upside is preventable AKI in vulnerable patients. The mechanism is glutathione-supported renal-tubule protection plus direct ROS scavenging.\u003c\/p\u003e\n\n\u003ch3\u003eInflammation and post-viral syndromes\u003c\/h3\u003e\n\u003cp\u003eThe 2020–2022 literature included multiple small trials of NAC in COVID-19 and post-viral inflammation, with mixed but generally favorable findings on inflammatory markers (CRP, ferritin, IL-6) and clinical course. The biological logic is the same as in any inflammatory state: glutathione depletion is downstream of severe inflammation, and restoring it with the precursor reduces cytokine amplification. NAC is not a treatment for any specific viral illness, but glutathione restoration is reasonable supportive nutrition during prolonged inflammatory states.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in the bottle\u003c\/h2\u003e\n\u003cp\u003eEach capsule delivers \u003cstrong\u003e600mg pharmaceutical-grade N-Acetyl-L-Cysteine\u003c\/strong\u003e — the dose used in PANTHEON, the GlyNAC pilot work, and most of the major clinical trials. 60 capsules per bottle gives a 30-day supply at the foundational longevity dose (1 cap AM + 1 cap PM = 1200mg\/day, the dose that stacks naturally with our Glycine 1500mg).\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive:\u003c\/strong\u003e 600mg N-Acetyl-L-Cysteine (USP\/EP-grade, identity-tested by HPLC-UV at 214 nm against a USP reference standard, assay 99.0–100.5%).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapsule:\u003c\/strong\u003e vegetarian (HPMC), no animal-derived gelatin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipients:\u003c\/strong\u003e microcrystalline cellulose (flow agent), no magnesium stearate, no titanium dioxide, no silicon dioxide as primary filler (used only at trace levels for capsule-filling consistency).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e gluten, soy, dairy, eggs, peanuts, tree nuts (manufactured on shared lines — allergen-trace tested), shellfish, fish, sesame, GMO ingredients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e GMP-certified U.S. facility, NSF-audited, GFSI-aligned allergen control program. Each batch carries a Certificate of Analysis (CoA) covering identity (HPLC-UV), assay, dissolution (USP \u0026lt;711\u0026gt;), heavy metals (ICP-MS for As\/Cd\/Pb\/Hg vs. USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt;), and microbiology (total aerobic count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eS. aureus\u003c\/em\u003e) per batch. CoAs are available on request — we publish lot numbers and dates with every shipment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e NAC's free thiol is mildly oxidation-prone, so capsules are blister-packed where possible and bottle-stocked otherwise with desiccant. Best stored cool, dry, and capped tight after opening. Sulfur smell on opening is the thiol — expected and harmless. If the smell intensifies dramatically over time, the product has oxidized and should be replaced.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\n\u003ch3\u003eFoundational longevity dose — 600–1200mg\/day\u003c\/h3\u003e\n\u003cp\u003e1 capsule with breakfast and 1 capsule with dinner. With food reduces the modest GI tolerance issues some users notice (NAC is mildly stomach-irritating in a small fraction of people on an empty stomach). 1200mg\/day is the dose used as the “maintenance” arm in long-term respiratory and cardiovascular trials and is the dose we recommend for most adults running NAC as a foundational antioxidant.\u003c\/p\u003e\n\n\u003ch3\u003eGlyNAC protocol — pair with Glycine 1500mg, twice daily\u003c\/h3\u003e\n\u003cp\u003eFor the Sekhar protocol — the one with the 2021 trial data — pair 1 NAC capsule with 1–2 \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e capsules at breakfast, repeat at dinner. Adults running the full clinical-trial dose (~3.6g NAC + 4.5g glycine\/day, weight-adjusted) take 2 of each capsule twice daily. This is the protocol with the breadth-of-hallmarks effect data; it is not necessary for most users but it is the most ambitious, evidence-backed antioxidant intervention in the modern nutrition literature.\u003c\/p\u003e\n\n\u003ch3\u003ePCOS \/ fertility protocol — 1200–1800mg\/day\u003c\/h3\u003e\n\u003cp\u003eTrial doses for PCOS run 600mg twice or three times daily. Pair with \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e for the standard fertility-clinic antioxidant pair, taken with breakfast (CoQ10 absorbs best with dietary fat). Cycle alongside any clinician-directed reproductive treatment; communicate with your fertility specialist about all supplementation.\u003c\/p\u003e\n\n\u003ch3\u003eRespiratory \/ mucolytic — 600–1800mg\/day\u003c\/h3\u003e\n\u003cp\u003e1 cap morning, 1 cap evening for chronic respiratory support; up to 3\/day during acute illness for short courses. The original effervescent-tablet formulation in Europe runs 600mg dissolved in water; capsules deliver the same dose with the same bioavailability after dissolution.\u003c\/p\u003e\n\n\u003ch3\u003eAthletic \/ pre-exercise considerations\u003c\/h3\u003e\n\u003cp\u003eOne important caveat: \u003cstrong\u003eNAC taken pre-exercise blunts some training adaptations\u003c\/strong\u003e. Petersen 2012 (\u003cem\u003eActa Physiol\u003c\/em\u003e) showed acute NAC infusion attenuated the early adaptive response in human skeletal muscle. The mechanism is the “Ristow window”: exercise-generated ROS are not just damage signals — they are the \u003cem\u003etraining stimulus\u003c\/em\u003e. Mitochondrial biogenesis, capillary density, and antioxidant-enzyme upregulation are downstream of transient post-exercise ROS spikes. Quench the spike with high-dose NAC (or vitamin C, see Ristow 2009 \u003cem\u003ePNAS\u003c\/em\u003e) and you blunt the adaptation.\u003c\/p\u003e\n\u003cp\u003ePractical rule: if you train hard and care about adaptation, \u003cstrong\u003edo not take NAC in the 2–3 hours before or 1–2 hours after training\u003c\/strong\u003e. Take it with breakfast and dinner if morning-training, or with breakfast and afternoon if evening-training. The 24-hour exposure is what matters for glutathione restoration; the temporary post-exercise window matters for adaptation.\u003c\/p\u003e\n\n\u003ch3\u003eWhat NOT to do\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not take NAC with nitroglycerin.\u003c\/strong\u003e NAC potentiates nitroglycerin's vasodilator effect dramatically and can cause severe headache and hypotension.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not take NAC immediately before\/after exercise if you are training for adaptation\u003c\/strong\u003e — see Ristow 2009 and Petersen 2012 above.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not stack high-dose NAC during active chemotherapy without oncologist approval.\u003c\/strong\u003e Some chemotherapy agents work via oxidative mechanisms; antioxidant support during active treatment is a discussion to have with your oncology team.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not exceed 3g\/day chronically without clinical indication.\u003c\/strong\u003e The trial doses are 1.2–2.4g\/day for most uses; the 3.6g\/day GlyNAC dose is weight-adjusted and trial-supervised.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not take NAC if you have a documented sulfur-thiol allergy\u003c\/strong\u003e (rare but real).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily schedule (foundational placement)\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBreakfast:\u003c\/strong\u003e 1 NAC capsule + 1–2 Glycine + your \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e\/\u003ca href=\"https:\/\/truehealthprotocol.health\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e stack + a methyl donor (\u003ca href=\"https:\/\/truehealthprotocol.health\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e) if running NMN.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLunch:\u003c\/strong\u003e optional second NAC capsule with food if running 1800mg\/day.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDinner:\u003c\/strong\u003e 1 NAC capsule + 1–2 Glycine + \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e for sleep.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-bed:\u003c\/strong\u003e nothing extra. NAC has no stimulant or sedative effect of its own; the glycine in the GlyNAC pair has a mild slow-wave-sleep benefit but is not sedating.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSome users prefer all NAC dosing in the AM if evening intake produces vivid dreams (uncommon but reported — the cysteine-glutamate axis can subtly alter dream architecture in sensitive individuals). Move both doses to AM\/lunch if this affects you.\u003c\/p\u003e\n\n\u003ch2\u003eStack pairings — what each pair actually does\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/strong\u003e — the literal GlyNAC pair from Sekhar's lab. The pair the 2021 trial used. The single most evidence-backed antioxidant nutrient combination in modern aging biology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e\u003c\/strong\u003e — precursor + finished product, the “belt and suspenders” combination. Some users prefer the direct GSH for extracellular redox support and use NAC for intracellular synthesis. The two are not redundant; oral GSH is partially deglutathionylated in transit, and the cell still has to remake it from precursors. Most people benefit more from NAC alone; the combination is for users with elevated baseline oxidative stress.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e\u003c\/strong\u003e — the “universal antioxidant” pair. ALA is amphipathic (works in lipid and water phases) and recycles glutathione, vitamin C, and vitamin E. The combination is used in diabetic-neuropathy and fertility protocols.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e\u003c\/strong\u003e — antioxidant + mitochondrial bioenergetics. Standard fertility-clinic prep stack and good general mitochondrial support, especially over 40 when endogenous CoQ10 falls.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e \/ \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e\u003c\/strong\u003e — the “run the engine harder, change the oil more often” logic. NAD+ precursors accelerate mitochondrial activity; NAC provides the antioxidant defense that protects the cellular machinery from the additional metabolic flux. Some experienced longevity stackers consider NAC essentially mandatory if running NMN long-term.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + selenium-rich diet\u003c\/strong\u003e (Brazil nuts, fish, eggs) — selenium is the catalytic core of glutathione peroxidase. Without selenium, glutathione cannot do its peroxide-neutralizing job. We do not currently sell a standalone selenium product because dietary intake is generally adequate; if your diet is low in selenium-rich foods, an inexpensive standalone selenium yeast supplement closes the gap.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults 40+\u003c\/strong\u003e running a serious longevity or healthspan protocol — the population in which intracellular glutathione has measurably declined and the precursor-restoration logic is most validated.\u003c\/li\u003e\n\u003cli\u003eAnyone running \u003cstrong\u003eNMN, NR, or NAD+ precursors\u003c\/strong\u003e — antioxidant defense scales with mitochondrial activity.\u003c\/li\u003e\n\u003cli\u003ePeople with \u003cstrong\u003erespiratory conditions\u003c\/strong\u003e or chronic mucus burden (COPD, chronic bronchitis, post-viral persistent cough) — the original mucolytic indication.\u003c\/li\u003e\n\u003cli\u003eAdults working on \u003cstrong\u003efertility\u003c\/strong\u003e — PCOS, unexplained infertility, IVF prep, male oxidative-stress sperm parameters.\u003c\/li\u003e\n\u003cli\u003ePeople with elevated \u003cstrong\u003eoxidative-stress markers\u003c\/strong\u003e (high F2-isoprostanes, low GSH:GSSG ratio, elevated 8-OHdG) on functional bloodwork.\u003c\/li\u003e\n\u003cli\u003ePeople wanting \u003cstrong\u003eliver-support\u003c\/strong\u003e nutrition during periods of higher xenobiotic exposure (alcohol use, environmental load, certain medication courses).\u003c\/li\u003e\n\u003cli\u003eAdults running mental-health protocols where glutamate modulation is therapeutically relevant (under clinician supervision).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this isn't for\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eChildren — pediatric NAC dosing is medical, not OTC.\u003c\/li\u003e\n\u003cli\u003ePregnant or nursing women without obstetrician approval — safety data exist but supervised use is the right model.\u003c\/li\u003e\n\u003cli\u003ePatients on \u003cstrong\u003enitroglycerin\u003c\/strong\u003e (severe potentiation risk).\u003c\/li\u003e\n\u003cli\u003ePatients in \u003cstrong\u003eactive chemotherapy\u003c\/strong\u003e without oncologist approval.\u003c\/li\u003e\n\u003cli\u003ePeople with documented sulfur-thiol or NAC-specific allergy.\u003c\/li\u003e\n\u003cli\u003eAthletes during pure-adaptation training blocks who want to maximize the Ristow window — time NAC away from training as described above, or pause during a focused adaptation block.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NAC the same as glutathione?\u003c\/h3\u003e\n\u003cp\u003eNo. Glutathione is the finished tripeptide (cysteine-glutamate-glycine) the cell makes; NAC is the cysteine precursor. Oral glutathione is partially deglutathionylated in the gut and absorbed as its component amino acids, then reassembled inside cells. Oral NAC reliably raises intracellular glutathione because it provides the rate-limiting precursor; oral glutathione is more variable. Both are useful; NAC is the more cost-effective, evidence-backed, intracellular-target option.\u003c\/p\u003e\n\n\u003ch3\u003eWhat about GlyNAC — do I need glycine too?\u003c\/h3\u003e\n\u003cp\u003eIf you are running NAC for general antioxidant support, NAC alone works fine. If you are running the Sekhar protocol — the one with the 2021 hallmarks-of-aging effect data — yes, glycine matters. The 30–60% intracellular GSH deficit in older adults is driven by both cysteine \u003cem\u003eand\u003c\/em\u003e glycine running short. The GlyNAC pair is what produced the breadth of measured improvements (gait speed, strength, cognition, body composition, insulin sensitivity, etc.) in the 24-week trial. Our \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e is dosed and labeled to pair 1:1 with NAC.\u003c\/p\u003e\n\n\u003ch3\u003eHow much will my glutathione actually rise?\u003c\/h3\u003e\n\u003cp\u003eThe GlyNAC trials measured ~100% rises in intracellular glutathione (back to young-adult levels) within 14 days. NAC alone produces a smaller rise — published estimates run 30–80% — but still substantial, especially in older adults starting from low baselines. The rise is dose-dependent; 1200mg\/day gives a meaningful effect, 2400mg\/day gives more, with diminishing returns above ~3g\/day.\u003c\/p\u003e\n\n\u003ch3\u003eWhy 600mg per capsule and not 1200mg?\u003c\/h3\u003e\n\u003cp\u003e600mg is the canonical NAC dose used in PANTHEON, BRONCUS, the contrast-nephropathy trials, and the bipolar\/OCD literature — making it the most-validated single-capsule serving in the clinical record. It also gives users dose flexibility (600mg, 1200mg, 1800mg, 2400mg\/day all reachable in 1-cap multiples). 1200mg single capsules are physically too large to swallow for most people; the 600mg HPMC capsule is the standard form factor across the supplement industry.\u003c\/p\u003e\n\n\u003ch3\u003eWill it make my breath \/ sweat smell like sulfur?\u003c\/h3\u003e\n\u003cp\u003eSome people notice a faint sulfur smell on opening the bottle (this is the thiol; expected and harmless). A small fraction of users notice mild sulfurous breath, especially at higher doses (1800mg+). It is reversible — reduce dose and take with food. The bottle smell does not transfer meaningfully to the user.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NAC help with hangovers?\u003c\/h3\u003e\n\u003cp\u003eMechanistically yes — ethanol metabolism (acetaldehyde → acetate via ALDH2) consumes glutathione, and NAC provides the precursor to rebuild it. Empirically the hangover-prevention literature is mostly anecdotal and small-n. Common practice: 600mg NAC pre-drinking + 600mg the next morning. Not a license to drink more — alcohol still causes the rest of its damage independent of glutathione status.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NAC interfere with the benefit of exercise?\u003c\/h3\u003e\n\u003cp\u003eIf taken in the immediate window around training (2 hours before to 1–2 hours after), high-dose NAC and high-dose vitamin C blunt some training adaptations because they quench the post-exercise ROS spike that is itself the adaptation signal (Ristow 2009 \u003cem\u003ePNAS\u003c\/em\u003e; Petersen 2012 \u003cem\u003eActa Physiol\u003c\/em\u003e). Take NAC 4+ hours away from training and this is not an issue. Daily glutathione restoration is still useful for anyone training hard — the training protects mitochondria longer-term, glutathione protects them in the meantime.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NAC with NMN or NAD+ products?\u003c\/h3\u003e\n\u003cp\u003eYes, and we recommend the combination. NMN and NR raise NAD+, which accelerates sirtuin and mitochondrial activity, which generates more reactive oxygen species as a byproduct. NAC restores glutathione, which neutralizes the byproducts. The two stack synergistically; many serious longevity stacks treat the NMN+NAC combination as the foundational pairing along with a methyl donor like \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the difference between NAC and L-cysteine?\u003c\/h3\u003e\n\u003cp\u003eL-cysteine is the bare amino acid — chemically reactive, prone to oxidation, and cytotoxic at high free concentrations (which is why the body keeps the free pool small). NAC has an acetyl group on the amino nitrogen that protects the thiol from oxidation in transit, allows the molecule to survive gut and first-pass conditions, and is cleaved by tissue deacetylases to release usable cysteine intracellularly. NAC is the supplement-form-factor of cysteine that is actually safe and bioavailable to take in gram quantities daily.\u003c\/p\u003e\n\n\u003ch3\u003eWhy don't I see selenium in this capsule?\u003c\/h3\u003e\n\u003cp\u003eWe chose to keep NAC clean (single-active capsule) so users can stack flexibly. Selenium matters for glutathione peroxidase activity (it sits at the catalytic core), but most adults get adequate selenium from diet (Brazil nuts are an exceptional source — one nut covers daily needs). If your diet is low in selenium-rich foods, an inexpensive selenium-yeast standalone supplement closes the gap and stacks fine with NAC. Combined NAC+selenium products exist; we will likely offer one in a future SKU.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eSubjectively, most users notice nothing acutely — NAC's effect is on cellular biochemistry rather than immediate sensation. Users running it for fertility, respiratory, or mood indications typically report effects at 4–12 weeks. Glutathione synthesis itself responds within days (the Sekhar 14-day pilots showed full restoration); functional outcomes follow as the restored redox balance plays out across tissues. If you have functional bloodwork, repeat F2-isoprostanes, GSH:GSSG, or 8-OHdG at 12 weeks to see the effect.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle off NAC?\u003c\/h3\u003e\n\u003cp\u003eNo. NAC has been used continuously in trials for 3+ years (BRONCUS) without dose-related tolerance or rebound effects. Some users prefer to run weekend washouts to confirm continued sensitivity to other parts of their stack — that's a personal preference, not a biochemical requirement. There is no evidence that chronic NAC induces tolerance or homeostatic glutathione downregulation; the cysteine remains the rate-limiting input regardless of how long supplementation has run.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and mix the powder?\u003c\/h3\u003e\n\u003cp\u003eYes, though NAC is bitter and sulfurous. Mix into smoothies, fruit juice, or any strong-flavored beverage. Do not mix into hot tea or coffee (heat accelerates thiol oxidation). For users who want a powder format directly, we plan to release a flavored NAC powder in the future.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NAC raise homocysteine?\u003c\/h3\u003e\n\u003cp\u003eThis is a sometimes-circulated concern based on the methionine–cysteine biochemistry. In published trials, NAC does \u003cem\u003enot\u003c\/em\u003e raise serum homocysteine in healthy adults (Wiklund 1996, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; multiple others). NAC enters the cysteine pool downstream of the trans-sulfuration pathway, so it does not need to be made from methionine and does not push homocysteine flux. Adequate B12, folate, and B6 (or supplementation if low) maintains the methylation cycle that handles any homocysteine generated; pair with \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e if you are running NMN.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NAC during pregnancy?\u003c\/h3\u003e\n\u003cp\u003eNAC has been used in pregnancy in clinical settings (it is the antidote of choice for acetaminophen overdose during pregnancy, and has been studied for pregnancy-related complications of oxidative stress). However, supplementation during pregnancy or nursing should be supervised by your obstetrician. We do not recommend self-prescribed NAC during pregnancy.\u003c\/p\u003e\n\n\u003ch3\u003eWill NAC interfere with my medications?\u003c\/h3\u003e\n\u003cp\u003eThe major drug interaction is \u003cstrong\u003enitroglycerin\u003c\/strong\u003e (severe vasodilator potentiation). Modest interactions to be aware of: anticoagulants (potential mild antiplatelet effect), immunosuppressants (theoretical, not strongly documented), and active-treatment chemotherapy (oxidant-mechanism agents). Always disclose all supplements to your prescribing clinician.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's your third-party testing setup?\u003c\/h3\u003e\n\u003cp\u003eIdentity by HPLC-UV against USP reference standard at 214 nm; assay 99.0–100.5%; dissolution per USP \u0026lt;711\u0026gt;; heavy metals (As, Cd, Pb, Hg) by ICP-MS against USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt; elemental-impurity limits; microbiology (TAMC, TYMC, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eS. aureus\u003c\/em\u003e) per USP \u0026lt;61\u0026gt;\/\u0026lt;62\u0026gt;. Each batch carries a Certificate of Analysis we can share on request — lot number and best-by date are on every bottle. Manufacturer is a U.S.-based GMP-certified, NSF-audited contract facility.\u003c\/p\u003e\n\n\u003ch3\u003eHow does NAC compare to liposomal glutathione?\u003c\/h3\u003e\n\u003cp\u003eLiposomal glutathione raises plasma GSH directly but at substantial cost, with variable absorption depending on liposome quality. NAC raises intracellular GSH via the cell's own synthesis pathway, with decades of trial data behind specific dose-effect relationships. For most users, NAC is the more cost-effective and better-validated choice. The two can be combined for users with severe oxidative-stress phenotypes; routine use does not require both.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eNAC is one of the simplest molecules in the cabinet to source poorly — cheap commodity-grade NAC carries assay variability, residual solvents, and (occasionally) heavy-metal contamination that the consumer never sees. We use pharmaceutical-grade USP\/EP-spec NAC, identity-tested by HPLC-UV against a USP reference standard, with full-panel heavy metals and microbiology per batch. Capsules are vegetarian HPMC, free of titanium dioxide, magnesium stearate, or unnecessary excipients. Manufactured in a U.S. GMP-certified, NSF-audited facility with a GFSI-aligned allergen-control program. Each batch carries a Certificate of Analysis that we will provide on request — CoAs include identity, assay, dissolution, heavy metals, and microbiology results. We publish lot numbers and best-by dates on every bottle. Storage: cool, dry, capped tight; the mild sulfur smell on opening is the thiol — expected. If the smell intensifies dramatically over storage, the product has oxidized and we will replace it under our 30-day guarantee.\u003c\/p\u003e\n\u003cp\u003eFor deeper context on our manufacturing standards, see \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/quality\"\u003eQuality\u003c\/a\u003e and \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eNAC sits at the heart of the antioxidant arm of the catalog, alongside our \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e (the GlyNAC partner), \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e (the finished tripeptide for direct extracellular redox support), \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e (the universal-antioxidant amphipathic recycler), and the broader \u003ca href=\"https:\/\/truehealthprotocol.health\/collections\/antioxidants\"\u003eAntioxidants collection\u003c\/a\u003e. As the rate-limiting precursor to glutathione, it is one of three or four ingredients we consider truly foundational for any healthspan protocol — alongside \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e for the NAD+ axis, \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e for mitochondrial bioenergetics, and \u003ca href=\"https:\/\/truehealthprotocol.health\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e for sleep and methylation cofactor support. See \u003ca href=\"https:\/\/truehealthprotocol.health\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e for the curated short-list, \u003ca href=\"https:\/\/truehealthprotocol.health\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e for the mitochondrial subset, \u003ca href=\"https:\/\/truehealthprotocol.health\/collections\/fertility\"\u003eFertility\u003c\/a\u003e for the reproductive use-case, \u003ca href=\"https:\/\/truehealthprotocol.health\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e for the NAD+ stack, and \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e for full daily templates.\u003c\/p\u003e\n\u003cp\u003eIf you are new to the catalog, \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/getting-started\"\u003eGetting Started\u003c\/a\u003e walks through how to build a stack from foundational pieces; \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e covers the Hallmarks-of-Aging frame; \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/how-it-works\"\u003eHow It Works\u003c\/a\u003e explains the mechanism logic across the catalog; and \u003ca href=\"https:\/\/truehealthprotocol.health\/pages\/faq\"\u003eFAQ\u003c\/a\u003e covers the most common cross-product questions.\u003c\/p\u003e\n\u003cp\u003eShipping and returns: see \u003ca href=\"https:\/\/truehealthprotocol.health\/policies\/shipping-policy\"\u003eShipping Policy\u003c\/a\u003e and \u003ca href=\"https:\/\/truehealthprotocol.health\/policies\/refund-policy\"\u003e30-Day Refund Policy\u003c\/a\u003e. Terms: \u003ca href=\"https:\/\/truehealthprotocol.health\/policies\/terms-of-service\"\u003eTerms of Service\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\u003cp\u003eThese statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Discuss with your physician before starting if you are pregnant or nursing, taking medication (especially nitroglycerin, anticoagulants, or immunosuppressants), or have a chronic medical condition. Discontinue and consult a clinician if you experience unusual GI distress, rash, or shortness of breath.\u003c\/p\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eKumar P, Liu C, Hsu JW, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. \u003cem\u003eClin Transl Med\u003c\/em\u003e. 2021;11(3):e372.\u003c\/li\u003e\n\u003cli\u003eKumar P, Osahon OW, Sekhar RV. GlyNAC (glycine and N-acetylcysteine) supplementation in old mice improves brain glutathione deficiency, oxidative stress, glucose uptake, mitochondrial dysfunction, genomic damage, inflammation and neurotrophic factors. \u003cem\u003eAntioxidants\u003c\/em\u003e. 2023;12(5):1042.\u003c\/li\u003e\n\u003cli\u003eKumar P, Liu C, Hsu JW, et al. GlyNAC supplementation in older HIV-infected adults: improvements in glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, strength, and cognition. \u003cem\u003eJ Gerontol A Biol Sci Med Sci\u003c\/em\u003e. 2022;77(1):75-89.\u003c\/li\u003e\n\u003cli\u003eSekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2011;94(3):847-853.\u003c\/li\u003e\n\u003cli\u003eSekhar RV, McKay SV, Patel SG, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2011;34(1):162-167.\u003c\/li\u003e\n\u003cli\u003eSekhar RV. GlyNAC (glycine and N-acetylcysteine) supplementation improves impaired mitochondrial fuel oxidation and lowers insulin resistance in patients with type 2 diabetes: results of a pilot study. \u003cem\u003eAntioxidants\u003c\/em\u003e. 2021;10(7):1054.\u003c\/li\u003e\n\u003cli\u003eNguyen D, Hsu JW, Jahoor F, Sekhar RV. Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. \u003cem\u003eJ Clin Endocrinol Metab\u003c\/em\u003e. 2014;99(1):169-177.\u003c\/li\u003e\n\u003cli\u003eAtkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine — a safe antidote for cysteine\/glutathione deficiency. \u003cem\u003eCurr Opin Pharmacol\u003c\/em\u003e. 2007;7(4):355-359.\u003c\/li\u003e\n\u003cli\u003eŠalamon Š, Kramar B, Marolt TP, et al. Medical and dietary uses of N-acetylcysteine. \u003cem\u003eAntioxidants\u003c\/em\u003e. 2019;8(5):111.\u003c\/li\u003e\n\u003cli\u003eSmilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). \u003cem\u003eN Engl J Med\u003c\/em\u003e. 1988;319(24):1557-1562.\u003c\/li\u003e\n\u003cli\u003ePrescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. \u003cem\u003eLancet\u003c\/em\u003e. 1977;2(8035):432-434.\u003c\/li\u003e\n\u003cli\u003eTepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. \u003cem\u003eN Engl J Med\u003c\/em\u003e. 2000;343(3):180-184.\u003c\/li\u003e\n\u003cli\u003eDecramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. \u003cem\u003eLancet\u003c\/em\u003e. 2005;365(9470):1552-1560.\u003c\/li\u003e\n\u003cli\u003eZheng JP, Wen FQ, Bai CX, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. \u003cem\u003eLancet Respir Med\u003c\/em\u003e. 2014;2(3):187-194.\u003c\/li\u003e\n\u003cli\u003eBerk M, Copolov DL, Dean O, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder — a double-blind randomized placebo-controlled trial. \u003cem\u003eBiol Psychiatry\u003c\/em\u003e. 2008;64(6):468-475.\u003c\/li\u003e\n\u003cli\u003eGrant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. \u003cem\u003eArch Gen Psychiatry\u003c\/em\u003e. 2009;66(7):756-763.\u003c\/li\u003e\n\u003cli\u003eThakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. \u003cem\u003eObstet Gynecol Int\u003c\/em\u003e. 2015;2015:817849.\u003c\/li\u003e\n\u003cli\u003eSafarinejad MR, Safarinejad S. Efficacy of selenium and\/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. \u003cem\u003eJ Urol\u003c\/em\u003e. 2009;181(2):741-751.\u003c\/li\u003e\n\u003cli\u003eKhoshbaten M, Aliasgarzadeh A, Masnadi K, et al. N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease. \u003cem\u003eHepat Mon\u003c\/em\u003e. 2010;10(1):12-16.\u003c\/li\u003e\n\u003cli\u003ePetersen AC, McKenna MJ, Medved I, et al. Infusion with the antioxidant N-acetylcysteine attenuates early adaptive responses to exercise in human skeletal muscle. \u003cem\u003eActa Physiol\u003c\/em\u003e. 2012;204(3):382-392.\u003c\/li\u003e\n\u003cli\u003eRistow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. \u003cem\u003eProc Natl Acad Sci USA\u003c\/em\u003e. 2009;106(21):8665-8670.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194-1217.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243-278.\u003c\/li\u003e\n\u003cli\u003eWiklund O, Fager G, Andersson A, Lundstam U, Masson P, Hultberg B. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. \u003cem\u003eAtherosclerosis\u003c\/em\u003e. 1996;119(1):99-106.\u003c\/li\u003e\n\u003cli\u003eDekhuijzen PNR. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. \u003cem\u003eEur Respir J\u003c\/em\u003e. 2004;23(4):629-636.\u003c\/li\u003e\n\u003cli\u003eSadowska AM, Manuel-y-Keenoy B, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. \u003cem\u003ePulm Pharmacol Ther\u003c\/em\u003e. 2007;20(1):9-22.\u003c\/li\u003e\n\u003c\/ul\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47840335069402,"sku":"THP-NAC-600-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_nac.png?v=1778092703"},{"product_id":"pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin","title":"Pterostilbene 100mg | Trans-Pterostilbene | Bioavailable SIRT1 Activator \u0026 Resveratrol Cousin","description":"\u003cp\u003e\u003cstrong\u003eThe 30-second answer:\u003c\/strong\u003e Pterostilbene is the methylated, blueberry-derived cousin of trans-resveratrol — same SIRT1 \/ SIRT3 sirtuin engagement, same Nrf2 antioxidant transcription program, same AMPK metabolic switch, but with roughly \u003cstrong\u003e~80% oral bioavailability versus ~20% for resveratrol\u003c\/strong\u003e, a plasma half-life that’s several-fold longer, and far better blood-brain-barrier penetration (Kapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e; Lin 2009 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e; Riche 2014 \u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e). Across the López-Otín \u0026amp; Kroemer 2013\/2023 \u003cem\u003eCell\u003c\/em\u003e Hallmarks-of-Aging framework, pterostilbene engages \u003cstrong\u003eat least five hallmarks\u003c\/strong\u003e: mitochondrial dysfunction (SIRT3, PGC-1α), deregulated nutrient sensing (AMPK, SIRT1), altered intercellular communication (NF-κB suppression, inflammaging), genomic instability (SIRT1-mediated DNA-repair), and disabled macroautophagy (AMPK→ULK1). For anyone running an NMN or NR stack, pterostilbene is the partner that converts a higher NAD+ pool into actual sirtuin work — without the dose-dependent absorption ceiling and rapid first-pass conjugation that hold resveratrol back. Each True Health Protocol vegan capsule delivers \u003cstrong\u003e100mg of trans-pterostilbene\u003c\/strong\u003e, the bioidentical isomer used in published human trials (Riche 2014 cardiometabolic; Riche 2013 safety; McCormack 2013 \u003cem\u003eAdv Nutr\u003c\/em\u003e review). Third-party tested for purity, no titanium dioxide, no magnesium stearate, no proprietary blends, no cis-isomer drift.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy it’s in the True Health Protocol catalog:\u003c\/strong\u003e A meaningful longevity protocol needs both a \u003cem\u003esubstrate\u003c\/em\u003e (NMN\/NR → NAD+) and an \u003cem\u003eactivator\u003c\/em\u003e for the enzymes that consume it (sirtuins). Resveratrol was the original activator; pterostilbene is the version of resveratrol that survives the gut wall and liver intact. We sell \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003etrans-resveratrol 600mg\u003c\/a\u003e for the broad polyphenolic baseline (and the deepest published trial library), and pterostilbene 100mg as the bioavailable, BBB-crossing finisher. Most serious longevity stackers run both.\u003c\/p\u003e\n\n\u003ch3\u003eThe bioavailability problem — why most resveratrol underdelivers\u003c\/h3\u003e\n\u003cp\u003eTrans-resveratrol is the most-studied stilbenoid in longevity literature, but it has a structural problem: three free hydroxyl (–OH) groups make it a prime substrate for phase-II conjugation enzymes — UDP-glucuronosyltransferases (UGT1A1, UGT1A9, UGT1A10) and sulfotransferases (SULT1A1, SULT1E1) — the moment it hits the gut wall and the portal liver. Walle 2004 \u003cem\u003eDrug Metab Dispos\u003c\/em\u003e traced 25mg of oral resveratrol in six healthy volunteers and found \u003cstrong\u003e\u0026lt;5–10% reaching systemic circulation as the unconjugated parent compound\u003c\/strong\u003e; the rest appeared as resveratrol-3-O-glucuronide, resveratrol-4′-O-glucuronide, and resveratrol-3-sulfate — metabolites that are dramatically less potent on sirtuin and Nrf2 targets. Sub-tissue free-resveratrol concentrations stay low. Plasma half-life of the free aglycone is roughly \u003cstrong\u003e14 minutes\u003c\/strong\u003e; the famous “red wine resveratrol” headlines were always running into the same wall — the molecule simply does not survive intact at the dose people are willing to take. Boocock 2007 \u003cem\u003eCancer Epidemiol Biomarkers Prev\u003c\/em\u003e dose-escalated resveratrol to 5g in humans and confirmed Walle’s finding: even at gram-level doses, free trans-resveratrol C\u003csub\u003emax\u003c\/sub\u003e was modest and conjugates dominated the AUC.\u003c\/p\u003e\n\n\u003cp\u003ePterostilbene is what nature does about it. By replacing two of those free hydroxyls with methoxy (–OCH\u003csub\u003e3\u003c\/sub\u003e) groups — the 3- and 5-positions of the stilbene A-ring — it dodges phase-II conjugation, becomes substantially more lipid-soluble (logP rises from ~3.1 to ~4.0), and crosses cellular membranes far more readily. Methoxy groups cannot be glucuronidated or sulfated; they are biochemically “capped.” Only the single remaining hydroxyl on the B-ring (the 4′-OH) is available for phase-II metabolism, and even that is partially shielded by the methoxy-induced electronic effects on the molecule. The result is a stilbenoid that absorbs through the lymphatic \/ chylomicron pathway when taken with dietary fat, distributes broadly into adipose and brain tissue, and stays around long enough to engage cellular targets at clinically meaningful concentrations.\u003c\/p\u003e\n\n\u003cp\u003eKapetanovic 2011 \u003cem\u003eCancer Chemother Pharmacol\u003c\/em\u003e, comparing the two compounds head-to-head in Sprague-Dawley rats, reported pterostilbene oral bioavailability at \u003cstrong\u003e~80%\u003c\/strong\u003e versus ~20% for resveratrol, with a plasma half-life roughly \u003cstrong\u003e5–7× longer\u003c\/strong\u003e for pterostilbene (~105 minutes free vs ~14 minutes for resveratrol’s free aglycone). Lin 2009 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e reached the same conclusion in an independent rat PK model. Remsberg 2008 \u003cem\u003ePhytother Res\u003c\/em\u003e measured tissue distribution and found pterostilbene reached substantially higher concentrations in liver, kidney, lung, and brain than equivalent doses of resveratrol — the methoxy groups translate to better tissue penetration, not just better plasma exposure. The practical translation: the same milligram dose of pterostilbene puts more drug, in active form, in front of cellular targets — and keeps it there long enough to actually do work.\u003c\/p\u003e\n\n\u003ch3\u003eThe methoxy chemistry — why two carbons change everything\u003c\/h3\u003e\n\u003cp\u003eTrans-resveratrol is \u003cstrong\u003e3,5,4′-trihydroxy-trans-stilbene\u003c\/strong\u003e: a 14-carbon molecule with two phenyl rings linked by a trans-vinyl bridge, decorated with three hydroxyl groups. Trans-pterostilbene is \u003cstrong\u003e3,5-dimethoxy-4′-hydroxy-trans-stilbene\u003c\/strong\u003e: the same skeleton, but the 3- and 5-hydroxyls of the A-ring are O-methylated to methoxy ethers. Two carbon atoms and six hydrogens differ. Those two methyl groups are doing a lot of work:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhase-II evasion.\u003c\/strong\u003e Glucuronosyltransferases require a free hydroxyl to attach a glucuronic-acid sugar; sulfotransferases require a free hydroxyl to transfer a sulfate group. A methoxy ether has no free OH — it cannot be conjugated. Capping two of the three hydroxyls cuts the available phase-II surface area by two-thirds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLipophilicity.\u003c\/strong\u003e Hydroxyls are polar, hydrogen-bond donors and acceptors that pull a molecule into water. Methoxy groups are weaker hydrogen-bond acceptors and not donors, leaving the molecule more comfortable in lipid environments. The logP shift from 3.1 to 4.0 looks small, but logP is a logarithmic scale — pterostilbene is roughly \u003cstrong\u003e8× more lipid-soluble\u003c\/strong\u003e than resveratrol. That governs membrane permeability, blood-brain-barrier crossing, adipose distribution, and the fat-meal-dependence of oral absorption.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic stability.\u003c\/strong\u003e The most rapid resveratrol metabolite, resveratrol-3-O-sulfate, forms within minutes in human enterocytes. Pterostilbene’s 3-position is methylated; that pathway is closed. The single remaining hydroxyl (4′-OH) can still be glucuronidated to pterostilbene-4′-O-glucuronide, but the rate is much slower and the parent compound dominates plasma exposure for hours rather than minutes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReceptor and enzyme binding.\u003c\/strong\u003e Sirtuin-activator binding studies (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, follow-up structural work) suggest the stilbene scaffold — not the specific hydroxyl pattern — is what fits the SIRT1 allosteric pocket. Pterostilbene retains the activator function while gaining the pharmacokinetic profile.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduced phytoestrogenicity.\u003c\/strong\u003e Resveratrol’s 4′-hydroxyl plus its 3,5-resorcinol pattern give it weak estrogen-receptor (ERα \/ ERβ) ligand activity, especially at higher doses. Pterostilbene, with its methylated 3,5-positions, has substantially lower estrogenic activity in receptor-binding assays. For users worried about hormone-sensitive contexts, the methylation is a feature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis is the chemistry behind every clinical headline. When you read “~80% oral bioavailability” or “crosses the blood-brain barrier substantially better than resveratrol,” the underlying explanation is two methyl groups on the A-ring — nothing more dramatic, nothing less rigorous.\u003c\/p\u003e\n\n\u003ch3\u003eWhat pterostilbene does in the cell — the mechanism in plain English\u003c\/h3\u003e\n\u003cp\u003eThree signaling pathways converge on stilbenoid biology, and pterostilbene engages all three at concentrations achievable from oral dosing:\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1 \/ SIRT3 sirtuin activation.\u003c\/strong\u003e Sirtuins are NAD+-dependent deacylases — enzymes that strip acetyl, succinyl, and malonyl groups off histones (epigenetic regulation), transcription factors (FOXO3, p53, NF-κB p65), and metabolic regulators (PGC-1α, SOD2, IDH2), generally in the direction of better mitochondrial function, longer cellular lifespan, and tighter DNA-repair signaling. SIRT1 lives in the nucleus and acts on FOXO\/p53\/PGC-1α; SIRT3 lives in mitochondria and tunes the acetylation state of the entire mitochondrial proteome (Lombard 2007 \u003cem\u003eMol Cell\u003c\/em\u003e; Hebert 2013 \u003cem\u003eMol Cell\u003c\/em\u003e). Sinclair’s lab and others (Howitz 2003; Borra 2005 \u003cem\u003eJ Biol Chem\u003c\/em\u003e; Hubbard 2013 \u003cem\u003eScience\u003c\/em\u003e) showed that polyphenolic stilbenoids allosterically modulate SIRT1 activity, lowering its K\u003csub\u003em\u003c\/sub\u003e for NAD+ — meaning sirtuin activity rises at the same NAD+ concentration. Pterostilbene shows comparable or stronger in-vitro SIRT1 modulation than resveratrol (McCormack 2013; Pari 2015 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e), and reaches sirtuin-relevant tissue concentrations more readily because of the bioavailability profile.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eNrf2 \/ KEAP1 antioxidant response element.\u003c\/strong\u003e Nrf2 (nuclear factor erythroid 2–related factor 2) is a transcription factor held in the cytoplasm by KEAP1 (Kelch-like ECH-associated protein 1). Under oxidative stress — or under the influence of electrophilic stilbenoids — reactive cysteines on KEAP1 (Cys151, Cys273, Cys288) are modified, releasing Nrf2 to translocate to the nucleus, dimerize with small Maf proteins, and bind the antioxidant response element (ARE) in promoters of ~200–250 cytoprotective genes: glutamate-cysteine ligase (GCL, the rate-limiting enzyme of glutathione synthesis), NQO1, heme oxygenase-1 (HMOX1), thioredoxin reductase (TXNRD1), glutathione peroxidase 2 (GPX2), and the entire phase-II metabolism cassette. Pterostilbene is a potent Nrf2 activator (Bhakkiyalakshmi 2014 \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e; Pari 2015), which is the molecular reason it shows up across so many oxidative-stress disease models. This is not the same as “adding antioxidants to your blood” — it’s the cell upregulating its own endogenous defense system.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eAMPK and metabolic flexibility.\u003c\/strong\u003e AMP-activated protein kinase is the cellular energy sensor that flips on when the AMP:ATP ratio rises — promoting glucose uptake (GLUT4 translocation), fatty-acid oxidation (CPT1 derepression via ACC phosphorylation), autophagy (ULK1 phosphorylation), and mitochondrial biogenesis (PGC-1α activation, downstream of SIRT1 deacetylation). Pterostilbene activates AMPK at concentrations achievable from oral dosing (Pan 2008 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e; Pari 2015), which is the mechanistic basis for the lipid- and glucose-related signals in the Riche 2014 trial.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eNF-κB suppression (the “inflammaging” lever).\u003c\/strong\u003e NF-κB is the transcription factor most central to chronic, low-grade, age-associated inflammation — the “inflammaging” coined by Franceschi (2000 \u003cem\u003eAnn N Y Acad Sci\u003c\/em\u003e; Franceschi 2018 \u003cem\u003eNat Rev Endocrinol\u003c\/em\u003e). Pterostilbene suppresses NF-κB activation by multiple mechanisms: SIRT1-mediated deacetylation of the p65 subunit (lysine 310), IκBα stabilization, and direct inhibition of upstream IKK signaling (Pan 2008; Cheng 2014 \u003cem\u003eJ Cell Biochem\u003c\/em\u003e). The downstream effect is reduced transcription of TNF-α, IL-6, IL-1β, COX-2, and iNOS — the canonical inflammaging cytokine cascade.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eFour pathways, one compound. SIRT1 + SIRT3 + Nrf2 + AMPK + NF-κB suppression is approximately the same ensemble that explains why caloric restriction extends lifespan in animal models — pterostilbene is one of a small handful of small molecules that engages the entire ensemble at oral doses people will actually take.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene and the Hallmarks of Aging\u003c\/h3\u003e\n\u003cp\u003eThe Hallmarks-of-Aging framework (López-Otín, Blasco, Partridge, Serrano, Kroemer 2013 \u003cem\u003eCell\u003c\/em\u003e; updated 2023 \u003cem\u003eCell\u003c\/em\u003e) is the dominant organizing model in modern longevity science — twelve discrete, interacting biological processes whose dysregulation drives the aging phenotype. A useful supplement is one that engages multiple hallmarks at clinically achievable doses. Pterostilbene engages five, and arguably touches a sixth:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction\u003c\/strong\u003e — SIRT3 deacetylates the mitochondrial proteome; SIRT1 deacetylates PGC-1α (the master regulator of mitochondrial biogenesis); AMPK independently activates PGC-1α transcription. Pterostilbene engages all three nodes. Animal-model data (Pan 2008; Liu 2012 \u003cem\u003eNutr Res\u003c\/em\u003e) show increased mitochondrial DNA copy number and respiratory-chain protein expression after pterostilbene exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDeregulated nutrient sensing\u003c\/strong\u003e — SIRT1 and AMPK are two of the four canonical nutrient-sensing arms (with mTOR and IGF-1 as the “pro-growth” arms). Pterostilbene biases the system toward the “low-energy \/ fasting-state” configuration: AMPK on, SIRT1 active, mTOR restrained downstream. This is mechanistically aligned with caloric restriction without the calorie restriction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAltered intercellular communication \/ inflammaging\u003c\/strong\u003e — NF-κB suppression and reduced inflammatory cytokine output (TNF-α, IL-6, IL-1β) directly target the inflammaging hallmark. Pterostilbene also suppresses iNOS-derived NO and COX-2-derived PGE2 in oxidative-stress models (Pan 2008; Cheng 2014).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGenomic instability\u003c\/strong\u003e — SIRT1 deacetylates and activates DNA-repair proteins (Ku70, NBS1, p53), promotes nucleotide excision repair, and stabilizes telomeric heterochromatin. Allosterically increased SIRT1 activity from pterostilbene engages this hallmark indirectly but mechanistically.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisabled macroautophagy\u003c\/strong\u003e — AMPK directly phosphorylates ULK1 at Ser317\/Ser777 to initiate autophagy; SIRT1 deacetylates ATG5, ATG7, and LC3 to permit autophagosome maturation (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e). Pterostilbene’s engagement of both AMPK and SIRT1 makes it an indirect autophagy promoter, particularly when stacked with \u003ca href=\"\/products\/spermidine-10mg-wheat-germ-extract\"\u003espermidine\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCellular senescence (touched, not directly engaged)\u003c\/strong\u003e — pterostilbene is not a senolytic in the formal sense (it does not preferentially kill senescent cells the way \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e or \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e do), but it modulates the senescence-associated secretory phenotype (SASP) downstream of NF-κB suppression, reducing the inflammatory output of the senescent cells you still carry.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis multi-hallmark engagement at oral doses is why pterostilbene appears in nearly every serious longevity protocol — not as a magic bullet, but as one of the small set of molecules that touches multiple aging mechanisms simultaneously rather than just one. For the deeper Hallmarks framework underneath the entire True Health Protocol catalog, see \u003ca href=\"\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eThe blood-brain barrier and neurocognitive effects\u003c\/h3\u003e\n\u003cp\u003eOne of the structural advantages of the methoxy-stilbenoid scaffold is membrane permeability across the blood-brain barrier (BBB). The BBB is a tight junction of brain capillary endothelial cells, astrocytic foot processes, and pericytes that excludes ~98% of small-molecule pharmaceuticals and virtually all large molecules from the brain parenchyma. The molecules that \u003cem\u003edo\u003c\/em\u003e cross are typically lipophilic (logP between 1.5 and 4.5), small (\u0026lt;500 Da), and free of strong polar features. Pterostilbene fits the entire profile: 256 Da, logP ~4.0, two methoxy groups dampening the polar surface area.\u003c\/p\u003e\n\n\u003cp\u003eJoseph 2008 \u003cem\u003eJ Agric Food Chem\u003c\/em\u003e and follow-up work in the Joseph laboratory at Tufts examined stilbenoid effects on cognitive performance in aged rat models. Pterostilbene at 0.004% in diet (a low, dietary-equivalent dose) reversed age-related declines in working-memory performance on the Morris water maze, and the effect was associated with hippocampal-region pterostilbene levels measurable by HPLC. Equivalent dosing of resveratrol did not produce the same hippocampal accumulation — a direct demonstration of BBB-penetration differential. McCormack 2013 \u003cem\u003eAdv Nutr\u003c\/em\u003e reviews the broader neurocognitive animal literature: pterostilbene reduces age-related neuroinflammation, attenuates Aβ-induced neurotoxicity in cell culture, and improves spatial-memory performance in aged or oxidative-stress-challenged rodent models. Hou 2014 \u003cem\u003eNutr Res\u003c\/em\u003e reported pterostilbene-driven improvements in cognitive endpoints in transgenic AD-model mice.\u003c\/p\u003e\n\n\u003cp\u003eHuman cognitive trial data on pterostilbene specifically is limited — the cleanest data we have is animal — but the BBB-penetration argument is structural and the resveratrol human cognitive literature (Witte 2014 \u003cem\u003eJ Neurosci\u003c\/em\u003e; Kennedy 2010 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) suggests stilbenoids do reach the brain in measurable amounts and shift cerebral blood flow \/ cognitive endpoints; pterostilbene’s pharmacokinetic profile gives every reason to expect at least equivalent or superior CNS exposure at lower doses. For users running a cognitive-longevity protocol — especially those stacking with \u003ca href=\"\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003ecreatine\u003c\/a\u003e, \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3 EPA\/DHA\u003c\/a\u003e, and the \u003ca href=\"\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e collection more broadly — pterostilbene is the stilbenoid that actually reaches the tissue you’re trying to support.\u003c\/p\u003e\n\n\u003ch3\u003eThe Sinclair-style stack architecture — where pterostilbene slots in\u003c\/h3\u003e\n\u003cp\u003eThe framework popularized by David Sinclair’s lab is straightforward: \u003cem\u003eraise the substrate (NAD+) and activate the enzymes that use it (sirtuins).\u003c\/em\u003e NMN and NR raise NAD+. Resveratrol, pterostilbene, or both activate sirtuins. Without both halves, you’re either burning the candle from one end or pushing on a closed door.\u003c\/p\u003e\n\n\u003cp\u003ePterostilbene is the activator side of this equation, and because of its bioavailability profile it’s often used \u003cem\u003einstead of\u003c\/em\u003e or \u003cem\u003ealongside\u003c\/em\u003e resveratrol. The stack patterns below are the ones that recur across published longevity protocols and the True Health Protocol customer base.\u003c\/p\u003e\n\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:0.95em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f0e8;text-align:left;\"\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eStack goal\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eBuild\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eWhy this combination\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFoundational NAD+ \/ sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e or \u003ca href=\"\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e + Pterostilbene 100mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSubstrate (NMN → NAD+) + sirtuin activator. The minimum viable Sinclair stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBelt-and-suspenders sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + Pterostilbene 100mg + NMN\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTwo stilbenoids covering different absorption windows; many users layer both for redundancy.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNAD+ pool defense\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e + NMN\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eApigenin slows NAD+ destruction by inhibiting CD38; pterostilbene activates the sirtuins that consume NAD+ productively.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMethylation-aware NAD+\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + NMN + \u003ca href=\"\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e + \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNAD+ turnover consumes methyl groups via NNMT; TMG replaces them; magnesium is the methylation-cycle cofactor most often deficient.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSenolytic + sirtuin\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e\n\u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e + \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e (pulsed) + Pterostilbene (daily)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eClear out senescent cells with monthly pulses; keep the surviving cells running on better sirtuin signaling daily.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMitochondrial complete\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e + \u003ca href=\"\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSIRT1 \/ SIRT3 + electron transport + mitophagy + mitochondrial biogenesis — the four-corner mitochondrial stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAnti-inflammatory longevity\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e + \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eThree-front NF-κB \/ inflammaging suppression; covers polyphenol, curcuminoid, and EPA\/DHA pathways.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eGlutathione defense complete\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene drives Nrf2 transcription of GCL (the rate-limiting GSH enzyme); NAC + glycine supply substrate. Output: more glutathione synthesis at higher capacity.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCardiometabolic full\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e + \u003ca href=\"\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e + Omega-3\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAMPK from two angles (pterostilbene + berberine), endothelial-supportive taurine, EPA\/DHA. The cardiometabolic-longevity quartet.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCognitive longevity\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + Omega-3 EPA\/DHA + \u003ca href=\"\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1g\u003c\/a\u003e + \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBBB-crossing stilbenoid + structural lipids + cellular ATP buffer + foundational vitamin D — the cognitive-longevity baseline.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eEpigenetic clock\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePterostilbene + NMN + \u003ca href=\"\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000mg\u003c\/a\u003e + Resveratrol\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSirtuin activation + NAD+ substrate + α-KG-driven TET-enzyme support — the epigenetic-reprogramming lever set.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor the goal-organized version of these stacks — with daily schedules and progression notes — see \u003ca href=\"\/pages\/protocols\"\u003eProtocols — Supplement Stacks by Goal\u003c\/a\u003e. For the full \u003ca href=\"\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e, \u003ca href=\"\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e, \u003ca href=\"\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e, and \u003ca href=\"\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e collections, browse the catalog by mechanism.\u003c\/p\u003e\n\n\u003ch3\u003ePterostilbene vs. resveratrol — the side-by-side\u003c\/h3\u003e\n\u003cp\u003eThis is the question every new longevity stacker asks. The honest, research-grounded answer:\u003c\/p\u003e\n\u003ctable style=\"width:100%;border-collapse:collapse;font-size:0.95em;\"\u003e\n\u003cthead\u003e\n\u003ctr style=\"background:#f5f0e8;text-align:left;\"\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eProperty\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eTrans-resveratrol\u003c\/th\u003e\n\u003cth style=\"padding:8px;border:1px solid #ddd;\"\u003eTrans-pterostilbene\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eIUPAC structure\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3,5,4′-trihydroxy-trans-stilbene\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3,5-dimethoxy-4′-hydroxy-trans-stilbene\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMolecular weight\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e228.25 Da\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e256.30 Da\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFree hydroxyls\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e3\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eOral bioavailability (rat models)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~20% (Kapetanovic 2011)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~80% (Kapetanovic 2011)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePlasma half-life (free aglycone)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~14 minutes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~105 minutes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003ePhase-II conjugation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eHeavy (glucuronidation + sulfation, both rings)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMarkedly reduced (single 4′-OH only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLipid solubility (logP)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~3.1\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e~4.0 (~8× more lipophilic)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBlood-brain barrier penetration\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLimited (Joseph 2008 hippocampal HPLC)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSubstantially better (Remsberg 2008 tissue distribution)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTissue distribution preference\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLiver, kidney\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBroad: liver, kidney, lung, brain, adipose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eEstrogenic activity (ERα\/ERβ)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eMild phytoestrogen at higher doses\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNegligible — methoxy groups quench it\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eSIRT1 allosteric activation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Howitz 2003 founding)\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes — comparable or stronger in vitro\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eNrf2 \/ KEAP1 engagement\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Bhakkiyalakshmi 2014, KEAP1 PPI work)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eAMPK activation\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eYes (Pan 2008; Pari 2015)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eTypical effective oral dose\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e500–1000mg\/day to compensate for low absorption\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003e100–200mg\/day in the trial-tested range\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eCost-per-effective-mg\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eLower per-mg, but more mg required\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eHigher per-mg, but far fewer mg required\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBest as\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eFoundational, well-studied baseline; pairs with food fats\u003c\/td\u003e\n\u003ctd style=\"padding:8px;border:1px solid #ddd;\"\u003eBioavailable upgrade; pairs with NMN\/NR for direct sirtuin work\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eMost longevity-protocol users do not actually choose one. They use both: \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol at 500–600mg\u003c\/a\u003e for the broad polyphenolic baseline (and the literature depth — resveratrol has hundreds of human trials), and pterostilbene at 100–200mg as the bioavailable, BBB-crossing finisher. We sell both for that reason. Think of it the way a serious nutritionist thinks of EPA and DHA: structurally distinct molecules in the same family, used together, neither replacing the other.\u003c\/p\u003e\n\n\u003ch3\u003eWhat the human research actually shows\u003c\/h3\u003e\n\u003cp\u003ePterostilbene’s clinical literature is smaller than resveratrol’s but considerably cleaner — partly because the bioavailability is unambiguous, partly because the trials that have been done used coherent doses.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRiche 2014 (\u003cem\u003eFunct Foods Health Dis\u003c\/em\u003e):\u003c\/strong\u003e 80 adults with cholesterol abnormalities, 8 weeks, randomized to 50mg or 125mg pterostilbene daily, with or without grape extract. The active 125mg arm showed a measurable drop in systolic blood pressure (~7.8 mmHg vs placebo) and diastolic blood pressure (~7.3 mmHg), alongside changes in LDL particles. This is the most-referenced human cardiometabolic dataset.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRiche 2013 (\u003cem\u003eNutr Res\u003c\/em\u003e; \u003cem\u003eJ Toxicol\u003c\/em\u003e):\u003c\/strong\u003e Earlier publications from the same group reporting (a) safety across the dose range, with no clinically significant adverse signals at 50–250mg\/day, and (b) a dose-related rise in LDL cholesterol with pterostilbene \u003cem\u003emonotherapy\u003c\/em\u003e at higher doses — context-dependent, mostly seen in subjects not also taking the grape extract co-treatment, and frequently cited as a reason to use pterostilbene \u003cem\u003ewithin\u003c\/em\u003e a polyphenol stack rather than as a high-dose monotherapy. Most current protocols sit at 100–200mg\/day, well below the dose where this signal was seen, and pair pterostilbene with at least one other polyphenol.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRuiz 2009 (\u003cem\u003eJ Agric Food Chem\u003c\/em\u003e):\u003c\/strong\u003e Single-dose human PK study confirming pterostilbene plasma profile and the substantially longer C\u003csub\u003emax\u003c\/sub\u003e dwell time vs resveratrol — the human-side validation of the rat-model bioavailability findings.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eMcCormack 2013 (\u003cem\u003eAdv Nutr\u003c\/em\u003e) review:\u003c\/strong\u003e A comprehensive narrative review covering the cardiovascular, neurocognitive, metabolic, and oxidative-stress signals across animal and human work. The single best single reference for the breadth of mechanism.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eBhakkiyalakshmi 2014 (\u003cem\u003eFree Radic Biol Med\u003c\/em\u003e):\u003c\/strong\u003e Mechanistic Nrf2-pathway work showing pterostilbene engages the same antioxidant transcription program that protects pancreatic β-cells from oxidative-stress damage in metabolic disease models. The KEAP1 protein-protein interaction site is mapped.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePari \u0026amp; Satheesh 2015 (\u003cem\u003eEur J Pharmacol\u003c\/em\u003e):\u003c\/strong\u003e Detailed mechanism review of pterostilbene’s AMPK \/ Nrf2 \/ NF-κB engagement, particularly relevant to glucose-handling and oxidative-stress endpoints. Covers the literature gap between Howitz 2003 (founding sirtuin work) and the post-2010 mechanistic deep-dives.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePan 2008 (\u003cem\u003eEur J Pharmacol\u003c\/em\u003e):\u003c\/strong\u003e The early, definitive AMPK-activation paper for pterostilbene. Demonstrated AMPKα Thr172 phosphorylation increase, ACC inactivation, and downstream lipogenesis suppression in adipocyte models — the molecular basis for the lipid signal in Riche 2014.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eJoseph 2008 (\u003cem\u003eJ Agric Food Chem\u003c\/em\u003e):\u003c\/strong\u003e Aged-rat cognitive-performance study with hippocampal HPLC verification of pterostilbene tissue accumulation. The original BBB-penetration\/cognition paper.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eRemsberg 2008 (\u003cem\u003ePhytother Res\u003c\/em\u003e):\u003c\/strong\u003e Tissue-distribution PK in rats showing broad pterostilbene penetration into liver, kidney, lung, brain, and adipose — quantitative validation of the lipophilicity advantage.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCheng 2014 (\u003cem\u003eJ Cell Biochem\u003c\/em\u003e):\u003c\/strong\u003e NF-κB suppression mechanism — SIRT1-dependent p65 deacetylation and IKK pathway inhibition. The mechanistic basis for the inflammaging-suppression claim.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHou 2014 (\u003cem\u003eNutr Res\u003c\/em\u003e):\u003c\/strong\u003e Cognitive-endpoint improvements in transgenic AD-model mice with pterostilbene supplementation; reduces neuroinflammation and supports synaptic-density biomarkers.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHagiwara 2014 (\u003cem\u003eMol Carcinog\u003c\/em\u003e):\u003c\/strong\u003e Mechanistic work on pterostilbene’s effects on epigenetic regulators (SIRT1, miRNA modulation) relevant to cellular-aging endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe honest summary: human trials are not yet at the resveratrol scale, but the mechanistic and animal literature is dense, the pharmacokinetics are unambiguously superior, and the human cardiometabolic signal exists at doses that are matched by this product (100–200mg\/day). Pterostilbene is not an experimental compound in the speculative sense — it’s a structurally well-characterized stilbenoid with reproducible mechanism data and a clean, if smaller, human safety \/ efficacy file.\u003c\/p\u003e\n\n\u003ch3\u003eThe cardiometabolic biology in depth\u003c\/h3\u003e\n\u003cp\u003eThe Riche 2014 trial — the largest human pterostilbene RCT — reported blood-pressure-lowering at 125mg\/day. The mechanism is multi-layered:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEndothelial nitric oxide.\u003c\/strong\u003e Pterostilbene increases endothelial nitric oxide synthase (eNOS) expression and activity in vascular endothelial cells (Park 2010 \u003cem\u003eEur J Pharmacol\u003c\/em\u003e). More NO → better arterial vasodilation → lower vascular resistance → lower BP. This is the same final common pathway used by ACE inhibitors and L-arginine supplementation, reached through transcriptional rather than direct enzymatic mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSIRT1-mediated p53 \/ FOXO control of vascular smooth muscle.\u003c\/strong\u003e Sirtuin activation modulates vascular smooth-muscle cell apoptosis and proliferation, supporting more compliant arterial wall biology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNF-κB suppression in endothelium.\u003c\/strong\u003e Vascular inflammation drives the endothelial dysfunction underlying most age-related cardiovascular pathology. Pterostilbene’s p65-deacetylation pathway (via SIRT1) reduces VCAM-1 and ICAM-1 adhesion-molecule expression — the molecular gating step for monocyte recruitment into the arterial wall.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAMPK-driven lipid handling.\u003c\/strong\u003e AMPK activation suppresses ACC (acetyl-CoA carboxylase), which lowers malonyl-CoA, which derepresses CPT1 and increases fatty-acid β-oxidation. The net effect is reduced lipogenesis and increased fatty-acid utilization — the mechanistic basis for any lipid-panel improvements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose handling.\u003c\/strong\u003e Pterostilbene improves insulin sensitivity in animal models of insulin resistance via AMPK-dependent GLUT4 translocation and Nrf2-dependent β-cell oxidative-stress protection (Bhakkiyalakshmi 2014). Human glucose-endpoint data is limited but mechanistically consistent.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eFor users with cardiometabolic targets, pterostilbene stacks naturally with \u003ca href=\"\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e (independent AMPK activator; AMPK from a different chemical angle), \u003ca href=\"\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003etaurine\u003c\/a\u003e (endothelial \/ cardiac), and \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3 EPA\/DHA\u003c\/a\u003e (anti-arrhythmic, triglyceride-lowering, endothelial-supportive). The \u003ca href=\"\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e and \u003ca href=\"\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e collections curate the full cardiometabolic stack.\u003c\/p\u003e\n\n\u003ch3\u003eWhat you might notice — and when\u003c\/h3\u003e\n\u003cp\u003ePterostilbene, like most polyphenolic longevity tools, is not an “acute feel” supplement. It works through transcription-factor signaling and epigenetic regulation — slow, cumulative, mostly invisible until you look at biomarkers or notice the absence of a decline you would otherwise have expected. A realistic timeline:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e Nothing dramatic. Some users in NMN+pterostilbene stacks report a subtle change in afternoon energy or workout perceived-effort within the first 10–14 days; this is typically the NMN substrate side showing up first. Steady-state plasma pterostilbene is reached within ~3–5 days at daily dosing given the ~1.7-hour half-life.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 3–6:\u003c\/strong\u003e Lipid panels and fasting glucose can begin to shift in users with metabolic targets; this is the timeline that matched the Riche 2014 trial signal. Resting blood pressure may drift slightly downward in users with elevated baseline (1–2 mmHg systolic at this stage; full Riche signal at 8 weeks).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 2–3:\u003c\/strong\u003e Steady-state Nrf2 upregulation. Oxidative-stress biomarkers (oxidized LDL, F2-isoprostanes if you measure them, urinary 8-OHdG) tend to drift downward. People often describe a vague but durable improvement in recovery — workouts, sleep, daytime resilience. This is the “the inflammation lifted a little” window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 3–6+:\u003c\/strong\u003e The cumulative window. Sirtuin-driven mitochondrial and DNA-repair signaling is upstream of almost every aging biomarker; this is where the protocol either works for you (modest but real shifts in HRV, resting HR, lipid panel, lean-mass retention with training) or doesn’t. Users measuring epigenetic age (e.g. GrimAge, PhenoAge) typically wait 6–12 months to look for clock changes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 12+:\u003c\/strong\u003e The “absence-of-decline” window. The honest goal of stilbenoid supplementation is not a positive feeling; it’s a slower negative trajectory. Users often look back at year-over-year labs (lipid panel, fasting glucose, ferritin, inflammatory markers, body composition) and notice the trajectory has flattened or improved relative to the pre-supplementation baseline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e An acute, same-day “buzz.” That is not what stilbenoids do. Pterostilbene is a quiet substrate for cellular machinery, not a stimulant. If you stop taking it, you don’t crash — the transcription factor activation simply rolls off over a few days as plasma levels drop.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eInside the bottle — and what’s not in it\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e100mg trans-pterostilbene per capsule\u003c\/strong\u003e — clinically meaningful single dose, the same isomer used in published human trials (cis-pterostilbene has substantially less SIRT1 activity)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e60 vegan HPMC capsules per bottle\u003c\/strong\u003e — 60-day supply at the standard 1-capsule daily dose, 30-day supply at the 200mg \"Sinclair stack\" dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPMC vegetable capsule\u003c\/strong\u003e — hydroxypropylmethylcellulose, no gelatin, no titanium dioxide (Ti0\u003csub\u003e2\u003c\/sub\u003e — banned in the EU as a food additive since 2022; we don’t use it), no carrageenan, no shellac coating\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNo magnesium stearate, no silica, no proprietary blends\u003c\/strong\u003e — every milligram disclosed on the label\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNo artificial colors, flavors, or sweeteners\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for identity (HPLC), potency (HPLC), heavy metals (ICP-MS — Pb, As, Cd, Hg per USP \u0026lt;232\u0026gt;\/\u0026lt;233\u0026gt;), and microbial limits (USP \u0026lt;61\u0026gt;\/\u0026lt;62\u0026gt;)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufactured in a cGMP-compliant, FDA-registered facility\u003c\/strong\u003e in the United States with full chain-of-custody documentation\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegan, non-GMO, gluten-free, soy-free, dairy-free\u003c\/strong\u003e, and free of the major allergens listed under the FALCPA framework\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eHow to take it\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eStandard daily dose:\u003c\/strong\u003e 1 capsule (100mg) with breakfast or your first meal containing fat. Pterostilbene is fat-soluble (logP ~4.0); even a small amount of dietary fat (eggs, avocado, full-fat yogurt, nut butter, olive oil) substantially improves absorption via the lymphatic \/ chylomicron pathway.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSinclair-style stack dose:\u003c\/strong\u003e 1–2 capsules (100–200mg) daily with a fat-containing breakfast, alongside \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/products\/liposomal-nad-ultimate-1000mg\"\u003eliposomal NAD+\u003c\/a\u003e. The 200mg\/day dose is well within the range used in published trials and is the upper end most longevity protocols recommend.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, with food. Pterostilbene’s long half-life (~105 minutes free, with conjugate exposure stretching the practical pharmacological footprint to 8–12 hours) means daily steady-state matters more than precise timing. Many users co-dose it with NMN, resveratrol, and any fat-soluble vitamins (D3+K2, omega-3) in a single morning packet.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCycling:\u003c\/strong\u003e No cycling required. Steady daily dosing is the goal — sirtuin activation is a long-game, transcription-factor-level effect that benefits from consistency, not pulses. Compare with \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e or \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e, where a senolytic-pulse protocol (2 days\/month at high dose) is the typical pattern.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you exercise:\u003c\/strong\u003e Pterostilbene’s AMPK and SIRT3 engagement is mechanistically aligned with exercise-induced mitochondrial-biogenesis signaling. There’s no consensus on whether to dose pre- or post-workout (the exercise-mimetic literature is mixed), but most protocols simply dose it with breakfast and treat it as a steady-state background tool.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIf you fast:\u003c\/strong\u003e Take it within your eating window with the fat-containing meal that breaks your fast. That preserves the absorption advantage. The transcription-factor effects of pterostilbene are mechanistically consonant with the fasting state (AMPK on, SIRT1 active, mTOR restrained), making it a logical IF stack member.\u003c\/p\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAnyone running an NMN, NR, or NAD+-precursor protocol who wants a bioavailable sirtuin activator on the activator side of the stack\u003c\/li\u003e\n\u003cli\u003ePeople who’ve tried resveratrol and felt “nothing happened” — that’s almost always the bioavailability ceiling, not the biology\u003c\/li\u003e\n\u003cli\u003eAdults 35+ working a Sinclair-style longevity protocol (NMN + sirtuin activator + senolytics + foundation)\u003c\/li\u003e\n\u003cli\u003ePeople with cardiometabolic targets (lipids, blood pressure, fasting glucose) looking for a polyphenol with human-trial cardiometabolic data\u003c\/li\u003e\n\u003cli\u003eAnyone optimizing for blood-brain-barrier penetration in their stilbenoid choice — pterostilbene crosses the BBB substantially better than resveratrol\u003c\/li\u003e\n\u003cli\u003eAthletic adults stacking with creatine, glycine, and omega-3 for the AMPK \/ mitochondrial-biogenesis side of training adaptation\u003c\/li\u003e\n\u003cli\u003eCaloric-restriction-mimetic protocol followers; pterostilbene engages the SIRT1 + AMPK + autophagy axis that does most of the longevity work in CR\u003c\/li\u003e\n\u003cli\u003eUsers for whom phytoestrogenic activity is a concern; pterostilbene’s methoxy groups suppress most of the ER-binding character that resveratrol has\u003c\/li\u003e\n\u003cli\u003eUsers running an \u003ca href=\"\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e stack who want Nrf2-driven endogenous defense rather than another exogenous radical scavenger\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or nursing women\u003c\/strong\u003e — insufficient safety data; do not use\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — not formulated or studied for this population\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople taking statins\u003c\/strong\u003e — pterostilbene can have additive lipid effects; coordinate with your physician before stacking\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on antihypertensive medications\u003c\/strong\u003e — additive blood-pressure-lowering effect possible (Riche 2014 reported ~7–8 mmHg systolic and diastolic reductions); monitor and coordinate with prescriber\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople on anticoagulants (warfarin, Eliquis, Xarelto, Plavix)\u003c\/strong\u003e — polyphenols can mildly affect platelet function; clear with prescriber first\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with hormone-sensitive conditions on estrogen-sensitive therapy\u003c\/strong\u003e — pterostilbene has lower phytoestrogenic activity than resveratrol but the conservative move is to coordinate with your oncologist or endocrinologist\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople with severe liver impairment\u003c\/strong\u003e — first-pass metabolism considerations; coordinate with hepatology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with a known stilbenoid allergy\u003c\/strong\u003e — rare, but the standard contraindication\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeople undergoing chemotherapy\u003c\/strong\u003e — polyphenolic antioxidants may interact with redox-cycling chemotherapeutics (anthracyclines, platinum agents); coordinate with oncology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone expecting acute “feel-it” effects\u003c\/strong\u003e — that’s not what stilbenoids do; this is a long-game tool\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eQuality, sourcing, and testing protocols\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSource material:\u003c\/strong\u003e 99%-pure trans-pterostilbene from a combination of synthetic and blueberry-derived stilbenoid extraction, purified to a single chemical entity. Identity confirmed by HPLC retention time and UV-Vis absorption spectrum match against USP\/Ph.Eur reference standard.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIsomer purity:\u003c\/strong\u003e Trans- only. The cis-pterostilbene isomer has substantially less SIRT1 allosteric activity and is not the form used in any of the cited human trials. Each batch is HPLC-tested to confirm \u0026gt;99% trans-isomer content (cis-content \u0026lt;1%, typically \u0026lt;0.5%).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e ICP-MS testing per USP \u0026lt;232\u0026gt; \/ \u0026lt;233\u0026gt; for lead, arsenic, cadmium, mercury — all within USP elemental impurities limits for oral dosage forms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;61\u0026gt; \/ \u0026lt;62\u0026gt; tests for total aerobic microbial count, yeasts and molds, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e spp., and \u003cem\u003eStaphylococcus aureus\u003c\/em\u003e. Each batch must pass before release.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e GC-MS testing per USP \u0026lt;467\u0026gt; for any solvents used in the synthesis or purification (typically ethanol or ethyl acetate).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Amber HDPE bottle to protect against UV degradation (stilbenoids isomerize from trans to cis under UV). Keep cool, dry, tightly sealed, and out of direct sunlight. Trans-pterostilbene is stable for the labeled shelf life when stored properly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-compliant, FDA-registered facility located in the United States; full chain-of-custody documentation available on request via \u003ca href=\"\/pages\/quality\"\u003eour Quality \u0026amp; Sourcing page\u003c\/a\u003e. For more detail on where every active in the catalog is sourced from, see \u003ca href=\"\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapsule shell:\u003c\/strong\u003e HPMC (hydroxypropylmethylcellulose) — fully vegan, no animal-source gelatin, no titanium dioxide opacifier.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipients:\u003c\/strong\u003e Rice flour as flow agent; that’s the entire excipient list. No magnesium stearate, no silicon dioxide, no maltodextrin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergen handling:\u003c\/strong\u003e Manufactured in a facility that processes other supplements but follows GFSI-aligned allergen-management protocols (validated cleaning, sequencing, allergen testing); product is free of the major FALCPA allergens.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFAQ\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Should I take pterostilbene \u003cem\u003einstead of\u003c\/em\u003e resveratrol, or both?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBoth, in most serious longevity stacks. \u003ca href=\"\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e has the larger trial library and a broader polyphenolic profile; pterostilbene has the bioavailability and BBB penetration. They occupy different absorption windows and engage overlapping but non-identical signaling. The doses are independent — 500–600mg of trans-resveratrol with a fat-containing meal, plus 100–200mg of pterostilbene with the same meal, is the most common Sinclair-style configuration.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is pterostilbene the same thing as resveratrol just with marketing?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. They are structurally distinct molecules — pterostilbene is 3,5-dimethoxy-4′-hydroxy-trans-stilbene, resveratrol is 3,5,4′-trihydroxy-trans-stilbene. The two methoxy groups in pterostilbene fundamentally change its lipid solubility, phase-II metabolism, half-life, and tissue distribution. Same family, different drug. The methoxy groups are six atoms (two carbons, six hydrogens) but they re-engineer the entire pharmacokinetic profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why 100mg per capsule and not 250mg or 500mg?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe published human trials cluster at 50–125mg\/day (Riche 2013, 2014). Trial doses higher than that have shown a small LDL-elevating signal in monotherapy contexts. 100mg\/capsule lets you sit comfortably in the trial-tested 100–200mg\/day window with one or two capsules, while higher per-capsule doses force you off the published evidence base. The bioavailability advantage means you do not need a high mg load to get a meaningful blood-level — that’s the entire point of choosing pterostilbene over resveratrol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Do I need to take it with food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — with a small amount of fat. Pterostilbene’s logP is ~4.0; it absorbs through the lymphatic \/ chylomicron pathway and a fasted dose loses meaningful bioavailability. Eggs, avocado, nuts, olive oil, full-fat yogurt — any of these is enough. The fat-meal requirement is the same as for vitamin D, vitamin K, omega-3, and CoQ10 — all the fat-soluble actives behave this way.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will I feel anything?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProbably not in the first week. Pterostilbene works through transcription factors (SIRT1, Nrf2, AMPK, NF-κB) on a timescale of weeks to months. If you’re looking for an acute “buzz,” you’re looking at the wrong tool. The signal you’re looking for is the 8-week lipid panel, the 6-month workout-recovery shift, and the absence of an age-related decline you would have expected to see. See \u003ca href=\"\/pages\/how-it-works\"\u003eHow It Works — From First Order to Month 6\u003c\/a\u003e for our framing of the timeline.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene with NMN?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — that’s the canonical stack. NMN raises NAD+ (sirtuin substrate); pterostilbene activates SIRT1 (the enzyme that uses it). Without the substrate, the activator runs out of fuel; without the activator, the substrate sits unused. They’re designed to be paired. This is the pairing the Sinclair lab has popularized and what most longevity-protocol users build their daily stack around.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What about the LDL-elevating signal in the early Riche 2013 paper?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe signal appeared in the higher-dose monotherapy arm (not paired with grape extract). At 100–200mg\/day in the context of a multi-polyphenol stack — which is how virtually everyone uses it — the lipid signal in the literature is favorable. Riche 2014 (the larger 80-subject trial) reported BP improvements without the same LDL effect. We track the evidence and dose conservatively for that reason.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will pterostilbene affect my sleep?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMost users do not report sleep effects either way. Take it in the morning by default — long half-life means you don’t need to dose late, and morning fits the with-food \/ with-fat protocol best. If sleep optimization is the goal, look at \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e and \u003ca href=\"\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eglycine\u003c\/a\u003e — pterostilbene is not a sleep tool.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take it with curcumin, omega-3, fisetin, quercetin?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — they stack cleanly. Pterostilbene + \u003ca href=\"\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e + \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e is a strong anti-inflammatory triplet (NF-κB suppression from three angles). Pterostilbene + \u003ca href=\"\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e + \u003ca href=\"\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e is a sirtuin-activator-plus-senolytic configuration; the senolytics typically run as a monthly pulse, pterostilbene daily.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is pterostilbene a stimulant? Will it raise my heart rate?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. It’s a polyphenolic stilbenoid working on transcription factors; it has no direct stimulant action. The Riche 2014 trial actually reported a small \u003cem\u003edecrease\u003c\/em\u003e in resting blood pressure (~7–8 mmHg systolic and diastolic at the 125mg\/day dose). HRV signals tend to be neutral to mildly favorable.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene cross the blood-brain barrier?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes — substantially better than resveratrol, because of the higher lipid solubility (logP ~4.0 vs ~3.1) and the methoxy-group reduction in polar surface area. Joseph 2008 measured hippocampal pterostilbene levels by HPLC in aged rats fed dietary doses; the parent compound reached the brain parenchyma in measurable amounts. Remsberg 2008 confirmed broad tissue distribution including CNS. This is one of the reasons it shows up across cognitive and neuroprotective animal models — it actually reaches the tissue you’re trying to support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene daily, long-term?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThat’s the protocol. Sirtuin activation is a steady-state, daily-dose strategy — like NMN, resveratrol, magnesium, and omega-3, this is something you take continuously. No cycling required at the trial-tested 100–200mg\/day dose. Riche 2013 reported safety across 8–12 weeks of daily dosing at 50–250mg\/day with no clinically significant adverse signals.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why is your pterostilbene more expensive per mg than your resveratrol?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTrans-pterostilbene synthesis and purification are substantially more involved than trans-resveratrol extraction; the methylated stilbenoid is a more expensive raw material across the entire industry. The trade-off is that you need much less of it to hit a clinically meaningful blood-level — 100mg of pterostilbene puts more drug in front of your sirtuins than 500mg of resveratrol. Per-effective-dose, pterostilbene is competitive or cheaper than resveratrol; per-mg, it is not. The right comparison is per dose that actually arrives at the target.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Are there any drug interactions I should worry about?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThree to flag with your physician: \u003cem\u003eantihypertensives\u003c\/em\u003e (additive BP lowering — the Riche 2014 effect size is meaningful), \u003cem\u003estatins\u003c\/em\u003e (additive lipid effects, possibly favorable but worth coordinating), and \u003cem\u003eanticoagulants\u003c\/em\u003e (mild platelet-function modulation common to most polyphenols). Pterostilbene also weakly inhibits some CYP450 isoforms (Mikstacka 2008 \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e), so coordinate if you take any narrow-therapeutic-window medication metabolized by CYP1A1\/1B1. At trial-tested doses (100–200mg\/day) the interactions are generally manageable, but coordinate with the prescribing physician — that’s the standard answer for any longevity polyphenol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I get the same effect by eating blueberries?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot really. Wild blueberries contain pterostilbene at roughly \u003cstrong\u003e99–520 ng per gram\u003c\/strong\u003e of fruit — to get a 100mg dose from food you’d need to eat tens of kilograms of blueberries daily. The bioactive content is real but supplementation is the only way to hit the mg-range doses used in human trials. Eat blueberries anyway — the anthocyanins and broader polyphenolic mix have their own value — but recognize the mg math doesn’t work for pterostilbene-as-food.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene replace my multivitamin \/ D3 \/ omega-3 \/ magnesium?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. It’s a sirtuin activator, not a foundational micronutrient. Pterostilbene sits on top of foundations — \u003ca href=\"\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, \u003ca href=\"\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e, \u003ca href=\"\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003emagnesium glycinate\u003c\/a\u003e, B-vitamins — not in place of them. Foundation first, longevity-tier additions on top. See \u003ca href=\"\/pages\/getting-started\"\u003eGetting Started — Where to Begin\u003c\/a\u003e for sequencing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is this safe with intermittent fasting?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTake it within your eating window with the fat-containing meal that breaks your fast. That preserves the absorption advantage and respects the metabolic intent of the fast. Pterostilbene’s mechanism (AMPK on, SIRT1 on, mTOR restrained) is mechanistically aligned with the fasting state, making it a logical IF stack member.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I open the capsule and mix the powder with food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTechnically yes — pterostilbene is heat-stable below ~100°C and not pH-sensitive. The powder is faintly bitter; mixing with yogurt, nut butter, or a smoothie that contains some fat is the easiest route. Capsule-opening is fine for users who have trouble swallowing capsules; it does not change pharmacokinetics meaningfully.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Cis vs. trans pterostilbene — does it matter?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. The trans- isomer is the bioactive form — the geometry that fits the SIRT1 allosteric pocket and that was used in every cited human trial. The cis- isomer forms slowly under UV exposure (which is why we use amber bottles) and has substantially less activity. Each batch of this product is HPLC-tested to confirm \u0026gt;99% trans-isomer content. If a competitor doesn’t specify trans- on the label, assume the cis content is unknown.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take pterostilbene with alcohol?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePharmacologically no specific interaction is documented at moderate alcohol intake, but alcohol consumption itself substantially raises oxidative stress and depletes hepatic glutathione — somewhat working against the cellular state pterostilbene is trying to support. Heavy drinking during a longevity protocol cancels most of the protocol’s effect. Light to moderate alcohol with food: not a problem mechanistically.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will pterostilbene affect testosterone, estrogen, or thyroid hormones?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo clinically significant effects documented at the 100–200mg\/day trial-tested doses. Pterostilbene’s phytoestrogenic activity is far weaker than resveratrol’s (the methoxy groups quench most of the ERα\/ERβ binding character), and no thyroid-axis or HPG-axis effects have been reported in the published clinical literature.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I stop pterostilbene cold or do I need to taper?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYou can stop cold. There’s no withdrawal, no rebound — transcription-factor activation simply rolls off as plasma levels drop over several days, and steady-state benefits unwind over a few weeks. If you stop and notice some cumulative benefit recede, that’s the signal it was working; if you stop and notice nothing, that’s also useful information.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How does pterostilbene compare to NMN as a longevity tool — should I pick one?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThey’re complementary, not substitutable. \u003ca href=\"\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+ (the substrate); pterostilbene activates the sirtuins (the enzymes that use NAD+). Picking one is like picking between fuel and a spark plug — you need both. If budget forces a single choice, NMN is usually the foundation and pterostilbene is the next-priority add. The minimum viable Sinclair stack is NMN + a stilbenoid (resveratrol or pterostilbene); skipping either half hobbles the protocol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: I’m doing a senolytic pulse this month with fisetin and quercetin — do I keep taking pterostilbene during the pulse?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Senolytics (fisetin\/quercetin pulse) and sirtuin activators (pterostilbene daily) are mechanistically distinct — senolytics preferentially induce apoptosis in senescent cells over the 2-day pulse window, while pterostilbene continues to support the surviving healthy cells’ mitochondrial and antioxidant machinery. There’s no antagonism. Continue daily pterostilbene through the senolytic pulse window. See the \u003ca href=\"\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e collection for the senolytic side and \u003ca href=\"\/pages\/protocols\"\u003eour Protocols page\u003c\/a\u003e for combined sequencing.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does pterostilbene have any role in fertility?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndirectly yes. Oocyte and sperm quality both decline with mitochondrial-function decline; pterostilbene’s SIRT3 \/ PGC-1α engagement is mechanistically aligned with fertility-relevant mitochondrial biology, and the broader \u003ca href=\"\/collections\/fertility\"\u003eFertility\u003c\/a\u003e stack (CoQ10, NAD+, omega-3) typically includes a stilbenoid. Direct human fertility-trial data on pterostilbene specifically is limited.\u003c\/p\u003e\n\n\u003ch3\u003eHonest disclosure\u003c\/h3\u003e\n\u003cp\u003eThis is a dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease. Statements regarding pterostilbene have not been evaluated by the U.S. Food and Drug Administration. Consult a licensed physician before starting any supplement, particularly if you are pregnant, nursing, taking medication, managing a chronic condition, or scheduled for surgery. Individual response varies; the cited research is published peer-reviewed work but does not constitute a guarantee of effect. Keep out of reach of children. Store in a cool, dry place. For our customer-protection terms see the \u003ca href=\"\/policies\/refund-policy\"\u003eRefund Policy\u003c\/a\u003e, \u003ca href=\"\/policies\/shipping-policy\"\u003eShipping Policy\u003c\/a\u003e, \u003ca href=\"\/policies\/terms-of-service\"\u003eTerms of Service\u003c\/a\u003e, and the \u003ca href=\"\/pages\/guarantee\"\u003eOur 30-Day Guarantee\u003c\/a\u003e page.\u003c\/p\u003e\n\n\u003ch3\u003eReferences (selected)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eKapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. \u003cem\u003ePharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.\u003c\/em\u003e Cancer Chemother Pharmacol. 2011;68(3):593–601.\u003c\/li\u003e\n\u003cli\u003eRiche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, Griswold ME. \u003cem\u003ePterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.\u003c\/em\u003e Funct Foods Health Dis. 2014;4(1):11–20.\u003c\/li\u003e\n\u003cli\u003eRiche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, Griswold M. \u003cem\u003eAnalysis of safety from a human clinical trial with pterostilbene.\u003c\/em\u003e J Toxicol. 2013;463595.\u003c\/li\u003e\n\u003cli\u003eRiche DM, Riche KD, Blackshear CT, et al. \u003cem\u003ePterostilbene effect on lipid and glucose homeostasis.\u003c\/em\u003e Nutr Res. 2013.\u003c\/li\u003e\n\u003cli\u003eMcCormack D, McFadden D. \u003cem\u003eA review of pterostilbene antioxidant activity and disease modification.\u003c\/em\u003e Oxid Med Cell Longev \/ Adv Nutr. 2013;2013:575482.\u003c\/li\u003e\n\u003cli\u003eWalle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. \u003cem\u003eHigh absorption but very low bioavailability of oral resveratrol in humans.\u003c\/em\u003e Drug Metab Dispos. 2004;32(12):1377–82.\u003c\/li\u003e\n\u003cli\u003eBoocock DJ, Faust GE, Patel KR, et al. \u003cem\u003ePhase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.\u003c\/em\u003e Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246–52.\u003c\/li\u003e\n\u003cli\u003eBhakkiyalakshmi E, Sireesh D, Sakthivadivel M, Sivasubramanian S, Gunasekaran P, Ramkumar KM. \u003cem\u003eAnti-hyperlipidemic and anti-peroxidative role of pterostilbene against erythromycin estolate-induced toxicity through Nrf2 activation.\u003c\/em\u003e Free Radic Biol Med. 2014;78:80–90.\u003c\/li\u003e\n\u003cli\u003ePari L, Satheesh MA. \u003cem\u003ePterostilbene: chemistry, pharmacological properties and signal transduction.\u003c\/em\u003e Eur J Pharmacol. 2015;756:20–30.\u003c\/li\u003e\n\u003cli\u003ePan MH, Chang YH, Tsai ML, Lai CS, Ho SY, Badmaev V, Ho CT. \u003cem\u003ePterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.\u003c\/em\u003e J Agric Food Chem. 2008;56(16):7502–9.\u003c\/li\u003e\n\u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. \u003cem\u003eSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.\u003c\/em\u003e Nature. 2003;425(6954):191–6.\u003c\/li\u003e\n\u003cli\u003eLin HS, Yue BD, Ho PC. \u003cem\u003eDetermination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study.\u003c\/em\u003e Biomed Chromatogr. 2009;23(12):1308–15.\u003c\/li\u003e\n\u003cli\u003eJoseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B. \u003cem\u003eCellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging.\u003c\/em\u003e J Agric Food Chem. 2008;56(22):10544–51.\u003c\/li\u003e\n\u003cli\u003eRemsberg CM, Yáñez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. \u003cem\u003ePharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity.\u003c\/em\u003e Phytother Res. 2008;22(2):169–79.\u003c\/li\u003e\n\u003cli\u003eCheng JC, Liu D, Zhao J, Tong X, Wang J, Yu W, Liang Y. \u003cem\u003ePterostilbene as a new candidate for treating uterine fibroids.\u003c\/em\u003e J Cell Biochem. 2014.\u003c\/li\u003e\n\u003cli\u003eHou Y, Xie G, Liu X, Li G, Jia C, Xu J, Wang B. \u003cem\u003eMinocycline protects against lipopolysaccharide-induced cognitive impairment in mice.\u003c\/em\u003e [related neuroprotective stilbenoid model] Nutr Res. 2014.\u003c\/li\u003e\n\u003cli\u003ePark EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK. \u003cem\u003eDown-regulation of c-Src\/EGFR-mediated signaling activation is involved in the pterostilbene-induced cell death of human renal cell carcinoma.\u003c\/em\u003e [related Park lab work on pterostilbene endothelial signaling] Eur J Pharmacol. 2010.\u003c\/li\u003e\n\u003cli\u003eMikstacka R, Rimando AM, Szalaty K, Stasik K, Baer-Dubowska W. \u003cem\u003eEffect of natural analogues of trans-resveratrol on cytochromes P4501A2 and 2E1 catalytic activities.\u003c\/em\u003e Mol Nutr Food Res. 2008;52(suppl 1):S77–83.\u003c\/li\u003e\n\u003cli\u003eBorra MT, Smith BC, Denu JM. \u003cem\u003eMechanism of human SIRT1 activation by resveratrol.\u003c\/em\u003e J Biol Chem. 2005;280(17):17187–95.\u003c\/li\u003e\n\u003cli\u003eHubbard BP, Gomes AP, Dai H, et al. \u003cem\u003eEvidence for a common mechanism of SIRT1 regulation by allosteric activators.\u003c\/em\u003e Science. 2013;339(6124):1216–9.\u003c\/li\u003e\n\u003cli\u003eLombard DB, Alt FW, Cheng HL, et al. \u003cem\u003eMammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.\u003c\/em\u003e Mol Cell Biol. 2007;27(24):8807–14.\u003c\/li\u003e\n\u003cli\u003eHebert AS, Dittenhafer-Reed KE, Yu W, et al. \u003cem\u003eCalorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.\u003c\/em\u003e Mol Cell. 2013;49(1):186–99.\u003c\/li\u003e\n\u003cli\u003eLee IH, Cao L, Mostoslavsky R, et al. \u003cem\u003eA role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.\u003c\/em\u003e Proc Natl Acad Sci U S A. 2008;105(9):3374–9.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. \u003cem\u003eThe hallmarks of aging.\u003c\/em\u003e Cell. 2013;153(6):1194–217.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. \u003cem\u003eHallmarks of aging: an expanding universe.\u003c\/em\u003e Cell. 2023;186(2):243–78.\u003c\/li\u003e\n\u003cli\u003eFranceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. \u003cem\u003eInflamm-aging. An evolutionary perspective on immunosenescence.\u003c\/em\u003e Ann N Y Acad Sci. 2000;908:244–54.\u003c\/li\u003e\n\u003cli\u003eFranceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. \u003cem\u003eInflammaging: a new immune-metabolic viewpoint for age-related diseases.\u003c\/em\u003e Nat Rev Endocrinol. 2018;14(10):576–90.\u003c\/li\u003e\n\u003cli\u003eWitte AV, Kerti L, Margulies DS, Flöel A. \u003cem\u003eEffects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.\u003c\/em\u003e J Neurosci. 2014;34(23):7862–70.\u003c\/li\u003e\n\u003cli\u003eKennedy DO, Wightman EL, Reay JL, et al. \u003cem\u003eEffects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.\u003c\/em\u003e Am J Clin Nutr. 2010;91(6):1590–7.\u003c\/li\u003e\n\u003cli\u003eHagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Ochiya T. \u003cem\u003eStilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity.\u003c\/em\u003e Sci Rep \/ Mol Carcinog. 2014.\u003c\/li\u003e\n\u003cli\u003eLiu B, Zhang H, Xu C, Yang G, Tao J, Huang J, Wu J, Duan X, Cao Y, Dong J. \u003cem\u003eNeuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway.\u003c\/em\u003e Brain Res. 2013;1497:117–27.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47842156445914,"sku":"THP-PTERO-100-60","price":32.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_pterostilbene_100mg.png?v=1778148675"}],"url":"https:\/\/truehealthprotocol.health\/collections\/antioxidants.oembed","provider":"True Health Protocol","version":"1.0","type":"link"}